data_1z0r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z0r _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.588 ' HB3' ' O ' ' B' ' 38' ' ' VAL . 97.7 p . . . . . 0 CA--C 1.506 -0.75 0 CA-C-O 121.278 0.561 . . . . 1.28 110.352 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.696 ' HB ' HD11 ' A' ' 6' ' ' ILE . 10.6 p -103.21 -35.94 8.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.728 -0.669 . . . . 1.11 110.654 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.03 46.51 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.063 -1.615 . . . . 0.36 109.063 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.696 HD11 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -118.25 126.15 74.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 113.989 -1.105 . . . . 1.05 109.731 -167.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.51 148.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.995 -0.682 . . . . 1.01 110.756 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.759 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 32.2 mmt180 -137.26 157.3 46.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 2.14 110.301 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 8.6 mmpt? -80.06 154.61 28.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.036 -0.529 . . . . 1.63 109.841 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.902 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t -88.57 14.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.21 1.005 . . . . 1.04 109.677 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.506 ' OD2' ' HG2' ' A' ' 12' ' ' GLU . 24.4 t70 73.32 -91.81 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.237 -1.347 . . . . 1.32 112.558 167.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.506 ' HG2' ' OD2' ' A' ' 11' ' ' ASP . 4.8 pt-20 -161.12 -54.24 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 2.06 111.746 -174.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.407 ' CD2' ' HG3' ' A' ' 12' ' ' GLU . 4.4 mm? -85.01 -9.88 57.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.217 -0.447 . . . . 1.05 110.715 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA2' HG13 ' A' ' 10' ' ' VAL . . . 114.23 14.18 9.29 Favored Glycine 0 CA--C 1.499 -0.918 0 C-N-CA 120.726 -0.75 . . . . 0.23 111.351 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.778 ' HB3' HG21 ' B' ' 17' ' ' VAL . 19.4 ptt180 -97.6 117.08 31.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.575 -0.313 . . . . 1.98 110.536 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.679 HG11 HG11 ' B' ' 16' ' ' VAL . 9.8 p -82.92 127.04 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.374 -0.973 . . . . 1.07 108.374 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.731 HG21 ' HB3' ' B' ' 15' ' ' ARG . 19.6 t -75.63 84.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.742 -0.783 . . . . 1.05 109.127 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 ' CD1' HD11 ' B' ' 43' ' ' ILE . 2.1 tt -68.47 118.44 59.92 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-N 115.036 -0.984 . . . . 1.05 108.797 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.759 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 74.1 Cg_exo -52.0 143.45 40.41 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.341 2.027 . . . . 0.26 113.209 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -57.42 -32.85 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 115.528 -0.76 . . . . 1.16 110.008 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -67.0 -41.84 86.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.708 -1.133 . . . . 1.33 110.295 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.539 ' O ' HD22 ' A' ' 26' ' ' LEU . 4.1 mp -68.74 -47.85 65.23 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.549 -0.75 . . . . 1.15 110.578 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 2.0 ppt_? -70.11 -11.07 60.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.748 -0.781 . . . . 1.67 109.769 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 12.7 ttt180 -80.87 -31.88 35.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.622 -0.717 . . . . 2.51 109.456 171.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.4 m -67.57 -43.17 81.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.117 -0.947 . . . . 1.09 110.058 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 22' ' ' LEU . 1.1 mm? -86.54 -9.21 56.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.599 -0.728 . . . . 1.24 109.942 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.54 91.76 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.796 -0.638 . . . . 0.42 112.696 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 1.104 HD13 HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.47 -176.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.939 0.496 . . . . 1.34 109.705 173.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 175.73 10.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.263 -0.426 . . . . 0.91 110.444 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.793 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.4 pt-20 -67.87 -37.85 82.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.53 0.681 . . . . 2.0 111.25 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.612 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 10.9 mmpt? -80.75 -3.25 50.21 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.583 -0.735 . . . . 1.32 109.652 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.52 171.89 12.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.549 -0.75 . . . . 1.65 110.111 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HB3' ' HE3' ' B' ' 9' ' ' LYS . . . -117.75 158.12 25.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.38 -0.827 . . . . 1.06 108.986 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 1.104 HD23 HD13 ' A' ' 28' ' ' ILE . 61.8 mt -131.01 127.81 39.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.547 -0.909 . . . . 1.12 108.547 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.562 ' HA ' HG11 ' B' ' 7' ' ' VAL . 30.7 tt0 -89.09 96.46 10.73 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.736 -0.839 . . . . 1.11 108.736 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.8 mp -90.25 136.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.857 -1.065 . . . . 0.97 112.789 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.542 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 16.4 m-85 -132.68 -178.05 4.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.278 -1.328 . . . . 2.44 107.455 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.6 t -147.7 129.66 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.688 0.756 . . . . 1.08 111.259 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.534 ' H ' HD13 ' A' ' 44' ' ' ILE . 17.5 t70 -92.51 87.27 5.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.702 -1.135 . . . . 1.74 108.718 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.8 t70 61.46 -67.42 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.662 -1.154 . . . . 2.01 112.394 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -120.9 -9.19 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.681 -0.691 . . . . 1.67 111.916 -172.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' O ' HG11 ' A' ' 38' ' ' VAL . 20.3 pttm -127.65 154.9 44.72 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.727 1.01 . . . . 1.41 113.727 -173.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.895 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 25.7 mt -92.27 139.04 18.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.548 -1.205 . . . . 1.06 110.924 -170.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -124.5 105.62 15.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.9 -0.408 . . . . 0.99 109.9 -177.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.938 HD12 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -97.6 109.09 21.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.223 0.535 . . . . 1.07 110.733 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -98.04 157.19 16.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.186 -1.412 . . . . 2.8 107.186 168.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.808 ' HA ' HD21 ' A' ' 34' ' ' LEU . 17.5 ptmt -75.76 148.32 38.59 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 2.92 108.395 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.461 ' HD1' HG12 ' B' ' 7' ' ' VAL . 76.9 t80 . . . . . 0 C--N 1.319 -0.72 0 C-N-CA 120.798 -0.361 . . . . 3.76 110.091 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 94.2 p . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.364 0.602 . . . . 1.53 109.938 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.734 ' HB ' HD11 ' B' ' 6' ' ' ILE . 8.1 p -102.8 -37.02 8.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.395 -0.82 . . . . 1.02 110.746 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.6 44.15 41.26 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 108.973 -1.651 . . . . 0.29 108.973 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.734 HD11 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.94 125.97 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.038 -1.081 . . . . 1.03 109.692 -168.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.2 m -93.91 149.6 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.168 -0.613 . . . . 0.9 110.822 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' B' ' 8' ' ' ARG . 21.6 mmt180 -139.38 156.34 47.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.874 -0.603 . . . . 2.62 110.323 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 33' ' ' ALA . 7.1 mmpt? -80.26 154.08 28.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.629 -0.714 . . . . 2.21 110.011 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.793 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 22.1 t -89.82 17.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.029 0.919 . . . . 1.12 110.025 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t70 71.65 -109.84 0.05 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.682 -1.144 . . . . 1.17 110.441 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.0 pt-20 -151.63 -42.23 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.337 0.589 . . . . 2.09 111.043 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.47 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.25 -6.39 59.39 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.519 -0.472 . . . . 1.2 111.42 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.97 11.21 16.84 Favored Glycine 0 CA--C 1.497 -1.073 0 N-CA-C 110.975 -0.85 . . . . 0.2 110.975 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.731 ' HB3' HG21 ' A' ' 17' ' ' VAL . 5.3 ptt180 -99.13 119.87 38.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.527 -0.337 . . . . 1.98 111.277 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 16' ' ' VAL . 9.0 p -82.85 127.5 39.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.277 -1.009 . . . . 1.02 108.277 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.778 HG21 ' HB3' ' A' ' 15' ' ' ARG . 23.1 t -75.74 85.24 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 119.576 -0.85 . . . . 1.05 109.013 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.452 ' CD1' HD12 ' A' ' 43' ' ' ILE . 1.9 tt -68.73 117.47 51.18 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 115.331 -0.85 . . . . 1.07 108.989 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.459 ' HB2' HD13 ' B' ' 22' ' ' LEU . 74.2 Cg_exo -50.68 140.74 36.43 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.605 2.203 . . . . 0.22 113.087 -171.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.411 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.5 pp -53.17 -32.14 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.336 -0.847 . . . . 1.11 110.776 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -66.67 -44.64 81.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.299 -0.864 . . . . 1.27 110.191 -176.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.78 ' O ' HD23 ' B' ' 26' ' ' LEU . 6.6 mp -67.42 -46.9 71.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.552 -0.749 . . . . 1.24 110.559 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 6.5 ppt_? -68.49 -18.12 64.32 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.065 -0.654 . . . . 1.4 109.342 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.645 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 2.6 ttt180 -72.34 -31.61 65.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.098 -0.956 . . . . 2.72 109.054 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 25.3 m -73.71 -43.44 59.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.043 -0.98 . . . . 0.93 110.699 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.78 HD23 ' O ' ' B' ' 22' ' ' LEU . 0.3 OUTLIER -89.05 -1.36 58.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.614 -0.434 . . . . 1.42 111.467 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.1 35.55 71.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.643 -0.789 . . . . 0.52 112.661 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 1.008 HD13 HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -102.06 -178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 1.54 110.642 176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.57 13.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.92 109.348 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.902 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.5 pm0 -76.94 -21.56 54.62 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.458 0.647 . . . . 1.5 110.413 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.493 ' HG2' ' HG2' ' B' ' 30' ' ' GLU . 8.3 mmpt? -93.34 0.37 56.9 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.926 -0.768 . . . . 1.21 108.926 176.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.448 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 1.5 t0 -84.33 -179.5 7.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.0 -1.0 . . . . 2.05 110.128 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.03 156.79 41.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.353 -0.84 . . . . 0.7 108.897 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 1.008 HD23 HD13 ' B' ' 28' ' ' ILE . 37.8 mt -131.16 126.98 37.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.585 -0.894 . . . . 1.17 108.585 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 7' ' ' VAL . 31.9 tt0 -88.33 96.38 10.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.482 -0.933 . . . . 1.29 108.482 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.419 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.43 136.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.739 -1.118 . . . . 1.05 112.962 -171.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.435 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 23.6 m-85 -132.22 -178.35 4.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.218 -1.356 . . . . 2.5 107.671 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' B' ' 43' ' ' ILE . 6.9 t -147.56 133.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 1.02 110.521 174.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.519 ' H ' HD13 ' B' ' 44' ' ' ILE . 30.1 t70 -101.89 93.9 5.52 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.64 -0.874 . . . . 1.71 108.64 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.72 -70.46 0.06 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 124.751 1.282 . . . . 2.08 112.014 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -123.75 -2.86 8.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.164 -0.925 . . . . 2.39 111.501 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 42.3 pttt -133.14 152.45 51.95 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 119.291 -0.964 . . . . 1.48 113.29 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 28.5 mt -92.6 139.12 18.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.954 -1.021 . . . . 1.27 110.894 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.519 HD13 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.91 105.73 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.74 -0.467 . . . . 1.01 109.74 -176.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.938 HD13 HD12 ' A' ' 45' ' ' LEU . 11.0 mp -97.97 109.03 21.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.062 0.458 . . . . 1.03 110.831 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' B' ' 35' ' ' GLU . 7.6 mtmp? -100.46 154.84 18.21 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.412 -1.329 . . . . 2.34 107.412 168.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.734 ' HE3' HG23 ' B' ' 28' ' ' ILE . 1.3 ptmt -75.58 140.62 42.77 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.761 -0.829 . . . . 2.75 108.761 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 t80 . . . . . 0 C--N 1.319 -0.746 0 CA-C-O 121.035 0.445 . . . . 3.63 110.289 -178.384 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.52 ' HA ' ' N ' ' B' ' 38' ' ' VAL . 77.3 p . . . . . 0 N--CA 1.439 -1.023 0 CA-C-O 121.175 0.512 . . . . 1.28 110.405 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.8 ' HB ' HD11 ' A' ' 6' ' ' ILE . 17.6 p -96.09 -32.42 12.54 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.235 -0.893 . . . . 1.11 110.624 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' B' ' 37' ' ' TYR . . . 70.0 33.64 70.19 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.612 -1.395 . . . . 0.36 109.612 -172.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.8 HD11 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -104.2 123.02 57.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.181 -1.009 . . . . 1.05 109.887 -169.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.0 OUTLIER -91.34 146.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.969 -0.692 . . . . 1.01 110.669 -177.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.479 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 21.3 mmt180 -138.26 154.11 49.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.469 -0.787 . . . . 2.14 110.112 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -80.36 151.75 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.973 -0.558 . . . . 1.63 109.772 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.876 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 24.9 t -94.47 15.9 2.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.806 0.813 . . . . 1.04 110.554 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 13.5 t70 66.29 -147.28 0.19 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.396 -0.82 . . . . 1.32 110.111 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.85 -41.76 2.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.593 -0.891 . . . . 2.06 108.593 176.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -10.8 60.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.728 -1.124 . . . . 1.05 111.011 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.19 11.38 34.14 Favored Glycine 0 CA--C 1.494 -1.243 0 C-N-CA 120.709 -0.758 . . . . 0.23 112.054 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.809 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 8.9 ptp180 -103.88 118.94 37.87 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.047 0.451 . . . . 1.98 111.323 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 8.9 p -82.81 129.6 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.933 -0.766 . . . . 1.07 108.933 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.5 t -75.89 84.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.975 -0.69 . . . . 1.05 109.455 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.472 ' CD1' HD12 ' B' ' 43' ' ' ILE . 1.9 tt -69.27 121.27 81.43 Favored Pre-proline 0 N--CA 1.435 -1.184 0 CA-C-N 115.1 -0.955 . . . . 1.05 109.27 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.479 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 55.0 Cg_exo -54.61 143.67 67.44 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.246 1.964 . . . . 0.26 112.969 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.499 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -59.02 -28.88 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 115.603 -0.726 . . . . 1.16 109.857 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.558 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -65.91 -44.63 84.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.946 -1.025 . . . . 1.33 110.286 -175.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.632 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.9 mp -69.17 -44.82 71.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.642 -0.708 . . . . 1.15 110.34 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.648 ' HB2' HG13 ' A' ' 28' ' ' ILE . 4.6 ppt_? -71.05 -10.88 60.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.443 0.639 . . . . 1.67 109.62 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.8 -30.52 32.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.11 -0.95 . . . . 2.51 108.916 171.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -67.35 -41.95 84.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.303 -0.862 . . . . 1.09 109.851 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.632 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -86.64 -11.85 50.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.647 -0.706 . . . . 1.24 110.08 176.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.01 77.56 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.477 -0.783 . . . . 0.42 112.771 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.737 HD12 HD21 ' A' ' 34' ' ' LEU . 36.9 pt -88.12 -157.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 1.34 109.818 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.425 ' HB3' ' OE2' ' A' ' 30' ' ' GLU . . . -161.45 -174.97 4.52 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.917 -0.401 . . . . 0.91 109.917 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.929 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.6 pm0 -79.87 -27.97 40.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.886 0.851 . . . . 2.0 109.922 -176.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 8.1 mmpt? -80.02 -2.09 42.6 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.138 -0.937 . . . . 1.32 109.697 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.79 177.36 8.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.944 -0.571 . . . . 1.65 110.026 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.77 141.16 52.29 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.856 -1.165 . . . . 1.06 107.856 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.784 HD22 ' HA ' ' A' ' 47' ' ' LYS . 47.8 mt -118.09 127.68 54.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.196 -0.668 . . . . 1.12 109.196 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.633 ' HG3' HG11 ' B' ' 7' ' ' VAL . 17.9 tt0 -89.18 99.22 12.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.928 -1.138 . . . . 1.11 107.928 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.462 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.9 mp -89.38 135.34 26.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.551 -1.204 . . . . 0.97 112.324 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.485 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 4.2 m-85 -128.74 -178.55 4.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.174 -1.375 . . . . 2.44 107.582 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 43' ' ' ILE . 3.8 t -148.34 136.77 14.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.659 -0.497 . . . . 1.08 109.659 172.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' H ' HD12 ' A' ' 44' ' ' ILE . 65.0 m-20 -115.78 116.8 28.66 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.458 -0.571 . . . . 1.74 109.458 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 60.79 -79.37 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 124.231 0.957 . . . . 2.01 111.177 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -141.25 20.82 2.25 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.191 -0.913 . . . . 1.67 111.274 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 55.4 pttt -135.63 152.29 51.09 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 112.908 0.707 . . . . 1.41 112.908 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.958 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 40.1 mt -92.26 139.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.812 -1.085 . . . . 1.06 110.745 -172.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -126.34 106.0 15.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.074 -0.343 . . . . 0.99 110.074 -175.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.931 HD11 HD11 ' B' ' 45' ' ' LEU . 11.2 mp -97.51 109.48 22.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.843 0.354 . . . . 1.07 110.523 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.485 ' HB3' ' HE2' ' A' ' 37' ' ' TYR . 31.7 ttmt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.659 -0.867 . . . . 2.8 108.659 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.784 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -50.28 142.59 9.84 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.834 0.35 . . . . 2.92 111.282 -173.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CD1' HG12 ' B' ' 7' ' ' VAL . 52.7 t80 . . . . . 0 N--CA 1.448 -0.566 0 CA-C-N 115.905 -0.588 . . . . 3.76 109.68 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 91.2 p . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 121.563 0.697 . . . . 1.53 109.406 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.559 ' HB ' ' HB ' ' B' ' 6' ' ' ILE . 3.1 p -93.88 -36.77 12.06 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.312 -0.858 . . . . 1.02 110.563 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . 0.461 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 68.78 38.01 84.91 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 108.954 -1.658 . . . . 0.29 108.954 -170.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -111.82 124.8 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.925 -1.138 . . . . 1.03 109.689 -167.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.4 m -94.18 146.41 6.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.07 -0.652 . . . . 0.9 110.833 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.587 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 10.4 mmt180 -138.21 153.53 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 2.62 110.305 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -79.67 148.66 31.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 2.21 109.843 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.929 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 13.2 t -91.71 15.84 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.603 0.716 . . . . 1.12 110.635 -174.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 7.4 t70 70.17 -148.43 0.1 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-N 115.289 -0.869 . . . . 1.17 110.002 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.507 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -121.11 -41.16 2.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.531 -0.915 . . . . 2.09 108.531 175.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.77 -10.54 59.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.563 -1.199 . . . . 1.2 111.473 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.52 5.48 36.64 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.643 -0.789 . . . . 0.2 111.982 172.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.809 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 11.3 ptp180 -101.02 118.55 37.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.079 0.466 . . . . 1.98 111.232 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.84 129.47 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.783 -0.821 . . . . 1.02 108.783 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.656 HG23 ' HB3' ' A' ' 15' ' ' ARG . 4.0 t -76.0 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.932 -0.707 . . . . 1.05 109.361 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.472 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.3 tt -70.03 120.8 80.28 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.892 -1.049 . . . . 1.07 109.412 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.587 ' HD3' ' HG3' ' B' ' 8' ' ' ARG . 73.6 Cg_exo -52.56 142.37 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.493 2.129 . . . . 0.22 113.197 -175.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' B' ' 23' ' ' ARG . 2.3 pp -57.39 -27.46 28.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.517 -0.765 . . . . 1.11 109.988 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 3.5 mt-10 -65.89 -47.26 75.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.159 -0.928 . . . . 1.27 110.391 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.686 ' O ' HD22 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -66.42 -45.31 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.546 -0.462 . . . . 1.24 110.799 178.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.784 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.4 ppt_? -69.36 -15.79 63.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.567 0.699 . . . . 1.4 109.699 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -80.93 -24.01 38.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.949 -1.023 . . . . 2.72 109.298 172.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 57.0 m -71.62 -42.41 67.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.713 -0.676 . . . . 0.93 110.399 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.686 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.8 OUTLIER -87.79 -16.1 35.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.142 -0.481 . . . . 1.42 111.841 -178.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 6.14 79.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.086 -0.578 . . . . 0.52 112.984 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.784 HG13 ' HB2' ' B' ' 23' ' ' ARG . 39.8 pt -78.34 -153.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.321 0.248 . . . . 1.54 110.372 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.44 -105.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.585 0.958 . . . . 0.92 113.585 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.876 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 9.4 pt-20 -154.7 -39.34 0.09 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.094 -1.817 . . . . 1.5 106.094 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.479 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 7.4 mmpt? -75.1 -6.53 50.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 113.527 -1.669 . . . . 1.21 108.967 172.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.574 ' CG ' ' HB ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -77.6 168.65 19.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.072 -0.967 . . . . 2.05 109.492 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.43 142.44 49.23 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.495 -0.928 . . . . 0.7 108.495 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.802 HD11 HD21 ' B' ' 45' ' ' LEU . 33.7 mt -119.93 125.73 49.16 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.773 -0.825 . . . . 1.17 108.773 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.661 ' HG3' HG13 ' A' ' 7' ' ' VAL . 29.2 tt0 -88.77 100.36 13.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.072 -1.085 . . . . 1.29 108.072 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.42 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.19 134.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.729 -1.123 . . . . 1.05 112.694 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.459 ' CD1' ' HA2' ' A' ' 5' ' ' GLY . 16.9 m-85 -124.29 -179.14 4.33 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.01 -1.45 . . . . 2.5 107.804 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.651 HG23 ' HA ' ' B' ' 43' ' ' ILE . 9.5 t -148.93 134.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.67 -0.493 . . . . 1.02 109.67 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.4 ' H ' HD13 ' B' ' 44' ' ' ILE . 7.8 m-20 -111.91 94.01 4.73 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.391 -0.368 . . . . 1.71 110.683 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 67.04 -13.31 0.2 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.23 -1.35 . . . . 2.08 113.975 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -179.91 -15.46 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.393 -0.367 . . . . 2.39 111.548 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 50.1 pttt -137.84 156.12 48.27 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 119.251 -0.98 . . . . 1.48 113.381 -172.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.89 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -92.38 139.65 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.596 -1.184 . . . . 1.27 110.445 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.4 HD13 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -127.01 104.11 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.215 -0.291 . . . . 1.01 110.215 -175.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.958 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.12 108.59 20.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.081 0.467 . . . . 1.03 110.331 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -114.74 127.23 55.63 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.229 -1.026 . . . . 2.34 108.229 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.752 ' HA ' HD22 ' B' ' 34' ' ' LEU . 14.6 ptpt -46.07 139.04 4.74 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.456 0.472 . . . . 2.75 110.697 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.465 ' CD1' HG11 ' A' ' 7' ' ' VAL . 55.1 t80 . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 109.847 -0.427 . . . . 3.63 109.847 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.547 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 35.3 t . . . . . 0 CA--C 1.496 -1.102 0 CA-C-O 121.685 0.755 . . . . 1.28 110.836 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.735 ' HB ' HD13 ' A' ' 6' ' ' ILE . 21.9 p -118.84 -27.26 5.84 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.615 -1.175 . . . . 1.11 110.481 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.54 44.38 92.98 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.788 -1.325 . . . . 0.36 109.788 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.735 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -115.3 126.02 72.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.463 -0.868 . . . . 1.05 109.992 -170.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.4 m -92.79 146.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.107 -0.637 . . . . 1.01 110.382 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.501 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 31.3 mmt180 -137.84 154.93 49.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.118 -0.492 . . . . 2.14 109.929 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 6.7 mmpt? -80.62 154.42 27.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.249 -0.432 . . . . 1.63 109.933 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.84 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.7 t -91.06 16.83 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.792 0.806 . . . . 1.04 110.228 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 26.2 t70 66.94 -133.34 0.14 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.412 -0.813 . . . . 1.32 109.584 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -131.19 -37.13 1.27 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.253 0.549 . . . . 2.06 110.438 177.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 13' ' ' LEU . 3.8 mm? -87.09 6.26 33.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.177 -0.465 . . . . 1.05 111.529 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.42 18.14 31.74 Favored Glycine 0 CA--C 1.496 -1.114 0 C-N-CA 121.056 -0.592 . . . . 0.23 112.15 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.702 ' HB3' HG22 ' B' ' 17' ' ' VAL . 10.1 ptt180 -106.12 120.13 41.02 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.849 0.357 . . . . 1.98 111.234 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.789 HG12 HG12 ' B' ' 16' ' ' VAL . 9.6 p -82.96 126.75 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.191 -1.04 . . . . 1.07 108.191 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.702 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 21.5 t -75.41 85.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.891 -0.724 . . . . 1.05 109.154 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.469 HD13 HD11 ' B' ' 43' ' ' ILE . 1.2 tt -69.79 124.46 90.66 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 115.063 -0.971 . . . . 1.05 108.967 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.54 ' HG2' HD11 ' A' ' 22' ' ' LEU . 50.9 Cg_exo -54.13 145.15 55.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.239 1.959 . . . . 0.26 112.965 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.31 -32.15 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 1.16 109.946 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.0 pt-20 -70.43 -34.38 72.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.697 -1.138 . . . . 1.33 110.771 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.748 ' O ' HD22 ' A' ' 26' ' ' LEU . 6.0 mp -74.17 -44.63 52.74 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.269 -0.573 . . . . 1.15 110.542 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HB2' HG13 ' A' ' 28' ' ' ILE . 2.2 ppt_? -70.12 -12.91 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 1.67 109.407 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.1 ttt180 -82.74 -27.07 31.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.894 -1.048 . . . . 2.51 109.431 171.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 96.7 m -69.68 -42.8 73.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.36 -0.836 . . . . 1.09 109.681 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.748 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.15 -18.58 45.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.202 -0.666 . . . . 1.24 109.202 177.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.69 81.99 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.286 -0.87 . . . . 0.42 112.202 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' ' 23' ' ' ARG . 46.5 pt -83.11 -153.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.645 -0.502 . . . . 1.34 109.645 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.448 ' HB3' ' OE2' ' A' ' 30' ' ' GLU . . . -162.47 -168.61 1.88 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.403 -0.362 . . . . 0.91 110.036 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.926 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -82.93 -30.81 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.645 0.736 . . . . 2.0 109.798 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 11.8 mmpt? -77.04 -6.26 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.578 -0.737 . . . . 1.32 109.918 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -84.48 162.73 19.8 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.916 -0.584 . . . . 1.65 110.829 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HB1' ' HE3' ' B' ' 9' ' ' LYS . . . -107.69 157.45 18.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.576 -0.738 . . . . 1.06 109.511 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.785 HD11 HD23 ' A' ' 45' ' ' LEU . 52.1 mt -129.93 130.5 45.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.516 -0.92 . . . . 1.12 108.516 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.621 ' HG3' HG13 ' B' ' 7' ' ' VAL . 19.9 tt0 -88.82 96.24 10.61 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.486 -0.931 . . . . 1.11 108.486 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -89.78 137.19 21.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.0 -1.0 . . . . 0.97 112.942 -171.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -130.8 -177.99 4.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.201 -1.363 . . . . 2.44 107.916 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 43' ' ' ILE . 12.8 t -147.25 130.52 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 1.08 111.029 174.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.492 ' H ' HD11 ' A' ' 44' ' ' ILE . 31.7 t70 -115.16 121.93 44.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.784 -0.643 . . . . 1.74 109.527 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.87 -73.82 0.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 124.177 0.923 . . . . 2.01 110.784 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.5 17.88 0.4 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.176 -0.92 . . . . 1.67 110.281 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -133.06 157.06 46.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.372 0.606 . . . . 1.41 112.32 -174.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.909 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.1 mt -92.88 139.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.832 -1.076 . . . . 1.06 111.652 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.492 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -124.0 104.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.149 -0.478 . . . . 0.99 109.775 -178.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.872 HD13 HD12 ' B' ' 45' ' ' LEU . 10.9 mp -95.86 107.68 19.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.481 0.658 . . . . 1.07 110.488 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -97.93 159.0 15.21 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.142 -1.429 . . . . 2.8 107.142 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HA ' HD22 ' A' ' 34' ' ' LEU . 3.9 ptpp? -74.17 145.18 44.44 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.134 -1.061 . . . . 2.92 108.134 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 p90 . . . . . 0 C--N 1.32 -0.681 0 N-CA-C 110.02 -0.363 . . . . 3.76 110.02 -177.488 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.436 ' HA ' ' N ' ' A' ' 38' ' ' VAL . 3.5 m . . . . . 0 CA--C 1.507 -0.705 0 CA-C-O 121.495 0.664 . . . . 1.53 111.551 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.413 ' HB ' HD11 ' B' ' 6' ' ' ILE . 17.0 p -110.64 -30.38 7.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.895 -1.048 . . . . 1.02 109.936 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.97 44.44 78.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.662 -1.375 . . . . 0.29 109.662 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -118.28 125.98 74.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.099 -1.05 . . . . 1.03 109.826 -167.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.74 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 m -93.88 142.43 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.035 -0.666 . . . . 0.9 110.831 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 71.8 mmt-85 -134.36 155.15 50.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.472 -0.331 . . . . 2.62 110.957 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.517 ' HE3' ' HB1' ' A' ' 33' ' ' ALA . 7.6 mmpt? -80.7 152.59 28.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.772 -0.649 . . . . 2.21 110.003 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.926 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.7 t -94.36 19.35 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.687 0.756 . . . . 1.12 110.743 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 14.3 t70 64.69 -145.14 0.25 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.604 -0.725 . . . . 1.17 109.692 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.535 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -116.92 -43.06 2.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.482 0.658 . . . . 2.09 109.716 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' B' ' 13' ' ' LEU . 4.1 mm? -73.94 -15.07 61.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.967 -1.015 . . . . 1.2 111.197 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.46 13.64 11.5 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.751 -0.738 . . . . 0.2 111.716 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 3.8 ptt180 -99.78 121.69 41.65 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 120.836 0.351 . . . . 1.98 111.389 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.789 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.31 126.81 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.128 -1.064 . . . . 1.02 108.128 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.702 HG22 ' HB3' ' A' ' 15' ' ' ARG . 21.4 t -76.07 84.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.58 -0.848 . . . . 1.05 109.314 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.455 ' CD1' HD11 ' A' ' 43' ' ' ILE . 2.5 tt -69.28 122.08 84.23 Favored Pre-proline 0 N--CA 1.436 -1.16 0 CA-C-N 114.743 -1.117 . . . . 1.07 109.15 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.415 ' HB2' HD11 ' B' ' 22' ' ' LEU . 69.8 Cg_exo -51.58 139.25 47.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.194 1.929 . . . . 0.22 113.224 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.5 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -53.18 -29.71 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 1.11 110.831 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 1.8 mt-10 -67.18 -41.15 86.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.969 . . . . 1.27 110.334 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.694 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.5 mp -70.9 -42.65 69.66 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.851 -0.613 . . . . 1.24 110.855 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.664 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.9 ppt_? -67.79 -22.7 65.17 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.659 -0.867 . . . . 1.4 108.659 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -71.4 -31.64 67.5 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.748 -1.115 . . . . 2.72 108.504 174.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 96.8 m -70.52 -38.4 74.25 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.813 -1.085 . . . . 0.93 110.795 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.694 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -84.29 -20.14 32.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.482 -0.487 . . . . 1.42 110.706 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.74 8.12 67.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.034 -0.603 . . . . 0.52 112.061 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.664 HG13 ' HB2' ' B' ' 23' ' ' ARG . 44.0 pt -88.81 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 1.54 110.181 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.644 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -164.69 -177.28 4.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.795 -0.639 . . . . 0.92 109.838 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.84 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -69.22 -34.8 75.41 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.567 0.699 . . . . 1.5 110.676 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.1 mmpt? -79.13 -5.38 54.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.528 -0.76 . . . . 1.21 109.951 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.535 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 1.8 m-20 -86.89 160.39 18.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.478 -0.783 . . . . 2.05 111.306 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.429 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -108.03 155.86 19.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.525 -0.762 . . . . 0.7 109.521 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.778 HD11 HD21 ' B' ' 45' ' ' LEU . 26.2 mt -130.15 129.15 43.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.101 -1.074 . . . . 1.17 108.101 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.643 ' HG3' HG13 ' A' ' 7' ' ' VAL . 23.9 tt0 -88.75 99.62 12.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.626 -0.879 . . . . 1.29 108.626 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.16 138.06 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.541 -1.208 . . . . 1.05 112.775 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.511 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 11.6 m-85 -130.18 -177.6 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.325 -1.307 . . . . 2.5 108.156 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.547 ' H ' ' CB ' ' A' ' 3' ' ' SER . 9.9 t -145.63 135.98 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.024 0.44 . . . . 1.02 110.271 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.426 ' H ' HD13 ' B' ' 44' ' ' ILE . 15.4 t70 -117.33 115.03 24.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.478 -0.783 . . . . 1.71 109.473 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t0 69.73 -69.47 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 124.347 1.03 . . . . 2.08 110.569 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.81 20.82 0.21 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.135 -0.939 . . . . 2.39 110.207 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 44.1 pttt -133.67 156.85 47.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.195 0.521 . . . . 1.48 112.035 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.821 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.7 mt -93.17 139.31 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.283 -0.872 . . . . 1.27 111.393 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.426 HD13 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.11 104.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 1.01 109.885 -177.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.909 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.8 mp -94.64 108.42 20.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.134 0.493 . . . . 1.03 110.644 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -101.22 157.08 17.04 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.39 -1.337 . . . . 2.34 107.39 171.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.59 ' HA ' HD22 ' B' ' 34' ' ' LEU . 17.5 ptpt -65.79 148.98 50.9 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.601 -0.888 . . . . 2.75 108.601 172.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 109.031 -0.729 . . . . 3.63 109.031 176.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.637 ' HB2' ' O ' ' B' ' 38' ' ' VAL . 4.0 t . . . . . 0 CA--C 1.498 -1.042 0 CA-C-O 121.389 0.614 . . . . 1.28 109.99 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.868 ' HB ' HD13 ' A' ' 6' ' ' ILE . 41.2 p -135.77 -34.51 0.82 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.042 -0.981 . . . . 1.11 111.035 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.56 24.89 71.5 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.591 -1.403 . . . . 0.36 109.591 -174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.868 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.3 mp -89.97 125.73 42.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.062 -1.069 . . . . 1.05 110.061 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.709 HG11 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -95.15 147.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.019 -0.673 . . . . 1.01 110.471 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -141.25 157.23 45.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.196 -0.456 . . . . 2.14 110.416 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.477 ' CE ' ' HB2' ' B' ' 33' ' ' ALA . 9.4 mmpt? -80.33 158.03 26.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.689 -0.687 . . . . 1.63 110.18 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.915 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.2 t -97.2 18.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.763 0.792 . . . . 1.04 110.392 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 15' ' ' ARG . 1.1 t70 66.35 -135.62 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.357 1.075 . . . . 1.32 110.472 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.25 -47.96 1.09 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.314 -1.766 . . . . 2.06 108.455 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.4 mm? -67.04 -22.05 65.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.245 -1.343 . . . . 1.05 110.55 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.11 14.33 7.84 Favored Glycine 0 CA--C 1.499 -0.968 0 C-N-CA 120.898 -0.668 . . . . 0.23 111.55 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 18.3 ptt180 -100.83 120.24 39.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.176 0.513 . . . . 1.98 111.617 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.773 HG13 HD23 ' B' ' 45' ' ' LEU . 7.8 p -84.07 128.15 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 108.372 -0.973 . . . . 1.07 108.372 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.66 HG22 ' HB3' ' B' ' 15' ' ' ARG . 13.8 t -76.53 84.44 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.685 -0.806 . . . . 1.05 109.442 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.476 HD13 HD11 ' B' ' 43' ' ' ILE . 0.9 OUTLIER -67.07 124.63 89.33 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.86 -1.064 . . . . 1.05 109.293 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HG2' HD12 ' A' ' 22' ' ' LEU . 50.8 Cg_exo -55.91 139.45 84.38 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.333 2.022 . . . . 0.26 113.329 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.656 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.2 pp -50.52 -35.91 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.697 -1.138 . . . . 1.16 111.107 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.514 ' HG3' HD13 ' A' ' 22' ' ' LEU . 3.6 pt-20 -69.91 -36.21 75.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.817 -1.083 . . . . 1.33 110.727 -174.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.726 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -72.58 -43.73 62.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.827 -0.624 . . . . 1.15 110.921 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.656 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -67.26 -20.92 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.656 -0.868 . . . . 1.67 108.656 178.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -24.87 41.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.703 -1.135 . . . . 2.51 109.57 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 97.5 m -70.67 -42.25 70.98 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.37 -0.832 . . . . 1.09 109.895 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.07 -19.7 39.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 1.24 109.28 178.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.57 17.8 78.52 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.244 -0.889 . . . . 0.42 112.126 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.819 HD12 HD22 ' A' ' 34' ' ' LEU . 44.2 pt -81.1 -156.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.283 -0.636 . . . . 1.34 109.283 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -161.68 176.5 10.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.91 111.243 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.768 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.0 pt-20 -65.21 -41.05 94.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.852 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.682 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 7.4 mmpt? -76.39 -1.44 26.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.52 -0.764 . . . . 1.32 109.785 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -85.55 176.16 8.38 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.902 -0.59 . . . . 1.65 109.898 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' B' ' 8' ' ' ARG . . . -126.84 145.33 50.69 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.558 -0.905 . . . . 1.06 108.558 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.819 HD22 HD12 ' A' ' 28' ' ' ILE . 84.5 mt -123.51 130.61 52.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.501 -0.926 . . . . 1.12 108.501 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.634 ' HG3' HG13 ' B' ' 7' ' ' VAL . 24.4 tt0 -88.6 101.32 13.85 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.705 -1.221 . . . . 1.11 107.705 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.422 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -88.91 135.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.576 -1.193 . . . . 0.97 112.254 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.494 ' HB3' ' OG ' ' B' ' 3' ' ' SER . 4.6 m-85 -127.06 -179.55 4.91 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.397 -1.274 . . . . 2.44 107.979 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 43' ' ' ILE . 9.7 t -147.3 136.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 1.08 110.101 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -119.82 118.83 31.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.641 -0.709 . . . . 1.74 109.098 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.83 -83.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.734 0.646 . . . . 2.01 110.576 -172.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -143.97 18.15 1.78 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.007 -0.997 . . . . 1.67 109.915 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 16.0 pttm -125.82 151.44 46.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.085 -0.646 . . . . 1.41 112.345 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.873 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 17.6 mt -92.37 138.82 19.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.653 -1.158 . . . . 1.06 110.715 -171.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.55 103.11 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.639 -0.504 . . . . 0.99 109.639 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.907 HD13 HD12 ' B' ' 45' ' ' LEU . 10.9 mp -92.12 109.15 20.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.001 0.429 . . . . 1.07 110.424 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.15 159.62 16.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.035 -1.469 . . . . 2.8 107.035 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HA ' HD23 ' A' ' 34' ' ' LEU . 8.4 ptpp? -66.59 150.75 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.622 -0.881 . . . . 2.92 108.622 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 29.5 p90 . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 109.901 -0.407 . . . . 3.76 109.901 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.576 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 2.4 t . . . . . 0 CA--C 1.5 -0.97 0 CA-C-O 122.004 0.907 . . . . 1.53 110.013 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.877 ' HB ' HD11 ' B' ' 6' ' ' ILE . 25.0 p -137.86 -39.66 0.56 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.312 -1.313 . . . . 1.02 110.175 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 74.88 28.55 62.52 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.342 -1.503 . . . . 0.29 109.342 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.877 HD11 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -96.7 125.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.939 -1.131 . . . . 1.03 110.049 -173.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.694 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -93.59 148.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.235 -0.586 . . . . 0.9 111.084 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.479 ' HA ' ' HD3' ' B' ' 8' ' ' ARG . 16.4 mmt85 -140.15 154.87 47.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 2.62 110.593 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -79.99 153.71 28.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.085 -0.507 . . . . 2.21 110.082 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.768 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.6 t -93.0 18.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.764 0.792 . . . . 1.12 110.527 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.593 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 23.1 t70 67.18 -136.74 0.12 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.525 -0.761 . . . . 1.17 110.163 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.593 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -131.56 -42.33 1.04 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.76 -1.109 . . . . 2.09 109.11 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.86 -24.21 59.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.038 -0.983 . . . . 1.2 110.077 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.05 16.38 4.42 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 120.716 -0.754 . . . . 0.2 111.751 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.66 ' HB3' HG22 ' A' ' 17' ' ' VAL . 10.6 ptt180 -103.73 121.41 42.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.939 0.4 . . . . 1.98 111.897 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.741 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.75 128.15 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.335 -0.987 . . . . 1.02 108.335 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 17.3 t -76.41 84.75 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 119.673 -0.811 . . . . 1.05 109.507 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.481 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.3 tt -71.08 121.6 84.62 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.145 -0.934 . . . . 1.07 109.209 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.68 140.18 46.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.256 1.971 . . . . 0.22 113.131 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -57.36 -26.59 26.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.67 -0.696 . . . . 1.11 110.13 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.5 mt-10 -66.77 -41.68 87.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.671 -1.149 . . . . 1.27 110.448 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.724 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -71.88 -43.55 65.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.675 -0.693 . . . . 1.24 110.34 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.622 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.4 ppt_? -69.3 -17.95 63.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.355 0.598 . . . . 1.4 109.71 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -75.99 -31.11 58.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.817 -1.083 . . . . 2.72 108.474 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 93.2 m -68.09 -41.14 82.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.144 -0.935 . . . . 0.93 110.516 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.724 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 -19.69 35.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 1.42 111.266 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.93 7.15 78.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.886 -0.673 . . . . 0.52 112.261 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.795 HD11 HD23 ' B' ' 34' ' ' LEU . 42.9 pt -80.9 -156.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.948 0.404 . . . . 1.54 110.294 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -160.25 179.35 8.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.369 -0.378 . . . . 0.92 110.97 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.915 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -74.98 -37.48 61.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.585 0.707 . . . . 1.5 109.986 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.9 mmpt? -77.14 -2.62 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.732 -0.667 . . . . 1.21 109.884 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' B' ' 33' ' ' ALA . 20.7 t70 -84.12 -178.83 7.07 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.104 -0.498 . . . . 2.05 109.852 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.477 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . . . -133.86 144.28 48.83 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.044 -0.724 . . . . 0.7 109.044 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.795 HD23 HD11 ' B' ' 28' ' ' ILE . 92.0 mt -124.67 130.08 51.73 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.755 -0.831 . . . . 1.17 108.755 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.709 ' HG3' HG11 ' A' ' 7' ' ' VAL . 21.7 tt0 -88.33 103.12 15.53 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 107.62 -1.252 . . . . 1.29 107.62 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.441 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.35 133.82 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.273 -1.331 . . . . 1.05 112.588 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.511 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 5.4 m-85 -126.39 -178.99 4.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.716 -1.129 . . . . 2.5 108.152 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 3' ' ' SER . 8.7 t -147.58 137.91 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.399 0.618 . . . . 1.02 110.871 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.426 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.9 t70 -119.46 121.98 40.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.604 -0.726 . . . . 1.71 109.156 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 -87.11 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.798 0.686 . . . . 2.08 110.354 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.43 29.81 1.26 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.262 -0.881 . . . . 2.39 109.649 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 34.7 pttt -127.66 149.45 50.19 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.432 0.634 . . . . 1.48 111.479 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.863 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.5 mt -92.8 139.26 18.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.995 -1.002 . . . . 1.27 110.943 -170.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.07 103.69 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.856 -0.424 . . . . 1.01 109.856 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.907 HD12 HD13 ' A' ' 45' ' ' LEU . 10.9 mp -95.24 109.57 21.67 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.852 0.358 . . . . 1.03 110.494 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' B' ' 35' ' ' GLU . 29.3 ttmt -112.38 153.87 26.64 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 108.047 -1.094 . . . . 2.34 108.047 171.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.784 ' HA ' HD21 ' B' ' 34' ' ' LEU . 9.9 ptpp? -58.49 144.08 43.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.501 -0.555 . . . . 2.75 109.501 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.451 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 3.4 p90 . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 3.63 109.605 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.516 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 98.7 p . . . . . 0 CA--C 1.511 -0.543 0 CA-C-O 121.679 0.752 . . . . 1.28 111.81 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.717 ' HB ' HD12 ' A' ' 6' ' ' ILE . 15.2 p -100.06 -34.04 10.23 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.824 -1.08 . . . . 1.11 110.344 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.67 43.68 51.11 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.222 -1.551 . . . . 0.36 109.222 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.717 HD12 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -117.12 126.45 74.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.808 -1.196 . . . . 1.05 109.55 -168.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.663 HG13 ' HA ' ' B' ' 35' ' ' GLU . 3.0 m -97.68 148.58 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.118 -0.633 . . . . 1.01 111.13 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 59.9 mmt-85 -137.41 150.3 47.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.721 -0.672 . . . . 2.14 110.515 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 0.4 OUTLIER -77.84 148.62 34.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.096 -0.502 . . . . 1.63 110.059 172.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.905 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 35.8 t -86.8 20.98 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.847 0.832 . . . . 1.04 110.86 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 38.0 t70 68.51 -124.45 0.15 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.524 -0.762 . . . . 1.32 110.191 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 2.0 pt-20 -142.9 -40.4 0.32 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.472 0.653 . . . . 2.06 109.986 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.448 ' CD2' ' HG3' ' A' ' 12' ' ' GLU . 4.0 mm? -85.47 -0.66 55.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.769 . . . . 1.05 110.395 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' HA2' HG13 ' A' ' 10' ' ' VAL . . . 98.61 16.19 32.25 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 115.741 -0.663 . . . . 0.23 112.407 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.922 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 11.0 ptt180 -100.71 116.95 33.83 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.83 0.348 . . . . 1.98 110.831 176.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.692 HG11 HG11 ' B' ' 16' ' ' VAL . 4.5 p -82.82 127.44 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.765 -1.198 . . . . 1.07 107.765 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 19.3 t -76.5 84.73 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.809 -0.756 . . . . 1.05 109.31 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.481 ' CD1' HD11 ' B' ' 43' ' ' ILE . 2.8 tt -67.95 120.57 74.97 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 115.22 -0.9 . . . . 1.05 109.117 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.4 142.84 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.455 2.103 . . . . 0.26 113.617 -173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -55.59 -29.79 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.066 -0.97 . . . . 1.16 110.02 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.2 mt-10 -67.92 -44.23 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.33 110.145 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.761 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.1 mp -70.42 -43.01 70.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.38 -0.827 . . . . 1.15 110.653 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.59 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.0 ppt_? -70.92 -13.75 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.525 0.678 . . . . 1.67 109.181 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -82.74 -25.49 32.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.998 -1.001 . . . . 2.51 109.375 171.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 88.4 m -70.43 -42.82 71.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.566 -0.743 . . . . 1.09 109.815 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -85.54 -15.22 43.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.618 -0.719 . . . . 1.24 109.781 177.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 17.42 78.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.351 -0.841 . . . . 0.42 112.493 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.718 HD13 HD23 ' A' ' 34' ' ' LEU . 37.6 pt -77.85 -160.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.86 -0.422 . . . . 1.34 109.86 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.04 177.37 10.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.91 110.77 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.885 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 11.8 pt-20 -69.4 -40.74 77.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.805 0.812 . . . . 2.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -78.92 0.86 25.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.244 -0.889 . . . . 1.32 109.481 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.14 165.95 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.4 -0.818 . . . . 1.65 109.779 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.9 154.99 24.38 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.071 -0.715 . . . . 1.06 109.071 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.722 HD21 ' HA ' ' A' ' 47' ' ' LYS . 80.6 mt -129.95 130.97 45.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.671 -1.233 . . . . 1.12 107.671 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.544 ' HA ' HG13 ' B' ' 7' ' ' VAL . 29.3 tt0 -89.38 98.01 11.52 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.991 -0.744 . . . . 1.11 108.991 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.502 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 3.0 mp -89.57 135.4 26.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.968 -1.014 . . . . 0.97 112.611 -171.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 83.4 m-85 -130.65 -177.75 4.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.16 -1.382 . . . . 2.44 107.877 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 43' ' ' ILE . 7.7 t -146.8 131.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.39 0.614 . . . . 1.08 110.309 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' H ' HD11 ' A' ' 44' ' ' ILE . 15.2 t70 -104.95 104.61 14.4 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.914 -1.039 . . . . 1.74 109.278 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 t70 68.47 -71.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 O-C-N 124.165 0.916 . . . . 2.01 111.106 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -143.47 8.45 1.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 1.67 111.238 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 17.4 pttm -129.05 155.98 44.56 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 112.947 0.721 . . . . 1.41 112.947 -175.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.861 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.4 mt -93.03 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.118 -0.946 . . . . 1.06 111.147 -170.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.489 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -125.73 104.84 13.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.686 -0.487 . . . . 0.99 109.686 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.897 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -93.48 107.46 19.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.462 0.649 . . . . 1.07 110.321 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 26.0 ttmt -95.37 157.24 15.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.701 -1.222 . . . . 2.8 107.701 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.722 ' HA ' HD21 ' A' ' 34' ' ' LEU . 9.6 ptpp? -73.51 138.92 45.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.589 -0.893 . . . . 2.92 108.589 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.485 ' HD1' HG11 ' B' ' 7' ' ' VAL . 72.5 t80 . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 109.227 -0.657 . . . . 3.76 109.227 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.508 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 57.2 p . . . . . 0 CA--C 1.51 -0.575 0 CA-C-O 121.698 0.761 . . . . 1.53 110.842 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.717 ' HB ' HD13 ' B' ' 6' ' ' ILE . 7.4 p -99.74 -32.6 10.96 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.109 -0.951 . . . . 1.02 110.195 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.81 40.44 64.45 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.321 -1.511 . . . . 0.29 109.321 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.717 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -114.02 125.68 71.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 113.952 -1.124 . . . . 1.03 109.709 -168.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.0 m -95.06 146.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.392 -0.523 . . . . 0.9 110.883 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -136.42 155.29 50.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 2.62 110.416 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.444 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.2 mmpp? -78.5 153.86 30.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.039 -0.528 . . . . 2.21 109.773 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.885 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 25.3 t -92.38 19.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.815 0.817 . . . . 1.12 110.35 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 9.7 t70 65.43 -139.12 0.2 Allowed 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.29 -0.868 . . . . 1.17 109.33 174.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.483 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -121.71 -47.57 2.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.46 0.648 . . . . 2.09 110.528 176.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.09 -16.62 61.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.753 -0.658 . . . . 1.2 111.392 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.13 12.16 7.11 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.755 -0.736 . . . . 0.2 111.428 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.922 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -98.19 121.48 40.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.98 0.419 . . . . 1.98 111.466 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.692 HG11 HG11 ' A' ' 16' ' ' VAL . 9.9 p -83.27 125.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.028 -1.101 . . . . 1.02 108.028 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 11.0 t -76.33 84.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 119.583 -0.847 . . . . 1.05 109.042 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.446 ' CD1' HD11 ' A' ' 43' ' ' ILE . 2.4 tt -68.58 120.78 77.78 Favored Pre-proline 0 N--CA 1.437 -1.082 0 CA-C-N 115.268 -0.878 . . . . 1.07 108.985 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.79 142.97 40.14 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.267 1.978 . . . . 0.22 113.172 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.4 pp -58.02 -26.69 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.69 -0.687 . . . . 1.11 109.787 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.4 mt-10 -67.18 -44.15 80.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.599 -1.182 . . . . 1.27 110.228 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.746 ' O ' HD23 ' B' ' 26' ' ' LEU . 6.0 mp -70.74 -42.99 69.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.677 -0.692 . . . . 1.24 110.612 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.595 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.2 ppt_? -66.28 -23.8 66.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.703 -0.851 . . . . 1.4 108.703 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.7 OUTLIER -73.62 -29.32 62.29 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.557 -1.201 . . . . 2.72 109.151 175.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 92.9 m -70.14 -42.03 73.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.754 -1.112 . . . . 0.93 110.917 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.746 HD23 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -86.15 -16.6 37.38 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.684 -0.406 . . . . 1.42 110.951 -178.213 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.23 50.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.787 -0.72 . . . . 0.52 111.937 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.614 HD13 HD23 ' B' ' 34' ' ' LEU . 30.4 pt -100.18 -163.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.818 -0.438 . . . . 1.54 109.818 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' B' ' 32' ' ' ASP . . . -161.81 175.02 12.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.453 -0.34 . . . . 0.92 110.653 -176.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.905 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 11.2 pt-20 -65.82 -37.68 86.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.708 0.766 . . . . 1.5 110.499 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -82.5 1.4 37.94 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.325 -0.852 . . . . 1.21 109.458 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.439 ' O ' HG21 ' A' ' 10' ' ' VAL . 33.7 t70 -93.84 148.62 21.96 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.77 -0.65 . . . . 2.05 110.173 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.493 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -94.99 151.88 18.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.334 0.588 . . . . 0.7 109.972 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 82.0 mt -123.4 133.38 54.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.658 -1.238 . . . . 1.17 107.658 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.663 ' HA ' HG13 ' A' ' 7' ' ' VAL . 27.3 tt0 -90.42 95.83 10.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.684 -0.858 . . . . 1.29 108.684 -175.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.461 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 3.1 mp -89.96 134.12 29.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.183 0.992 . . . . 1.05 112.763 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.574 ' HE1' ' HG2' ' B' ' 35' ' ' GLU . 25.4 m-85 -132.09 -178.35 4.86 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.969 -1.469 . . . . 2.5 107.758 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' B' ' 43' ' ' ILE . 8.8 t -147.51 132.24 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 1.02 110.142 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.5 ' H ' HD11 ' B' ' 44' ' ' ILE . 21.8 t70 -107.98 107.79 18.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.499 -0.773 . . . . 1.71 109.486 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 64.47 -69.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.802 1.314 . . . . 2.08 112.08 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.84 12.07 1.43 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.62 -0.718 . . . . 2.39 111.427 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.458 ' O ' HG12 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -137.77 157.05 47.25 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.232 -0.987 . . . . 1.48 112.503 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.897 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 20.0 mt -92.5 139.29 18.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.768 -1.105 . . . . 1.27 111.308 -168.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.5 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -123.2 104.86 14.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 1.01 109.418 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.883 HD12 HD11 ' A' ' 45' ' ' LEU . 10.7 mp -94.04 107.5 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.387 0.613 . . . . 1.03 109.891 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.402 ' HB3' ' HB3' ' B' ' 35' ' ' GLU . 30.7 ttmt -94.53 159.03 15.27 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.427 -1.323 . . . . 2.34 107.427 172.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' B' ' 34' ' ' LEU . 18.1 ptpt -75.49 141.49 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.783 -1.191 . . . . 2.75 107.783 171.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.45 ' CD1' HG11 ' A' ' 7' ' ' VAL . 26.1 t80 . . . . . 0 N--CA 1.441 -0.916 0 C-N-CA 119.726 -0.79 . . . . 3.63 109.364 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' B' ' 37' ' ' TYR . 31.2 t . . . . . 0 CA--C 1.501 -0.927 0 CA-C-O 121.726 0.774 . . . . 1.28 111.196 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.845 ' HB ' HD12 ' A' ' 6' ' ' ILE . 23.2 p -119.84 -28.68 5.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.893 -1.048 . . . . 1.11 111.052 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.05 39.91 93.05 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.012 -1.235 . . . . 0.36 110.012 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.845 HD12 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -106.77 125.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.518 -0.841 . . . . 1.05 109.653 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.95 144.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 119.968 -0.693 . . . . 1.01 111.121 -176.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 36.7 mmt180 -135.38 158.64 43.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.938 -0.573 . . . . 2.14 110.142 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.28 155.77 28.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.06 -0.518 . . . . 1.63 110.527 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.807 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.9 t -89.28 15.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.973 0.892 . . . . 1.04 109.587 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 73.85 -108.34 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 114.879 -1.055 . . . . 1.32 111.008 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.97 -42.17 0.07 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.649 0.738 . . . . 2.06 109.961 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.38 -5.14 59.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.569 -0.741 . . . . 1.05 110.392 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.81 18.39 10.76 Favored Glycine 0 CA--C 1.498 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.23 111.831 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.728 ' HB3' HG22 ' B' ' 17' ' ' VAL . 2.5 ptt180 -105.69 121.62 44.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.869 0.366 . . . . 1.98 111.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.819 HG13 HD22 ' B' ' 45' ' ' LEU . 8.0 p -83.44 126.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.453 -0.943 . . . . 1.07 108.453 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' B' ' 15' ' ' ARG . 18.7 t -76.49 85.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.873 -0.731 . . . . 1.05 109.515 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.429 HD12 HD11 ' B' ' 43' ' ' ILE . 1.8 tt -67.09 121.63 79.11 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 115.096 -0.956 . . . . 1.05 109.458 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HG2' HD13 ' A' ' 22' ' ' LEU . 53.0 Cg_exo -54.79 146.16 57.14 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.462 2.108 . . . . 0.26 113.883 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.562 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.4 pp -53.56 -35.62 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.91 -1.041 . . . . 1.16 110.88 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.546 ' HG3' HD11 ' A' ' 22' ' ' LEU . 3.7 pt-20 -72.65 -37.31 68.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.757 -1.111 . . . . 1.33 110.546 -174.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.741 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -72.94 -42.2 63.7 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.698 -0.683 . . . . 1.15 110.377 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -69.37 -17.34 63.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.05 -0.722 . . . . 1.67 109.05 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -79.27 -29.78 42.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.3 -0.864 . . . . 2.51 108.685 172.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 99.8 m -66.85 -41.71 86.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.317 -0.856 . . . . 1.09 110.111 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.741 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.12 -19.18 40.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.056 -0.72 . . . . 1.24 109.056 176.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.37 20.09 79.03 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.942 -1.026 . . . . 0.42 112.148 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.767 HD13 HD23 ' A' ' 34' ' ' LEU . 42.2 pt -83.67 -158.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.074 0.464 . . . . 1.34 110.085 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -160.84 -179.38 7.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.787 -0.642 . . . . 0.91 110.093 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.727 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 7.8 pt-20 -72.09 -28.37 63.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.473 0.654 . . . . 2.0 110.723 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.659 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 1.7 mmpt? -89.66 2.4 54.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.312 -0.858 . . . . 1.32 109.02 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -84.15 163.71 19.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.395 -0.821 . . . . 1.65 110.461 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.49 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.58 155.19 23.72 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.818 -0.808 . . . . 1.06 108.818 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.767 HD23 HD13 ' A' ' 28' ' ' ILE . 96.0 mt -130.05 131.43 45.8 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.269 -1.011 . . . . 1.12 108.269 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.589 ' HG3' HG11 ' B' ' 7' ' ' VAL . 40.1 tt0 -89.43 101.19 13.86 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.335 -0.987 . . . . 1.11 108.335 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.528 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 3.3 mp -90.15 133.92 30.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.998 0.904 . . . . 0.97 112.776 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -124.73 -179.01 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.238 -1.346 . . . . 2.44 108.061 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.0 t -147.16 127.35 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.731 0.777 . . . . 1.08 111.609 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.554 ' H ' HD12 ' A' ' 44' ' ' ILE . 21.5 t70 -99.09 103.86 15.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.051 -0.977 . . . . 1.74 108.851 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 -74.23 0.06 Allowed 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 124.091 0.87 . . . . 2.01 110.981 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' O ' HD12 ' B' ' 26' ' ' LEU . 13.3 pt-20 -149.51 22.46 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.538 -0.756 . . . . 1.67 110.571 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 14.5 pttm -126.66 157.14 39.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.341 0.591 . . . . 1.41 112.124 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.908 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 8.4 mt -93.25 139.9 17.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.238 -0.892 . . . . 1.06 111.456 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.554 HD12 ' H ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -128.24 104.01 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.795 -0.446 . . . . 0.99 109.795 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.948 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -94.33 108.58 20.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.532 0.682 . . . . 1.07 110.773 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HE2' ' HB3' ' A' ' 35' ' ' GLU . 32.3 ttpt -98.61 155.44 17.3 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.326 -1.361 . . . . 2.8 107.326 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.707 ' HA ' HD21 ' A' ' 34' ' ' LEU . 18.9 ptpt -71.64 142.72 49.91 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.978 -0.749 . . . . 2.92 108.978 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CD1' HG12 ' B' ' 7' ' ' VAL . 47.6 t80 . . . . . 0 C--N 1.321 -0.651 0 C-N-CA 120.602 -0.439 . . . . 3.76 109.923 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.427 ' HA ' ' N ' ' A' ' 38' ' ' VAL . 13.9 m . . . . . 0 CA--C 1.508 -0.65 0 CA-C-O 121.475 0.655 . . . . 1.53 111.428 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.558 ' HB ' HD12 ' B' ' 6' ' ' ILE . 12.4 p -102.28 -30.71 10.92 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.139 -0.937 . . . . 1.02 110.146 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.55 40.37 96.06 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.49 -1.444 . . . . 0.29 109.49 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.558 HD12 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -110.61 126.1 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.354 -0.923 . . . . 1.03 109.906 -168.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -94.88 143.09 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.106 -0.638 . . . . 0.9 111.163 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.755 ' HE ' ' HG3' ' B' ' 19' ' ' PRO . 34.3 mmt180 -133.54 157.4 45.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 2.62 109.773 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.49 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.5 mmpp? -79.32 157.24 27.73 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.39 0.431 . . . . 2.21 110.168 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.727 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.3 t -89.8 12.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.158 0.98 . . . . 1.12 109.437 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 74.77 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 114.435 -1.257 . . . . 1.17 111.62 168.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.3 pt-20 -160.12 -45.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.279 0.561 . . . . 2.09 110.082 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.447 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.05 -3.25 57.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.085 -0.507 . . . . 1.2 110.909 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 14.24 17.56 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 120.77 -0.728 . . . . 0.2 111.612 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 17' ' ' VAL . 8.3 ptt180 -103.13 121.19 42.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.721 0.296 . . . . 1.98 111.568 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.741 HG13 HD21 ' A' ' 45' ' ' LEU . 9.7 p -83.21 125.68 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.346 -0.983 . . . . 1.02 108.346 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 15' ' ' ARG . 16.3 t -76.12 85.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.948 -0.701 . . . . 1.05 109.402 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.425 HD11 HD11 ' A' ' 43' ' ' ILE . 1.9 tt -67.62 121.26 78.47 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 115.101 -0.954 . . . . 1.07 109.242 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.755 ' HG3' ' HE ' ' B' ' 8' ' ' ARG . 51.2 Cg_exo -54.84 147.36 51.49 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.504 2.136 . . . . 0.22 113.293 -172.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.2 pp -59.34 -30.65 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.212 0.53 . . . . 1.11 109.973 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.11 -42.97 93.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.688 -1.142 . . . . 1.27 109.99 -177.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.7 ' O ' HD22 ' B' ' 26' ' ' LEU . 7.1 mp -73.02 -42.62 63.01 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.262 -0.881 . . . . 1.24 110.756 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.628 ' HB2' HG13 ' B' ' 28' ' ' ILE . 7.0 ppt_? -68.68 -20.04 64.42 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.933 -0.766 . . . . 1.4 108.933 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.568 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.9 OUTLIER -73.78 -30.94 63.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.483 -1.235 . . . . 2.72 109.073 172.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 99.6 m -72.1 -39.03 69.21 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.67 -1.15 . . . . 0.93 110.846 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.7 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -83.89 -19.28 35.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 1.42 110.471 -178.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.18 25.47 55.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.983 -0.627 . . . . 0.52 112.079 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.8 HD11 HD22 ' B' ' 34' ' ' LEU . 39.6 pt -99.72 -159.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.799 0.333 . . . . 1.54 110.142 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 32' ' ' ASP . . . -165.3 179.34 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.882 -0.599 . . . . 0.92 109.657 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.807 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 13.1 pt-20 -69.47 -32.77 71.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.481 0.658 . . . . 1.5 111.044 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -85.48 1.64 48.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.521 -0.763 . . . . 1.21 109.368 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' B' ' 29' ' ' ALA . 0.7 OUTLIER -88.16 160.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.44 -0.8 . . . . 2.05 111.054 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.75 155.84 20.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 0.7 109.233 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.8 HD22 HD11 ' B' ' 28' ' ' ILE . 98.8 mt -130.72 130.66 44.09 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.319 -0.993 . . . . 1.17 108.319 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.593 ' HG3' HG13 ' A' ' 7' ' ' VAL . 40.1 tt0 -89.25 100.3 13.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.994 -1.113 . . . . 1.29 107.994 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.24 135.89 24.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.021 -0.99 . . . . 1.05 112.477 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.52 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 41.0 m-85 -127.06 -178.89 4.59 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.154 -1.385 . . . . 2.5 108.134 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 42' ' ' LYS . 24.0 t -145.29 134.68 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.274 0.559 . . . . 1.02 110.846 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.515 ' N ' HD12 ' B' ' 44' ' ' ILE . 6.2 t70 -100.1 97.05 7.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.246 -0.888 . . . . 1.71 108.788 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.09 -65.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.232 0.958 . . . . 2.08 111.398 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 26' ' ' LEU . 6.7 pt-20 -150.35 19.39 0.84 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.494 -0.776 . . . . 2.39 111.205 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 52.8 pttt -130.18 156.96 43.71 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.256 -0.578 . . . . 1.48 111.865 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.948 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 9.7 mt -92.7 139.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.534 -0.757 . . . . 1.27 111.414 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.515 HD12 ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -128.08 104.64 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.684 -0.487 . . . . 1.01 109.684 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.913 HD12 HD12 ' A' ' 45' ' ' LEU . 11.2 mp -92.81 107.94 19.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.343 0.592 . . . . 1.03 110.689 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.526 ' HE2' ' HB3' ' B' ' 35' ' ' GLU . 30.4 ttpt -96.76 156.46 16.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.283 -1.377 . . . . 2.34 107.283 171.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.711 ' HA ' HD23 ' B' ' 34' ' ' LEU . 16.4 ptpt -74.93 139.5 43.09 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.734 -0.839 . . . . 2.75 108.734 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 . . . . . 0 C--N 1.322 -0.616 0 C-N-CA 120.296 -0.561 . . . . 3.63 109.794 179.082 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.56 ' HB3' ' O ' ' B' ' 38' ' ' VAL . 92.7 p . . . . . 0 CA--C 1.504 -0.824 0 CA-C-O 121.224 0.535 . . . . 1.28 110.85 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.808 ' HB ' HD12 ' A' ' 6' ' ' ILE . 17.7 p -100.06 -35.92 9.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.438 -0.801 . . . . 1.11 110.353 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.06 50.13 11.36 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.254 -1.539 . . . . 0.36 109.254 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.808 HD12 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -122.42 125.32 72.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.447 -0.876 . . . . 1.05 109.83 -168.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.9 m -95.99 145.53 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.94 -0.704 . . . . 1.01 110.861 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.59 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 38.7 mmt180 -135.97 157.95 45.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 2.14 110.442 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.528 ' CE ' ' HB2' ' B' ' 33' ' ' ALA . 2.5 mmpp? -78.63 153.61 30.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.266 -0.424 . . . . 1.63 110.489 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.785 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.3 t -94.21 13.47 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.683 -0.69 . . . . 1.04 110.566 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 11.1 t70 66.2 -149.65 0.21 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.692 -0.686 . . . . 1.32 110.037 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.553 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -115.75 -44.27 2.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.81 0.814 . . . . 2.06 109.061 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.57 -16.87 62.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.691 -1.141 . . . . 1.05 111.033 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.34 26.5 Favored Glycine 0 CA--C 1.495 -1.157 0 C-N-CA 120.798 -0.715 . . . . 0.23 112.467 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.758 ' HD2' ' HG3' ' B' ' 15' ' ' ARG . 1.9 ptt85 -95.55 121.31 37.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 120.329 -0.548 . . . . 1.98 111.465 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 9.7 p -82.55 131.05 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 108.261 -1.014 . . . . 1.07 108.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 14.6 t -75.58 85.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 119.666 -0.814 . . . . 1.05 109.304 -176.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.9 tt -71.28 116.96 52.41 Favored Pre-proline 0 N--CA 1.429 -1.481 0 N-CA-C 108.047 -1.094 . . . . 1.05 108.047 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.59 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 52.2 Cg_exo -54.17 138.82 72.05 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.046 1.831 . . . . 0.26 112.689 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.422 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.6 pp -56.2 -29.64 28.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.692 -0.685 . . . . 1.16 109.945 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -66.34 -44.34 83.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.599 -1.182 . . . . 1.33 110.011 -177.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.785 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -69.89 -45.13 68.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.384 -0.826 . . . . 1.15 110.708 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.562 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -70.18 -13.8 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.694 0.759 . . . . 1.67 108.966 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.0 tmt_? -82.83 -28.38 30.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.981 -1.009 . . . . 2.51 109.397 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 92.0 m -69.72 -43.91 71.39 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.199 -0.909 . . . . 1.09 109.919 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.38 -15.47 56.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.622 -0.717 . . . . 1.24 109.2 177.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.65 21.8 76.29 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.051 -0.977 . . . . 0.42 112.475 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.725 HD11 HD22 ' A' ' 34' ' ' LEU . 35.1 pt -83.91 -158.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.853 -0.795 . . . . 1.34 108.853 171.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -154.8 179.34 9.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.136 -0.32 . . . . 0.91 110.136 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.971 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -77.97 -32.74 51.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.951 0.881 . . . . 2.0 109.126 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.637 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 11.3 mmpt? -79.52 -0.01 31.55 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.026 -0.988 . . . . 1.32 109.712 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -87.53 172.96 9.38 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.601 -0.727 . . . . 1.65 109.16 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.491 ' HB3' ' HE3' ' B' ' 9' ' ' LYS . . . -120.95 150.92 40.36 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.613 -0.884 . . . . 1.06 108.613 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.8 HD11 HD23 ' A' ' 45' ' ' LEU . 53.5 mt -124.75 128.97 49.59 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.73 -0.841 . . . . 1.12 108.73 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 61.0 tt0 -88.57 97.65 11.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.952 -0.759 . . . . 1.11 108.952 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.7 mp -89.89 135.98 24.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.739 -1.119 . . . . 0.97 112.792 -173.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 1.058 ' HE2' ' HE2' ' A' ' 46' ' ' LYS . 78.5 m-85 -130.11 -177.62 4.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.126 -1.397 . . . . 2.44 107.57 174.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.643 HG12 HD12 ' B' ' 26' ' ' LEU . 6.4 t -147.05 133.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.391 0.615 . . . . 1.08 110.798 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.527 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 22.4 t70 -99.09 95.18 6.94 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.079 -0.964 . . . . 1.74 108.671 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 65.52 -66.05 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.361 1.038 . . . . 2.01 112.181 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -137.08 -3.2 2.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.674 -0.694 . . . . 1.67 111.254 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 36.4 pttt -118.56 150.21 40.03 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.744 -0.783 . . . . 1.41 112.086 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.937 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 19.4 mt -92.64 138.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.003 -0.999 . . . . 1.06 110.814 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.44 HD12 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -124.32 106.76 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.489 -0.56 . . . . 0.99 109.489 -177.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.866 HD11 HD11 ' B' ' 45' ' ' LEU . 10.9 mp -98.59 112.04 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.933 0.397 . . . . 1.07 110.657 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 1.058 ' HE2' ' HE2' ' A' ' 37' ' ' TYR . 38.0 mtmt -100.65 165.68 11.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.864 -1.162 . . . . 2.8 107.864 167.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.494 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.0 ptpt -72.19 143.76 48.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.042 -1.466 . . . . 2.92 107.042 165.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 5.3 p90 . . . . . 0 C--N 1.322 -0.594 0 C-N-CA 120.023 -0.671 . . . . 3.76 111.026 -173.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' SER . . . . . 0.595 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 79.1 p . . . . . 0 CA--C 1.503 -0.831 0 CA-C-O 121.574 0.702 . . . . 1.53 112.115 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.784 ' HB ' HD12 ' B' ' 6' ' ' ILE . 16.2 p -104.64 -37.02 7.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.842 -1.072 . . . . 1.02 110.253 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.1 46.25 10.59 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.394 -1.482 . . . . 0.29 109.394 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.784 HD12 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.221 -0.989 . . . . 1.03 109.945 -167.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.74 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.3 m -93.01 149.32 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.197 -0.601 . . . . 0.9 110.582 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 13.3 mmt85 -139.76 156.76 46.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.184 -0.462 . . . . 2.62 110.813 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.491 ' HE3' ' HB3' ' A' ' 33' ' ' ALA . 4.3 mmpp? -77.98 153.91 32.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.892 -0.595 . . . . 2.21 110.153 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.971 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 19.5 t -96.12 15.74 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.54 -0.754 . . . . 1.12 110.489 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 13.8 t70 68.19 -146.88 0.13 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.627 -0.715 . . . . 1.17 109.832 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.576 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -119.52 -44.93 2.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.984 0.897 . . . . 2.09 108.682 175.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.69 -28.86 69.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.021 -1.445 . . . . 1.2 110.715 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.9 0.14 9.08 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 120.557 -0.83 . . . . 0.2 111.42 174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.758 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 5.6 ptt180 -92.48 121.41 33.91 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.913 0.387 . . . . 1.98 111.853 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 16' ' ' VAL . 7.7 p -82.82 128.96 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.131 -1.063 . . . . 1.02 108.131 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 10.0 t -75.77 85.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.556 -0.858 . . . . 1.05 109.089 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.476 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.6 tt -70.19 115.66 36.67 Favored Pre-proline 0 N--CA 1.428 -1.539 0 N-CA-C 108.285 -1.006 . . . . 1.07 108.285 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.494 ' HB2' HD11 ' B' ' 22' ' ' LEU . 78.2 Cg_exo -50.09 138.99 35.37 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.304 2.003 . . . . 0.22 112.863 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.86 -30.89 23.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.684 -0.689 . . . . 1.11 109.977 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.8 -42.94 90.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.621 -1.172 . . . . 1.27 110.555 -177.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -70.5 -46.81 62.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.017 -0.538 . . . . 1.24 110.856 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.554 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.5 ppt_? -69.78 -15.07 63.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.39 0.614 . . . . 1.4 109.635 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -76.93 -32.55 57.42 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.057 -0.974 . . . . 2.72 109.041 170.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.1 m -72.0 -39.86 68.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.167 -0.924 . . . . 0.93 110.696 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.766 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -82.87 -14.58 54.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.863 -0.608 . . . . 1.42 110.778 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.3 80.66 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.829 -0.7 . . . . 0.52 112.592 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.62 HD12 HD22 ' B' ' 34' ' ' LEU . 38.0 pt -83.39 -158.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.603 -0.517 . . . . 1.54 109.603 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.51 175.17 14.02 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.878 0.371 . . . . 0.92 110.92 -176.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.785 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.6 pt-20 -72.41 -40.98 66.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.124 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 10.3 mmpt? -80.8 4.26 19.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.39 -0.823 . . . . 1.21 109.616 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' B' ' 33' ' ' ALA . 17.6 t70 -85.77 -176.11 5.89 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.109 -0.7 . . . . 2.05 109.109 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.528 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . . . -135.25 146.17 48.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.673 -0.862 . . . . 0.7 108.673 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.859 HD11 HD22 ' B' ' 45' ' ' LEU . 53.0 mt -123.72 127.42 48.13 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.302 -0.629 . . . . 1.17 109.302 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' B' ' 48' ' ' TYR . 27.8 tt0 -87.63 95.89 10.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.263 -1.014 . . . . 1.29 108.263 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 2.7 mp -89.87 136.62 23.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.543 -1.208 . . . . 1.05 112.783 -173.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.431 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 77.6 m-85 -134.37 -177.99 4.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.083 -1.417 . . . . 2.5 107.4 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' B' ' 43' ' ' ILE . 6.5 t -147.56 135.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.311 0.577 . . . . 1.02 111.182 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -104.58 105.85 16.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.344 -0.844 . . . . 1.71 109.204 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 61.15 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.269 0.981 . . . . 2.08 111.035 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.62 14.99 2.15 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.632 -0.713 . . . . 2.39 111.485 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 9.7 pttm -124.11 151.53 43.81 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 119.62 -0.832 . . . . 1.48 112.077 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.843 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 4.9 mp -92.54 138.83 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.101 -0.954 . . . . 1.27 111.612 -169.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' B' ' 36' ' ' ILE . 0.1 OUTLIER -121.74 110.62 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 1.01 109.546 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.937 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -103.54 109.18 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 1.03 110.992 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.48 ' HG2' ' HB2' ' A' ' 42' ' ' LYS . 53.4 mtmt -105.66 165.19 11.34 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.665 -1.235 . . . . 2.34 107.665 168.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.453 ' HE2' HG22 ' B' ' 28' ' ' ILE . 16.4 ptpt -68.89 150.97 47.16 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.153 -1.054 . . . . 2.75 108.153 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.614 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 35.9 p90 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 110.324 -0.25 . . . . 3.63 110.324 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.294 0.569 . . . . 3.56 110.544 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.533 ' HE2' ' OG ' ' A' ' 3' ' ' SER . 17.9 ptmt -163.3 -124.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.438 -0.801 . . . . 2.48 108.897 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.588 ' HB3' ' O ' ' B' ' 38' ' ' VAL . 97.7 p -54.19 130.92 40.21 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.278 0.561 . . . . 1.28 110.352 170.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.696 ' HB ' HD11 ' A' ' 6' ' ' ILE . 10.6 p -103.21 -35.94 8.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.728 -0.669 . . . . 1.11 110.654 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.03 46.51 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.063 -1.615 . . . . 0.36 109.063 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.696 HD11 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -118.25 126.15 74.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 113.989 -1.105 . . . . 1.05 109.731 -167.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.51 148.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.995 -0.682 . . . . 1.01 110.756 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.759 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 32.2 mmt180 -137.26 157.3 46.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 2.14 110.301 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 8.6 mmpt? -80.06 154.61 28.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.036 -0.529 . . . . 1.63 109.841 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.902 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t -88.57 14.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.21 1.005 . . . . 1.04 109.677 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.506 ' OD2' ' HG2' ' A' ' 12' ' ' GLU . 24.4 t70 73.32 -91.81 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.237 -1.347 . . . . 1.32 112.558 167.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.506 ' HG2' ' OD2' ' A' ' 11' ' ' ASP . 4.8 pt-20 -161.12 -54.24 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 2.06 111.746 -174.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.407 ' CD2' ' HG3' ' A' ' 12' ' ' GLU . 4.4 mm? -85.01 -9.88 57.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.217 -0.447 . . . . 1.05 110.715 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA2' HG13 ' A' ' 10' ' ' VAL . . . 114.23 14.18 9.29 Favored Glycine 0 CA--C 1.499 -0.918 0 C-N-CA 120.726 -0.75 . . . . 0.23 111.351 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.778 ' HB3' HG21 ' B' ' 17' ' ' VAL . 19.4 ptt180 -97.6 117.08 31.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.575 -0.313 . . . . 1.98 110.536 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.679 HG11 HG11 ' B' ' 16' ' ' VAL . 9.8 p -82.92 127.04 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.374 -0.973 . . . . 1.07 108.374 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.731 HG21 ' HB3' ' B' ' 15' ' ' ARG . 19.6 t -75.63 84.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.742 -0.783 . . . . 1.05 109.127 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 ' CD1' HD11 ' B' ' 43' ' ' ILE . 2.1 tt -68.47 118.44 59.92 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-N 115.036 -0.984 . . . . 1.05 108.797 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.759 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 74.1 Cg_exo -52.0 143.45 40.41 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.341 2.027 . . . . 0.26 113.209 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -57.42 -32.85 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 115.528 -0.76 . . . . 1.16 110.008 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -67.0 -41.84 86.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.708 -1.133 . . . . 1.33 110.295 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.539 ' O ' HD22 ' A' ' 26' ' ' LEU . 4.1 mp -68.74 -47.85 65.23 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.549 -0.75 . . . . 1.15 110.578 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 2.0 ppt_? -70.11 -11.07 60.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.748 -0.781 . . . . 1.67 109.769 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 12.7 ttt180 -80.87 -31.88 35.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.622 -0.717 . . . . 2.51 109.456 171.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.4 m -67.57 -43.17 81.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.117 -0.947 . . . . 1.09 110.058 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.539 HD22 ' O ' ' A' ' 22' ' ' LEU . 1.1 mm? -86.54 -9.21 56.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.599 -0.728 . . . . 1.24 109.942 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.54 91.76 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.796 -0.638 . . . . 0.42 112.696 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 1.104 HD13 HD23 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.47 -176.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.939 0.496 . . . . 1.34 109.705 173.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 175.73 10.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.263 -0.426 . . . . 0.91 110.444 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.793 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.4 pt-20 -67.87 -37.85 82.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.53 0.681 . . . . 2.0 111.25 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.612 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 10.9 mmpt? -80.75 -3.25 50.21 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.583 -0.735 . . . . 1.32 109.652 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.52 171.89 12.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.549 -0.75 . . . . 1.65 110.111 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.486 ' HB3' ' HE3' ' B' ' 9' ' ' LYS . . . -117.75 158.12 25.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.38 -0.827 . . . . 1.06 108.986 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 1.104 HD23 HD13 ' A' ' 28' ' ' ILE . 61.8 mt -131.01 127.81 39.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.547 -0.909 . . . . 1.12 108.547 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.562 ' HA ' HG11 ' B' ' 7' ' ' VAL . 30.7 tt0 -89.09 96.46 10.73 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.736 -0.839 . . . . 1.11 108.736 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.8 mp -90.25 136.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.857 -1.065 . . . . 0.97 112.789 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.542 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 16.4 m-85 -132.68 -178.05 4.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.278 -1.328 . . . . 2.44 107.455 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.6 t -147.7 129.66 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.688 0.756 . . . . 1.08 111.259 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' H ' HD13 ' A' ' 44' ' ' ILE . 17.5 t70 -92.51 87.27 5.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.702 -1.135 . . . . 1.74 108.718 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.8 t70 61.46 -67.42 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.662 -1.154 . . . . 2.01 112.394 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -120.9 -9.19 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.681 -0.691 . . . . 1.67 111.916 -172.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' O ' HG11 ' A' ' 38' ' ' VAL . 20.3 pttm -127.65 154.9 44.72 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.727 1.01 . . . . 1.41 113.727 -173.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.895 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 25.7 mt -92.27 139.04 18.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.548 -1.205 . . . . 1.06 110.924 -170.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -124.5 105.62 15.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.9 -0.408 . . . . 0.99 109.9 -177.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.938 HD12 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -97.6 109.09 21.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.223 0.535 . . . . 1.07 110.733 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -98.04 157.19 16.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.186 -1.412 . . . . 2.8 107.186 168.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.808 ' HA ' HD21 ' A' ' 34' ' ' LEU . 17.5 ptmt -75.76 148.32 38.59 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 2.92 108.395 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.461 ' HD1' HG12 ' B' ' 7' ' ' VAL . 76.9 t80 -64.42 144.97 56.79 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.798 -0.361 . . . . 3.76 110.091 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 10.2 tppt? -68.75 115.34 29.77 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.759 -0.655 . . . . 2.33 109.551 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.74 41.25 0.79 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.903 2.402 . . . . 1.3 112.584 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -82.77 97.13 8.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.261 -0.882 . . . . 2.65 109.909 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -109.86 117.95 35.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.741 -0.663 . . . . 3.54 109.945 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.465 -0.779 . . . . 3.35 110.165 -178.789 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.243 0.544 . . . . 4.28 111.318 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.573 ' HE2' ' OG ' ' B' ' 3' ' ' SER . 17.4 ptmt -168.98 -120.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.19 -0.914 . . . . 2.68 108.947 173.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.573 ' OG ' ' HE2' ' B' ' 2' ' ' LYS . 94.2 p -58.86 129.99 44.81 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.364 0.602 . . . . 1.53 109.938 169.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.734 ' HB ' HD11 ' B' ' 6' ' ' ILE . 8.1 p -102.8 -37.02 8.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.395 -0.82 . . . . 1.02 110.746 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.6 44.15 41.26 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 108.973 -1.651 . . . . 0.29 108.973 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.734 HD11 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.94 125.97 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.038 -1.081 . . . . 1.03 109.692 -168.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.723 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.2 m -93.91 149.6 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.168 -0.613 . . . . 0.9 110.822 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' B' ' 8' ' ' ARG . 21.6 mmt180 -139.38 156.34 47.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.874 -0.603 . . . . 2.62 110.323 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 33' ' ' ALA . 7.1 mmpt? -80.26 154.08 28.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.629 -0.714 . . . . 2.21 110.011 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.793 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 22.1 t -89.82 17.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.029 0.919 . . . . 1.12 110.025 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t70 71.65 -109.84 0.05 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.682 -1.144 . . . . 1.17 110.441 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.0 pt-20 -151.63 -42.23 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.337 0.589 . . . . 2.09 111.043 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.47 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.25 -6.39 59.39 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.519 -0.472 . . . . 1.2 111.42 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.97 11.21 16.84 Favored Glycine 0 CA--C 1.497 -1.073 0 N-CA-C 110.975 -0.85 . . . . 0.2 110.975 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.731 ' HB3' HG21 ' A' ' 17' ' ' VAL . 5.3 ptt180 -99.13 119.87 38.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.527 -0.337 . . . . 1.98 111.277 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 16' ' ' VAL . 9.0 p -82.85 127.5 39.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.277 -1.009 . . . . 1.02 108.277 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.778 HG21 ' HB3' ' A' ' 15' ' ' ARG . 23.1 t -75.74 85.24 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 119.576 -0.85 . . . . 1.05 109.013 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.452 ' CD1' HD12 ' A' ' 43' ' ' ILE . 1.9 tt -68.73 117.47 51.18 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 115.331 -0.85 . . . . 1.07 108.989 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.459 ' HB2' HD13 ' B' ' 22' ' ' LEU . 74.2 Cg_exo -50.68 140.74 36.43 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.605 2.203 . . . . 0.22 113.087 -171.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.411 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.5 pp -53.17 -32.14 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.336 -0.847 . . . . 1.11 110.776 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -66.67 -44.64 81.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.299 -0.864 . . . . 1.27 110.191 -176.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.78 ' O ' HD23 ' B' ' 26' ' ' LEU . 6.6 mp -67.42 -46.9 71.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.552 -0.749 . . . . 1.24 110.559 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 6.5 ppt_? -68.49 -18.12 64.32 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.065 -0.654 . . . . 1.4 109.342 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.645 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 2.6 ttt180 -72.34 -31.61 65.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.098 -0.956 . . . . 2.72 109.054 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 25.3 m -73.71 -43.44 59.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.043 -0.98 . . . . 0.93 110.699 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.78 HD23 ' O ' ' B' ' 22' ' ' LEU . 0.3 OUTLIER -89.05 -1.36 58.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.614 -0.434 . . . . 1.42 111.467 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.1 35.55 71.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.643 -0.789 . . . . 0.52 112.661 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 1.008 HD13 HD23 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -102.06 -178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 1.54 110.642 176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.41 173.57 13.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.92 109.348 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.902 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.5 pm0 -76.94 -21.56 54.62 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.458 0.647 . . . . 1.5 110.413 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.493 ' HG2' ' HG2' ' B' ' 30' ' ' GLU . 8.3 mmpt? -93.34 0.37 56.9 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.926 -0.768 . . . . 1.21 108.926 176.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.448 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 1.5 t0 -84.33 -179.5 7.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.0 -1.0 . . . . 2.05 110.128 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.03 156.79 41.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.353 -0.84 . . . . 0.7 108.897 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 1.008 HD23 HD13 ' B' ' 28' ' ' ILE . 37.8 mt -131.16 126.98 37.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.585 -0.894 . . . . 1.17 108.585 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 7' ' ' VAL . 31.9 tt0 -88.33 96.38 10.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.482 -0.933 . . . . 1.29 108.482 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.419 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.43 136.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.739 -1.118 . . . . 1.05 112.962 -171.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.435 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 23.6 m-85 -132.22 -178.35 4.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.218 -1.356 . . . . 2.5 107.671 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.7 HG21 ' HA ' ' B' ' 43' ' ' ILE . 6.9 t -147.56 133.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 1.02 110.521 174.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.519 ' H ' HD13 ' B' ' 44' ' ' ILE . 30.1 t70 -101.89 93.9 5.52 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.64 -0.874 . . . . 1.71 108.64 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.72 -70.46 0.06 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 124.751 1.282 . . . . 2.08 112.014 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -123.75 -2.86 8.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.164 -0.925 . . . . 2.39 111.501 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 42.3 pttt -133.14 152.45 51.95 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 119.291 -0.964 . . . . 1.48 113.29 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.866 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 28.5 mt -92.6 139.12 18.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.954 -1.021 . . . . 1.27 110.894 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.519 HD13 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.91 105.73 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.74 -0.467 . . . . 1.01 109.74 -176.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.938 HD13 HD12 ' A' ' 45' ' ' LEU . 11.0 mp -97.97 109.03 21.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.062 0.458 . . . . 1.03 110.831 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' B' ' 35' ' ' GLU . 7.6 mtmp? -100.46 154.84 18.21 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.412 -1.329 . . . . 2.34 107.412 168.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.734 ' HE3' HG23 ' B' ' 28' ' ' ILE . 1.3 ptmt -75.58 140.62 42.77 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.761 -0.829 . . . . 2.75 108.761 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -60.67 147.93 40.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.035 0.445 . . . . 3.63 110.289 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.466 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 17.4 tppt? -65.74 119.12 58.04 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.413 -0.812 . . . . 2.74 109.385 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.466 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 89.3 Cg_endo -80.24 27.08 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.508 2.139 . . . . 1.25 111.763 -173.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' B' ' 49' ' ' LYS . 32.4 t30 -71.31 102.52 2.61 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.245 -0.888 . . . . 2.8 110.283 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 13.8 ptt? -111.25 111.48 22.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.8 -0.636 . . . . 3.79 110.085 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.471 -0.776 . . . . 3.57 110.45 -177.682 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.0 ttp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.597 0.713 . . . . 3.56 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.642 ' CG ' ' H ' ' A' ' 3' ' ' SER . 6.6 tttp -146.6 -133.77 0.08 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.279 -1.378 . . . . 2.48 107.279 175.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.642 ' H ' ' CG ' ' A' ' 2' ' ' LYS . 77.3 p -62.93 127.89 33.36 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.175 0.512 . . . . 1.28 110.405 170.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.8 ' HB ' HD11 ' A' ' 6' ' ' ILE . 17.6 p -96.09 -32.42 12.54 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.235 -0.893 . . . . 1.11 110.624 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' B' ' 37' ' ' TYR . . . 70.0 33.64 70.19 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.612 -1.395 . . . . 0.36 109.612 -172.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.8 HD11 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -104.2 123.02 57.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.181 -1.009 . . . . 1.05 109.887 -169.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.0 OUTLIER -91.34 146.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.969 -0.692 . . . . 1.01 110.669 -177.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.479 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 21.3 mmt180 -138.26 154.11 49.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.469 -0.787 . . . . 2.14 110.112 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -80.36 151.75 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.973 -0.558 . . . . 1.63 109.772 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.876 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 24.9 t -94.47 15.9 2.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.806 0.813 . . . . 1.04 110.554 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.51 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 13.5 t70 66.29 -147.28 0.19 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.396 -0.82 . . . . 1.32 110.111 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.51 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.85 -41.76 2.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.593 -0.891 . . . . 2.06 108.593 176.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -10.8 60.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.728 -1.124 . . . . 1.05 111.011 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.19 11.38 34.14 Favored Glycine 0 CA--C 1.494 -1.243 0 C-N-CA 120.709 -0.758 . . . . 0.23 112.054 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.809 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 8.9 ptp180 -103.88 118.94 37.87 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.047 0.451 . . . . 1.98 111.323 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 8.9 p -82.81 129.6 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.933 -0.766 . . . . 1.07 108.933 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 3.5 t -75.89 84.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.975 -0.69 . . . . 1.05 109.455 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.472 ' CD1' HD12 ' B' ' 43' ' ' ILE . 1.9 tt -69.27 121.27 81.43 Favored Pre-proline 0 N--CA 1.435 -1.184 0 CA-C-N 115.1 -0.955 . . . . 1.05 109.27 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.479 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 55.0 Cg_exo -54.61 143.67 67.44 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.246 1.964 . . . . 0.26 112.969 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.499 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -59.02 -28.88 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 115.603 -0.726 . . . . 1.16 109.857 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.558 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -65.91 -44.63 84.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.946 -1.025 . . . . 1.33 110.286 -175.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.632 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.9 mp -69.17 -44.82 71.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.642 -0.708 . . . . 1.15 110.34 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.648 ' HB2' HG13 ' A' ' 28' ' ' ILE . 4.6 ppt_? -71.05 -10.88 60.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.443 0.639 . . . . 1.67 109.62 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.8 -30.52 32.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.11 -0.95 . . . . 2.51 108.916 171.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -67.35 -41.95 84.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.303 -0.862 . . . . 1.09 109.851 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.632 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -86.64 -11.85 50.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.647 -0.706 . . . . 1.24 110.08 176.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.01 77.56 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.477 -0.783 . . . . 0.42 112.771 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.737 HD12 HD21 ' A' ' 34' ' ' LEU . 36.9 pt -88.12 -157.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 1.34 109.818 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.425 ' HB3' ' OE2' ' A' ' 30' ' ' GLU . . . -161.45 -174.97 4.52 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.917 -0.401 . . . . 0.91 109.917 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.929 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.6 pm0 -79.87 -27.97 40.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.886 0.851 . . . . 2.0 109.922 -176.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 8.1 mmpt? -80.02 -2.09 42.6 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.138 -0.937 . . . . 1.32 109.697 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.79 177.36 8.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.944 -0.571 . . . . 1.65 110.026 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.77 141.16 52.29 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.856 -1.165 . . . . 1.06 107.856 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.784 HD22 ' HA ' ' A' ' 47' ' ' LYS . 47.8 mt -118.09 127.68 54.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.196 -0.668 . . . . 1.12 109.196 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.633 ' HG3' HG11 ' B' ' 7' ' ' VAL . 17.9 tt0 -89.18 99.22 12.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.928 -1.138 . . . . 1.11 107.928 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.462 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.9 mp -89.38 135.34 26.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.551 -1.204 . . . . 0.97 112.324 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.485 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 4.2 m-85 -128.74 -178.55 4.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.174 -1.375 . . . . 2.44 107.582 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 43' ' ' ILE . 3.8 t -148.34 136.77 14.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.659 -0.497 . . . . 1.08 109.659 172.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' H ' HD12 ' A' ' 44' ' ' ILE . 65.0 m-20 -115.78 116.8 28.66 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.458 -0.571 . . . . 1.74 109.458 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 60.79 -79.37 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 124.231 0.957 . . . . 2.01 111.177 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -141.25 20.82 2.25 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.191 -0.913 . . . . 1.67 111.274 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 55.4 pttt -135.63 152.29 51.09 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 112.908 0.707 . . . . 1.41 112.908 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.958 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 40.1 mt -92.26 139.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.812 -1.085 . . . . 1.06 110.745 -172.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -126.34 106.0 15.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.074 -0.343 . . . . 0.99 110.074 -175.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.931 HD11 HD11 ' B' ' 45' ' ' LEU . 11.2 mp -97.51 109.48 22.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.843 0.354 . . . . 1.07 110.523 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' HB3' ' HE2' ' A' ' 37' ' ' TYR . 31.7 ttmt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.659 -0.867 . . . . 2.8 108.659 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.784 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -50.28 142.59 9.84 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.834 0.35 . . . . 2.92 111.282 -173.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CD1' HG12 ' B' ' 7' ' ' VAL . 52.7 t80 -59.86 148.07 36.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.905 -0.588 . . . . 3.76 109.68 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 11.6 tppt? -66.91 113.31 12.65 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.643 -0.708 . . . . 2.33 109.474 -175.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -79.79 19.56 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.764 2.309 . . . . 1.3 112.179 -172.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.11 95.36 5.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.286 -0.87 . . . . 2.65 109.895 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 21.4 ptp -149.14 143.55 26.05 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.561 -1.199 . . . . 3.54 108.367 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.595 -0.717 . . . . 3.35 110.85 -175.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.2 ttp . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 121.068 0.461 . . . . 4.28 110.107 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 11.4 ttpp -136.91 -104.25 0.2 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.689 -0.856 . . . . 2.68 108.689 171.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 91.2 p -82.03 131.51 35.25 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.563 0.697 . . . . 1.53 109.406 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.559 ' HB ' ' HB ' ' B' ' 6' ' ' ILE . 3.1 p -93.88 -36.77 12.06 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.312 -0.858 . . . . 1.02 110.563 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.461 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 68.78 38.01 84.91 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 108.954 -1.658 . . . . 0.29 108.954 -170.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -111.82 124.8 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.925 -1.138 . . . . 1.03 109.689 -167.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.707 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.4 m -94.18 146.41 6.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.07 -0.652 . . . . 0.9 110.833 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.587 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 10.4 mmt180 -138.21 153.53 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 2.62 110.305 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -79.67 148.66 31.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 2.21 109.843 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.929 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 13.2 t -91.71 15.84 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.603 0.716 . . . . 1.12 110.635 -174.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 7.4 t70 70.17 -148.43 0.1 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-N 115.289 -0.869 . . . . 1.17 110.002 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.507 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -121.11 -41.16 2.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.531 -0.915 . . . . 2.09 108.531 175.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.77 -10.54 59.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.563 -1.199 . . . . 1.2 111.473 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.52 5.48 36.64 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.643 -0.789 . . . . 0.2 111.982 172.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.809 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 11.3 ptp180 -101.02 118.55 37.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.079 0.466 . . . . 1.98 111.232 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.84 129.47 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.783 -0.821 . . . . 1.02 108.783 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.656 HG23 ' HB3' ' A' ' 15' ' ' ARG . 4.0 t -76.0 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.932 -0.707 . . . . 1.05 109.361 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.472 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.3 tt -70.03 120.8 80.28 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.892 -1.049 . . . . 1.07 109.412 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.587 ' HD3' ' HG3' ' B' ' 8' ' ' ARG . 73.6 Cg_exo -52.56 142.37 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.493 2.129 . . . . 0.22 113.197 -175.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.458 ' HA ' ' HG3' ' B' ' 23' ' ' ARG . 2.3 pp -57.39 -27.46 28.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.517 -0.765 . . . . 1.11 109.988 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 3.5 mt-10 -65.89 -47.26 75.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.159 -0.928 . . . . 1.27 110.391 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.686 ' O ' HD22 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -66.42 -45.31 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.546 -0.462 . . . . 1.24 110.799 178.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.784 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.4 ppt_? -69.36 -15.79 63.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.567 0.699 . . . . 1.4 109.699 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -80.93 -24.01 38.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.949 -1.023 . . . . 2.72 109.298 172.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 57.0 m -71.62 -42.41 67.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.713 -0.676 . . . . 0.93 110.399 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.686 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.8 OUTLIER -87.79 -16.1 35.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.142 -0.481 . . . . 1.42 111.841 -178.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 6.14 79.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.086 -0.578 . . . . 0.52 112.984 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.784 HG13 ' HB2' ' B' ' 23' ' ' ARG . 39.8 pt -78.34 -153.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.321 0.248 . . . . 1.54 110.372 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.44 -105.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.585 0.958 . . . . 0.92 113.585 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.876 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 9.4 pt-20 -154.7 -39.34 0.09 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.094 -1.817 . . . . 1.5 106.094 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.479 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 7.4 mmpt? -75.1 -6.53 50.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 113.527 -1.669 . . . . 1.21 108.967 172.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.574 ' CG ' ' HB ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -77.6 168.65 19.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.072 -0.967 . . . . 2.05 109.492 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.43 142.44 49.23 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.495 -0.928 . . . . 0.7 108.495 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.802 HD11 HD21 ' B' ' 45' ' ' LEU . 33.7 mt -119.93 125.73 49.16 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.773 -0.825 . . . . 1.17 108.773 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.661 ' HG3' HG13 ' A' ' 7' ' ' VAL . 29.2 tt0 -88.77 100.36 13.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.072 -1.085 . . . . 1.29 108.072 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.42 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.19 134.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.729 -1.123 . . . . 1.05 112.694 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.459 ' CD1' ' HA2' ' A' ' 5' ' ' GLY . 16.9 m-85 -124.29 -179.14 4.33 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.01 -1.45 . . . . 2.5 107.804 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.651 HG23 ' HA ' ' B' ' 43' ' ' ILE . 9.5 t -148.93 134.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.67 -0.493 . . . . 1.02 109.67 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.4 ' H ' HD13 ' B' ' 44' ' ' ILE . 7.8 m-20 -111.91 94.01 4.73 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.391 -0.368 . . . . 1.71 110.683 178.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 67.04 -13.31 0.2 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.23 -1.35 . . . . 2.08 113.975 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -179.91 -15.46 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.393 -0.367 . . . . 2.39 111.548 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 50.1 pttt -137.84 156.12 48.27 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 119.251 -0.98 . . . . 1.48 113.381 -172.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.89 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -92.38 139.65 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.596 -1.184 . . . . 1.27 110.445 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.4 HD13 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -127.01 104.11 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.215 -0.291 . . . . 1.01 110.215 -175.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.958 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.12 108.59 20.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.081 0.467 . . . . 1.03 110.331 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -114.74 127.23 55.63 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.229 -1.026 . . . . 2.34 108.229 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.752 ' HA ' HD22 ' B' ' 34' ' ' LEU . 14.6 ptpt -46.07 139.04 4.74 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.456 0.472 . . . . 2.75 110.697 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.465 ' CD1' HG11 ' A' ' 7' ' ' VAL . 55.1 t80 -61.3 143.27 55.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.847 -0.427 . . . . 3.63 109.847 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.446 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 16.9 tppt? -67.31 116.0 32.07 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.178 -0.675 . . . . 2.74 109.178 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.446 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 82.9 Cg_endo -81.08 22.62 0.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.519 2.146 . . . . 1.25 111.915 -172.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.57 85.48 3.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.476 -0.784 . . . . 2.8 110.221 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 17.3 ptp -140.85 110.79 6.53 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.976 -1.011 . . . . 3.79 109.111 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 C--N 1.314 -0.948 0 CA-C-N 115.663 -0.699 . . . . 3.57 110.713 -174.306 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mmm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.344 -0.613 . . . . 3.56 109.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.816 ' HG2' ' H ' ' A' ' 3' ' ' SER . 17.6 tttt 63.22 -151.08 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.676 -0.49 . . . . 2.48 109.676 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.816 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 35.3 t -56.43 146.5 24.27 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.685 0.755 . . . . 1.28 110.836 175.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.735 ' HB ' HD13 ' A' ' 6' ' ' ILE . 21.9 p -118.84 -27.26 5.84 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.615 -1.175 . . . . 1.11 110.481 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.54 44.38 92.98 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.788 -1.325 . . . . 0.36 109.788 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.735 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -115.3 126.02 72.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.463 -0.868 . . . . 1.05 109.992 -170.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.4 m -92.79 146.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.107 -0.637 . . . . 1.01 110.382 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.501 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 31.3 mmt180 -137.84 154.93 49.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.118 -0.492 . . . . 2.14 109.929 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 6.7 mmpt? -80.62 154.42 27.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.249 -0.432 . . . . 1.63 109.933 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.84 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.7 t -91.06 16.83 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.792 0.806 . . . . 1.04 110.228 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 26.2 t70 66.94 -133.34 0.14 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.412 -0.813 . . . . 1.32 109.584 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -131.19 -37.13 1.27 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.253 0.549 . . . . 2.06 110.438 177.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 13' ' ' LEU . 3.8 mm? -87.09 6.26 33.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.177 -0.465 . . . . 1.05 111.529 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.42 18.14 31.74 Favored Glycine 0 CA--C 1.496 -1.114 0 C-N-CA 121.056 -0.592 . . . . 0.23 112.15 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.702 ' HB3' HG22 ' B' ' 17' ' ' VAL . 10.1 ptt180 -106.12 120.13 41.02 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.849 0.357 . . . . 1.98 111.234 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.789 HG12 HG12 ' B' ' 16' ' ' VAL . 9.6 p -82.96 126.75 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.191 -1.04 . . . . 1.07 108.191 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.702 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 21.5 t -75.41 85.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.891 -0.724 . . . . 1.05 109.154 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.469 HD13 HD11 ' B' ' 43' ' ' ILE . 1.2 tt -69.79 124.46 90.66 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 115.063 -0.971 . . . . 1.05 108.967 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.54 ' HG2' HD11 ' A' ' 22' ' ' LEU . 50.9 Cg_exo -54.13 145.15 55.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.239 1.959 . . . . 0.26 112.965 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.31 -32.15 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 1.16 109.946 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.0 pt-20 -70.43 -34.38 72.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.697 -1.138 . . . . 1.33 110.771 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.748 ' O ' HD22 ' A' ' 26' ' ' LEU . 6.0 mp -74.17 -44.63 52.74 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.269 -0.573 . . . . 1.15 110.542 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HB2' HG13 ' A' ' 28' ' ' ILE . 2.2 ppt_? -70.12 -12.91 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 1.67 109.407 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.1 ttt180 -82.74 -27.07 31.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.894 -1.048 . . . . 2.51 109.431 171.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 96.7 m -69.68 -42.8 73.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.36 -0.836 . . . . 1.09 109.681 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.748 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.15 -18.58 45.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.202 -0.666 . . . . 1.24 109.202 177.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.69 81.99 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.286 -0.87 . . . . 0.42 112.202 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.678 HG13 ' HB2' ' A' ' 23' ' ' ARG . 46.5 pt -83.11 -153.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.645 -0.502 . . . . 1.34 109.645 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.448 ' HB3' ' OE2' ' A' ' 30' ' ' GLU . . . -162.47 -168.61 1.88 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.403 -0.362 . . . . 0.91 110.036 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.926 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -82.93 -30.81 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.645 0.736 . . . . 2.0 109.798 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 11.8 mmpt? -77.04 -6.26 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.578 -0.737 . . . . 1.32 109.918 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -84.48 162.73 19.8 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.916 -0.584 . . . . 1.65 110.829 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.517 ' HB1' ' HE3' ' B' ' 9' ' ' LYS . . . -107.69 157.45 18.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.576 -0.738 . . . . 1.06 109.511 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.785 HD11 HD23 ' A' ' 45' ' ' LEU . 52.1 mt -129.93 130.5 45.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.516 -0.92 . . . . 1.12 108.516 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.621 ' HG3' HG13 ' B' ' 7' ' ' VAL . 19.9 tt0 -88.82 96.24 10.61 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.486 -0.931 . . . . 1.11 108.486 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -89.78 137.19 21.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.0 -1.0 . . . . 0.97 112.942 -171.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -130.8 -177.99 4.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.201 -1.363 . . . . 2.44 107.916 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 43' ' ' ILE . 12.8 t -147.25 130.52 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 1.08 111.029 174.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.492 ' H ' HD11 ' A' ' 44' ' ' ILE . 31.7 t70 -115.16 121.93 44.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.784 -0.643 . . . . 1.74 109.527 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.87 -73.82 0.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 124.177 0.923 . . . . 2.01 110.784 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.5 17.88 0.4 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.176 -0.92 . . . . 1.67 110.281 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -133.06 157.06 46.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.372 0.606 . . . . 1.41 112.32 -174.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.909 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.1 mt -92.88 139.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.832 -1.076 . . . . 1.06 111.652 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.492 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -124.0 104.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.149 -0.478 . . . . 0.99 109.775 -178.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.872 HD13 HD12 ' B' ' 45' ' ' LEU . 10.9 mp -95.86 107.68 19.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.481 0.658 . . . . 1.07 110.488 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -97.93 159.0 15.21 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.142 -1.429 . . . . 2.8 107.142 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HA ' HD22 ' A' ' 34' ' ' LEU . 3.9 ptpp? -74.17 145.18 44.44 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.134 -1.061 . . . . 2.92 108.134 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -59.83 143.98 49.77 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.02 -0.363 . . . . 3.76 110.02 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -68.92 115.44 31.29 Favored Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 121.148 0.499 . . . . 2.33 110.415 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.47 62.6 7.34 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 122.883 2.389 . . . . 1.3 111.065 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.04 94.43 1.89 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.785 -1.098 . . . . 2.65 110.914 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.2 ptm -120.3 121.02 37.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.391 -0.822 . . . . 3.54 109.085 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.645 -0.693 . . . . 3.35 110.309 -177.142 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.403 ' HE3' ' HA ' ' B' ' 25' ' ' THR . 98.3 mmm . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.897 -0.409 . . . . 4.28 109.897 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.643 ' HG2' ' H ' ' B' ' 3' ' ' SER . 27.5 ttpt 62.93 -148.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.447 -0.575 . . . . 2.68 109.447 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.643 ' H ' ' HG2' ' B' ' 2' ' ' LYS . 3.5 m -50.76 138.1 19.1 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.495 0.664 . . . . 1.53 111.551 175.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.413 ' HB ' HD11 ' B' ' 6' ' ' ILE . 17.0 p -110.64 -30.38 7.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.895 -1.048 . . . . 1.02 109.936 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.97 44.44 78.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.662 -1.375 . . . . 0.29 109.662 -173.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -118.28 125.98 74.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.099 -1.05 . . . . 1.03 109.826 -167.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.74 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 m -93.88 142.43 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.035 -0.666 . . . . 0.9 110.831 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 71.8 mmt-85 -134.36 155.15 50.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.472 -0.331 . . . . 2.62 110.957 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.517 ' HE3' ' HB1' ' A' ' 33' ' ' ALA . 7.6 mmpt? -80.7 152.59 28.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.772 -0.649 . . . . 2.21 110.003 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.926 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.7 t -94.36 19.35 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.687 0.756 . . . . 1.12 110.743 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.535 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 14.3 t70 64.69 -145.14 0.25 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.604 -0.725 . . . . 1.17 109.692 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.535 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -116.92 -43.06 2.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.482 0.658 . . . . 2.09 109.716 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' B' ' 13' ' ' LEU . 4.1 mm? -73.94 -15.07 61.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.967 -1.015 . . . . 1.2 111.197 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.46 13.64 11.5 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.751 -0.738 . . . . 0.2 111.716 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 3.8 ptt180 -99.78 121.69 41.65 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 120.836 0.351 . . . . 1.98 111.389 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.789 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.31 126.81 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.128 -1.064 . . . . 1.02 108.128 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.702 HG22 ' HB3' ' A' ' 15' ' ' ARG . 21.4 t -76.07 84.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.58 -0.848 . . . . 1.05 109.314 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.455 ' CD1' HD11 ' A' ' 43' ' ' ILE . 2.5 tt -69.28 122.08 84.23 Favored Pre-proline 0 N--CA 1.436 -1.16 0 CA-C-N 114.743 -1.117 . . . . 1.07 109.15 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.415 ' HB2' HD11 ' B' ' 22' ' ' LEU . 69.8 Cg_exo -51.58 139.25 47.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.194 1.929 . . . . 0.22 113.224 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.5 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -53.18 -29.71 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 1.11 110.831 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 1.8 mt-10 -67.18 -41.15 86.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.969 . . . . 1.27 110.334 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.694 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.5 mp -70.9 -42.65 69.66 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.851 -0.613 . . . . 1.24 110.855 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.664 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.9 ppt_? -67.79 -22.7 65.17 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.659 -0.867 . . . . 1.4 108.659 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -71.4 -31.64 67.5 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.748 -1.115 . . . . 2.72 108.504 174.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 96.8 m -70.52 -38.4 74.25 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.813 -1.085 . . . . 0.93 110.795 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.694 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -84.29 -20.14 32.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.482 -0.487 . . . . 1.42 110.706 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.74 8.12 67.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.034 -0.603 . . . . 0.52 112.061 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.664 HG13 ' HB2' ' B' ' 23' ' ' ARG . 44.0 pt -88.81 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 1.54 110.181 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.644 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -164.69 -177.28 4.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.795 -0.639 . . . . 0.92 109.838 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.84 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -69.22 -34.8 75.41 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.567 0.699 . . . . 1.5 110.676 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.639 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.1 mmpt? -79.13 -5.38 54.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.528 -0.76 . . . . 1.21 109.951 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.535 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 1.8 m-20 -86.89 160.39 18.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.478 -0.783 . . . . 2.05 111.306 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.429 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -108.03 155.86 19.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.525 -0.762 . . . . 0.7 109.521 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.778 HD11 HD21 ' B' ' 45' ' ' LEU . 26.2 mt -130.15 129.15 43.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.101 -1.074 . . . . 1.17 108.101 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.643 ' HG3' HG13 ' A' ' 7' ' ' VAL . 23.9 tt0 -88.75 99.62 12.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.626 -0.879 . . . . 1.29 108.626 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.16 138.06 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.541 -1.208 . . . . 1.05 112.775 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.511 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 11.6 m-85 -130.18 -177.6 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.325 -1.307 . . . . 2.5 108.156 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.547 ' H ' ' CB ' ' A' ' 3' ' ' SER . 9.9 t -145.63 135.98 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.024 0.44 . . . . 1.02 110.271 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.426 ' H ' HD13 ' B' ' 44' ' ' ILE . 15.4 t70 -117.33 115.03 24.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.478 -0.783 . . . . 1.71 109.473 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t0 69.73 -69.47 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 124.347 1.03 . . . . 2.08 110.569 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.81 20.82 0.21 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.135 -0.939 . . . . 2.39 110.207 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 44.1 pttt -133.67 156.85 47.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.195 0.521 . . . . 1.48 112.035 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.821 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.7 mt -93.17 139.31 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.283 -0.872 . . . . 1.27 111.393 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.426 HD13 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.11 104.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 1.01 109.885 -177.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.909 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.8 mp -94.64 108.42 20.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.134 0.493 . . . . 1.03 110.644 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -101.22 157.08 17.04 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.39 -1.337 . . . . 2.34 107.39 171.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.59 ' HA ' HD22 ' B' ' 34' ' ' LEU . 17.5 ptpt -65.79 148.98 50.9 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.601 -0.888 . . . . 2.75 108.601 172.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.83 144.79 56.24 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.031 -0.729 . . . . 3.63 109.031 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -68.3 115.21 26.99 Favored Pre-proline 0 CA--C 1.505 -0.78 0 CA-C-O 121.515 0.674 . . . . 2.74 109.954 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -83.85 55.34 4.76 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.943 2.429 . . . . 1.25 111.448 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -69.62 105.44 2.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.876 -1.056 . . . . 2.8 110.919 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 23.0 ptm -124.1 112.26 16.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.468 -0.787 . . . . 3.79 109.602 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.773 -0.632 . . . . 3.57 111.019 -177.747 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.885 0.374 . . . . 3.56 111.204 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.679 ' HG2' ' H ' ' A' ' 3' ' ' SER . 20.9 tttt 64.68 -151.01 0.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.095 -0.957 . . . . 2.48 110.833 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.679 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 4.0 t -55.61 145.43 23.45 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.389 0.614 . . . . 1.28 109.99 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.868 ' HB ' HD13 ' A' ' 6' ' ' ILE . 41.2 p -135.77 -34.51 0.82 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.042 -0.981 . . . . 1.11 111.035 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.56 24.89 71.5 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.591 -1.403 . . . . 0.36 109.591 -174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.868 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.3 mp -89.97 125.73 42.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.062 -1.069 . . . . 1.05 110.061 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.709 HG11 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -95.15 147.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.019 -0.673 . . . . 1.01 110.471 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -141.25 157.23 45.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.196 -0.456 . . . . 2.14 110.416 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.477 ' CE ' ' HB2' ' B' ' 33' ' ' ALA . 9.4 mmpt? -80.33 158.03 26.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.689 -0.687 . . . . 1.63 110.18 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.915 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.2 t -97.2 18.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.763 0.792 . . . . 1.04 110.392 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 15' ' ' ARG . 1.1 t70 66.35 -135.62 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.357 1.075 . . . . 1.32 110.472 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.25 -47.96 1.09 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.314 -1.766 . . . . 2.06 108.455 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.4 mm? -67.04 -22.05 65.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.245 -1.343 . . . . 1.05 110.55 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.11 14.33 7.84 Favored Glycine 0 CA--C 1.499 -0.968 0 C-N-CA 120.898 -0.668 . . . . 0.23 111.55 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.661 ' HA ' ' HA ' ' B' ' 17' ' ' VAL . 18.3 ptt180 -100.83 120.24 39.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.176 0.513 . . . . 1.98 111.617 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.773 HG13 HD23 ' B' ' 45' ' ' LEU . 7.8 p -84.07 128.15 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 108.372 -0.973 . . . . 1.07 108.372 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.66 HG22 ' HB3' ' B' ' 15' ' ' ARG . 13.8 t -76.53 84.44 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.685 -0.806 . . . . 1.05 109.442 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.476 HD13 HD11 ' B' ' 43' ' ' ILE . 0.9 OUTLIER -67.07 124.63 89.33 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.86 -1.064 . . . . 1.05 109.293 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HG2' HD12 ' A' ' 22' ' ' LEU . 50.8 Cg_exo -55.91 139.45 84.38 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.333 2.022 . . . . 0.26 113.329 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.656 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.2 pp -50.52 -35.91 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.697 -1.138 . . . . 1.16 111.107 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.514 ' HG3' HD13 ' A' ' 22' ' ' LEU . 3.6 pt-20 -69.91 -36.21 75.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.817 -1.083 . . . . 1.33 110.727 -174.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.726 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -72.58 -43.73 62.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.827 -0.624 . . . . 1.15 110.921 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.656 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -67.26 -20.92 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.656 -0.868 . . . . 1.67 108.656 178.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -24.87 41.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.703 -1.135 . . . . 2.51 109.57 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.653 HG23 ' HA ' ' A' ' 2' ' ' LYS . 97.5 m -70.67 -42.25 70.98 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.37 -0.832 . . . . 1.09 109.895 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.07 -19.7 39.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 1.24 109.28 178.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.57 17.8 78.52 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.244 -0.889 . . . . 0.42 112.126 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.819 HD12 HD22 ' A' ' 34' ' ' LEU . 44.2 pt -81.1 -156.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.283 -0.636 . . . . 1.34 109.283 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -161.68 176.5 10.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.91 111.243 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.768 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.0 pt-20 -65.21 -41.05 94.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.852 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.682 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 7.4 mmpt? -76.39 -1.44 26.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.52 -0.764 . . . . 1.32 109.785 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -85.55 176.16 8.38 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.902 -0.59 . . . . 1.65 109.898 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' B' ' 8' ' ' ARG . . . -126.84 145.33 50.69 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.558 -0.905 . . . . 1.06 108.558 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.819 HD22 HD12 ' A' ' 28' ' ' ILE . 84.5 mt -123.51 130.61 52.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.501 -0.926 . . . . 1.12 108.501 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.634 ' HG3' HG13 ' B' ' 7' ' ' VAL . 24.4 tt0 -88.6 101.32 13.85 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.705 -1.221 . . . . 1.11 107.705 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.422 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -88.91 135.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.576 -1.193 . . . . 0.97 112.254 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.494 ' HB3' ' OG ' ' B' ' 3' ' ' SER . 4.6 m-85 -127.06 -179.55 4.91 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.397 -1.274 . . . . 2.44 107.979 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 43' ' ' ILE . 9.7 t -147.3 136.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 1.08 110.101 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -119.82 118.83 31.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.641 -0.709 . . . . 1.74 109.098 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.83 -83.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.734 0.646 . . . . 2.01 110.576 -172.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -143.97 18.15 1.78 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.007 -0.997 . . . . 1.67 109.915 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 16.0 pttm -125.82 151.44 46.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.085 -0.646 . . . . 1.41 112.345 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.873 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 17.6 mt -92.37 138.82 19.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.653 -1.158 . . . . 1.06 110.715 -171.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.55 103.11 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.639 -0.504 . . . . 0.99 109.639 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.907 HD13 HD12 ' B' ' 45' ' ' LEU . 10.9 mp -92.12 109.15 20.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.001 0.429 . . . . 1.07 110.424 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -107.15 159.62 16.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.035 -1.469 . . . . 2.8 107.035 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HA ' HD23 ' A' ' 34' ' ' LEU . 8.4 ptpp? -66.59 150.75 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.622 -0.881 . . . . 2.92 108.622 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 29.5 p90 -60.16 159.44 9.67 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.901 -0.407 . . . . 3.76 109.901 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 8.8 tppt? -69.01 111.86 9.78 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.655 -0.498 . . . . 2.33 109.655 -177.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.98 13.61 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.438 2.092 . . . . 1.3 112.339 -173.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -77.48 108.31 10.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.565 -0.743 . . . . 2.65 110.384 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 65.8 mtm -114.25 130.04 56.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.417 -0.811 . . . . 3.54 109.041 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.306 -0.854 . . . . 3.35 110.355 -176.859 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.634 ' HE3' ' HA ' ' B' ' 25' ' ' THR . 87.5 mtp . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.198 -0.297 . . . . 4.28 110.198 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.885 ' HG2' ' H ' ' B' ' 3' ' ' SER . 25.1 ttpt 66.01 -155.37 0.26 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.528 0.517 . . . . 2.68 109.769 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.885 ' H ' ' HG2' ' B' ' 2' ' ' LYS . 2.4 t -55.18 154.55 5.64 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.004 0.907 . . . . 1.53 110.013 172.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.877 ' HB ' HD11 ' B' ' 6' ' ' ILE . 25.0 p -137.86 -39.66 0.56 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.312 -1.313 . . . . 1.02 110.175 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 74.88 28.55 62.52 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.342 -1.503 . . . . 0.29 109.342 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.877 HD11 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -96.7 125.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.939 -1.131 . . . . 1.03 110.049 -173.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.694 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -93.59 148.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.235 -0.586 . . . . 0.9 111.084 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.479 ' HA ' ' HD3' ' B' ' 8' ' ' ARG . 16.4 mmt85 -140.15 154.87 47.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 2.62 110.593 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -79.99 153.71 28.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.085 -0.507 . . . . 2.21 110.082 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.768 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.6 t -93.0 18.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.764 0.792 . . . . 1.12 110.527 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.593 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 23.1 t70 67.18 -136.74 0.12 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.525 -0.761 . . . . 1.17 110.163 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.593 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -131.56 -42.33 1.04 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.76 -1.109 . . . . 2.09 109.11 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.86 -24.21 59.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.038 -0.983 . . . . 1.2 110.077 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.05 16.38 4.42 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 120.716 -0.754 . . . . 0.2 111.751 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.66 ' HB3' HG22 ' A' ' 17' ' ' VAL . 10.6 ptt180 -103.73 121.41 42.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.939 0.4 . . . . 1.98 111.897 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.741 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.75 128.15 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.335 -0.987 . . . . 1.02 108.335 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 17.3 t -76.41 84.75 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 119.673 -0.811 . . . . 1.05 109.507 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.481 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.3 tt -71.08 121.6 84.62 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.145 -0.934 . . . . 1.07 109.209 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.68 140.18 46.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.256 1.971 . . . . 0.22 113.131 -174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -57.36 -26.59 26.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.67 -0.696 . . . . 1.11 110.13 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.5 mt-10 -66.77 -41.68 87.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.671 -1.149 . . . . 1.27 110.448 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.724 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -71.88 -43.55 65.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.675 -0.693 . . . . 1.24 110.34 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.622 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.4 ppt_? -69.3 -17.95 63.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.355 0.598 . . . . 1.4 109.71 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -75.99 -31.11 58.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.817 -1.083 . . . . 2.72 108.474 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.634 ' HA ' ' HE3' ' B' ' 1' ' ' MET . 93.2 m -68.09 -41.14 82.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.144 -0.935 . . . . 0.93 110.516 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.724 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 -19.69 35.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 1.42 111.266 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.93 7.15 78.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.886 -0.673 . . . . 0.52 112.261 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.795 HD11 HD23 ' B' ' 34' ' ' LEU . 42.9 pt -80.9 -156.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.948 0.404 . . . . 1.54 110.294 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -160.25 179.35 8.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.369 -0.378 . . . . 0.92 110.97 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.915 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -74.98 -37.48 61.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.585 0.707 . . . . 1.5 109.986 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.9 mmpt? -77.14 -2.62 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.732 -0.667 . . . . 1.21 109.884 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' B' ' 33' ' ' ALA . 20.7 t70 -84.12 -178.83 7.07 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.104 -0.498 . . . . 2.05 109.852 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.477 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . . . -133.86 144.28 48.83 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.044 -0.724 . . . . 0.7 109.044 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.795 HD23 HD11 ' B' ' 28' ' ' ILE . 92.0 mt -124.67 130.08 51.73 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.755 -0.831 . . . . 1.17 108.755 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.709 ' HG3' HG11 ' A' ' 7' ' ' VAL . 21.7 tt0 -88.33 103.12 15.53 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 107.62 -1.252 . . . . 1.29 107.62 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.441 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.35 133.82 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.273 -1.331 . . . . 1.05 112.588 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.511 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 5.4 m-85 -126.39 -178.99 4.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.716 -1.129 . . . . 2.5 108.152 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 3' ' ' SER . 8.7 t -147.58 137.91 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.399 0.618 . . . . 1.02 110.871 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.426 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.9 t70 -119.46 121.98 40.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.604 -0.726 . . . . 1.71 109.156 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 -87.11 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.798 0.686 . . . . 2.08 110.354 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.43 29.81 1.26 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.262 -0.881 . . . . 2.39 109.649 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 34.7 pttt -127.66 149.45 50.19 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.432 0.634 . . . . 1.48 111.479 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.863 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.5 mt -92.8 139.26 18.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.995 -1.002 . . . . 1.27 110.943 -170.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.07 103.69 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.856 -0.424 . . . . 1.01 109.856 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.907 HD12 HD13 ' A' ' 45' ' ' LEU . 10.9 mp -95.24 109.57 21.67 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.852 0.358 . . . . 1.03 110.494 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' B' ' 35' ' ' GLU . 29.3 ttmt -112.38 153.87 26.64 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 108.047 -1.094 . . . . 2.34 108.047 171.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.784 ' HA ' HD21 ' B' ' 34' ' ' LEU . 9.9 ptpp? -58.49 144.08 43.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.501 -0.555 . . . . 2.75 109.501 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.451 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 3.4 p90 -60.74 151.58 29.1 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 3.63 109.605 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -67.26 112.11 9.12 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.863 0.363 . . . . 2.74 110.128 -174.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.44 23.46 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.098 2.532 . . . . 1.25 112.43 -173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -77.54 90.28 3.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.678 -0.692 . . . . 2.8 110.455 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 64.4 mtt -93.19 116.76 29.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.698 -0.683 . . . . 3.79 109.365 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 38.5 p . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.585 -0.721 . . . . 3.57 110.571 -179.783 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mmt . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 120.904 0.383 . . . . 3.56 111.555 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 3' ' ' SER . 17.8 ptmt -151.92 -140.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.794 -0.817 . . . . 2.48 108.794 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.516 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 98.7 p -45.53 132.2 8.3 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.679 0.752 . . . . 1.28 111.81 176.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.717 ' HB ' HD12 ' A' ' 6' ' ' ILE . 15.2 p -100.06 -34.04 10.23 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.824 -1.08 . . . . 1.11 110.344 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.67 43.68 51.11 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.222 -1.551 . . . . 0.36 109.222 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.717 HD12 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -117.12 126.45 74.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.808 -1.196 . . . . 1.05 109.55 -168.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.663 HG13 ' HA ' ' B' ' 35' ' ' GLU . 3.0 m -97.68 148.58 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.118 -0.633 . . . . 1.01 111.13 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 59.9 mmt-85 -137.41 150.3 47.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.721 -0.672 . . . . 2.14 110.515 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 0.4 OUTLIER -77.84 148.62 34.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.096 -0.502 . . . . 1.63 110.059 172.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.905 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 35.8 t -86.8 20.98 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.847 0.832 . . . . 1.04 110.86 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 38.0 t70 68.51 -124.45 0.15 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.524 -0.762 . . . . 1.32 110.191 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 2.0 pt-20 -142.9 -40.4 0.32 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.472 0.653 . . . . 2.06 109.986 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.448 ' CD2' ' HG3' ' A' ' 12' ' ' GLU . 4.0 mm? -85.47 -0.66 55.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.769 . . . . 1.05 110.395 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' HA2' HG13 ' A' ' 10' ' ' VAL . . . 98.61 16.19 32.25 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 115.741 -0.663 . . . . 0.23 112.407 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.922 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 11.0 ptt180 -100.71 116.95 33.83 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.83 0.348 . . . . 1.98 110.831 176.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.692 HG11 HG11 ' B' ' 16' ' ' VAL . 4.5 p -82.82 127.44 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.765 -1.198 . . . . 1.07 107.765 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 19.3 t -76.5 84.73 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.809 -0.756 . . . . 1.05 109.31 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.481 ' CD1' HD11 ' B' ' 43' ' ' ILE . 2.8 tt -67.95 120.57 74.97 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 115.22 -0.9 . . . . 1.05 109.117 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.4 142.84 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.455 2.103 . . . . 0.26 113.617 -173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -55.59 -29.79 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.066 -0.97 . . . . 1.16 110.02 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.2 mt-10 -67.92 -44.23 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.33 110.145 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.761 ' O ' HD23 ' A' ' 26' ' ' LEU . 5.1 mp -70.42 -43.01 70.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.38 -0.827 . . . . 1.15 110.653 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.59 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.0 ppt_? -70.92 -13.75 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.525 0.678 . . . . 1.67 109.181 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -82.74 -25.49 32.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.998 -1.001 . . . . 2.51 109.375 171.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 88.4 m -70.43 -42.82 71.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.566 -0.743 . . . . 1.09 109.815 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -85.54 -15.22 43.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.618 -0.719 . . . . 1.24 109.781 177.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 17.42 78.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.351 -0.841 . . . . 0.42 112.493 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.718 HD13 HD23 ' A' ' 34' ' ' LEU . 37.6 pt -77.85 -160.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.86 -0.422 . . . . 1.34 109.86 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.04 177.37 10.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.91 110.77 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.885 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 11.8 pt-20 -69.4 -40.74 77.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.805 0.812 . . . . 2.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -78.92 0.86 25.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.244 -0.889 . . . . 1.32 109.481 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.14 165.95 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.4 -0.818 . . . . 1.65 109.779 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.9 154.99 24.38 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.071 -0.715 . . . . 1.06 109.071 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.722 HD21 ' HA ' ' A' ' 47' ' ' LYS . 80.6 mt -129.95 130.97 45.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.671 -1.233 . . . . 1.12 107.671 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' HA ' HG13 ' B' ' 7' ' ' VAL . 29.3 tt0 -89.38 98.01 11.52 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.991 -0.744 . . . . 1.11 108.991 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.502 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 3.0 mp -89.57 135.4 26.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.968 -1.014 . . . . 0.97 112.611 -171.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 83.4 m-85 -130.65 -177.75 4.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.16 -1.382 . . . . 2.44 107.877 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.634 HG23 ' HA ' ' A' ' 43' ' ' ILE . 7.7 t -146.8 131.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.39 0.614 . . . . 1.08 110.309 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' H ' HD11 ' A' ' 44' ' ' ILE . 15.2 t70 -104.95 104.61 14.4 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.914 -1.039 . . . . 1.74 109.278 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 t70 68.47 -71.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 O-C-N 124.165 0.916 . . . . 2.01 111.106 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -143.47 8.45 1.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 1.67 111.238 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 17.4 pttm -129.05 155.98 44.56 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 112.947 0.721 . . . . 1.41 112.947 -175.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.861 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.4 mt -93.03 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.118 -0.946 . . . . 1.06 111.147 -170.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.489 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -125.73 104.84 13.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.686 -0.487 . . . . 0.99 109.686 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.897 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -93.48 107.46 19.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.462 0.649 . . . . 1.07 110.321 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 26.0 ttmt -95.37 157.24 15.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.701 -1.222 . . . . 2.8 107.701 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.722 ' HA ' HD21 ' A' ' 34' ' ' LEU . 9.6 ptpp? -73.51 138.92 45.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.589 -0.893 . . . . 2.92 108.589 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.485 ' HD1' HG11 ' B' ' 7' ' ' VAL . 72.5 t80 -60.89 143.99 53.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.227 -0.657 . . . . 3.76 109.227 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.639 ' HD3' ' HD2' ' A' ' 50' ' ' PRO . 17.8 tppt? -67.18 112.07 8.93 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.621 -0.881 . . . . 2.33 108.621 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.639 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 89.4 Cg_endo -75.97 34.19 0.42 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.914 2.409 . . . . 1.3 112.555 -171.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 49' ' ' LYS . 16.9 t30 -87.73 90.15 8.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.037 -0.983 . . . . 2.65 109.413 174.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.2 mtm -91.78 113.76 26.12 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.755 -0.657 . . . . 3.54 109.796 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.591 -0.719 . . . . 3.35 110.353 -176.152 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.956 0.407 . . . . 4.28 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.544 ' HE2' ' OG ' ' B' ' 3' ' ' SER . 15.5 ptmt -170.76 -144.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.817 -0.809 . . . . 2.68 108.817 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.544 ' OG ' ' HE2' ' B' ' 2' ' ' LYS . 57.2 p -51.04 132.63 27.68 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.698 0.761 . . . . 1.53 110.842 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.717 ' HB ' HD13 ' B' ' 6' ' ' ILE . 7.4 p -99.74 -32.6 10.96 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.109 -0.951 . . . . 1.02 110.195 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.81 40.44 64.45 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.321 -1.511 . . . . 0.29 109.321 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.717 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -114.02 125.68 71.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 113.952 -1.124 . . . . 1.03 109.709 -168.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.0 m -95.06 146.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.392 -0.523 . . . . 0.9 110.883 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -136.42 155.29 50.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 2.62 110.416 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.444 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.2 mmpp? -78.5 153.86 30.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.039 -0.528 . . . . 2.21 109.773 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.885 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 25.3 t -92.38 19.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.815 0.817 . . . . 1.12 110.35 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 9.7 t70 65.43 -139.12 0.2 Allowed 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.29 -0.868 . . . . 1.17 109.33 174.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.483 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -121.71 -47.57 2.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.46 0.648 . . . . 2.09 110.528 176.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.09 -16.62 61.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.753 -0.658 . . . . 1.2 111.392 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.13 12.16 7.11 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.755 -0.736 . . . . 0.2 111.428 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.922 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -98.19 121.48 40.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.98 0.419 . . . . 1.98 111.466 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.692 HG11 HG11 ' A' ' 16' ' ' VAL . 9.9 p -83.27 125.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.028 -1.101 . . . . 1.02 108.028 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 11.0 t -76.33 84.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 119.583 -0.847 . . . . 1.05 109.042 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.446 ' CD1' HD11 ' A' ' 43' ' ' ILE . 2.4 tt -68.58 120.78 77.78 Favored Pre-proline 0 N--CA 1.437 -1.082 0 CA-C-N 115.268 -0.878 . . . . 1.07 108.985 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.79 142.97 40.14 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.267 1.978 . . . . 0.22 113.172 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.4 pp -58.02 -26.69 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.69 -0.687 . . . . 1.11 109.787 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.4 mt-10 -67.18 -44.15 80.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.599 -1.182 . . . . 1.27 110.228 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.746 ' O ' HD23 ' B' ' 26' ' ' LEU . 6.0 mp -70.74 -42.99 69.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.677 -0.692 . . . . 1.24 110.612 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.595 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.2 ppt_? -66.28 -23.8 66.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.703 -0.851 . . . . 1.4 108.703 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.7 OUTLIER -73.62 -29.32 62.29 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.557 -1.201 . . . . 2.72 109.151 175.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 92.9 m -70.14 -42.03 73.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.754 -1.112 . . . . 0.93 110.917 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.746 HD23 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -86.15 -16.6 37.38 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.684 -0.406 . . . . 1.42 110.951 -178.213 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.23 50.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.787 -0.72 . . . . 0.52 111.937 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.614 HD13 HD23 ' B' ' 34' ' ' LEU . 30.4 pt -100.18 -163.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.818 -0.438 . . . . 1.54 109.818 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' B' ' 32' ' ' ASP . . . -161.81 175.02 12.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.453 -0.34 . . . . 0.92 110.653 -176.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.905 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 11.2 pt-20 -65.82 -37.68 86.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.708 0.766 . . . . 1.5 110.499 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.539 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -82.5 1.4 37.94 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.325 -0.852 . . . . 1.21 109.458 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.439 ' O ' HG21 ' A' ' 10' ' ' VAL . 33.7 t70 -93.84 148.62 21.96 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.77 -0.65 . . . . 2.05 110.173 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.493 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -94.99 151.88 18.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.334 0.588 . . . . 0.7 109.972 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 82.0 mt -123.4 133.38 54.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.658 -1.238 . . . . 1.17 107.658 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.663 ' HA ' HG13 ' A' ' 7' ' ' VAL . 27.3 tt0 -90.42 95.83 10.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.684 -0.858 . . . . 1.29 108.684 -175.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.461 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 3.1 mp -89.96 134.12 29.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.183 0.992 . . . . 1.05 112.763 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.574 ' HE1' ' HG2' ' B' ' 35' ' ' GLU . 25.4 m-85 -132.09 -178.35 4.86 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.969 -1.469 . . . . 2.5 107.758 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.64 HG22 ' HA ' ' B' ' 43' ' ' ILE . 8.8 t -147.51 132.24 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 1.02 110.142 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.5 ' H ' HD11 ' B' ' 44' ' ' ILE . 21.8 t70 -107.98 107.79 18.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.499 -0.773 . . . . 1.71 109.486 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 64.47 -69.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.802 1.314 . . . . 2.08 112.08 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.84 12.07 1.43 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.62 -0.718 . . . . 2.39 111.427 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.458 ' O ' HG12 ' B' ' 38' ' ' VAL . 0.0 OUTLIER -137.77 157.05 47.25 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.232 -0.987 . . . . 1.48 112.503 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.897 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 20.0 mt -92.5 139.29 18.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.768 -1.105 . . . . 1.27 111.308 -168.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.5 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -123.2 104.86 14.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 1.01 109.418 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.883 HD12 HD11 ' A' ' 45' ' ' LEU . 10.7 mp -94.04 107.5 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.387 0.613 . . . . 1.03 109.891 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.402 ' HB3' ' HB3' ' B' ' 35' ' ' GLU . 30.7 ttmt -94.53 159.03 15.27 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.427 -1.323 . . . . 2.34 107.427 172.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.597 ' HA ' HD21 ' B' ' 34' ' ' LEU . 18.1 ptpt -75.49 141.49 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.783 -1.191 . . . . 2.75 107.783 171.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.45 ' CD1' HG11 ' A' ' 7' ' ' VAL . 26.1 t80 -67.3 144.19 56.02 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 119.726 -0.79 . . . . 3.63 109.364 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.461 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 15.7 tppt? -66.81 121.19 76.54 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.507 -0.923 . . . . 2.74 108.507 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 97.9 Cg_endo -80.42 22.3 0.78 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.342 2.028 . . . . 1.25 112.118 -170.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -71.51 87.03 0.88 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.41 -0.814 . . . . 2.8 109.429 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 44.6 mtm -92.31 109.18 20.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.366 -0.834 . . . . 3.79 109.013 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.885 -0.579 . . . . 3.57 110.324 -178.892 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.379 0.609 . . . . 3.56 110.375 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -170.72 -157.82 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.256 -0.883 . . . . 2.48 109.479 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' B' ' 37' ' ' TYR . 31.2 t -51.58 142.85 13.41 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.726 0.774 . . . . 1.28 111.196 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.845 ' HB ' HD12 ' A' ' 6' ' ' ILE . 23.2 p -119.84 -28.68 5.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.893 -1.048 . . . . 1.11 111.052 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.05 39.91 93.05 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.012 -1.235 . . . . 0.36 110.012 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.845 HD12 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -106.77 125.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.518 -0.841 . . . . 1.05 109.653 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.95 144.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 119.968 -0.693 . . . . 1.01 111.121 -176.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 36.7 mmt180 -135.38 158.64 43.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.938 -0.573 . . . . 2.14 110.142 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.28 155.77 28.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.06 -0.518 . . . . 1.63 110.527 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.807 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.9 t -89.28 15.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.973 0.892 . . . . 1.04 109.587 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 73.85 -108.34 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 114.879 -1.055 . . . . 1.32 111.008 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.97 -42.17 0.07 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.649 0.738 . . . . 2.06 109.961 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.38 -5.14 59.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.569 -0.741 . . . . 1.05 110.392 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.81 18.39 10.76 Favored Glycine 0 CA--C 1.498 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.23 111.831 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.728 ' HB3' HG22 ' B' ' 17' ' ' VAL . 2.5 ptt180 -105.69 121.62 44.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.869 0.366 . . . . 1.98 111.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.819 HG13 HD22 ' B' ' 45' ' ' LEU . 8.0 p -83.44 126.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.453 -0.943 . . . . 1.07 108.453 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' B' ' 15' ' ' ARG . 18.7 t -76.49 85.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.873 -0.731 . . . . 1.05 109.515 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.429 HD12 HD11 ' B' ' 43' ' ' ILE . 1.8 tt -67.09 121.63 79.11 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 115.096 -0.956 . . . . 1.05 109.458 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HG2' HD13 ' A' ' 22' ' ' LEU . 53.0 Cg_exo -54.79 146.16 57.14 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.462 2.108 . . . . 0.26 113.883 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.562 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.4 pp -53.56 -35.62 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.91 -1.041 . . . . 1.16 110.88 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.546 ' HG3' HD11 ' A' ' 22' ' ' LEU . 3.7 pt-20 -72.65 -37.31 68.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.757 -1.111 . . . . 1.33 110.546 -174.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.741 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -72.94 -42.2 63.7 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.698 -0.683 . . . . 1.15 110.377 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -69.37 -17.34 63.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.05 -0.722 . . . . 1.67 109.05 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -79.27 -29.78 42.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.3 -0.864 . . . . 2.51 108.685 172.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 99.8 m -66.85 -41.71 86.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.317 -0.856 . . . . 1.09 110.111 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.741 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.12 -19.18 40.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.056 -0.72 . . . . 1.24 109.056 176.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.37 20.09 79.03 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.942 -1.026 . . . . 0.42 112.148 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.767 HD13 HD23 ' A' ' 34' ' ' LEU . 42.2 pt -83.67 -158.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.074 0.464 . . . . 1.34 110.085 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -160.84 -179.38 7.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.787 -0.642 . . . . 0.91 110.093 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.727 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 7.8 pt-20 -72.09 -28.37 63.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.473 0.654 . . . . 2.0 110.723 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.659 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 1.7 mmpt? -89.66 2.4 54.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.312 -0.858 . . . . 1.32 109.02 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -84.15 163.71 19.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.395 -0.821 . . . . 1.65 110.461 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.49 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.58 155.19 23.72 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.818 -0.808 . . . . 1.06 108.818 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.767 HD23 HD13 ' A' ' 28' ' ' ILE . 96.0 mt -130.05 131.43 45.8 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.269 -1.011 . . . . 1.12 108.269 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.589 ' HG3' HG11 ' B' ' 7' ' ' VAL . 40.1 tt0 -89.43 101.19 13.86 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.335 -0.987 . . . . 1.11 108.335 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.528 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 3.3 mp -90.15 133.92 30.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.998 0.904 . . . . 0.97 112.776 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -124.73 -179.01 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.238 -1.346 . . . . 2.44 108.061 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.0 t -147.16 127.35 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.731 0.777 . . . . 1.08 111.609 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.554 ' H ' HD12 ' A' ' 44' ' ' ILE . 21.5 t70 -99.09 103.86 15.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.051 -0.977 . . . . 1.74 108.851 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 -74.23 0.06 Allowed 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 124.091 0.87 . . . . 2.01 110.981 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' O ' HD12 ' B' ' 26' ' ' LEU . 13.3 pt-20 -149.51 22.46 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.538 -0.756 . . . . 1.67 110.571 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 14.5 pttm -126.66 157.14 39.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.341 0.591 . . . . 1.41 112.124 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.908 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 8.4 mt -93.25 139.9 17.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.238 -0.892 . . . . 1.06 111.456 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.554 HD12 ' H ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -128.24 104.01 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.795 -0.446 . . . . 0.99 109.795 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.948 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -94.33 108.58 20.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.532 0.682 . . . . 1.07 110.773 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HE2' ' HB3' ' A' ' 35' ' ' GLU . 32.3 ttpt -98.61 155.44 17.3 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.326 -1.361 . . . . 2.8 107.326 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.707 ' HA ' HD21 ' A' ' 34' ' ' LEU . 18.9 ptpt -71.64 142.72 49.91 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.978 -0.749 . . . . 2.92 108.978 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.403 ' CD1' HG12 ' B' ' 7' ' ' VAL . 47.6 t80 -63.94 144.47 57.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.602 -0.439 . . . . 3.76 109.923 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -68.34 112.37 10.77 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.231 -0.895 . . . . 2.33 109.521 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -82.37 20.57 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.925 2.417 . . . . 1.3 111.565 -174.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -87.94 107.93 18.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.235 -0.893 . . . . 2.65 110.108 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -131.64 122.07 25.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.598 -0.519 . . . . 3.54 109.598 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.591 -0.718 . . . . 3.35 110.784 -175.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.105 0.478 . . . . 4.28 110.934 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.31 -159.03 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.552 -0.749 . . . . 2.68 109.562 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.427 ' HA ' ' N ' ' A' ' 38' ' ' VAL . 13.9 m -51.44 131.06 28.69 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.475 0.655 . . . . 1.53 111.428 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.558 ' HB ' HD12 ' B' ' 6' ' ' ILE . 12.4 p -102.28 -30.71 10.92 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.139 -0.937 . . . . 1.02 110.146 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.55 40.37 96.06 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.49 -1.444 . . . . 0.29 109.49 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.558 HD12 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -110.61 126.1 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.354 -0.923 . . . . 1.03 109.906 -168.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -94.88 143.09 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.106 -0.638 . . . . 0.9 111.163 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.755 ' HE ' ' HG3' ' B' ' 19' ' ' PRO . 34.3 mmt180 -133.54 157.4 45.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 2.62 109.773 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.49 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.5 mmpp? -79.32 157.24 27.73 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.39 0.431 . . . . 2.21 110.168 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.727 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.3 t -89.8 12.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.158 0.98 . . . . 1.12 109.437 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 74.77 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 114.435 -1.257 . . . . 1.17 111.62 168.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.447 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.3 pt-20 -160.12 -45.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.279 0.561 . . . . 2.09 110.082 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.447 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.05 -3.25 57.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.085 -0.507 . . . . 1.2 110.909 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 14.24 17.56 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 120.77 -0.728 . . . . 0.2 111.612 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 17' ' ' VAL . 8.3 ptt180 -103.13 121.19 42.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.721 0.296 . . . . 1.98 111.568 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.741 HG13 HD21 ' A' ' 45' ' ' LEU . 9.7 p -83.21 125.68 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.346 -0.983 . . . . 1.02 108.346 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 15' ' ' ARG . 16.3 t -76.12 85.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.948 -0.701 . . . . 1.05 109.402 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.425 HD11 HD11 ' A' ' 43' ' ' ILE . 1.9 tt -67.62 121.26 78.47 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 115.101 -0.954 . . . . 1.07 109.242 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.755 ' HG3' ' HE ' ' B' ' 8' ' ' ARG . 51.2 Cg_exo -54.84 147.36 51.49 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.504 2.136 . . . . 0.22 113.293 -172.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.2 pp -59.34 -30.65 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.212 0.53 . . . . 1.11 109.973 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.11 -42.97 93.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.688 -1.142 . . . . 1.27 109.99 -177.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.7 ' O ' HD22 ' B' ' 26' ' ' LEU . 7.1 mp -73.02 -42.62 63.01 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.262 -0.881 . . . . 1.24 110.756 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.628 ' HB2' HG13 ' B' ' 28' ' ' ILE . 7.0 ppt_? -68.68 -20.04 64.42 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.933 -0.766 . . . . 1.4 108.933 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.568 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.9 OUTLIER -73.78 -30.94 63.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.483 -1.235 . . . . 2.72 109.073 172.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 99.6 m -72.1 -39.03 69.21 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.67 -1.15 . . . . 0.93 110.846 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.7 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -83.89 -19.28 35.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 1.42 110.471 -178.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.18 25.47 55.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.983 -0.627 . . . . 0.52 112.079 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.8 HD11 HD22 ' B' ' 34' ' ' LEU . 39.6 pt -99.72 -159.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.799 0.333 . . . . 1.54 110.142 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 32' ' ' ASP . . . -165.3 179.34 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.882 -0.599 . . . . 0.92 109.657 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.807 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 13.1 pt-20 -69.47 -32.77 71.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.481 0.658 . . . . 1.5 111.044 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.535 ' HA ' ' HE3' ' B' ' 31' ' ' LYS . 0.0 OUTLIER -85.48 1.64 48.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.521 -0.763 . . . . 1.21 109.368 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' B' ' 29' ' ' ALA . 0.7 OUTLIER -88.16 160.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.44 -0.8 . . . . 2.05 111.054 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.75 155.84 20.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 0.7 109.233 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.8 HD22 HD11 ' B' ' 28' ' ' ILE . 98.8 mt -130.72 130.66 44.09 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.319 -0.993 . . . . 1.17 108.319 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.593 ' HG3' HG13 ' A' ' 7' ' ' VAL . 40.1 tt0 -89.25 100.3 13.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.994 -1.113 . . . . 1.29 107.994 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.24 135.89 24.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.021 -0.99 . . . . 1.05 112.477 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.52 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 41.0 m-85 -127.06 -178.89 4.59 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.154 -1.385 . . . . 2.5 108.134 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 42' ' ' LYS . 24.0 t -145.29 134.68 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.274 0.559 . . . . 1.02 110.846 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.515 ' N ' HD12 ' B' ' 44' ' ' ILE . 6.2 t70 -100.1 97.05 7.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.246 -0.888 . . . . 1.71 108.788 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.09 -65.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.232 0.958 . . . . 2.08 111.398 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 26' ' ' LEU . 6.7 pt-20 -150.35 19.39 0.84 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.494 -0.776 . . . . 2.39 111.205 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 52.8 pttt -130.18 156.96 43.71 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.256 -0.578 . . . . 1.48 111.865 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.948 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 9.7 mt -92.7 139.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.534 -0.757 . . . . 1.27 111.414 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.515 HD12 ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -128.08 104.64 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.684 -0.487 . . . . 1.01 109.684 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.913 HD12 HD12 ' A' ' 45' ' ' LEU . 11.2 mp -92.81 107.94 19.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.343 0.592 . . . . 1.03 110.689 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.526 ' HE2' ' HB3' ' B' ' 35' ' ' GLU . 30.4 ttpt -96.76 156.46 16.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.283 -1.377 . . . . 2.34 107.283 171.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.711 ' HA ' HD23 ' B' ' 34' ' ' LEU . 16.4 ptpt -74.93 139.5 43.09 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.734 -0.839 . . . . 2.75 108.734 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -64.64 136.87 57.43 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.296 -0.561 . . . . 3.63 109.794 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.408 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 15.6 tppt? -68.56 114.18 20.43 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.876 -0.602 . . . . 2.74 109.52 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.408 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 69.1 Cg_endo -82.52 21.4 0.99 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.784 2.323 . . . . 1.25 111.994 -174.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.31 99.15 5.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.286 -0.87 . . . . 2.8 110.081 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -123.76 111.19 15.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.752 -0.658 . . . . 3.79 109.806 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.675 -0.693 . . . . 3.57 110.635 -179.231 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.202 -0.296 . . . . 3.56 110.202 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' HE2' ' OG ' ' A' ' 3' ' ' SER . 17.1 ptmt -160.92 -123.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.238 -0.653 . . . . 2.48 109.238 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.56 ' HB3' ' O ' ' B' ' 38' ' ' VAL . 92.7 p -55.6 127.8 31.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.224 0.535 . . . . 1.28 110.85 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.808 ' HB ' HD12 ' A' ' 6' ' ' ILE . 17.7 p -100.06 -35.92 9.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.438 -0.801 . . . . 1.11 110.353 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.06 50.13 11.36 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.254 -1.539 . . . . 0.36 109.254 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.808 HD12 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -122.42 125.32 72.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.447 -0.876 . . . . 1.05 109.83 -168.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.9 m -95.99 145.53 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.94 -0.704 . . . . 1.01 110.861 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.59 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 38.7 mmt180 -135.97 157.95 45.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 2.14 110.442 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.528 ' CE ' ' HB2' ' B' ' 33' ' ' ALA . 2.5 mmpp? -78.63 153.61 30.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.266 -0.424 . . . . 1.63 110.489 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.785 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.3 t -94.21 13.47 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.683 -0.69 . . . . 1.04 110.566 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 11.1 t70 66.2 -149.65 0.21 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.692 -0.686 . . . . 1.32 110.037 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.553 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -115.75 -44.27 2.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.81 0.814 . . . . 2.06 109.061 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.57 -16.87 62.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.691 -1.141 . . . . 1.05 111.033 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.34 26.5 Favored Glycine 0 CA--C 1.495 -1.157 0 C-N-CA 120.798 -0.715 . . . . 0.23 112.467 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.758 ' HD2' ' HG3' ' B' ' 15' ' ' ARG . 1.9 ptt85 -95.55 121.31 37.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 120.329 -0.548 . . . . 1.98 111.465 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 9.7 p -82.55 131.05 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 108.261 -1.014 . . . . 1.07 108.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 14.6 t -75.58 85.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 119.666 -0.814 . . . . 1.05 109.304 -176.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.9 tt -71.28 116.96 52.41 Favored Pre-proline 0 N--CA 1.429 -1.481 0 N-CA-C 108.047 -1.094 . . . . 1.05 108.047 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.59 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 52.2 Cg_exo -54.17 138.82 72.05 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.046 1.831 . . . . 0.26 112.689 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.422 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.6 pp -56.2 -29.64 28.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.692 -0.685 . . . . 1.16 109.945 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -66.34 -44.34 83.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.599 -1.182 . . . . 1.33 110.011 -177.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.785 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -69.89 -45.13 68.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.384 -0.826 . . . . 1.15 110.708 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.562 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -70.18 -13.8 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.694 0.759 . . . . 1.67 108.966 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.0 tmt_? -82.83 -28.38 30.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.981 -1.009 . . . . 2.51 109.397 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 92.0 m -69.72 -43.91 71.39 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.199 -0.909 . . . . 1.09 109.919 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.785 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.38 -15.47 56.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.622 -0.717 . . . . 1.24 109.2 177.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.65 21.8 76.29 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.051 -0.977 . . . . 0.42 112.475 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.725 HD11 HD22 ' A' ' 34' ' ' LEU . 35.1 pt -83.91 -158.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.853 -0.795 . . . . 1.34 108.853 171.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -154.8 179.34 9.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.136 -0.32 . . . . 0.91 110.136 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.971 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -77.97 -32.74 51.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.951 0.881 . . . . 2.0 109.126 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.637 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 11.3 mmpt? -79.52 -0.01 31.55 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.026 -0.988 . . . . 1.32 109.712 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -87.53 172.96 9.38 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.601 -0.727 . . . . 1.65 109.16 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.491 ' HB3' ' HE3' ' B' ' 9' ' ' LYS . . . -120.95 150.92 40.36 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.613 -0.884 . . . . 1.06 108.613 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.8 HD11 HD23 ' A' ' 45' ' ' LEU . 53.5 mt -124.75 128.97 49.59 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.73 -0.841 . . . . 1.12 108.73 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 61.0 tt0 -88.57 97.65 11.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.952 -0.759 . . . . 1.11 108.952 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.7 mp -89.89 135.98 24.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.739 -1.119 . . . . 0.97 112.792 -173.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 1.058 ' HE2' ' HE2' ' A' ' 46' ' ' LYS . 78.5 m-85 -130.11 -177.62 4.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.126 -1.397 . . . . 2.44 107.57 174.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.643 HG12 HD12 ' B' ' 26' ' ' LEU . 6.4 t -147.05 133.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.391 0.615 . . . . 1.08 110.798 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.527 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 22.4 t70 -99.09 95.18 6.94 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.079 -0.964 . . . . 1.74 108.671 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 65.52 -66.05 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.361 1.038 . . . . 2.01 112.181 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -137.08 -3.2 2.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.674 -0.694 . . . . 1.67 111.254 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 36.4 pttt -118.56 150.21 40.03 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.744 -0.783 . . . . 1.41 112.086 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.937 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 19.4 mt -92.64 138.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.003 -0.999 . . . . 1.06 110.814 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.44 HD12 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -124.32 106.76 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.489 -0.56 . . . . 0.99 109.489 -177.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.866 HD11 HD11 ' B' ' 45' ' ' LEU . 10.9 mp -98.59 112.04 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.933 0.397 . . . . 1.07 110.657 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.058 ' HE2' ' HE2' ' A' ' 37' ' ' TYR . 38.0 mtmt -100.65 165.68 11.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.864 -1.162 . . . . 2.8 107.864 167.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.494 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.0 ptpt -72.19 143.76 48.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.042 -1.466 . . . . 2.92 107.042 165.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 5.3 p90 -62.28 149.95 40.56 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.023 -0.671 . . . . 3.76 111.026 -173.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HD3' ' HD2' ' A' ' 50' ' ' PRO . 17.7 tppt? -66.85 111.93 8.29 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 115.819 -0.628 . . . . 2.33 110.352 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.424 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 95.4 Cg_endo -83.61 35.99 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.784 2.323 . . . . 1.3 111.594 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -73.61 87.84 1.66 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.646 -0.706 . . . . 2.65 110.212 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.1 ptm -93.58 111.54 23.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.349 -0.841 . . . . 3.54 109.372 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.249 1.037 0 CA-C-N 116.107 -0.497 . . . . 3.35 110.405 -176.391 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mmm . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.583 -0.154 . . . . 4.28 110.583 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.479 ' HE2' ' OG ' ' B' ' 3' ' ' SER . 13.2 ptmt 42.59 -145.17 0.07 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.207 1.003 . . . . 2.68 113.334 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.595 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 79.1 p -46.99 133.93 10.81 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 114.853 -1.067 . . . . 1.53 112.115 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.784 ' HB ' HD12 ' B' ' 6' ' ' ILE . 16.2 p -104.64 -37.02 7.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.842 -1.072 . . . . 1.02 110.253 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.1 46.25 10.59 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.394 -1.482 . . . . 0.29 109.394 -172.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.784 HD12 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.221 -0.989 . . . . 1.03 109.945 -167.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.74 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.3 m -93.01 149.32 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.197 -0.601 . . . . 0.9 110.582 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 13.3 mmt85 -139.76 156.76 46.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.184 -0.462 . . . . 2.62 110.813 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.491 ' HE3' ' HB3' ' A' ' 33' ' ' ALA . 4.3 mmpp? -77.98 153.91 32.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.892 -0.595 . . . . 2.21 110.153 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.971 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 19.5 t -96.12 15.74 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.54 -0.754 . . . . 1.12 110.489 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.576 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 13.8 t70 68.19 -146.88 0.13 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.627 -0.715 . . . . 1.17 109.832 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.576 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -119.52 -44.93 2.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.984 0.897 . . . . 2.09 108.682 175.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.69 -28.86 69.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.021 -1.445 . . . . 1.2 110.715 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.9 0.14 9.08 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 120.557 -0.83 . . . . 0.2 111.42 174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.758 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 5.6 ptt180 -92.48 121.41 33.91 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.913 0.387 . . . . 1.98 111.853 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 16' ' ' VAL . 7.7 p -82.82 128.96 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.131 -1.063 . . . . 1.02 108.131 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.624 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 10.0 t -75.77 85.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.556 -0.858 . . . . 1.05 109.089 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.476 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.6 tt -70.19 115.66 36.67 Favored Pre-proline 0 N--CA 1.428 -1.539 0 N-CA-C 108.285 -1.006 . . . . 1.07 108.285 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.494 ' HB2' HD11 ' B' ' 22' ' ' LEU . 78.2 Cg_exo -50.09 138.99 35.37 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.304 2.003 . . . . 0.22 112.863 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.86 -30.89 23.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.684 -0.689 . . . . 1.11 109.977 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.8 -42.94 90.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.621 -1.172 . . . . 1.27 110.555 -177.045 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -70.5 -46.81 62.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.017 -0.538 . . . . 1.24 110.856 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.554 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.5 ppt_? -69.78 -15.07 63.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.39 0.614 . . . . 1.4 109.635 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -76.93 -32.55 57.42 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.057 -0.974 . . . . 2.72 109.041 170.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.1 m -72.0 -39.86 68.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.167 -0.924 . . . . 0.93 110.696 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.766 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -82.87 -14.58 54.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.863 -0.608 . . . . 1.42 110.778 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.3 80.66 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.829 -0.7 . . . . 0.52 112.592 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.62 HD12 HD22 ' B' ' 34' ' ' LEU . 38.0 pt -83.39 -158.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.603 -0.517 . . . . 1.54 109.603 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.51 175.17 14.02 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.878 0.371 . . . . 0.92 110.92 -176.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.785 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.6 pt-20 -72.41 -40.98 66.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.124 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.536 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 10.3 mmpt? -80.8 4.26 19.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.39 -0.823 . . . . 1.21 109.616 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' B' ' 33' ' ' ALA . 17.6 t70 -85.77 -176.11 5.89 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.109 -0.7 . . . . 2.05 109.109 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.528 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . . . -135.25 146.17 48.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.673 -0.862 . . . . 0.7 108.673 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.859 HD11 HD22 ' B' ' 45' ' ' LEU . 53.0 mt -123.72 127.42 48.13 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.302 -0.629 . . . . 1.17 109.302 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' B' ' 48' ' ' TYR . 27.8 tt0 -87.63 95.89 10.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.263 -1.014 . . . . 1.29 108.263 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 2.7 mp -89.87 136.62 23.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.543 -1.208 . . . . 1.05 112.783 -173.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.431 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 77.6 m-85 -134.37 -177.99 4.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.083 -1.417 . . . . 2.5 107.4 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' B' ' 43' ' ' ILE . 6.5 t -147.56 135.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.311 0.577 . . . . 1.02 111.182 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -104.58 105.85 16.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.344 -0.844 . . . . 1.71 109.204 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 61.15 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.269 0.981 . . . . 2.08 111.035 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.62 14.99 2.15 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.632 -0.713 . . . . 2.39 111.485 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 9.7 pttm -124.11 151.53 43.81 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 119.62 -0.832 . . . . 1.48 112.077 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.843 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 4.9 mp -92.54 138.83 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.101 -0.954 . . . . 1.27 111.612 -169.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' B' ' 36' ' ' ILE . 0.1 OUTLIER -121.74 110.62 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 1.01 109.546 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.937 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -103.54 109.18 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 1.03 110.992 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.48 ' HG2' ' HB2' ' A' ' 42' ' ' LYS . 53.4 mtmt -105.66 165.19 11.34 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.665 -1.235 . . . . 2.34 107.665 168.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.453 ' HE2' HG22 ' B' ' 28' ' ' ILE . 16.4 ptpt -68.89 150.97 47.16 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.153 -1.054 . . . . 2.75 108.153 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.614 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 35.9 p90 -59.3 153.46 18.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.324 -0.25 . . . . 3.63 110.324 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.534 ' HB2' ' HZ1' ' B' ' 49' ' ' LYS . 0.8 OUTLIER -68.18 112.28 10.38 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 109.756 -0.461 . . . . 2.74 109.756 -178.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -86.52 18.79 1.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.872 2.381 . . . . 1.25 111.637 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -71.9 99.83 2.3 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.045 -0.979 . . . . 2.8 110.57 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 26.7 ptm -99.53 128.03 45.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.994 -1.003 . . . . 3.79 109.047 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.878 -0.582 . . . . 3.57 110.456 -178.058 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.585 ' HB3' ' O ' ' B' ' 38' ' ' VAL . 97.7 p . . . . . 0 CA--C 1.506 -0.75 0 CA-C-O 121.278 0.561 . . . . 1.1499999999999999 110.352 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.724 ' HB ' HD13 ' A' ' 6' ' ' ILE . 10.6 p -103.21 -35.94 8.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.728 -0.669 . . . . 0.26000000000000001 110.654 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.03 46.51 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.063 -1.615 . . . . 0.35999999999999999 109.063 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.724 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -118.25 126.15 74.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 113.989 -1.105 . . . . 0.19 109.731 -167.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.51 148.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.995 -0.682 . . . . 0.22 110.756 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.82 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 32.2 mmt180 -137.26 157.3 46.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 1.6000000000000001 110.301 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 8.6 mmpt? -80.06 154.61 28.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.036 -0.529 . . . . 1.0900000000000001 109.841 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.926 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t -88.57 14.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.21 1.005 . . . . 0.25 109.677 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 12' ' ' GLU . 24.4 t70 73.32 -91.81 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.237 -1.347 . . . . 1.3200000000000001 112.558 167.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.519 ' HG2' ' OD2' ' A' ' 11' ' ' ASP . 4.8 pt-20 -161.12 -54.24 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 2.0600000000000001 111.746 -174.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.4 mm? -85.01 -9.88 57.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.217 -0.447 . . . . 0.45000000000000001 110.715 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.428 ' HA2' HG12 ' A' ' 10' ' ' VAL . . . 114.23 14.18 9.29 Favored Glycine 0 CA--C 1.499 -0.918 0 C-N-CA 120.726 -0.75 . . . . 0.19 111.351 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.8 ' HB3' HG22 ' B' ' 17' ' ' VAL . 19.4 ptt180 -97.6 117.08 31.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.575 -0.313 . . . . 1.5800000000000001 110.536 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.691 HG12 HG12 ' B' ' 16' ' ' VAL . 9.8 p -82.92 127.04 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.374 -0.973 . . . . 0.17000000000000001 108.374 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' B' ' 15' ' ' ARG . 19.6 t -75.63 84.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.742 -0.783 . . . . 0.19 109.127 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.451 ' CD1' HD13 ' B' ' 43' ' ' ILE . 2.1 tt -68.47 118.44 59.92 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-N 115.036 -0.984 . . . . 0.20000000000000001 108.797 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.82 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 74.1 Cg_exo -52.0 143.45 40.41 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.341 2.027 . . . . 0.22 113.209 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.429 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -57.42 -32.85 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 115.528 -0.76 . . . . 0.51000000000000001 110.008 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -67.0 -41.84 86.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.708 -1.133 . . . . 1.3300000000000001 110.295 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.655 ' O ' HD22 ' A' ' 26' ' ' LEU . 4.1 mp -68.74 -47.85 65.23 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.549 -0.75 . . . . 0.34000000000000002 110.578 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 2.0 ppt_? -70.11 -11.07 60.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.748 -0.781 . . . . 1.3799999999999999 109.769 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 12.7 ttt180 -80.87 -31.88 35.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.622 -0.717 . . . . 1.9399999999999999 109.456 171.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.4 m -67.57 -43.17 81.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.117 -0.947 . . . . 0.47999999999999998 110.058 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.655 HD22 ' O ' ' A' ' 22' ' ' LEU . 1.1 mm? -86.54 -9.21 56.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.599 -0.728 . . . . 0.57999999999999996 109.942 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.54 91.76 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.796 -0.638 . . . . 0.41999999999999998 112.696 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 1.056 HD13 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.47 -176.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.939 0.496 . . . . 0.69999999999999996 109.705 173.065 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 175.73 10.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.263 -0.426 . . . . 0.31 110.444 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.834 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.4 pt-20 -67.87 -37.85 82.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.53 0.681 . . . . 2.0 111.25 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.63 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 10.9 mmpt? -80.75 -3.25 50.21 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.583 -0.735 . . . . 0.67000000000000004 109.652 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.52 171.89 12.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.549 -0.75 . . . . 1.6499999999999999 110.111 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -117.75 158.12 25.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.38 -0.827 . . . . 0.26000000000000001 108.986 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.056 HD21 HD13 ' A' ' 28' ' ' ILE . 61.8 mt -131.01 127.81 39.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.547 -0.909 . . . . 0.27000000000000002 108.547 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.613 ' HA ' HG12 ' B' ' 7' ' ' VAL . 30.7 tt0 -89.09 96.46 10.73 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.736 -0.839 . . . . 1.1100000000000001 108.736 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.8 mp -90.25 136.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.857 -1.065 . . . . 0.12 112.789 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 16.4 m-85 -132.68 -178.05 4.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.278 -1.328 . . . . 1.54 107.455 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.6 t -147.7 129.66 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.688 0.756 . . . . 0.26000000000000001 111.259 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 44' ' ' ILE . 17.5 t70 -92.51 87.27 5.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.702 -1.135 . . . . 1.74 108.718 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.8 t70 61.46 -67.42 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.662 -1.154 . . . . 2.0099999999999998 112.394 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -120.9 -9.19 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.681 -0.691 . . . . 1.6699999999999999 111.916 -172.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 38' ' ' VAL . 20.3 pttm -127.65 154.9 44.72 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.727 1.01 . . . . 0.75 113.727 -173.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.912 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 25.7 mt -92.27 139.04 18.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.548 -1.205 . . . . 0.16 110.924 -170.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.534 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -124.5 105.62 15.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.9 -0.408 . . . . 0.19 109.9 -177.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.942 HD13 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -97.6 109.09 21.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.223 0.535 . . . . 0.13 110.733 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -98.04 157.19 16.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.186 -1.412 . . . . 2.1099999999999999 107.186 168.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.817 ' HA ' HD23 ' A' ' 34' ' ' LEU . 17.5 ptmt -75.76 148.32 38.59 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 2.48 108.395 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HD1' HG11 ' B' ' 7' ' ' VAL . 76.9 t80 . . . . . 0 C--N 1.319 -0.72 0 C-N-CA 120.798 -0.361 . . . . 3.3300000000000001 110.091 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.544 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 94.2 p . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.364 0.602 . . . . 1.1699999999999999 109.938 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.749 ' HB ' HD13 ' B' ' 6' ' ' ILE . 8.1 p -102.8 -37.02 8.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.395 -0.82 . . . . 0.28000000000000003 110.746 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.6 44.15 41.26 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 108.973 -1.651 . . . . 0.28999999999999998 108.973 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.749 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.94 125.97 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.038 -1.081 . . . . 0.20000000000000001 109.692 -168.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.2 m -93.91 149.6 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.168 -0.613 . . . . 0.20000000000000001 110.822 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.42 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 21.6 mmt180 -139.38 156.34 47.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.874 -0.603 . . . . 1.9399999999999999 110.323 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 7.1 mmpt? -80.26 154.08 28.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.629 -0.714 . . . . 1.3700000000000001 110.011 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.834 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 22.1 t -89.82 17.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.029 0.919 . . . . 0.22 110.025 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t70 71.65 -109.84 0.05 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.682 -1.144 . . . . 1.1699999999999999 110.441 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.0 pt-20 -151.63 -42.23 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.337 0.589 . . . . 2.0899999999999999 111.043 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.47 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.25 -6.39 59.39 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.519 -0.472 . . . . 0.48999999999999999 111.42 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.97 11.21 16.84 Favored Glycine 0 CA--C 1.497 -1.073 0 N-CA-C 110.975 -0.85 . . . . 0.17000000000000001 110.975 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.726 ' HB3' HG22 ' A' ' 17' ' ' VAL . 5.3 ptt180 -99.13 119.87 38.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.527 -0.337 . . . . 1.72 111.277 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.691 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -82.85 127.5 39.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.277 -1.009 . . . . 0.17000000000000001 108.277 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.8 HG22 ' HB3' ' A' ' 15' ' ' ARG . 23.1 t -75.74 85.24 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 119.576 -0.85 . . . . 0.14000000000000001 109.013 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.473 ' CD1' HD13 ' A' ' 43' ' ' ILE . 1.9 tt -68.73 117.47 51.18 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 115.331 -0.85 . . . . 0.16 108.989 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.474 ' HB2' HD13 ' B' ' 22' ' ' LEU . 74.2 Cg_exo -50.68 140.74 36.43 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.605 2.203 . . . . 0.19 113.087 -171.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.5 pp -53.17 -32.14 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.42999999999999999 110.776 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -66.67 -44.64 81.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.299 -0.864 . . . . 1.27 110.191 -176.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.792 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.6 mp -67.42 -46.9 71.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.552 -0.749 . . . . 0.52000000000000002 110.559 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 6.5 ppt_? -68.49 -18.12 64.32 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.065 -0.654 . . . . 1.2 109.342 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.645 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 2.6 ttt180 -72.34 -31.61 65.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.098 -0.956 . . . . 2.1099999999999999 109.054 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 25.3 m -73.71 -43.44 59.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.043 -0.98 . . . . 0.51000000000000001 110.699 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.792 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.3 OUTLIER -89.05 -1.36 58.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.614 -0.434 . . . . 0.58999999999999997 111.467 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.1 35.55 71.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.643 -0.789 . . . . 0.52000000000000002 112.661 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 1.048 HD13 HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -102.06 -178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 0.72999999999999998 110.642 176.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -150.41 173.57 13.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.92000000000000004 109.348 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.926 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.5 pm0 -76.94 -21.56 54.62 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.458 0.647 . . . . 1.5 110.413 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.506 ' HG2' ' HG2' ' B' ' 30' ' ' GLU . 8.3 mmpt? -93.34 0.37 56.9 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.926 -0.768 . . . . 0.46000000000000002 108.926 176.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.456 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 1.5 t0 -84.33 -179.5 7.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.0 -1.0 . . . . 2.0499999999999998 110.128 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.03 156.79 41.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.353 -0.84 . . . . 0.25 108.897 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 1.048 HD21 HD13 ' B' ' 28' ' ' ILE . 37.8 mt -131.16 126.98 37.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.585 -0.894 . . . . 0.33000000000000002 108.585 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.543 ' HG3' HG12 ' A' ' 7' ' ' VAL . 31.9 tt0 -88.33 96.38 10.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.482 -0.933 . . . . 1.29 108.482 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.426 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.43 136.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.739 -1.118 . . . . 0.14000000000000001 112.962 -171.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.436 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 23.6 m-85 -132.22 -178.35 4.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.218 -1.356 . . . . 1.5900000000000001 107.671 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.684 HG22 ' HA ' ' B' ' 43' ' ' ILE . 6.9 t -147.56 133.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 0.19 110.521 174.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.49 ' H ' HD11 ' B' ' 44' ' ' ILE . 30.1 t70 -101.89 93.9 5.52 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.64 -0.874 . . . . 1.71 108.64 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.72 -70.46 0.06 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 124.751 1.282 . . . . 2.0800000000000001 112.014 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -123.75 -2.86 8.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.164 -0.925 . . . . 2.3900000000000001 111.501 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 42.3 pttt -133.14 152.45 51.95 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 119.291 -0.964 . . . . 0.82999999999999996 113.29 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 28.5 mt -92.6 139.12 18.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.954 -1.021 . . . . 0.46999999999999997 110.894 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.49 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.91 105.73 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.74 -0.467 . . . . 0.17999999999999999 109.74 -176.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -97.97 109.03 21.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.062 0.458 . . . . 0.13 110.831 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' B' ' 35' ' ' GLU . 7.6 mtmp? -100.46 154.84 18.21 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.412 -1.329 . . . . 1.98 107.412 168.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.741 ' HE3' HG23 ' B' ' 28' ' ' ILE . 1.3 ptmt -75.58 140.62 42.77 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.761 -0.829 . . . . 2.2000000000000002 108.761 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 t80 . . . . . 0 C--N 1.319 -0.746 0 CA-C-O 121.035 0.445 . . . . 3.3199999999999998 110.289 -178.384 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.52 ' HA ' ' N ' ' B' ' 38' ' ' VAL . 77.3 p . . . . . 0 N--CA 1.439 -1.023 0 CA-C-O 121.175 0.512 . . . . 1.1499999999999999 110.405 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.807 ' HB ' HD13 ' A' ' 6' ' ' ILE . 17.6 p -96.09 -32.42 12.54 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.26000000000000001 110.624 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' B' ' 37' ' ' TYR . . . 70.0 33.64 70.19 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.612 -1.395 . . . . 0.35999999999999999 109.612 -172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.807 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -104.2 123.02 57.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.181 -1.009 . . . . 0.19 109.887 -169.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.756 HG12 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -91.34 146.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.969 -0.692 . . . . 0.22 110.669 -177.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 21.3 mmt180 -138.26 154.11 49.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.469 -0.787 . . . . 1.6000000000000001 110.112 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 5.8 mmpt? -80.36 151.75 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.973 -0.558 . . . . 1.0900000000000001 109.772 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.865 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 24.9 t -94.47 15.9 2.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.806 0.813 . . . . 0.25 110.554 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 13.5 t70 66.29 -147.28 0.19 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.396 -0.82 . . . . 1.3200000000000001 110.111 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.537 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.85 -41.76 2.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.593 -0.891 . . . . 2.0600000000000001 108.593 176.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -10.8 60.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.728 -1.124 . . . . 0.45000000000000001 111.011 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.19 11.38 34.14 Favored Glycine 0 CA--C 1.494 -1.243 0 C-N-CA 120.709 -0.758 . . . . 0.19 112.054 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 8.9 ptp180 -103.88 118.94 37.87 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.047 0.451 . . . . 1.5800000000000001 111.323 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 8.9 p -82.81 129.6 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.933 -0.766 . . . . 0.17000000000000001 108.933 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' B' ' 15' ' ' ARG . 3.5 t -75.89 84.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.975 -0.69 . . . . 0.19 109.455 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.488 ' CD1' HD13 ' B' ' 43' ' ' ILE . 1.9 tt -69.27 121.27 81.43 Favored Pre-proline 0 N--CA 1.435 -1.184 0 CA-C-N 115.1 -0.955 . . . . 0.20000000000000001 109.27 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 55.0 Cg_exo -54.61 143.67 67.44 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.246 1.964 . . . . 0.22 112.969 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -59.02 -28.88 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.51000000000000001 109.857 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -65.91 -44.63 84.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.946 -1.025 . . . . 1.3300000000000001 110.286 -175.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.675 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.9 mp -69.17 -44.82 71.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.642 -0.708 . . . . 0.34000000000000002 110.34 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.681 ' HB2' HG13 ' A' ' 28' ' ' ILE . 4.6 ppt_? -71.05 -10.88 60.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.443 0.639 . . . . 1.3799999999999999 109.62 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.56 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.8 -30.52 32.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.11 -0.95 . . . . 1.9399999999999999 108.916 171.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -67.35 -41.95 84.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.303 -0.862 . . . . 0.47999999999999998 109.851 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.675 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -86.64 -11.85 50.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.647 -0.706 . . . . 0.57999999999999996 110.08 176.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.01 77.56 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.477 -0.783 . . . . 0.41999999999999998 112.771 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.747 HD13 HD21 ' A' ' 34' ' ' LEU . 36.9 pt -88.12 -157.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 0.69999999999999996 109.818 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB1' ' OE2' ' A' ' 30' ' ' GLU . . . -161.45 -174.97 4.52 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.917 -0.401 . . . . 0.31 109.917 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.947 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.6 pm0 -79.87 -27.97 40.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.886 0.851 . . . . 2.0 109.922 -176.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 8.1 mmpt? -80.02 -2.09 42.6 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.138 -0.937 . . . . 0.67000000000000004 109.697 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.79 177.36 8.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.944 -0.571 . . . . 1.6499999999999999 110.026 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.77 141.16 52.29 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.856 -1.165 . . . . 0.26000000000000001 107.856 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.801 HD23 ' HA ' ' A' ' 47' ' ' LYS . 47.8 mt -118.09 127.68 54.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.196 -0.668 . . . . 0.27000000000000002 109.196 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.761 ' HG3' HG12 ' B' ' 7' ' ' VAL . 17.9 tt0 -89.18 99.22 12.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.928 -1.138 . . . . 1.1100000000000001 107.928 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.497 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.9 mp -89.38 135.34 26.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.551 -1.204 . . . . 0.12 112.324 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.496 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 4.2 m-85 -128.74 -178.55 4.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.174 -1.375 . . . . 1.54 107.582 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 43' ' ' ILE . 3.8 t -148.34 136.77 14.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.659 -0.497 . . . . 0.26000000000000001 109.659 172.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' H ' HD11 ' A' ' 44' ' ' ILE . 65.0 m-20 -115.78 116.8 28.66 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.458 -0.571 . . . . 1.74 109.458 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 60.79 -79.37 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 124.231 0.957 . . . . 2.0099999999999998 111.177 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -141.25 20.82 2.25 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.191 -0.913 . . . . 1.6699999999999999 111.274 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 55.4 pttt -135.63 152.29 51.09 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 112.908 0.707 . . . . 0.75 112.908 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 40.1 mt -92.26 139.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.812 -1.085 . . . . 0.16 110.745 -172.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -126.34 106.0 15.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.074 -0.343 . . . . 0.19 110.074 -175.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.934 HD13 HD13 ' B' ' 45' ' ' LEU . 11.2 mp -97.51 109.48 22.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.843 0.354 . . . . 0.13 110.523 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 37' ' ' TYR . 31.7 ttmt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.659 -0.867 . . . . 2.1099999999999999 108.659 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.801 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -50.28 142.59 9.84 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.834 0.35 . . . . 2.48 111.282 -173.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.532 ' CD1' HG11 ' B' ' 7' ' ' VAL . 52.7 t80 . . . . . 0 N--CA 1.448 -0.566 0 CA-C-N 115.905 -0.588 . . . . 3.3300000000000001 109.68 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.536 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 91.2 p . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 121.563 0.697 . . . . 1.1699999999999999 109.406 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.532 ' HB ' ' HB ' ' B' ' 6' ' ' ILE . 3.1 p -93.88 -36.77 12.06 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.312 -0.858 . . . . 0.28000000000000003 110.563 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 68.78 38.01 84.91 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 108.954 -1.658 . . . . 0.28999999999999998 108.954 -170.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -111.82 124.8 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.925 -1.138 . . . . 0.20000000000000001 109.689 -167.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.761 HG12 ' HG3' ' A' ' 35' ' ' GLU . 1.4 m -94.18 146.41 6.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.07 -0.652 . . . . 0.20000000000000001 110.833 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.603 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 10.4 mmt180 -138.21 153.53 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 1.9399999999999999 110.305 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -79.67 148.66 31.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 1.3700000000000001 109.843 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.947 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 13.2 t -91.71 15.84 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.603 0.716 . . . . 0.22 110.635 -174.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 7.4 t70 70.17 -148.43 0.1 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-N 115.289 -0.869 . . . . 1.1699999999999999 110.002 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -121.11 -41.16 2.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.531 -0.915 . . . . 2.0899999999999999 108.531 175.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.77 -10.54 59.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.563 -1.199 . . . . 0.48999999999999999 111.473 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.52 5.48 36.64 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.643 -0.789 . . . . 0.17000000000000001 111.982 172.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 11.3 ptp180 -101.02 118.55 37.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.079 0.466 . . . . 1.72 111.232 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.84 129.47 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.783 -0.821 . . . . 0.17000000000000001 108.783 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 15' ' ' ARG . 4.0 t -76.0 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.932 -0.707 . . . . 0.14000000000000001 109.361 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.3 tt -70.03 120.8 80.28 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.892 -1.049 . . . . 0.16 109.412 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.603 ' HD3' ' HG3' ' B' ' 8' ' ' ARG . 73.6 Cg_exo -52.56 142.37 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.493 2.129 . . . . 0.19 113.197 -175.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.467 ' HA ' ' HG3' ' B' ' 23' ' ' ARG . 2.3 pp -57.39 -27.46 28.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.517 -0.765 . . . . 0.42999999999999999 109.988 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' B' ' 21' ' ' GLU . 3.5 mt-10 -65.89 -47.26 75.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.159 -0.928 . . . . 1.27 110.391 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.733 ' O ' HD22 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -66.42 -45.31 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.546 -0.462 . . . . 0.52000000000000002 110.799 178.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.809 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.4 ppt_? -69.36 -15.79 63.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.567 0.699 . . . . 1.2 109.699 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -80.93 -24.01 38.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.949 -1.023 . . . . 2.1099999999999999 109.298 172.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 57.0 m -71.62 -42.41 67.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.713 -0.676 . . . . 0.51000000000000001 110.399 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.733 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.8 OUTLIER -87.79 -16.1 35.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.142 -0.481 . . . . 0.58999999999999997 111.841 -178.144 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 6.14 79.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.086 -0.578 . . . . 0.52000000000000002 112.984 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.809 HG13 ' HB2' ' B' ' 23' ' ' ARG . 39.8 pt -78.34 -153.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.321 0.248 . . . . 0.72999999999999998 110.372 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.44 -105.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.585 0.958 . . . . 0.92000000000000004 113.585 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.865 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 9.4 pt-20 -154.7 -39.34 0.09 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.094 -1.817 . . . . 1.5 106.094 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.5 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 7.4 mmpt? -75.1 -6.53 50.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 113.527 -1.669 . . . . 0.46000000000000002 108.967 172.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.586 ' CG ' ' HB ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -77.6 168.65 19.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.072 -0.967 . . . . 2.0499999999999998 109.492 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.404 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -120.43 142.44 49.23 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.495 -0.928 . . . . 0.25 108.495 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.819 HD13 HD23 ' B' ' 45' ' ' LEU . 33.7 mt -119.93 125.73 49.16 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.773 -0.825 . . . . 0.33000000000000002 108.773 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.756 ' HG3' HG12 ' A' ' 7' ' ' VAL . 29.2 tt0 -88.77 100.36 13.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.072 -1.085 . . . . 1.29 108.072 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.428 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.19 134.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.729 -1.123 . . . . 0.14000000000000001 112.694 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.468 ' CD1' ' HA2' ' A' ' 5' ' ' GLY . 16.9 m-85 -124.29 -179.14 4.33 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.01 -1.45 . . . . 1.5900000000000001 107.804 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' B' ' 43' ' ' ILE . 9.5 t -148.93 134.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.67 -0.493 . . . . 0.19 109.67 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.91 94.01 4.73 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.391 -0.368 . . . . 1.71 110.683 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 67.04 -13.31 0.2 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.23 -1.35 . . . . 2.0800000000000001 113.975 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -179.91 -15.46 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.393 -0.367 . . . . 2.3900000000000001 111.548 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 50.1 pttt -137.84 156.12 48.27 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 119.251 -0.98 . . . . 0.82999999999999996 113.381 -172.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.912 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -92.38 139.65 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.596 -1.184 . . . . 0.46999999999999997 110.445 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.428 HD13 ' C ' ' B' ' 43' ' ' ILE . 0.1 OUTLIER -127.01 104.11 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.215 -0.291 . . . . 0.17999999999999999 110.215 -175.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.12 108.59 20.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.081 0.467 . . . . 0.13 110.331 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -114.74 127.23 55.63 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.761 ' HA ' HD23 ' B' ' 34' ' ' LEU . 14.6 ptpt -46.07 139.04 4.74 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.456 0.472 . . . . 2.2000000000000002 110.697 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.536 ' CD1' HG11 ' A' ' 7' ' ' VAL . 55.1 t80 . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 109.847 -0.427 . . . . 3.3199999999999998 109.847 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.596 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 35.3 t . . . . . 0 CA--C 1.496 -1.102 0 CA-C-O 121.685 0.755 . . . . 1.1499999999999999 110.836 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.76 ' HB ' HD13 ' A' ' 6' ' ' ILE . 21.9 p -118.84 -27.26 5.84 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.615 -1.175 . . . . 0.26000000000000001 110.481 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.54 44.38 92.98 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.788 -1.325 . . . . 0.35999999999999999 109.788 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.76 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -115.3 126.02 72.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.463 -0.868 . . . . 0.19 109.992 -170.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.4 m -92.79 146.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.107 -0.637 . . . . 0.22 110.382 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 31.3 mmt180 -137.84 154.93 49.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.118 -0.492 . . . . 1.6000000000000001 109.929 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 6.7 mmpt? -80.62 154.42 27.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.249 -0.432 . . . . 1.0900000000000001 109.933 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.867 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.7 t -91.06 16.83 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.792 0.806 . . . . 0.25 110.228 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 26.2 t70 66.94 -133.34 0.14 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.412 -0.813 . . . . 1.3200000000000001 109.584 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.463 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -131.19 -37.13 1.27 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.253 0.549 . . . . 2.0600000000000001 110.438 177.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 13' ' ' LEU . 3.8 mm? -87.09 6.26 33.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.177 -0.465 . . . . 0.45000000000000001 111.529 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.42 18.14 31.74 Favored Glycine 0 CA--C 1.496 -1.114 0 C-N-CA 121.056 -0.592 . . . . 0.19 112.15 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' B' ' 17' ' ' VAL . 10.1 ptt180 -106.12 120.13 41.02 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.849 0.357 . . . . 1.5800000000000001 111.234 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.767 HG12 HG12 ' B' ' 16' ' ' VAL . 9.6 p -82.96 126.75 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.191 -1.04 . . . . 0.17000000000000001 108.191 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' B' ' 15' ' ' ARG . 21.5 t -75.41 85.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.891 -0.724 . . . . 0.19 109.154 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 HD13 ' B' ' 43' ' ' ILE . 1.2 tt -69.79 124.46 90.66 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 115.063 -0.971 . . . . 0.20000000000000001 108.967 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 50.9 Cg_exo -54.13 145.15 55.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.239 1.959 . . . . 0.22 112.965 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.31 -32.15 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.51000000000000001 109.946 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.0 pt-20 -70.43 -34.38 72.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.697 -1.138 . . . . 1.3300000000000001 110.771 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.75 ' O ' HD22 ' A' ' 26' ' ' LEU . 6.0 mp -74.17 -44.63 52.74 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.269 -0.573 . . . . 0.34000000000000002 110.542 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.706 ' HB2' HG13 ' A' ' 28' ' ' ILE . 2.2 ppt_? -70.12 -12.91 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 1.3799999999999999 109.407 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.1 ttt180 -82.74 -27.07 31.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.894 -1.048 . . . . 1.9399999999999999 109.431 171.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 96.7 m -69.68 -42.8 73.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.36 -0.836 . . . . 0.47999999999999998 109.681 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.15 -18.58 45.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.202 -0.666 . . . . 0.57999999999999996 109.202 177.032 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.69 81.99 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.286 -0.87 . . . . 0.41999999999999998 112.202 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.706 HG13 ' HB2' ' A' ' 23' ' ' ARG . 46.5 pt -83.11 -153.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.645 -0.502 . . . . 0.69999999999999996 109.645 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.504 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -162.47 -168.61 1.88 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.403 -0.362 . . . . 0.31 110.036 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.942 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -82.93 -30.81 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.645 0.736 . . . . 2.0 109.798 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 11.8 mmpt? -77.04 -6.26 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.578 -0.737 . . . . 0.67000000000000004 109.918 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -84.48 162.73 19.8 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.916 -0.584 . . . . 1.6499999999999999 110.829 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.554 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -107.69 157.45 18.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.576 -0.738 . . . . 0.26000000000000001 109.511 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.817 HD13 HD23 ' A' ' 45' ' ' LEU . 52.1 mt -129.93 130.5 45.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.516 -0.92 . . . . 0.27000000000000002 108.516 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.653 ' HG3' HG12 ' B' ' 7' ' ' VAL . 19.9 tt0 -88.82 96.24 10.61 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.486 -0.931 . . . . 1.1100000000000001 108.486 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.412 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -89.78 137.19 21.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.0 -1.0 . . . . 0.12 112.942 -171.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.412 ' C ' HG12 ' A' ' 44' ' ' ILE . 7.2 m-85 -130.8 -177.99 4.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.201 -1.363 . . . . 1.54 107.916 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 43' ' ' ILE . 12.8 t -147.25 130.52 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.26000000000000001 111.029 174.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.457 ' H ' HD11 ' A' ' 44' ' ' ILE . 31.7 t70 -115.16 121.93 44.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.784 -0.643 . . . . 1.74 109.527 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.87 -73.82 0.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 124.177 0.923 . . . . 2.0099999999999998 110.784 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.5 17.88 0.4 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.176 -0.92 . . . . 1.6699999999999999 110.281 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -133.06 157.06 46.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.372 0.606 . . . . 0.75 112.32 -174.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.922 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.1 mt -92.88 139.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.832 -1.076 . . . . 0.16 111.652 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.457 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -124.0 104.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.149 -0.478 . . . . 0.19 109.775 -178.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.899 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -95.86 107.68 19.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.481 0.658 . . . . 0.13 110.488 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -97.93 159.0 15.21 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.142 -1.429 . . . . 2.1099999999999999 107.142 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD23 ' A' ' 34' ' ' LEU . 3.9 ptpp? -74.17 145.18 44.44 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.134 -1.061 . . . . 2.48 108.134 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 p90 . . . . . 0 C--N 1.32 -0.681 0 N-CA-C 110.02 -0.363 . . . . 3.3300000000000001 110.02 -177.488 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.443 ' HA ' ' N ' ' A' ' 38' ' ' VAL . 3.5 m . . . . . 0 CA--C 1.507 -0.705 0 CA-C-O 121.495 0.664 . . . . 1.1699999999999999 111.551 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.425 ' HB ' HD13 ' B' ' 6' ' ' ILE . 17.0 p -110.64 -30.38 7.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.895 -1.048 . . . . 0.28000000000000003 109.936 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 67.97 44.44 78.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.662 -1.375 . . . . 0.28999999999999998 109.662 -173.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.425 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -118.28 125.98 74.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.099 -1.05 . . . . 0.20000000000000001 109.826 -167.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 m -93.88 142.43 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.035 -0.666 . . . . 0.20000000000000001 110.831 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 71.8 mmt-85 -134.36 155.15 50.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.472 -0.331 . . . . 1.9399999999999999 110.957 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.554 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 7.6 mmpt? -80.7 152.59 28.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.772 -0.649 . . . . 1.3700000000000001 110.003 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.942 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.7 t -94.36 19.35 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.687 0.756 . . . . 0.22 110.743 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 14.3 t70 64.69 -145.14 0.25 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.604 -0.725 . . . . 1.1699999999999999 109.692 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.502 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -116.92 -43.06 2.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.482 0.658 . . . . 2.0899999999999999 109.716 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.94 -15.07 61.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.967 -1.015 . . . . 0.48999999999999999 111.197 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.46 13.64 11.5 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.751 -0.738 . . . . 0.17000000000000001 111.716 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.716 ' HB3' HG22 ' A' ' 17' ' ' VAL . 3.8 ptt180 -99.78 121.69 41.65 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 120.836 0.351 . . . . 1.72 111.389 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.767 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.31 126.81 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.128 -1.064 . . . . 0.17000000000000001 108.128 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 15' ' ' ARG . 21.4 t -76.07 84.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.58 -0.848 . . . . 0.14000000000000001 109.314 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.472 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.5 tt -69.28 122.08 84.23 Favored Pre-proline 0 N--CA 1.436 -1.16 0 CA-C-N 114.743 -1.117 . . . . 0.16 109.15 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.426 ' HB2' ' CD1' ' B' ' 22' ' ' LEU . 69.8 Cg_exo -51.58 139.25 47.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.194 1.929 . . . . 0.19 113.224 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -53.18 -29.71 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.42999999999999999 110.831 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 1.8 mt-10 -67.18 -41.15 86.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.969 . . . . 1.27 110.334 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.714 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.5 mp -70.9 -42.65 69.66 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.851 -0.613 . . . . 0.52000000000000002 110.855 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.699 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.9 ppt_? -67.79 -22.7 65.17 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.659 -0.867 . . . . 1.2 108.659 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -71.4 -31.64 67.5 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.748 -1.115 . . . . 2.1099999999999999 108.504 174.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 96.8 m -70.52 -38.4 74.25 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.813 -1.085 . . . . 0.51000000000000001 110.795 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.714 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -84.29 -20.14 32.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.482 -0.487 . . . . 0.58999999999999997 110.706 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.74 8.12 67.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.034 -0.603 . . . . 0.52000000000000002 112.061 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.699 HG13 ' HB2' ' B' ' 23' ' ' ARG . 44.0 pt -88.81 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.72999999999999998 110.181 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.649 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -164.69 -177.28 4.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.795 -0.639 . . . . 0.92000000000000004 109.838 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.867 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -69.22 -34.8 75.41 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.567 0.699 . . . . 1.5 110.676 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.1 mmpt? -79.13 -5.38 54.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.528 -0.76 . . . . 0.46000000000000002 109.951 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.615 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 1.8 m-20 -86.89 160.39 18.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.478 -0.783 . . . . 2.0499999999999998 111.306 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.485 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -108.03 155.86 19.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.525 -0.762 . . . . 0.25 109.521 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.811 HD13 HD23 ' B' ' 45' ' ' LEU . 26.2 mt -130.15 129.15 43.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.101 -1.074 . . . . 0.33000000000000002 108.101 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.678 ' HG3' HG12 ' A' ' 7' ' ' VAL . 23.9 tt0 -88.75 99.62 12.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.626 -0.879 . . . . 1.29 108.626 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.16 138.06 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.541 -1.208 . . . . 0.14000000000000001 112.775 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.502 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 11.6 m-85 -130.18 -177.6 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.325 -1.307 . . . . 1.5900000000000001 108.156 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.596 ' H ' ' CB ' ' A' ' 3' ' ' SER . 9.9 t -145.63 135.98 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.024 0.44 . . . . 0.19 110.271 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.454 ' N ' HD11 ' B' ' 44' ' ' ILE . 15.4 t70 -117.33 115.03 24.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.478 -0.783 . . . . 1.71 109.473 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t0 69.73 -69.47 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 124.347 1.03 . . . . 2.0800000000000001 110.569 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.81 20.82 0.21 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.135 -0.939 . . . . 2.3900000000000001 110.207 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 44.1 pttt -133.67 156.85 47.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.195 0.521 . . . . 0.82999999999999996 112.035 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.7 mt -93.17 139.31 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.283 -0.872 . . . . 0.46999999999999997 111.393 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.454 HD11 ' N ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.11 104.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.17999999999999999 109.885 -177.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.922 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.8 mp -94.64 108.42 20.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.134 0.493 . . . . 0.13 110.644 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 35' ' ' GLU . 34.3 ttpt -101.22 157.08 17.04 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.39 -1.337 . . . . 1.98 107.39 171.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.598 ' HA ' HD23 ' B' ' 34' ' ' LEU . 17.5 ptpt -65.79 148.98 50.9 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.601 -0.888 . . . . 2.2000000000000002 108.601 172.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 109.031 -0.729 . . . . 3.3199999999999998 109.031 176.958 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.642 ' HB2' ' O ' ' B' ' 38' ' ' VAL . 4.0 t . . . . . 0 CA--C 1.498 -1.042 0 CA-C-O 121.389 0.614 . . . . 1.1499999999999999 109.99 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.889 ' HB ' HD13 ' A' ' 6' ' ' ILE . 41.2 p -135.77 -34.51 0.82 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.042 -0.981 . . . . 0.26000000000000001 111.035 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.56 24.89 71.5 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.591 -1.403 . . . . 0.35999999999999999 109.591 -174.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.889 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.3 mp -89.97 125.73 42.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.062 -1.069 . . . . 0.19 110.061 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.802 HG12 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -95.15 147.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.019 -0.673 . . . . 0.22 110.471 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -141.25 157.23 45.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.196 -0.456 . . . . 1.6000000000000001 110.416 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.502 ' CE ' ' HB2' ' B' ' 33' ' ' ALA . 9.4 mmpt? -80.33 158.03 26.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.689 -0.687 . . . . 1.0900000000000001 110.18 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.94 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.2 t -97.2 18.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.763 0.792 . . . . 0.25 110.392 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 15' ' ' ARG . 1.1 t70 66.35 -135.62 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.357 1.075 . . . . 1.3200000000000001 110.472 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -130.25 -47.96 1.09 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.314 -1.766 . . . . 2.0600000000000001 108.455 177.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.4 mm? -67.04 -22.05 65.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.245 -1.343 . . . . 0.45000000000000001 110.55 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.11 14.33 7.84 Favored Glycine 0 CA--C 1.499 -0.968 0 C-N-CA 120.898 -0.668 . . . . 0.19 111.55 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.696 ' HB3' HG22 ' B' ' 17' ' ' VAL . 18.3 ptt180 -100.83 120.24 39.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.176 0.513 . . . . 1.5800000000000001 111.617 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.784 HG11 HD21 ' B' ' 45' ' ' LEU . 7.8 p -84.07 128.15 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 108.372 -0.973 . . . . 0.17000000000000001 108.372 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG22 ' HB3' ' B' ' 15' ' ' ARG . 13.8 t -76.53 84.44 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.685 -0.806 . . . . 0.19 109.442 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 HD13 ' B' ' 43' ' ' ILE . 0.9 OUTLIER -67.07 124.63 89.33 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.86 -1.064 . . . . 0.20000000000000001 109.293 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HG2' HD13 ' A' ' 22' ' ' LEU . 50.8 Cg_exo -55.91 139.45 84.38 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.333 2.022 . . . . 0.22 113.329 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.664 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.2 pp -50.52 -35.91 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.697 -1.138 . . . . 0.51000000000000001 111.107 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HG3' HD12 ' A' ' 22' ' ' LEU . 3.6 pt-20 -69.91 -36.21 75.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.817 -1.083 . . . . 1.3300000000000001 110.727 -174.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.728 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -72.58 -43.73 62.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.827 -0.624 . . . . 0.34000000000000002 110.921 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.664 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -67.26 -20.92 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.656 -0.868 . . . . 1.3799999999999999 108.656 178.072 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -24.87 41.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.703 -1.135 . . . . 1.9399999999999999 109.57 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 97.5 m -70.67 -42.25 70.98 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.37 -0.832 . . . . 0.47999999999999998 109.895 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.07 -19.7 39.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.57999999999999996 109.28 178.023 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.57 17.8 78.52 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.244 -0.889 . . . . 0.41999999999999998 112.126 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.867 HD13 HD21 ' A' ' 34' ' ' LEU . 44.2 pt -81.1 -156.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.283 -0.636 . . . . 0.69999999999999996 109.283 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -161.68 176.5 10.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.31 111.243 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.798 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.0 pt-20 -65.21 -41.05 94.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.852 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.693 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 7.4 mmpt? -76.39 -1.44 26.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.52 -0.764 . . . . 0.67000000000000004 109.785 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -85.55 176.16 8.38 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.902 -0.59 . . . . 1.6499999999999999 109.898 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' B' ' 8' ' ' ARG . . . -126.84 145.33 50.69 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.558 -0.905 . . . . 0.26000000000000001 108.558 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 28' ' ' ILE . 84.5 mt -123.51 130.61 52.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.501 -0.926 . . . . 0.27000000000000002 108.501 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.653 ' HG3' HG12 ' B' ' 7' ' ' VAL . 24.4 tt0 -88.6 101.32 13.85 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.705 -1.221 . . . . 1.1100000000000001 107.705 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.433 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -88.91 135.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.576 -1.193 . . . . 0.12 112.254 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.5 ' HB3' ' OG ' ' B' ' 3' ' ' SER . 4.6 m-85 -127.06 -179.55 4.91 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.397 -1.274 . . . . 1.54 107.979 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 ' HA ' ' A' ' 43' ' ' ILE . 9.7 t -147.3 136.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.26000000000000001 110.101 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 36.3 t70 -119.82 118.83 31.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.641 -0.709 . . . . 1.74 109.098 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.83 -83.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.734 0.646 . . . . 2.0099999999999998 110.576 -172.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -143.97 18.15 1.78 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.007 -0.997 . . . . 1.6699999999999999 109.915 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 16.0 pttm -125.82 151.44 46.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.085 -0.646 . . . . 0.75 112.345 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.89 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 17.6 mt -92.37 138.82 19.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.653 -1.158 . . . . 0.16 110.715 -171.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.446 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -125.55 103.11 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.639 -0.504 . . . . 0.19 109.639 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.949 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -92.12 109.15 20.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.001 0.429 . . . . 0.13 110.424 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLU . 39.8 ttmt -107.15 159.62 16.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.035 -1.469 . . . . 2.1099999999999999 107.035 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.743 ' HA ' HD23 ' A' ' 34' ' ' LEU . 8.4 ptpp? -66.59 150.75 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.622 -0.881 . . . . 2.48 108.622 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 29.5 p90 . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 109.901 -0.407 . . . . 3.3300000000000001 109.901 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 2.4 t . . . . . 0 CA--C 1.5 -0.97 0 CA-C-O 122.004 0.907 . . . . 1.1699999999999999 110.013 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.894 ' HB ' HD13 ' B' ' 6' ' ' ILE . 25.0 p -137.86 -39.66 0.56 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.312 -1.313 . . . . 0.28000000000000003 110.175 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 74.88 28.55 62.52 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.342 -1.503 . . . . 0.28999999999999998 109.342 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.894 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -96.7 125.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.939 -1.131 . . . . 0.20000000000000001 110.049 -173.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -93.59 148.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.235 -0.586 . . . . 0.20000000000000001 111.084 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' HD3' ' B' ' 8' ' ' ARG . 16.4 mmt85 -140.15 154.87 47.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 1.9399999999999999 110.593 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -79.99 153.71 28.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.085 -0.507 . . . . 1.3700000000000001 110.082 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.798 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.6 t -93.0 18.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.764 0.792 . . . . 0.22 110.527 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 23.1 t70 67.18 -136.74 0.12 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.525 -0.761 . . . . 1.1699999999999999 110.163 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.547 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -131.56 -42.33 1.04 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.76 -1.109 . . . . 2.0899999999999999 109.11 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.423 ' N ' HD22 ' B' ' 13' ' ' LEU . 3.8 mm? -73.86 -24.21 59.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.038 -0.983 . . . . 0.48999999999999999 110.077 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.05 16.38 4.42 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 120.716 -0.754 . . . . 0.17000000000000001 111.751 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.675 ' HB3' HG22 ' A' ' 17' ' ' VAL . 10.6 ptt180 -103.73 121.41 42.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.939 0.4 . . . . 1.72 111.897 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.75 128.15 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.335 -0.987 . . . . 0.17000000000000001 108.335 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 15' ' ' ARG . 17.3 t -76.41 84.75 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 119.673 -0.811 . . . . 0.14000000000000001 109.507 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.491 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.3 tt -71.08 121.6 84.62 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.145 -0.934 . . . . 0.16 109.209 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' B' ' 22' ' ' LEU . 70.9 Cg_exo -51.68 140.18 46.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.256 1.971 . . . . 0.19 113.131 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -57.36 -26.59 26.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.67 -0.696 . . . . 0.42999999999999999 110.13 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.5 mt-10 -66.77 -41.68 87.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.671 -1.149 . . . . 1.27 110.448 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.728 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -71.88 -43.55 65.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.675 -0.693 . . . . 0.52000000000000002 110.34 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.673 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.4 ppt_? -69.3 -17.95 63.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.355 0.598 . . . . 1.2 109.71 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -75.99 -31.11 58.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.817 -1.083 . . . . 2.1099999999999999 108.474 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 93.2 m -68.09 -41.14 82.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.144 -0.935 . . . . 0.51000000000000001 110.516 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.728 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 -19.69 35.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.58999999999999997 111.266 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.93 7.15 78.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.886 -0.673 . . . . 0.52000000000000002 112.261 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.881 HD13 HD21 ' B' ' 34' ' ' LEU . 42.9 pt -80.9 -156.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.948 0.404 . . . . 0.72999999999999998 110.294 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -160.25 179.35 8.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.369 -0.378 . . . . 0.92000000000000004 110.97 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.94 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -74.98 -37.48 61.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.585 0.707 . . . . 1.5 109.986 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.9 mmpt? -77.14 -2.62 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.732 -0.667 . . . . 0.46000000000000002 109.884 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.448 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 20.7 t70 -84.12 -178.83 7.07 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.104 -0.498 . . . . 2.0499999999999998 109.852 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.502 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . . . -133.86 144.28 48.83 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.044 -0.724 . . . . 0.25 109.044 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.881 HD21 HD13 ' B' ' 28' ' ' ILE . 92.0 mt -124.67 130.08 51.73 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.755 -0.831 . . . . 0.33000000000000002 108.755 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.802 ' HG3' HG12 ' A' ' 7' ' ' VAL . 21.7 tt0 -88.33 103.12 15.53 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 107.62 -1.252 . . . . 1.29 107.62 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.446 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.35 133.82 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.273 -1.331 . . . . 0.14000000000000001 112.588 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.511 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 5.4 m-85 -126.39 -178.99 4.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.716 -1.129 . . . . 1.5900000000000001 108.152 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 3' ' ' SER . 8.7 t -147.58 137.91 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.399 0.618 . . . . 0.19 110.871 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.9 t70 -119.46 121.98 40.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.604 -0.726 . . . . 1.71 109.156 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 -87.11 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.798 0.686 . . . . 2.0800000000000001 110.354 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.43 29.81 1.26 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.262 -0.881 . . . . 2.3900000000000001 109.649 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 34.7 pttt -127.66 149.45 50.19 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.432 0.634 . . . . 0.82999999999999996 111.479 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.883 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.5 mt -92.8 139.26 18.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.995 -1.002 . . . . 0.46999999999999997 110.943 -170.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.405 HG12 ' C ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER -125.07 103.69 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.856 -0.424 . . . . 0.17999999999999999 109.856 -176.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 45' ' ' LEU . 10.9 mp -95.24 109.57 21.67 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.852 0.358 . . . . 0.13 110.494 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' B' ' 35' ' ' GLU . 29.3 ttmt -112.38 153.87 26.64 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 108.047 -1.094 . . . . 1.98 108.047 171.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.784 ' HA ' HD23 ' B' ' 34' ' ' LEU . 9.9 ptpp? -58.49 144.08 43.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.501 -0.555 . . . . 2.2000000000000002 109.501 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.489 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 3.4 p90 . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 3.3199999999999998 109.605 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.573 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 98.7 p . . . . . 0 CA--C 1.511 -0.543 0 CA-C-O 121.679 0.752 . . . . 1.1499999999999999 111.81 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.729 ' HB ' HD13 ' A' ' 6' ' ' ILE . 15.2 p -100.06 -34.04 10.23 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.824 -1.08 . . . . 0.26000000000000001 110.344 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.67 43.68 51.11 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.222 -1.551 . . . . 0.35999999999999999 109.222 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.729 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -117.12 126.45 74.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.808 -1.196 . . . . 0.19 109.55 -168.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG12 ' HA ' ' B' ' 35' ' ' GLU . 3.0 m -97.68 148.58 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.118 -0.633 . . . . 0.22 111.13 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 59.9 mmt-85 -137.41 150.3 47.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.721 -0.672 . . . . 1.6000000000000001 110.515 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 0.4 OUTLIER -77.84 148.62 34.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.096 -0.502 . . . . 1.0900000000000001 110.059 172.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.941 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 35.8 t -86.8 20.98 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.847 0.832 . . . . 0.25 110.86 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 38.0 t70 68.51 -124.45 0.15 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.524 -0.762 . . . . 1.3200000000000001 110.191 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.468 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 2.0 pt-20 -142.9 -40.4 0.32 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.472 0.653 . . . . 2.0600000000000001 109.986 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' CD2' ' HG3' ' A' ' 12' ' ' GLU . 4.0 mm? -85.47 -0.66 55.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.769 . . . . 0.45000000000000001 110.395 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 10' ' ' VAL . . . 98.61 16.19 32.25 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 115.741 -0.663 . . . . 0.19 112.407 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.874 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 11.0 ptt180 -100.71 116.95 33.83 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.83 0.348 . . . . 1.5800000000000001 110.831 176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.69 HG12 HG12 ' B' ' 16' ' ' VAL . 4.5 p -82.82 127.44 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.765 -1.198 . . . . 0.17000000000000001 107.765 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.743 HG22 ' HB3' ' B' ' 15' ' ' ARG . 19.3 t -76.5 84.73 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.809 -0.756 . . . . 0.19 109.31 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CD1' HD13 ' B' ' 43' ' ' ILE . 2.8 tt -67.95 120.57 74.97 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 115.22 -0.9 . . . . 0.20000000000000001 109.117 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.4 142.84 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.455 2.103 . . . . 0.22 113.617 -173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -55.59 -29.79 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.066 -0.97 . . . . 0.51000000000000001 110.02 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.2 mt-10 -67.92 -44.23 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.3300000000000001 110.145 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.76 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -70.42 -43.01 70.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.38 -0.827 . . . . 0.34000000000000002 110.653 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.63 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.0 ppt_? -70.92 -13.75 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.525 0.678 . . . . 1.3799999999999999 109.181 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -82.74 -25.49 32.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.998 -1.001 . . . . 1.9399999999999999 109.375 171.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 88.4 m -70.43 -42.82 71.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.47999999999999998 109.815 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.76 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -85.54 -15.22 43.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.618 -0.719 . . . . 0.57999999999999996 109.781 177.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 17.42 78.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.351 -0.841 . . . . 0.41999999999999998 112.493 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.821 HD13 HD21 ' A' ' 34' ' ' LEU . 37.6 pt -77.85 -160.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.86 -0.422 . . . . 0.69999999999999996 109.86 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.04 177.37 10.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.31 110.77 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.924 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 11.8 pt-20 -69.4 -40.74 77.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.805 0.812 . . . . 2.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.73 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -78.92 0.86 25.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.244 -0.889 . . . . 0.67000000000000004 109.481 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.14 165.95 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.4 -0.818 . . . . 1.6499999999999999 109.779 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.9 154.99 24.38 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.071 -0.715 . . . . 0.26000000000000001 109.071 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.821 HD21 HD13 ' A' ' 28' ' ' ILE . 80.6 mt -129.95 130.97 45.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.671 -1.233 . . . . 0.27000000000000002 107.671 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.594 ' HA ' HG12 ' B' ' 7' ' ' VAL . 29.3 tt0 -89.38 98.01 11.52 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.991 -0.744 . . . . 1.1100000000000001 108.991 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.506 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 3.0 mp -89.57 135.4 26.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.968 -1.014 . . . . 0.12 112.611 -171.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 83.4 m-85 -130.65 -177.75 4.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.16 -1.382 . . . . 1.54 107.877 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.7 t -146.8 131.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.39 0.614 . . . . 0.26000000000000001 110.309 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.455 ' H ' HD11 ' A' ' 44' ' ' ILE . 15.2 t70 -104.95 104.61 14.4 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.914 -1.039 . . . . 1.74 109.278 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 t70 68.47 -71.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 O-C-N 124.165 0.916 . . . . 2.0099999999999998 111.106 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -143.47 8.45 1.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 1.6699999999999999 111.238 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 17.4 pttm -129.05 155.98 44.56 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 112.947 0.721 . . . . 0.75 112.947 -175.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.883 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.4 mt -93.03 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.118 -0.946 . . . . 0.16 111.147 -170.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.479 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -125.73 104.84 13.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.686 -0.487 . . . . 0.19 109.686 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.918 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -93.48 107.46 19.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.462 0.649 . . . . 0.13 110.321 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 26.0 ttmt -95.37 157.24 15.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.701 -1.222 . . . . 2.1099999999999999 107.701 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HA ' HD23 ' A' ' 34' ' ' LEU . 9.6 ptpp? -73.51 138.92 45.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.589 -0.893 . . . . 2.48 108.589 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HD1' HG11 ' B' ' 7' ' ' VAL . 72.5 t80 . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 109.227 -0.657 . . . . 3.3300000000000001 109.227 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.563 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 57.2 p . . . . . 0 CA--C 1.51 -0.575 0 CA-C-O 121.698 0.761 . . . . 1.1699999999999999 110.842 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.735 ' HB ' HD13 ' B' ' 6' ' ' ILE . 7.4 p -99.74 -32.6 10.96 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.109 -0.951 . . . . 0.28000000000000003 110.195 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.81 40.44 64.45 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.321 -1.511 . . . . 0.28999999999999998 109.321 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.735 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -114.02 125.68 71.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 113.952 -1.124 . . . . 0.20000000000000001 109.709 -168.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.0 m -95.06 146.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.392 -0.523 . . . . 0.20000000000000001 110.883 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -136.42 155.29 50.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 1.9399999999999999 110.416 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.462 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.2 mmpp? -78.5 153.86 30.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.039 -0.528 . . . . 1.3700000000000001 109.773 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.924 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 25.3 t -92.38 19.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.815 0.817 . . . . 0.22 110.35 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 9.7 t70 65.43 -139.12 0.2 Allowed 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.29 -0.868 . . . . 1.1699999999999999 109.33 174.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.491 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -121.71 -47.57 2.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.46 0.648 . . . . 2.0899999999999999 110.528 176.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.09 -16.62 61.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.753 -0.658 . . . . 0.48999999999999999 111.392 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.13 12.16 7.11 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.755 -0.736 . . . . 0.17000000000000001 111.428 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.874 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -98.19 121.48 40.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.98 0.419 . . . . 1.72 111.466 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.69 HG12 HG12 ' A' ' 16' ' ' VAL . 9.9 p -83.27 125.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.028 -1.101 . . . . 0.17000000000000001 108.028 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' A' ' 15' ' ' ARG . 11.0 t -76.33 84.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 119.583 -0.847 . . . . 0.14000000000000001 109.042 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.447 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.4 tt -68.58 120.78 77.78 Favored Pre-proline 0 N--CA 1.437 -1.082 0 CA-C-N 115.268 -0.878 . . . . 0.16 108.985 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 18' ' ' ILE . 78.2 Cg_exo -51.79 142.97 40.14 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.267 1.978 . . . . 0.19 113.172 -173.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.4 pp -58.02 -26.69 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.69 -0.687 . . . . 0.42999999999999999 109.787 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.4 mt-10 -67.18 -44.15 80.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.599 -1.182 . . . . 1.27 110.228 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.762 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.0 mp -70.74 -42.99 69.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.612 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.626 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.2 ppt_? -66.28 -23.8 66.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.703 -0.851 . . . . 1.2 108.703 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.7 OUTLIER -73.62 -29.32 62.29 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.557 -1.201 . . . . 2.1099999999999999 109.151 175.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 92.9 m -70.14 -42.03 73.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.754 -1.112 . . . . 0.51000000000000001 110.917 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.762 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -86.15 -16.6 37.38 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.684 -0.406 . . . . 0.58999999999999997 110.951 -178.213 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.23 50.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.787 -0.72 . . . . 0.52000000000000002 111.937 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.729 HD13 HD21 ' B' ' 34' ' ' LEU . 30.4 pt -100.18 -163.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.818 -0.438 . . . . 0.72999999999999998 109.818 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.501 ' H ' ' HB3' ' B' ' 32' ' ' ASP . . . -161.81 175.02 12.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.453 -0.34 . . . . 0.92000000000000004 110.653 -176.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.941 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 11.2 pt-20 -65.82 -37.68 86.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.708 0.766 . . . . 1.5 110.499 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -82.5 1.4 37.94 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.325 -0.852 . . . . 0.46000000000000002 109.458 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' B' ' 29' ' ' ALA . 33.7 t70 -93.84 148.62 21.96 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.77 -0.65 . . . . 2.0499999999999998 110.173 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.514 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -94.99 151.88 18.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.334 0.588 . . . . 0.25 109.972 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.729 HD21 HD13 ' B' ' 28' ' ' ILE . 82.0 mt -123.4 133.38 54.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.658 -1.238 . . . . 0.33000000000000002 107.658 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.766 ' HA ' HG12 ' A' ' 7' ' ' VAL . 27.3 tt0 -90.42 95.83 10.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.684 -0.858 . . . . 1.29 108.684 -175.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.468 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 3.1 mp -89.96 134.12 29.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.183 0.992 . . . . 0.14000000000000001 112.763 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.57 ' HE1' ' HG2' ' B' ' 35' ' ' GLU . 25.4 m-85 -132.09 -178.35 4.86 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.969 -1.469 . . . . 1.5900000000000001 107.758 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' B' ' 43' ' ' ILE . 8.8 t -147.51 132.24 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.19 110.142 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.464 ' H ' HD11 ' B' ' 44' ' ' ILE . 21.8 t70 -107.98 107.79 18.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.499 -0.773 . . . . 1.71 109.486 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 64.47 -69.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.802 1.314 . . . . 2.0800000000000001 112.08 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.84 12.07 1.43 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.62 -0.718 . . . . 2.3900000000000001 111.427 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 0.0 OUTLIER -137.77 157.05 47.25 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.232 -0.987 . . . . 0.82999999999999996 112.503 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.918 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 20.0 mt -92.5 139.29 18.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.768 -1.105 . . . . 0.46999999999999997 111.308 -168.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.464 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -123.2 104.86 14.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 0.17999999999999999 109.418 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.903 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 mp -94.04 107.5 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.387 0.613 . . . . 0.13 109.891 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' B' ' 35' ' ' GLU . 30.7 ttmt -94.53 159.03 15.27 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.427 -1.323 . . . . 1.98 107.427 172.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.609 ' HA ' HD23 ' B' ' 34' ' ' LEU . 18.1 ptpt -75.49 141.49 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.783 -1.191 . . . . 2.2000000000000002 107.783 171.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.563 ' CD1' HG11 ' A' ' 7' ' ' VAL . 26.1 t80 . . . . . 0 N--CA 1.441 -0.916 0 C-N-CA 119.726 -0.79 . . . . 3.3199999999999998 109.364 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.558 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 31.2 t . . . . . 0 CA--C 1.501 -0.927 0 CA-C-O 121.726 0.774 . . . . 1.1499999999999999 111.196 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.866 ' HB ' HD13 ' A' ' 6' ' ' ILE . 23.2 p -119.84 -28.68 5.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.893 -1.048 . . . . 0.26000000000000001 111.052 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.05 39.91 93.05 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.012 -1.235 . . . . 0.35999999999999999 110.012 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.866 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -106.77 125.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.518 -0.841 . . . . 0.19 109.653 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.95 144.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 119.968 -0.693 . . . . 0.22 111.121 -176.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 36.7 mmt180 -135.38 158.64 43.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.938 -0.573 . . . . 1.6000000000000001 110.142 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.28 155.77 28.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.06 -0.518 . . . . 1.0900000000000001 110.527 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.831 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.9 t -89.28 15.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.973 0.892 . . . . 0.25 109.587 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 73.85 -108.34 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 114.879 -1.055 . . . . 1.3200000000000001 111.008 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.97 -42.17 0.07 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.649 0.738 . . . . 2.0600000000000001 109.961 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.0 mm? -84.38 -5.14 59.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.569 -0.741 . . . . 0.45000000000000001 110.392 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.81 18.39 10.76 Favored Glycine 0 CA--C 1.498 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.19 111.831 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.766 ' HB3' HG22 ' B' ' 17' ' ' VAL . 2.5 ptt180 -105.69 121.62 44.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.869 0.366 . . . . 1.5800000000000001 111.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.842 HG11 HD21 ' B' ' 45' ' ' LEU . 8.0 p -83.44 126.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.453 -0.943 . . . . 0.17000000000000001 108.453 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.778 HG22 ' HB3' ' B' ' 15' ' ' ARG . 18.7 t -76.49 85.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.873 -0.731 . . . . 0.19 109.515 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.8 tt -67.09 121.63 79.11 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 115.096 -0.956 . . . . 0.20000000000000001 109.458 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HG2' HD13 ' A' ' 22' ' ' LEU . 53.0 Cg_exo -54.79 146.16 57.14 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.462 2.108 . . . . 0.22 113.883 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.4 pp -53.56 -35.62 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.91 -1.041 . . . . 0.51000000000000001 110.88 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.562 ' HG3' HD12 ' A' ' 22' ' ' LEU . 3.7 pt-20 -72.65 -37.31 68.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.757 -1.111 . . . . 1.3300000000000001 110.546 -174.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.748 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -72.94 -42.2 63.7 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.698 -0.683 . . . . 0.34000000000000002 110.377 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -69.37 -17.34 63.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.05 -0.722 . . . . 1.3799999999999999 109.05 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -79.27 -29.78 42.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.3 -0.864 . . . . 1.9399999999999999 108.685 172.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 99.8 m -66.85 -41.71 86.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.47999999999999998 110.111 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.748 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.12 -19.18 40.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.056 -0.72 . . . . 0.57999999999999996 109.056 176.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.37 20.09 79.03 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.942 -1.026 . . . . 0.41999999999999998 112.148 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.854 HD13 HD21 ' A' ' 34' ' ' LEU . 42.2 pt -83.67 -158.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.074 0.464 . . . . 0.69999999999999996 110.085 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.593 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -160.84 -179.38 7.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.787 -0.642 . . . . 0.31 110.093 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.748 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 7.8 pt-20 -72.09 -28.37 63.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.473 0.654 . . . . 2.0 110.723 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.666 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 1.7 mmpt? -89.66 2.4 54.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.312 -0.858 . . . . 0.67000000000000004 109.02 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.593 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -84.15 163.71 19.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.395 -0.821 . . . . 1.6499999999999999 110.461 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.58 155.19 23.72 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.818 -0.808 . . . . 0.26000000000000001 108.818 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.854 HD21 HD13 ' A' ' 28' ' ' ILE . 96.0 mt -130.05 131.43 45.8 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.269 -1.011 . . . . 0.27000000000000002 108.269 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.629 ' HG3' HG12 ' B' ' 7' ' ' VAL . 40.1 tt0 -89.43 101.19 13.86 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.335 -0.987 . . . . 1.1100000000000001 108.335 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.541 HG13 ' HG ' ' A' ' 45' ' ' LEU . 3.3 mp -90.15 133.92 30.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.998 0.904 . . . . 0.12 112.776 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.412 ' C ' HG12 ' A' ' 44' ' ' ILE . 22.4 m-85 -124.73 -179.01 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.238 -1.346 . . . . 1.54 108.061 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.0 t -147.16 127.35 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.731 0.777 . . . . 0.26000000000000001 111.609 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.535 ' H ' HD11 ' A' ' 44' ' ' ILE . 21.5 t70 -99.09 103.86 15.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.051 -0.977 . . . . 1.74 108.851 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 -74.23 0.06 Allowed 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 124.091 0.87 . . . . 2.0099999999999998 110.981 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' O ' HD12 ' B' ' 26' ' ' LEU . 13.3 pt-20 -149.51 22.46 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.538 -0.756 . . . . 1.6699999999999999 110.571 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 14.5 pttm -126.66 157.14 39.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.341 0.591 . . . . 0.75 112.124 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.929 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 8.4 mt -93.25 139.9 17.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.238 -0.892 . . . . 0.16 111.456 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.535 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -128.24 104.01 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.795 -0.446 . . . . 0.19 109.795 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.964 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -94.33 108.58 20.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.532 0.682 . . . . 0.13 110.773 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' A' ' 35' ' ' GLU . 32.3 ttpt -98.61 155.44 17.3 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.326 -1.361 . . . . 2.1099999999999999 107.326 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HA ' HD23 ' A' ' 34' ' ' LEU . 18.9 ptpt -71.64 142.72 49.91 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.978 -0.749 . . . . 2.48 108.978 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HD1' HG11 ' B' ' 7' ' ' VAL . 47.6 t80 . . . . . 0 C--N 1.321 -0.651 0 C-N-CA 120.602 -0.439 . . . . 3.3300000000000001 109.923 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.434 ' HA ' ' N ' ' A' ' 38' ' ' VAL . 13.9 m . . . . . 0 CA--C 1.508 -0.65 0 CA-C-O 121.475 0.655 . . . . 1.1699999999999999 111.428 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.573 ' HB ' HD13 ' B' ' 6' ' ' ILE . 12.4 p -102.28 -30.71 10.92 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.139 -0.937 . . . . 0.28000000000000003 110.146 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.55 40.37 96.06 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.49 -1.444 . . . . 0.28999999999999998 109.49 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -110.61 126.1 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.354 -0.923 . . . . 0.20000000000000001 109.906 -168.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -94.88 143.09 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.106 -0.638 . . . . 0.20000000000000001 111.163 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.813 ' HE ' ' HG3' ' B' ' 19' ' ' PRO . 34.3 mmt180 -133.54 157.4 45.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 1.9399999999999999 109.773 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.527 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.5 mmpp? -79.32 157.24 27.73 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.39 0.431 . . . . 1.3700000000000001 110.168 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.748 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.3 t -89.8 12.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.158 0.98 . . . . 0.22 109.437 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.405 ' CG ' ' HG2' ' B' ' 12' ' ' GLU . 38.8 t70 74.77 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 114.435 -1.257 . . . . 1.1699999999999999 111.62 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.449 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.3 pt-20 -160.12 -45.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.279 0.561 . . . . 2.0899999999999999 110.082 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.449 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.05 -3.25 57.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.085 -0.507 . . . . 0.48999999999999999 110.909 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 14.24 17.56 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 120.77 -0.728 . . . . 0.17000000000000001 111.612 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.778 ' HB3' HG22 ' A' ' 17' ' ' VAL . 8.3 ptt180 -103.13 121.19 42.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.721 0.296 . . . . 1.72 111.568 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.752 HG11 HD21 ' A' ' 45' ' ' LEU . 9.7 p -83.21 125.68 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.346 -0.983 . . . . 0.17000000000000001 108.346 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 15' ' ' ARG . 16.3 t -76.12 85.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.948 -0.701 . . . . 0.14000000000000001 109.402 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.439 HD12 HD13 ' A' ' 43' ' ' ILE . 1.9 tt -67.62 121.26 78.47 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 115.101 -0.954 . . . . 0.16 109.242 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.813 ' HG3' ' HE ' ' B' ' 8' ' ' ARG . 51.2 Cg_exo -54.84 147.36 51.49 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.504 2.136 . . . . 0.19 113.293 -172.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.2 pp -59.34 -30.65 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.212 0.53 . . . . 0.42999999999999999 109.973 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.11 -42.97 93.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.688 -1.142 . . . . 1.27 109.99 -177.204 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.704 ' O ' HD22 ' B' ' 26' ' ' LEU . 7.1 mp -73.02 -42.62 63.01 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.262 -0.881 . . . . 0.52000000000000002 110.756 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.668 ' HB2' HG13 ' B' ' 28' ' ' ILE . 7.0 ppt_? -68.68 -20.04 64.42 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.933 -0.766 . . . . 1.2 108.933 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.569 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.9 OUTLIER -73.78 -30.94 63.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.483 -1.235 . . . . 2.1099999999999999 109.073 172.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 99.6 m -72.1 -39.03 69.21 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.67 -1.15 . . . . 0.51000000000000001 110.846 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.704 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -83.89 -19.28 35.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.58999999999999997 110.471 -178.65 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.18 25.47 55.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.983 -0.627 . . . . 0.52000000000000002 112.079 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.85 HD13 HD21 ' B' ' 34' ' ' LEU . 39.6 pt -99.72 -159.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.799 0.333 . . . . 0.72999999999999998 110.142 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.517 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -165.3 179.34 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.882 -0.599 . . . . 0.92000000000000004 109.657 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.831 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 13.1 pt-20 -69.47 -32.77 71.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.481 0.658 . . . . 1.5 111.044 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.551 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -85.48 1.64 48.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.521 -0.763 . . . . 0.46000000000000002 109.368 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 0.7 OUTLIER -88.16 160.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.44 -0.8 . . . . 2.0499999999999998 111.054 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 8' ' ' ARG . . . -108.75 155.84 20.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 0.25 109.233 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.85 HD21 HD13 ' B' ' 28' ' ' ILE . 98.8 mt -130.72 130.66 44.09 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.319 -0.993 . . . . 0.33000000000000002 108.319 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.654 ' HG3' HG12 ' A' ' 7' ' ' VAL . 40.1 tt0 -89.25 100.3 13.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.994 -1.113 . . . . 1.29 107.994 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.24 135.89 24.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.021 -0.99 . . . . 0.14000000000000001 112.477 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.501 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 41.0 m-85 -127.06 -178.89 4.59 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.154 -1.385 . . . . 1.5900000000000001 108.134 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.558 ' H ' ' CB ' ' A' ' 3' ' ' SER . 24.0 t -145.29 134.68 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.274 0.559 . . . . 0.19 110.846 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.524 ' N ' HD11 ' B' ' 44' ' ' ILE . 6.2 t70 -100.1 97.05 7.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.246 -0.888 . . . . 1.71 108.788 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.09 -65.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.232 0.958 . . . . 2.0800000000000001 111.398 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.523 ' O ' HD12 ' A' ' 26' ' ' LEU . 6.7 pt-20 -150.35 19.39 0.84 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.494 -0.776 . . . . 2.3900000000000001 111.205 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 52.8 pttt -130.18 156.96 43.71 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.256 -0.578 . . . . 0.82999999999999996 111.865 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.964 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 9.7 mt -92.7 139.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.534 -0.757 . . . . 0.46999999999999997 111.414 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.524 HD11 ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -128.08 104.64 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.684 -0.487 . . . . 0.17999999999999999 109.684 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.929 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.81 107.94 19.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.343 0.592 . . . . 0.13 110.689 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.552 ' HE2' ' HB3' ' B' ' 35' ' ' GLU . 30.4 ttpt -96.76 156.46 16.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.283 -1.377 . . . . 1.98 107.283 171.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.705 ' HA ' HD23 ' B' ' 34' ' ' LEU . 16.4 ptpt -74.93 139.5 43.09 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.734 -0.839 . . . . 2.2000000000000002 108.734 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 . . . . . 0 C--N 1.322 -0.616 0 C-N-CA 120.296 -0.561 . . . . 3.3199999999999998 109.794 179.082 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.556 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 92.7 p . . . . . 0 CA--C 1.504 -0.824 0 CA-C-O 121.224 0.535 . . . . 1.1499999999999999 110.85 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.819 ' HB ' HD13 ' A' ' 6' ' ' ILE . 17.7 p -100.06 -35.92 9.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.438 -0.801 . . . . 0.26000000000000001 110.353 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.06 50.13 11.36 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.254 -1.539 . . . . 0.35999999999999999 109.254 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.819 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -122.42 125.32 72.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.447 -0.876 . . . . 0.19 109.83 -168.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.9 m -95.99 145.53 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.94 -0.704 . . . . 0.22 110.861 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.634 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 38.7 mmt180 -135.97 157.95 45.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 1.6000000000000001 110.442 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 2.5 mmpp? -78.63 153.61 30.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.266 -0.424 . . . . 1.0900000000000001 110.489 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.809 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.3 t -94.21 13.47 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.683 -0.69 . . . . 0.25 110.566 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 11.1 t70 66.2 -149.65 0.21 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.692 -0.686 . . . . 1.3200000000000001 110.037 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -115.75 -44.27 2.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.81 0.814 . . . . 2.0600000000000001 109.061 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.57 -16.87 62.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.691 -1.141 . . . . 0.45000000000000001 111.033 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.34 26.5 Favored Glycine 0 CA--C 1.495 -1.157 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.467 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.783 ' HD2' ' HG3' ' B' ' 15' ' ' ARG . 1.9 ptt85 -95.55 121.31 37.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 120.329 -0.548 . . . . 1.5800000000000001 111.465 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 9.7 p -82.55 131.05 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 108.261 -1.014 . . . . 0.17000000000000001 108.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 14.6 t -75.58 85.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 119.666 -0.814 . . . . 0.19 109.304 -176.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.9 tt -71.28 116.96 52.41 Favored Pre-proline 0 N--CA 1.429 -1.481 0 N-CA-C 108.047 -1.094 . . . . 0.20000000000000001 108.047 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.634 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 52.2 Cg_exo -54.17 138.82 72.05 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.046 1.831 . . . . 0.22 112.689 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.437 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.6 pp -56.2 -29.64 28.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.692 -0.685 . . . . 0.51000000000000001 109.945 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -66.34 -44.34 83.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.599 -1.182 . . . . 1.3300000000000001 110.011 -177.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.796 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -69.89 -45.13 68.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.384 -0.826 . . . . 0.34000000000000002 110.708 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -70.18 -13.8 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.694 0.759 . . . . 1.3799999999999999 108.966 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.0 tmt_? -82.83 -28.38 30.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.981 -1.009 . . . . 1.9399999999999999 109.397 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 92.0 m -69.72 -43.91 71.39 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.199 -0.909 . . . . 0.47999999999999998 109.919 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.38 -15.47 56.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.622 -0.717 . . . . 0.57999999999999996 109.2 177.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.65 21.8 76.29 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.051 -0.977 . . . . 0.41999999999999998 112.475 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.795 HD13 HD21 ' A' ' 34' ' ' LEU . 35.1 pt -83.91 -158.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.853 -0.795 . . . . 0.69999999999999996 108.853 171.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -154.8 179.34 9.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.136 -0.32 . . . . 0.31 110.136 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.979 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -77.97 -32.74 51.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.951 0.881 . . . . 2.0 109.126 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 11.3 mmpt? -79.52 -0.01 31.55 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.026 -0.988 . . . . 0.67000000000000004 109.712 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -87.53 172.96 9.38 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.601 -0.727 . . . . 1.6499999999999999 109.16 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -120.95 150.92 40.36 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.613 -0.884 . . . . 0.26000000000000001 108.613 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.838 HD13 HD23 ' A' ' 45' ' ' LEU . 53.5 mt -124.75 128.97 49.59 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.73 -0.841 . . . . 0.27000000000000002 108.73 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.559 ' HA ' HG12 ' B' ' 7' ' ' VAL . 61.0 tt0 -88.57 97.65 11.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.952 -0.759 . . . . 1.1100000000000001 108.952 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.7 mp -89.89 135.98 24.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.739 -1.119 . . . . 0.12 112.792 -173.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 1.053 ' HE2' ' HE2' ' A' ' 46' ' ' LYS . 78.5 m-85 -130.11 -177.62 4.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.126 -1.397 . . . . 1.54 107.57 174.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 43' ' ' ILE . 6.4 t -147.05 133.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.391 0.615 . . . . 0.26000000000000001 110.798 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 22.4 t70 -99.09 95.18 6.94 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.079 -0.964 . . . . 1.74 108.671 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 65.52 -66.05 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.361 1.038 . . . . 2.0099999999999998 112.181 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -137.08 -3.2 2.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.674 -0.694 . . . . 1.6699999999999999 111.254 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 36.4 pttt -118.56 150.21 40.03 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.744 -0.783 . . . . 0.75 112.086 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.959 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 19.4 mt -92.64 138.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.003 -0.999 . . . . 0.16 110.814 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.32 106.76 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.489 -0.56 . . . . 0.19 109.489 -177.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.888 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -98.59 112.04 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.933 0.397 . . . . 0.13 110.657 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.053 ' HE2' ' HE2' ' A' ' 37' ' ' TYR . 38.0 mtmt -100.65 165.68 11.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.864 -1.162 . . . . 2.1099999999999999 107.864 167.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.0 ptpt -72.19 143.76 48.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.042 -1.466 . . . . 2.48 107.042 165.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 5.3 p90 . . . . . 0 C--N 1.322 -0.594 0 C-N-CA 120.023 -0.671 . . . . 3.3300000000000001 111.026 -173.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' SER . . . . . 0.602 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 79.1 p . . . . . 0 CA--C 1.503 -0.831 0 CA-C-O 121.574 0.702 . . . . 1.1699999999999999 112.115 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.796 ' HB ' HD13 ' B' ' 6' ' ' ILE . 16.2 p -104.64 -37.02 7.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.842 -1.072 . . . . 0.28000000000000003 110.253 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 77.1 46.25 10.59 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.394 -1.482 . . . . 0.28999999999999998 109.394 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.796 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.221 -0.989 . . . . 0.20000000000000001 109.945 -167.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.3 m -93.01 149.32 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.197 -0.601 . . . . 0.20000000000000001 110.582 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 13.3 mmt85 -139.76 156.76 46.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.184 -0.462 . . . . 1.9399999999999999 110.813 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.544 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 4.3 mmpp? -77.98 153.91 32.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.892 -0.595 . . . . 1.3700000000000001 110.153 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.979 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 19.5 t -96.12 15.74 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.54 -0.754 . . . . 0.22 110.489 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 13.8 t70 68.19 -146.88 0.13 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.627 -0.715 . . . . 1.1699999999999999 109.832 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.536 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -119.52 -44.93 2.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.984 0.897 . . . . 2.0899999999999999 108.682 175.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.69 -28.86 69.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.021 -1.445 . . . . 0.48999999999999999 110.715 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.9 0.14 9.08 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 120.557 -0.83 . . . . 0.17000000000000001 111.42 174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.783 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 5.6 ptt180 -92.48 121.41 33.91 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.913 0.387 . . . . 1.72 111.853 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.82 128.96 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.131 -1.063 . . . . 0.17000000000000001 108.131 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 10.0 t -75.77 85.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.556 -0.858 . . . . 0.14000000000000001 109.089 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.489 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.6 tt -70.19 115.66 36.67 Favored Pre-proline 0 N--CA 1.428 -1.539 0 N-CA-C 108.285 -1.006 . . . . 0.16 108.285 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.503 ' HB2' HD13 ' B' ' 22' ' ' LEU . 78.2 Cg_exo -50.09 138.99 35.37 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.304 2.003 . . . . 0.19 112.863 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.86 -30.89 23.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.684 -0.689 . . . . 0.42999999999999999 109.977 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.8 -42.94 90.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.621 -1.172 . . . . 1.27 110.555 -177.045 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.777 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -70.5 -46.81 62.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.017 -0.538 . . . . 0.52000000000000002 110.856 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.597 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.5 ppt_? -69.78 -15.07 63.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.39 0.614 . . . . 1.2 109.635 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -76.93 -32.55 57.42 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.057 -0.974 . . . . 2.1099999999999999 109.041 170.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.1 m -72.0 -39.86 68.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.167 -0.924 . . . . 0.51000000000000001 110.696 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.777 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -82.87 -14.58 54.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.863 -0.608 . . . . 0.58999999999999997 110.778 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.3 80.66 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.829 -0.7 . . . . 0.52000000000000002 112.592 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.702 HD13 HD21 ' B' ' 34' ' ' LEU . 38.0 pt -83.39 -158.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.72999999999999998 109.603 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 32' ' ' ASP . . . -158.51 175.17 14.02 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.878 0.371 . . . . 0.92000000000000004 110.92 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.809 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.6 pt-20 -72.41 -40.98 66.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.124 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.55 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 10.3 mmpt? -80.8 4.26 19.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.39 -0.823 . . . . 0.46000000000000002 109.616 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' B' ' 29' ' ' ALA . 17.6 t70 -85.77 -176.11 5.89 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.109 -0.7 . . . . 2.0499999999999998 109.109 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.564 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -135.25 146.17 48.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.673 -0.862 . . . . 0.25 108.673 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.857 HD13 HD23 ' B' ' 45' ' ' LEU . 53.0 mt -123.72 127.42 48.13 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.302 -0.629 . . . . 0.33000000000000002 109.302 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' B' ' 48' ' ' TYR . 27.8 tt0 -87.63 95.89 10.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.263 -1.014 . . . . 1.29 108.263 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 2.7 mp -89.87 136.62 23.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.543 -1.208 . . . . 0.14000000000000001 112.783 -173.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.434 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 77.6 m-85 -134.37 -177.99 4.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.083 -1.417 . . . . 1.5900000000000001 107.4 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' B' ' 43' ' ' ILE . 6.5 t -147.56 135.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.311 0.577 . . . . 0.19 111.182 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -104.58 105.85 16.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.344 -0.844 . . . . 1.71 109.204 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 61.15 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.269 0.981 . . . . 2.0800000000000001 111.035 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.62 14.99 2.15 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.632 -0.713 . . . . 2.3900000000000001 111.485 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 9.7 pttm -124.11 151.53 43.81 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 119.62 -0.832 . . . . 0.82999999999999996 112.077 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 4.9 mp -92.54 138.83 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.101 -0.954 . . . . 0.46999999999999997 111.612 -169.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 36' ' ' ILE . 0.1 OUTLIER -121.74 110.62 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.17999999999999999 109.546 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.959 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -103.54 109.18 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.13 110.992 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 42' ' ' LYS . 53.4 mtmt -105.66 165.19 11.34 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.665 -1.235 . . . . 1.98 107.665 168.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.458 ' HE2' HG22 ' B' ' 28' ' ' ILE . 16.4 ptpt -68.89 150.97 47.16 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.153 -1.054 . . . . 2.2000000000000002 108.153 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.631 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 35.9 p90 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 110.324 -0.25 . . . . 3.3199999999999998 110.324 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.294 0.569 . . . . 2.9900000000000002 110.544 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HE2' ' OG ' ' A' ' 3' ' ' SER . 17.9 ptmt -163.3 -124.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.438 -0.801 . . . . 1.8600000000000001 108.897 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.585 ' HB3' ' O ' ' B' ' 38' ' ' VAL . 97.7 p -54.19 130.92 40.21 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.278 0.561 . . . . 1.1499999999999999 110.352 170.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.724 ' HB ' HD13 ' A' ' 6' ' ' ILE . 10.6 p -103.21 -35.94 8.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.728 -0.669 . . . . 0.26000000000000001 110.654 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.03 46.51 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.063 -1.615 . . . . 0.35999999999999999 109.063 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.724 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -118.25 126.15 74.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 113.989 -1.105 . . . . 0.19 109.731 -167.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.51 148.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.995 -0.682 . . . . 0.22 110.756 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.82 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 32.2 mmt180 -137.26 157.3 46.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 1.6000000000000001 110.301 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 8.6 mmpt? -80.06 154.61 28.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.036 -0.529 . . . . 1.0900000000000001 109.841 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.926 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t -88.57 14.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.21 1.005 . . . . 0.25 109.677 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 12' ' ' GLU . 24.4 t70 73.32 -91.81 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.237 -1.347 . . . . 1.3200000000000001 112.558 167.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.519 ' HG2' ' OD2' ' A' ' 11' ' ' ASP . 4.8 pt-20 -161.12 -54.24 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 2.0600000000000001 111.746 -174.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.4 mm? -85.01 -9.88 57.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.217 -0.447 . . . . 0.45000000000000001 110.715 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.428 ' HA2' HG12 ' A' ' 10' ' ' VAL . . . 114.23 14.18 9.29 Favored Glycine 0 CA--C 1.499 -0.918 0 C-N-CA 120.726 -0.75 . . . . 0.19 111.351 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.8 ' HB3' HG22 ' B' ' 17' ' ' VAL . 19.4 ptt180 -97.6 117.08 31.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.575 -0.313 . . . . 1.5800000000000001 110.536 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.691 HG12 HG12 ' B' ' 16' ' ' VAL . 9.8 p -82.92 127.04 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.374 -0.973 . . . . 0.17000000000000001 108.374 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' B' ' 15' ' ' ARG . 19.6 t -75.63 84.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.742 -0.783 . . . . 0.19 109.127 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.451 ' CD1' HD13 ' B' ' 43' ' ' ILE . 2.1 tt -68.47 118.44 59.92 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-N 115.036 -0.984 . . . . 0.20000000000000001 108.797 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.82 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 74.1 Cg_exo -52.0 143.45 40.41 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.341 2.027 . . . . 0.22 113.209 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.429 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -57.42 -32.85 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 115.528 -0.76 . . . . 0.51000000000000001 110.008 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -67.0 -41.84 86.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.708 -1.133 . . . . 1.3300000000000001 110.295 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.655 ' O ' HD22 ' A' ' 26' ' ' LEU . 4.1 mp -68.74 -47.85 65.23 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.549 -0.75 . . . . 0.34000000000000002 110.578 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 2.0 ppt_? -70.11 -11.07 60.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.748 -0.781 . . . . 1.3799999999999999 109.769 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 12.7 ttt180 -80.87 -31.88 35.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.622 -0.717 . . . . 1.9399999999999999 109.456 171.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.4 m -67.57 -43.17 81.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.117 -0.947 . . . . 0.47999999999999998 110.058 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.655 HD22 ' O ' ' A' ' 22' ' ' LEU . 1.1 mm? -86.54 -9.21 56.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.599 -0.728 . . . . 0.57999999999999996 109.942 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.54 91.76 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.796 -0.638 . . . . 0.41999999999999998 112.696 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 1.056 HD13 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.47 -176.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.939 0.496 . . . . 0.69999999999999996 109.705 173.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 175.73 10.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.263 -0.426 . . . . 0.31 110.444 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.834 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.4 pt-20 -67.87 -37.85 82.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.53 0.681 . . . . 2.0 111.25 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.63 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 10.9 mmpt? -80.75 -3.25 50.21 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.583 -0.735 . . . . 0.67000000000000004 109.652 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.52 171.89 12.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.549 -0.75 . . . . 1.6499999999999999 110.111 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -117.75 158.12 25.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.38 -0.827 . . . . 0.26000000000000001 108.986 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.056 HD21 HD13 ' A' ' 28' ' ' ILE . 61.8 mt -131.01 127.81 39.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.547 -0.909 . . . . 0.27000000000000002 108.547 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.613 ' HA ' HG12 ' B' ' 7' ' ' VAL . 30.7 tt0 -89.09 96.46 10.73 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.736 -0.839 . . . . 1.1100000000000001 108.736 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.8 mp -90.25 136.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.857 -1.065 . . . . 0.12 112.789 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 16.4 m-85 -132.68 -178.05 4.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.278 -1.328 . . . . 1.54 107.455 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.6 t -147.7 129.66 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.688 0.756 . . . . 0.26000000000000001 111.259 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 44' ' ' ILE . 17.5 t70 -92.51 87.27 5.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.702 -1.135 . . . . 1.74 108.718 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.8 t70 61.46 -67.42 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.662 -1.154 . . . . 2.0099999999999998 112.394 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -120.9 -9.19 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.681 -0.691 . . . . 1.6699999999999999 111.916 -172.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 38' ' ' VAL . 20.3 pttm -127.65 154.9 44.72 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.727 1.01 . . . . 0.75 113.727 -173.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.912 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 25.7 mt -92.27 139.04 18.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.548 -1.205 . . . . 0.16 110.924 -170.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.534 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -124.5 105.62 15.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.9 -0.408 . . . . 0.19 109.9 -177.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.942 HD13 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -97.6 109.09 21.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.223 0.535 . . . . 0.13 110.733 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -98.04 157.19 16.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.186 -1.412 . . . . 2.1099999999999999 107.186 168.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.817 ' HA ' HD23 ' A' ' 34' ' ' LEU . 17.5 ptmt -75.76 148.32 38.59 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 2.48 108.395 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HD1' HG11 ' B' ' 7' ' ' VAL . 76.9 t80 -64.42 144.97 56.79 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.798 -0.361 . . . . 3.3300000000000001 110.091 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 10.2 tppt? -68.75 115.34 29.77 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.759 -0.655 . . . . 1.8799999999999999 109.551 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.74 41.25 0.79 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.903 2.402 . . . . 1.22 112.584 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -82.77 97.13 8.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.261 -0.882 . . . . 2.1400000000000001 109.909 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -109.86 117.95 35.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.741 -0.663 . . . . 3.1499999999999999 109.945 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.465 -0.779 . . . . 3.3500000000000001 110.165 -178.789 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.243 0.544 . . . . 3.6000000000000001 111.318 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.578 ' HE2' ' OG ' ' B' ' 3' ' ' SER . 17.4 ptmt -168.98 -120.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.19 -0.914 . . . . 2.04 108.947 173.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.578 ' OG ' ' HE2' ' B' ' 2' ' ' LYS . 94.2 p -58.86 129.99 44.81 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.364 0.602 . . . . 1.1699999999999999 109.938 169.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.749 ' HB ' HD13 ' B' ' 6' ' ' ILE . 8.1 p -102.8 -37.02 8.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.395 -0.82 . . . . 0.28000000000000003 110.746 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.6 44.15 41.26 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 108.973 -1.651 . . . . 0.28999999999999998 108.973 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.749 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.94 125.97 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.038 -1.081 . . . . 0.20000000000000001 109.692 -168.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.2 m -93.91 149.6 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.168 -0.613 . . . . 0.20000000000000001 110.822 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.42 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 21.6 mmt180 -139.38 156.34 47.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.874 -0.603 . . . . 1.9399999999999999 110.323 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 7.1 mmpt? -80.26 154.08 28.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.629 -0.714 . . . . 1.3700000000000001 110.011 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.834 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 22.1 t -89.82 17.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.029 0.919 . . . . 0.22 110.025 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t70 71.65 -109.84 0.05 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.682 -1.144 . . . . 1.1699999999999999 110.441 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.0 pt-20 -151.63 -42.23 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.337 0.589 . . . . 2.0899999999999999 111.043 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.47 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.25 -6.39 59.39 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.519 -0.472 . . . . 0.48999999999999999 111.42 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.97 11.21 16.84 Favored Glycine 0 CA--C 1.497 -1.073 0 N-CA-C 110.975 -0.85 . . . . 0.17000000000000001 110.975 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.726 ' HB3' HG22 ' A' ' 17' ' ' VAL . 5.3 ptt180 -99.13 119.87 38.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.527 -0.337 . . . . 1.72 111.277 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.691 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -82.85 127.5 39.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.277 -1.009 . . . . 0.17000000000000001 108.277 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.8 HG22 ' HB3' ' A' ' 15' ' ' ARG . 23.1 t -75.74 85.24 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 119.576 -0.85 . . . . 0.14000000000000001 109.013 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.473 ' CD1' HD13 ' A' ' 43' ' ' ILE . 1.9 tt -68.73 117.47 51.18 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 115.331 -0.85 . . . . 0.16 108.989 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.474 ' HB2' HD13 ' B' ' 22' ' ' LEU . 74.2 Cg_exo -50.68 140.74 36.43 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.605 2.203 . . . . 0.19 113.087 -171.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.5 pp -53.17 -32.14 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.42999999999999999 110.776 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -66.67 -44.64 81.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.299 -0.864 . . . . 1.27 110.191 -176.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.792 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.6 mp -67.42 -46.9 71.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.552 -0.749 . . . . 0.52000000000000002 110.559 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 6.5 ppt_? -68.49 -18.12 64.32 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.065 -0.654 . . . . 1.2 109.342 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.645 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 2.6 ttt180 -72.34 -31.61 65.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.098 -0.956 . . . . 2.1099999999999999 109.054 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 25.3 m -73.71 -43.44 59.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.043 -0.98 . . . . 0.51000000000000001 110.699 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.792 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.3 OUTLIER -89.05 -1.36 58.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.614 -0.434 . . . . 0.58999999999999997 111.467 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.1 35.55 71.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.643 -0.789 . . . . 0.52000000000000002 112.661 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 1.048 HD13 HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -102.06 -178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 0.72999999999999998 110.642 176.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -150.41 173.57 13.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.92000000000000004 109.348 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.926 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.5 pm0 -76.94 -21.56 54.62 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.458 0.647 . . . . 1.5 110.413 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.506 ' HG2' ' HG2' ' B' ' 30' ' ' GLU . 8.3 mmpt? -93.34 0.37 56.9 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.926 -0.768 . . . . 0.46000000000000002 108.926 176.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.456 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 1.5 t0 -84.33 -179.5 7.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.0 -1.0 . . . . 2.0499999999999998 110.128 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.03 156.79 41.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.353 -0.84 . . . . 0.25 108.897 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 1.048 HD21 HD13 ' B' ' 28' ' ' ILE . 37.8 mt -131.16 126.98 37.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.585 -0.894 . . . . 0.33000000000000002 108.585 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.543 ' HG3' HG12 ' A' ' 7' ' ' VAL . 31.9 tt0 -88.33 96.38 10.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.482 -0.933 . . . . 1.29 108.482 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.426 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.43 136.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.739 -1.118 . . . . 0.14000000000000001 112.962 -171.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.436 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 23.6 m-85 -132.22 -178.35 4.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.218 -1.356 . . . . 1.5900000000000001 107.671 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.684 HG22 ' HA ' ' B' ' 43' ' ' ILE . 6.9 t -147.56 133.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 0.19 110.521 174.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.49 ' H ' HD11 ' B' ' 44' ' ' ILE . 30.1 t70 -101.89 93.9 5.52 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.64 -0.874 . . . . 1.71 108.64 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.72 -70.46 0.06 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 124.751 1.282 . . . . 2.0800000000000001 112.014 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -123.75 -2.86 8.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.164 -0.925 . . . . 2.3900000000000001 111.501 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 42.3 pttt -133.14 152.45 51.95 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 119.291 -0.964 . . . . 0.82999999999999996 113.29 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 28.5 mt -92.6 139.12 18.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.954 -1.021 . . . . 0.46999999999999997 110.894 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.49 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.91 105.73 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.74 -0.467 . . . . 0.17999999999999999 109.74 -176.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -97.97 109.03 21.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.062 0.458 . . . . 0.13 110.831 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' B' ' 35' ' ' GLU . 7.6 mtmp? -100.46 154.84 18.21 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.412 -1.329 . . . . 1.98 107.412 168.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.741 ' HE3' HG23 ' B' ' 28' ' ' ILE . 1.3 ptmt -75.58 140.62 42.77 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.761 -0.829 . . . . 2.2000000000000002 108.761 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -60.67 147.93 40.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.035 0.445 . . . . 3.3199999999999998 110.289 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.514 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 17.4 tppt? -65.74 119.12 58.04 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.413 -0.812 . . . . 2.21 109.385 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.514 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 89.3 Cg_endo -80.24 27.08 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.508 2.139 . . . . 1.25 111.763 -173.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -71.31 102.52 2.61 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.245 -0.888 . . . . 2.2599999999999998 110.283 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 13.8 ptt? -111.25 111.48 22.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.8 -0.636 . . . . 3.3700000000000001 110.085 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.471 -0.776 . . . . 3.04 110.45 -177.682 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.0 ttp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.597 0.713 . . . . 2.9900000000000002 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.6 ' CG ' ' H ' ' A' ' 3' ' ' SER . 6.6 tttp -146.6 -133.77 0.08 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.279 -1.378 . . . . 1.8600000000000001 107.279 175.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.6 ' H ' ' CG ' ' A' ' 2' ' ' LYS . 77.3 p -62.93 127.89 33.36 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.175 0.512 . . . . 1.1499999999999999 110.405 170.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.807 ' HB ' HD13 ' A' ' 6' ' ' ILE . 17.6 p -96.09 -32.42 12.54 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.26000000000000001 110.624 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' B' ' 37' ' ' TYR . . . 70.0 33.64 70.19 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.612 -1.395 . . . . 0.35999999999999999 109.612 -172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.807 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -104.2 123.02 57.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.181 -1.009 . . . . 0.19 109.887 -169.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.756 HG12 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -91.34 146.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.969 -0.692 . . . . 0.22 110.669 -177.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 21.3 mmt180 -138.26 154.11 49.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.469 -0.787 . . . . 1.6000000000000001 110.112 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 5.8 mmpt? -80.36 151.75 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.973 -0.558 . . . . 1.0900000000000001 109.772 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.865 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 24.9 t -94.47 15.9 2.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.806 0.813 . . . . 0.25 110.554 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 13.5 t70 66.29 -147.28 0.19 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.396 -0.82 . . . . 1.3200000000000001 110.111 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.537 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.85 -41.76 2.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.593 -0.891 . . . . 2.0600000000000001 108.593 176.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -10.8 60.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.728 -1.124 . . . . 0.45000000000000001 111.011 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.19 11.38 34.14 Favored Glycine 0 CA--C 1.494 -1.243 0 C-N-CA 120.709 -0.758 . . . . 0.19 112.054 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 8.9 ptp180 -103.88 118.94 37.87 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.047 0.451 . . . . 1.5800000000000001 111.323 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 8.9 p -82.81 129.6 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.933 -0.766 . . . . 0.17000000000000001 108.933 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' B' ' 15' ' ' ARG . 3.5 t -75.89 84.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.975 -0.69 . . . . 0.19 109.455 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.488 ' CD1' HD13 ' B' ' 43' ' ' ILE . 1.9 tt -69.27 121.27 81.43 Favored Pre-proline 0 N--CA 1.435 -1.184 0 CA-C-N 115.1 -0.955 . . . . 0.20000000000000001 109.27 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 55.0 Cg_exo -54.61 143.67 67.44 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.246 1.964 . . . . 0.22 112.969 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -59.02 -28.88 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.51000000000000001 109.857 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -65.91 -44.63 84.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.946 -1.025 . . . . 1.3300000000000001 110.286 -175.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.675 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.9 mp -69.17 -44.82 71.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.642 -0.708 . . . . 0.34000000000000002 110.34 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.681 ' HB2' HG13 ' A' ' 28' ' ' ILE . 4.6 ppt_? -71.05 -10.88 60.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.443 0.639 . . . . 1.3799999999999999 109.62 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.56 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.8 -30.52 32.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.11 -0.95 . . . . 1.9399999999999999 108.916 171.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -67.35 -41.95 84.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.303 -0.862 . . . . 0.47999999999999998 109.851 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.675 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -86.64 -11.85 50.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.647 -0.706 . . . . 0.57999999999999996 110.08 176.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.01 77.56 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.477 -0.783 . . . . 0.41999999999999998 112.771 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.747 HD13 HD21 ' A' ' 34' ' ' LEU . 36.9 pt -88.12 -157.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 0.69999999999999996 109.818 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB1' ' OE2' ' A' ' 30' ' ' GLU . . . -161.45 -174.97 4.52 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.917 -0.401 . . . . 0.31 109.917 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.947 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.6 pm0 -79.87 -27.97 40.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.886 0.851 . . . . 2.0 109.922 -176.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 8.1 mmpt? -80.02 -2.09 42.6 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.138 -0.937 . . . . 0.67000000000000004 109.697 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.79 177.36 8.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.944 -0.571 . . . . 1.6499999999999999 110.026 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.77 141.16 52.29 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.856 -1.165 . . . . 0.26000000000000001 107.856 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.801 HD23 ' HA ' ' A' ' 47' ' ' LYS . 47.8 mt -118.09 127.68 54.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.196 -0.668 . . . . 0.27000000000000002 109.196 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.761 ' HG3' HG12 ' B' ' 7' ' ' VAL . 17.9 tt0 -89.18 99.22 12.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.928 -1.138 . . . . 1.1100000000000001 107.928 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.497 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.9 mp -89.38 135.34 26.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.551 -1.204 . . . . 0.12 112.324 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.496 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 4.2 m-85 -128.74 -178.55 4.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.174 -1.375 . . . . 1.54 107.582 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 43' ' ' ILE . 3.8 t -148.34 136.77 14.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.659 -0.497 . . . . 0.26000000000000001 109.659 172.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' H ' HD11 ' A' ' 44' ' ' ILE . 65.0 m-20 -115.78 116.8 28.66 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.458 -0.571 . . . . 1.74 109.458 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 60.79 -79.37 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 124.231 0.957 . . . . 2.0099999999999998 111.177 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -141.25 20.82 2.25 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.191 -0.913 . . . . 1.6699999999999999 111.274 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 55.4 pttt -135.63 152.29 51.09 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 112.908 0.707 . . . . 0.75 112.908 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 40.1 mt -92.26 139.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.812 -1.085 . . . . 0.16 110.745 -172.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -126.34 106.0 15.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.074 -0.343 . . . . 0.19 110.074 -175.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.934 HD13 HD13 ' B' ' 45' ' ' LEU . 11.2 mp -97.51 109.48 22.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.843 0.354 . . . . 0.13 110.523 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 37' ' ' TYR . 31.7 ttmt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.659 -0.867 . . . . 2.1099999999999999 108.659 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.801 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -50.28 142.59 9.84 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.834 0.35 . . . . 2.48 111.282 -173.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' CD1' HG11 ' B' ' 7' ' ' VAL . 52.7 t80 -59.86 148.07 36.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.905 -0.588 . . . . 3.3300000000000001 109.68 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 11.6 tppt? -66.91 113.31 12.65 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.643 -0.708 . . . . 1.8799999999999999 109.474 -175.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -79.79 19.56 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.764 2.309 . . . . 1.22 112.179 -172.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -79.11 95.36 5.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.286 -0.87 . . . . 2.1400000000000001 109.895 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 21.4 ptp -149.14 143.55 26.05 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.561 -1.199 . . . . 3.1499999999999999 108.367 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.595 -0.717 . . . . 3.3500000000000001 110.85 -175.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.2 ttp . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 121.068 0.461 . . . . 3.6000000000000001 110.107 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.547 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 11.4 ttpp -136.91 -104.25 0.2 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.689 -0.856 . . . . 2.04 108.689 171.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.536 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 91.2 p -82.03 131.51 35.25 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.563 0.697 . . . . 1.1699999999999999 109.406 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.532 ' HB ' ' HB ' ' B' ' 6' ' ' ILE . 3.1 p -93.88 -36.77 12.06 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.312 -0.858 . . . . 0.28000000000000003 110.563 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 68.78 38.01 84.91 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 108.954 -1.658 . . . . 0.28999999999999998 108.954 -170.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -111.82 124.8 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.925 -1.138 . . . . 0.20000000000000001 109.689 -167.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.761 HG12 ' HG3' ' A' ' 35' ' ' GLU . 1.4 m -94.18 146.41 6.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.07 -0.652 . . . . 0.20000000000000001 110.833 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.603 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 10.4 mmt180 -138.21 153.53 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 1.9399999999999999 110.305 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -79.67 148.66 31.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 1.3700000000000001 109.843 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.947 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 13.2 t -91.71 15.84 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.603 0.716 . . . . 0.22 110.635 -174.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 7.4 t70 70.17 -148.43 0.1 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-N 115.289 -0.869 . . . . 1.1699999999999999 110.002 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -121.11 -41.16 2.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.531 -0.915 . . . . 2.0899999999999999 108.531 175.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.77 -10.54 59.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.563 -1.199 . . . . 0.48999999999999999 111.473 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.52 5.48 36.64 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.643 -0.789 . . . . 0.17000000000000001 111.982 172.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 11.3 ptp180 -101.02 118.55 37.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.079 0.466 . . . . 1.72 111.232 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.84 129.47 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.783 -0.821 . . . . 0.17000000000000001 108.783 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 15' ' ' ARG . 4.0 t -76.0 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.932 -0.707 . . . . 0.14000000000000001 109.361 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.3 tt -70.03 120.8 80.28 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.892 -1.049 . . . . 0.16 109.412 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.603 ' HD3' ' HG3' ' B' ' 8' ' ' ARG . 73.6 Cg_exo -52.56 142.37 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.493 2.129 . . . . 0.19 113.197 -175.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.467 ' HA ' ' HG3' ' B' ' 23' ' ' ARG . 2.3 pp -57.39 -27.46 28.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.517 -0.765 . . . . 0.42999999999999999 109.988 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' B' ' 21' ' ' GLU . 3.5 mt-10 -65.89 -47.26 75.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.159 -0.928 . . . . 1.27 110.391 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.733 ' O ' HD22 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -66.42 -45.31 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.546 -0.462 . . . . 0.52000000000000002 110.799 178.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.809 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.4 ppt_? -69.36 -15.79 63.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.567 0.699 . . . . 1.2 109.699 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -80.93 -24.01 38.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.949 -1.023 . . . . 2.1099999999999999 109.298 172.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 57.0 m -71.62 -42.41 67.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.713 -0.676 . . . . 0.51000000000000001 110.399 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.733 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.8 OUTLIER -87.79 -16.1 35.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.142 -0.481 . . . . 0.58999999999999997 111.841 -178.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 6.14 79.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.086 -0.578 . . . . 0.52000000000000002 112.984 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.809 HG13 ' HB2' ' B' ' 23' ' ' ARG . 39.8 pt -78.34 -153.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.321 0.248 . . . . 0.72999999999999998 110.372 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.44 -105.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.585 0.958 . . . . 0.92000000000000004 113.585 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.865 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 9.4 pt-20 -154.7 -39.34 0.09 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.094 -1.817 . . . . 1.5 106.094 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.5 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 7.4 mmpt? -75.1 -6.53 50.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 113.527 -1.669 . . . . 0.46000000000000002 108.967 172.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.586 ' CG ' ' HB ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -77.6 168.65 19.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.072 -0.967 . . . . 2.0499999999999998 109.492 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.404 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -120.43 142.44 49.23 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.495 -0.928 . . . . 0.25 108.495 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.819 HD13 HD23 ' B' ' 45' ' ' LEU . 33.7 mt -119.93 125.73 49.16 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.773 -0.825 . . . . 0.33000000000000002 108.773 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.756 ' HG3' HG12 ' A' ' 7' ' ' VAL . 29.2 tt0 -88.77 100.36 13.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.072 -1.085 . . . . 1.29 108.072 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.428 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.19 134.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.729 -1.123 . . . . 0.14000000000000001 112.694 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.468 ' CD1' ' HA2' ' A' ' 5' ' ' GLY . 16.9 m-85 -124.29 -179.14 4.33 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.01 -1.45 . . . . 1.5900000000000001 107.804 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' B' ' 43' ' ' ILE . 9.5 t -148.93 134.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.67 -0.493 . . . . 0.19 109.67 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.91 94.01 4.73 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.391 -0.368 . . . . 1.71 110.683 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 67.04 -13.31 0.2 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.23 -1.35 . . . . 2.0800000000000001 113.975 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -179.91 -15.46 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.393 -0.367 . . . . 2.3900000000000001 111.548 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 50.1 pttt -137.84 156.12 48.27 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 119.251 -0.98 . . . . 0.82999999999999996 113.381 -172.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.912 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -92.38 139.65 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.596 -1.184 . . . . 0.46999999999999997 110.445 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.428 HD13 ' C ' ' B' ' 43' ' ' ILE . 0.1 OUTLIER -127.01 104.11 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.215 -0.291 . . . . 0.17999999999999999 110.215 -175.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.12 108.59 20.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.081 0.467 . . . . 0.13 110.331 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -114.74 127.23 55.63 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.761 ' HA ' HD23 ' B' ' 34' ' ' LEU . 14.6 ptpt -46.07 139.04 4.74 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.456 0.472 . . . . 2.2000000000000002 110.697 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.536 ' CD1' HG11 ' A' ' 7' ' ' VAL . 55.1 t80 -61.3 143.27 55.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.847 -0.427 . . . . 3.3199999999999998 109.847 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.49 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 16.9 tppt? -67.31 116.0 32.07 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.178 -0.675 . . . . 2.21 109.178 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.49 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 82.9 Cg_endo -81.08 22.62 0.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.519 2.146 . . . . 1.25 111.915 -172.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -76.57 85.48 3.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.476 -0.784 . . . . 2.2599999999999998 110.221 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 17.3 ptp -140.85 110.79 6.53 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.976 -1.011 . . . . 3.3700000000000001 109.111 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 C--N 1.314 -0.948 0 CA-C-N 115.663 -0.699 . . . . 3.04 110.713 -174.306 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mmm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.344 -0.613 . . . . 2.9900000000000002 109.344 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.795 ' HG2' ' H ' ' A' ' 3' ' ' SER . 17.6 tttt 63.22 -151.08 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.676 -0.49 . . . . 1.8600000000000001 109.676 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.795 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 35.3 t -56.43 146.5 24.27 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.685 0.755 . . . . 1.1499999999999999 110.836 175.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.76 ' HB ' HD13 ' A' ' 6' ' ' ILE . 21.9 p -118.84 -27.26 5.84 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.615 -1.175 . . . . 0.26000000000000001 110.481 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.54 44.38 92.98 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.788 -1.325 . . . . 0.35999999999999999 109.788 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.76 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -115.3 126.02 72.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.463 -0.868 . . . . 0.19 109.992 -170.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.4 m -92.79 146.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.107 -0.637 . . . . 0.22 110.382 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 31.3 mmt180 -137.84 154.93 49.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.118 -0.492 . . . . 1.6000000000000001 109.929 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 6.7 mmpt? -80.62 154.42 27.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.249 -0.432 . . . . 1.0900000000000001 109.933 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.867 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.7 t -91.06 16.83 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.792 0.806 . . . . 0.25 110.228 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 26.2 t70 66.94 -133.34 0.14 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.412 -0.813 . . . . 1.3200000000000001 109.584 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.463 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -131.19 -37.13 1.27 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.253 0.549 . . . . 2.0600000000000001 110.438 177.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 13' ' ' LEU . 3.8 mm? -87.09 6.26 33.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.177 -0.465 . . . . 0.45000000000000001 111.529 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.42 18.14 31.74 Favored Glycine 0 CA--C 1.496 -1.114 0 C-N-CA 121.056 -0.592 . . . . 0.19 112.15 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' B' ' 17' ' ' VAL . 10.1 ptt180 -106.12 120.13 41.02 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.849 0.357 . . . . 1.5800000000000001 111.234 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.767 HG12 HG12 ' B' ' 16' ' ' VAL . 9.6 p -82.96 126.75 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.191 -1.04 . . . . 0.17000000000000001 108.191 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' B' ' 15' ' ' ARG . 21.5 t -75.41 85.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.891 -0.724 . . . . 0.19 109.154 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 HD13 ' B' ' 43' ' ' ILE . 1.2 tt -69.79 124.46 90.66 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 115.063 -0.971 . . . . 0.20000000000000001 108.967 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 50.9 Cg_exo -54.13 145.15 55.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.239 1.959 . . . . 0.22 112.965 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.31 -32.15 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.51000000000000001 109.946 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.0 pt-20 -70.43 -34.38 72.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.697 -1.138 . . . . 1.3300000000000001 110.771 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.75 ' O ' HD22 ' A' ' 26' ' ' LEU . 6.0 mp -74.17 -44.63 52.74 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.269 -0.573 . . . . 0.34000000000000002 110.542 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.706 ' HB2' HG13 ' A' ' 28' ' ' ILE . 2.2 ppt_? -70.12 -12.91 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 1.3799999999999999 109.407 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.1 ttt180 -82.74 -27.07 31.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.894 -1.048 . . . . 1.9399999999999999 109.431 171.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 96.7 m -69.68 -42.8 73.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.36 -0.836 . . . . 0.47999999999999998 109.681 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.15 -18.58 45.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.202 -0.666 . . . . 0.57999999999999996 109.202 177.032 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.69 81.99 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.286 -0.87 . . . . 0.41999999999999998 112.202 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.706 HG13 ' HB2' ' A' ' 23' ' ' ARG . 46.5 pt -83.11 -153.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.645 -0.502 . . . . 0.69999999999999996 109.645 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.504 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -162.47 -168.61 1.88 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.403 -0.362 . . . . 0.31 110.036 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.942 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -82.93 -30.81 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.645 0.736 . . . . 2.0 109.798 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 11.8 mmpt? -77.04 -6.26 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.578 -0.737 . . . . 0.67000000000000004 109.918 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -84.48 162.73 19.8 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.916 -0.584 . . . . 1.6499999999999999 110.829 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.554 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -107.69 157.45 18.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.576 -0.738 . . . . 0.26000000000000001 109.511 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.817 HD13 HD23 ' A' ' 45' ' ' LEU . 52.1 mt -129.93 130.5 45.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.516 -0.92 . . . . 0.27000000000000002 108.516 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.653 ' HG3' HG12 ' B' ' 7' ' ' VAL . 19.9 tt0 -88.82 96.24 10.61 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.486 -0.931 . . . . 1.1100000000000001 108.486 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.412 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -89.78 137.19 21.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.0 -1.0 . . . . 0.12 112.942 -171.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.412 ' C ' HG12 ' A' ' 44' ' ' ILE . 7.2 m-85 -130.8 -177.99 4.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.201 -1.363 . . . . 1.54 107.916 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 43' ' ' ILE . 12.8 t -147.25 130.52 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.26000000000000001 111.029 174.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.457 ' H ' HD11 ' A' ' 44' ' ' ILE . 31.7 t70 -115.16 121.93 44.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.784 -0.643 . . . . 1.74 109.527 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.87 -73.82 0.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 124.177 0.923 . . . . 2.0099999999999998 110.784 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.5 17.88 0.4 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.176 -0.92 . . . . 1.6699999999999999 110.281 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -133.06 157.06 46.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.372 0.606 . . . . 0.75 112.32 -174.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.922 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.1 mt -92.88 139.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.832 -1.076 . . . . 0.16 111.652 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.457 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -124.0 104.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.149 -0.478 . . . . 0.19 109.775 -178.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.899 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -95.86 107.68 19.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.481 0.658 . . . . 0.13 110.488 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -97.93 159.0 15.21 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.142 -1.429 . . . . 2.1099999999999999 107.142 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD23 ' A' ' 34' ' ' LEU . 3.9 ptpp? -74.17 145.18 44.44 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.134 -1.061 . . . . 2.48 108.134 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -59.83 143.98 49.77 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.02 -0.363 . . . . 3.3300000000000001 110.02 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 20.0 mmmt -68.92 115.44 31.29 Favored Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 121.148 0.499 . . . . 1.8799999999999999 110.415 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.47 62.6 7.34 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 122.883 2.389 . . . . 1.22 111.065 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.04 94.43 1.89 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.785 -1.098 . . . . 2.1400000000000001 110.914 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.2 ptm -120.3 121.02 37.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.391 -0.822 . . . . 3.1499999999999999 109.085 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.645 -0.693 . . . . 3.3500000000000001 110.309 -177.142 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.897 -0.409 . . . . 3.6000000000000001 109.897 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.624 ' HG2' ' H ' ' B' ' 3' ' ' SER . 27.5 ttpt 62.93 -148.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.447 -0.575 . . . . 2.04 109.447 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.624 ' H ' ' HG2' ' B' ' 2' ' ' LYS . 3.5 m -50.76 138.1 19.1 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.495 0.664 . . . . 1.1699999999999999 111.551 175.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.425 ' HB ' HD13 ' B' ' 6' ' ' ILE . 17.0 p -110.64 -30.38 7.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.895 -1.048 . . . . 0.28000000000000003 109.936 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 67.97 44.44 78.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.662 -1.375 . . . . 0.28999999999999998 109.662 -173.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.425 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -118.28 125.98 74.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.099 -1.05 . . . . 0.20000000000000001 109.826 -167.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 m -93.88 142.43 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.035 -0.666 . . . . 0.20000000000000001 110.831 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 71.8 mmt-85 -134.36 155.15 50.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.472 -0.331 . . . . 1.9399999999999999 110.957 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.554 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 7.6 mmpt? -80.7 152.59 28.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.772 -0.649 . . . . 1.3700000000000001 110.003 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.942 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.7 t -94.36 19.35 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.687 0.756 . . . . 0.22 110.743 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 14.3 t70 64.69 -145.14 0.25 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.604 -0.725 . . . . 1.1699999999999999 109.692 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.502 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -116.92 -43.06 2.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.482 0.658 . . . . 2.0899999999999999 109.716 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.94 -15.07 61.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.967 -1.015 . . . . 0.48999999999999999 111.197 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.46 13.64 11.5 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.751 -0.738 . . . . 0.17000000000000001 111.716 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.716 ' HB3' HG22 ' A' ' 17' ' ' VAL . 3.8 ptt180 -99.78 121.69 41.65 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 120.836 0.351 . . . . 1.72 111.389 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.767 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.31 126.81 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.128 -1.064 . . . . 0.17000000000000001 108.128 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 15' ' ' ARG . 21.4 t -76.07 84.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.58 -0.848 . . . . 0.14000000000000001 109.314 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.472 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.5 tt -69.28 122.08 84.23 Favored Pre-proline 0 N--CA 1.436 -1.16 0 CA-C-N 114.743 -1.117 . . . . 0.16 109.15 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.426 ' HB2' ' CD1' ' B' ' 22' ' ' LEU . 69.8 Cg_exo -51.58 139.25 47.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.194 1.929 . . . . 0.19 113.224 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -53.18 -29.71 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.42999999999999999 110.831 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 1.8 mt-10 -67.18 -41.15 86.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.969 . . . . 1.27 110.334 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.714 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.5 mp -70.9 -42.65 69.66 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.851 -0.613 . . . . 0.52000000000000002 110.855 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.699 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.9 ppt_? -67.79 -22.7 65.17 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.659 -0.867 . . . . 1.2 108.659 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -71.4 -31.64 67.5 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.748 -1.115 . . . . 2.1099999999999999 108.504 174.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 96.8 m -70.52 -38.4 74.25 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.813 -1.085 . . . . 0.51000000000000001 110.795 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.714 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -84.29 -20.14 32.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.482 -0.487 . . . . 0.58999999999999997 110.706 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.74 8.12 67.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.034 -0.603 . . . . 0.52000000000000002 112.061 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.699 HG13 ' HB2' ' B' ' 23' ' ' ARG . 44.0 pt -88.81 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.72999999999999998 110.181 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.649 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -164.69 -177.28 4.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.795 -0.639 . . . . 0.92000000000000004 109.838 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.867 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -69.22 -34.8 75.41 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.567 0.699 . . . . 1.5 110.676 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.1 mmpt? -79.13 -5.38 54.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.528 -0.76 . . . . 0.46000000000000002 109.951 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.615 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 1.8 m-20 -86.89 160.39 18.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.478 -0.783 . . . . 2.0499999999999998 111.306 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.485 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -108.03 155.86 19.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.525 -0.762 . . . . 0.25 109.521 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.811 HD13 HD23 ' B' ' 45' ' ' LEU . 26.2 mt -130.15 129.15 43.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.101 -1.074 . . . . 0.33000000000000002 108.101 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.678 ' HG3' HG12 ' A' ' 7' ' ' VAL . 23.9 tt0 -88.75 99.62 12.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.626 -0.879 . . . . 1.29 108.626 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.16 138.06 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.541 -1.208 . . . . 0.14000000000000001 112.775 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.502 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 11.6 m-85 -130.18 -177.6 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.325 -1.307 . . . . 1.5900000000000001 108.156 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.596 ' H ' ' CB ' ' A' ' 3' ' ' SER . 9.9 t -145.63 135.98 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.024 0.44 . . . . 0.19 110.271 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.454 ' N ' HD11 ' B' ' 44' ' ' ILE . 15.4 t70 -117.33 115.03 24.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.478 -0.783 . . . . 1.71 109.473 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t0 69.73 -69.47 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 124.347 1.03 . . . . 2.0800000000000001 110.569 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.81 20.82 0.21 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.135 -0.939 . . . . 2.3900000000000001 110.207 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 44.1 pttt -133.67 156.85 47.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.195 0.521 . . . . 0.82999999999999996 112.035 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.7 mt -93.17 139.31 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.283 -0.872 . . . . 0.46999999999999997 111.393 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.454 HD11 ' N ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.11 104.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.17999999999999999 109.885 -177.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.922 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.8 mp -94.64 108.42 20.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.134 0.493 . . . . 0.13 110.644 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 35' ' ' GLU . 34.3 ttpt -101.22 157.08 17.04 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.39 -1.337 . . . . 1.98 107.39 171.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.598 ' HA ' HD23 ' B' ' 34' ' ' LEU . 17.5 ptpt -65.79 148.98 50.9 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.601 -0.888 . . . . 2.2000000000000002 108.601 172.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.83 144.79 56.24 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.031 -0.729 . . . . 3.3199999999999998 109.031 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -68.3 115.21 26.99 Favored Pre-proline 0 CA--C 1.505 -0.78 0 CA-C-O 121.515 0.674 . . . . 2.21 109.954 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -83.85 55.34 4.76 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.943 2.429 . . . . 1.25 111.448 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -69.62 105.44 2.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.876 -1.056 . . . . 2.2599999999999998 110.919 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 23.0 ptm -124.1 112.26 16.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.468 -0.787 . . . . 3.3700000000000001 109.602 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.773 -0.632 . . . . 3.04 111.019 -177.747 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.885 0.374 . . . . 2.9900000000000002 111.204 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.644 ' HA ' HG21 ' A' ' 25' ' ' THR . 20.9 tttt 64.68 -151.01 0.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.095 -0.957 . . . . 1.8600000000000001 110.833 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.644 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 4.0 t -55.61 145.43 23.45 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.389 0.614 . . . . 1.1499999999999999 109.99 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.889 ' HB ' HD13 ' A' ' 6' ' ' ILE . 41.2 p -135.77 -34.51 0.82 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.042 -0.981 . . . . 0.26000000000000001 111.035 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.56 24.89 71.5 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.591 -1.403 . . . . 0.35999999999999999 109.591 -174.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.889 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.3 mp -89.97 125.73 42.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.062 -1.069 . . . . 0.19 110.061 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.802 HG12 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -95.15 147.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.019 -0.673 . . . . 0.22 110.471 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -141.25 157.23 45.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.196 -0.456 . . . . 1.6000000000000001 110.416 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.502 ' CE ' ' HB2' ' B' ' 33' ' ' ALA . 9.4 mmpt? -80.33 158.03 26.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.689 -0.687 . . . . 1.0900000000000001 110.18 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.94 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.2 t -97.2 18.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.763 0.792 . . . . 0.25 110.392 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 15' ' ' ARG . 1.1 t70 66.35 -135.62 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.357 1.075 . . . . 1.3200000000000001 110.472 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -130.25 -47.96 1.09 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.314 -1.766 . . . . 2.0600000000000001 108.455 177.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.4 mm? -67.04 -22.05 65.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.245 -1.343 . . . . 0.45000000000000001 110.55 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.11 14.33 7.84 Favored Glycine 0 CA--C 1.499 -0.968 0 C-N-CA 120.898 -0.668 . . . . 0.19 111.55 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.696 ' HB3' HG22 ' B' ' 17' ' ' VAL . 18.3 ptt180 -100.83 120.24 39.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.176 0.513 . . . . 1.5800000000000001 111.617 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.784 HG11 HD21 ' B' ' 45' ' ' LEU . 7.8 p -84.07 128.15 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 108.372 -0.973 . . . . 0.17000000000000001 108.372 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG22 ' HB3' ' B' ' 15' ' ' ARG . 13.8 t -76.53 84.44 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.685 -0.806 . . . . 0.19 109.442 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 HD13 ' B' ' 43' ' ' ILE . 0.9 OUTLIER -67.07 124.63 89.33 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.86 -1.064 . . . . 0.20000000000000001 109.293 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HG2' HD13 ' A' ' 22' ' ' LEU . 50.8 Cg_exo -55.91 139.45 84.38 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.333 2.022 . . . . 0.22 113.329 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.664 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.2 pp -50.52 -35.91 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.697 -1.138 . . . . 0.51000000000000001 111.107 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HG3' HD12 ' A' ' 22' ' ' LEU . 3.6 pt-20 -69.91 -36.21 75.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.817 -1.083 . . . . 1.3300000000000001 110.727 -174.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.728 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -72.58 -43.73 62.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.827 -0.624 . . . . 0.34000000000000002 110.921 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.664 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -67.26 -20.92 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.656 -0.868 . . . . 1.3799999999999999 108.656 178.072 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -24.87 41.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.703 -1.135 . . . . 1.9399999999999999 109.57 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 2' ' ' LYS . 97.5 m -70.67 -42.25 70.98 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.37 -0.832 . . . . 0.47999999999999998 109.895 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.07 -19.7 39.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.57999999999999996 109.28 178.023 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.57 17.8 78.52 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.244 -0.889 . . . . 0.41999999999999998 112.126 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.867 HD13 HD21 ' A' ' 34' ' ' LEU . 44.2 pt -81.1 -156.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.283 -0.636 . . . . 0.69999999999999996 109.283 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -161.68 176.5 10.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.31 111.243 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.798 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.0 pt-20 -65.21 -41.05 94.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.852 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.693 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 7.4 mmpt? -76.39 -1.44 26.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.52 -0.764 . . . . 0.67000000000000004 109.785 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -85.55 176.16 8.38 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.902 -0.59 . . . . 1.6499999999999999 109.898 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' B' ' 8' ' ' ARG . . . -126.84 145.33 50.69 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.558 -0.905 . . . . 0.26000000000000001 108.558 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 28' ' ' ILE . 84.5 mt -123.51 130.61 52.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.501 -0.926 . . . . 0.27000000000000002 108.501 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.653 ' HG3' HG12 ' B' ' 7' ' ' VAL . 24.4 tt0 -88.6 101.32 13.85 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.705 -1.221 . . . . 1.1100000000000001 107.705 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.433 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -88.91 135.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.576 -1.193 . . . . 0.12 112.254 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.5 ' HB3' ' OG ' ' B' ' 3' ' ' SER . 4.6 m-85 -127.06 -179.55 4.91 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.397 -1.274 . . . . 1.54 107.979 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 ' HA ' ' A' ' 43' ' ' ILE . 9.7 t -147.3 136.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.26000000000000001 110.101 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 36.3 t70 -119.82 118.83 31.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.641 -0.709 . . . . 1.74 109.098 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.83 -83.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.734 0.646 . . . . 2.0099999999999998 110.576 -172.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -143.97 18.15 1.78 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.007 -0.997 . . . . 1.6699999999999999 109.915 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 16.0 pttm -125.82 151.44 46.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.085 -0.646 . . . . 0.75 112.345 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.89 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 17.6 mt -92.37 138.82 19.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.653 -1.158 . . . . 0.16 110.715 -171.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.446 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -125.55 103.11 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.639 -0.504 . . . . 0.19 109.639 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.949 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -92.12 109.15 20.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.001 0.429 . . . . 0.13 110.424 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLU . 39.8 ttmt -107.15 159.62 16.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.035 -1.469 . . . . 2.1099999999999999 107.035 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.743 ' HA ' HD23 ' A' ' 34' ' ' LEU . 8.4 ptpp? -66.59 150.75 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.622 -0.881 . . . . 2.48 108.622 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 29.5 p90 -60.16 159.44 9.67 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.901 -0.407 . . . . 3.3300000000000001 109.901 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 8.8 tppt? -69.01 111.86 9.78 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.655 -0.498 . . . . 1.8799999999999999 109.655 -177.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.98 13.61 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.438 2.092 . . . . 1.22 112.339 -173.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -77.48 108.31 10.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.565 -0.743 . . . . 2.1400000000000001 110.384 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 65.8 mtm -114.25 130.04 56.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.417 -0.811 . . . . 3.1499999999999999 109.041 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.306 -0.854 . . . . 3.3500000000000001 110.355 -176.859 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.198 -0.297 . . . . 3.6000000000000001 110.198 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.858 ' HG2' ' H ' ' B' ' 3' ' ' SER . 25.1 ttpt 66.01 -155.37 0.26 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.528 0.517 . . . . 2.04 109.769 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.858 ' H ' ' HG2' ' B' ' 2' ' ' LYS . 2.4 t -55.18 154.55 5.64 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.004 0.907 . . . . 1.1699999999999999 110.013 172.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.894 ' HB ' HD13 ' B' ' 6' ' ' ILE . 25.0 p -137.86 -39.66 0.56 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.312 -1.313 . . . . 0.28000000000000003 110.175 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 74.88 28.55 62.52 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.342 -1.503 . . . . 0.28999999999999998 109.342 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.894 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -96.7 125.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.939 -1.131 . . . . 0.20000000000000001 110.049 -173.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -93.59 148.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.235 -0.586 . . . . 0.20000000000000001 111.084 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' HD3' ' B' ' 8' ' ' ARG . 16.4 mmt85 -140.15 154.87 47.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 1.9399999999999999 110.593 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -79.99 153.71 28.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.085 -0.507 . . . . 1.3700000000000001 110.082 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.798 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.6 t -93.0 18.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.764 0.792 . . . . 0.22 110.527 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 23.1 t70 67.18 -136.74 0.12 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.525 -0.761 . . . . 1.1699999999999999 110.163 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.547 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -131.56 -42.33 1.04 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.76 -1.109 . . . . 2.0899999999999999 109.11 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.423 ' N ' HD22 ' B' ' 13' ' ' LEU . 3.8 mm? -73.86 -24.21 59.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.038 -0.983 . . . . 0.48999999999999999 110.077 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.05 16.38 4.42 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 120.716 -0.754 . . . . 0.17000000000000001 111.751 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.675 ' HB3' HG22 ' A' ' 17' ' ' VAL . 10.6 ptt180 -103.73 121.41 42.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.939 0.4 . . . . 1.72 111.897 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.75 128.15 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.335 -0.987 . . . . 0.17000000000000001 108.335 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 15' ' ' ARG . 17.3 t -76.41 84.75 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 119.673 -0.811 . . . . 0.14000000000000001 109.507 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.491 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.3 tt -71.08 121.6 84.62 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.145 -0.934 . . . . 0.16 109.209 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' B' ' 22' ' ' LEU . 70.9 Cg_exo -51.68 140.18 46.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.256 1.971 . . . . 0.19 113.131 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -57.36 -26.59 26.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.67 -0.696 . . . . 0.42999999999999999 110.13 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.5 mt-10 -66.77 -41.68 87.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.671 -1.149 . . . . 1.27 110.448 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.728 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -71.88 -43.55 65.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.675 -0.693 . . . . 0.52000000000000002 110.34 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.673 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.4 ppt_? -69.3 -17.95 63.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.355 0.598 . . . . 1.2 109.71 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -75.99 -31.11 58.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.817 -1.083 . . . . 2.1099999999999999 108.474 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 93.2 m -68.09 -41.14 82.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.144 -0.935 . . . . 0.51000000000000001 110.516 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.728 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 -19.69 35.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.58999999999999997 111.266 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.93 7.15 78.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.886 -0.673 . . . . 0.52000000000000002 112.261 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.881 HD13 HD21 ' B' ' 34' ' ' LEU . 42.9 pt -80.9 -156.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.948 0.404 . . . . 0.72999999999999998 110.294 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -160.25 179.35 8.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.369 -0.378 . . . . 0.92000000000000004 110.97 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.94 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -74.98 -37.48 61.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.585 0.707 . . . . 1.5 109.986 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.9 mmpt? -77.14 -2.62 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.732 -0.667 . . . . 0.46000000000000002 109.884 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.448 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 20.7 t70 -84.12 -178.83 7.07 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.104 -0.498 . . . . 2.0499999999999998 109.852 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.502 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . . . -133.86 144.28 48.83 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.044 -0.724 . . . . 0.25 109.044 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.881 HD21 HD13 ' B' ' 28' ' ' ILE . 92.0 mt -124.67 130.08 51.73 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.755 -0.831 . . . . 0.33000000000000002 108.755 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.802 ' HG3' HG12 ' A' ' 7' ' ' VAL . 21.7 tt0 -88.33 103.12 15.53 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 107.62 -1.252 . . . . 1.29 107.62 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.446 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.35 133.82 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.273 -1.331 . . . . 0.14000000000000001 112.588 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.511 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 5.4 m-85 -126.39 -178.99 4.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.716 -1.129 . . . . 1.5900000000000001 108.152 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 3' ' ' SER . 8.7 t -147.58 137.91 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.399 0.618 . . . . 0.19 110.871 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.9 t70 -119.46 121.98 40.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.604 -0.726 . . . . 1.71 109.156 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 -87.11 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.798 0.686 . . . . 2.0800000000000001 110.354 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.43 29.81 1.26 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.262 -0.881 . . . . 2.3900000000000001 109.649 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 34.7 pttt -127.66 149.45 50.19 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.432 0.634 . . . . 0.82999999999999996 111.479 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.883 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.5 mt -92.8 139.26 18.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.995 -1.002 . . . . 0.46999999999999997 110.943 -170.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.405 HG12 ' C ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER -125.07 103.69 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.856 -0.424 . . . . 0.17999999999999999 109.856 -176.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 45' ' ' LEU . 10.9 mp -95.24 109.57 21.67 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.852 0.358 . . . . 0.13 110.494 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' B' ' 35' ' ' GLU . 29.3 ttmt -112.38 153.87 26.64 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 108.047 -1.094 . . . . 1.98 108.047 171.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.784 ' HA ' HD23 ' B' ' 34' ' ' LEU . 9.9 ptpp? -58.49 144.08 43.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.501 -0.555 . . . . 2.2000000000000002 109.501 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.489 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 3.4 p90 -60.74 151.58 29.1 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 3.3199999999999998 109.605 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -67.26 112.11 9.12 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.863 0.363 . . . . 2.21 110.128 -174.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.408 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 74.3 Cg_endo -85.44 23.46 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.098 2.532 . . . . 1.25 112.43 -173.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -77.54 90.28 3.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.678 -0.692 . . . . 2.2599999999999998 110.455 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 64.4 mtt -93.19 116.76 29.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.698 -0.683 . . . . 3.3700000000000001 109.365 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 38.5 p . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.585 -0.721 . . . . 3.04 110.571 -179.783 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mmt . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 120.904 0.383 . . . . 2.9900000000000002 111.555 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HE2' ' OG ' ' A' ' 3' ' ' SER . 17.8 ptmt -151.92 -140.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.794 -0.817 . . . . 1.8600000000000001 108.794 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.573 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 98.7 p -45.53 132.2 8.3 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.679 0.752 . . . . 1.1499999999999999 111.81 176.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.729 ' HB ' HD13 ' A' ' 6' ' ' ILE . 15.2 p -100.06 -34.04 10.23 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.824 -1.08 . . . . 0.26000000000000001 110.344 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.67 43.68 51.11 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.222 -1.551 . . . . 0.35999999999999999 109.222 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.729 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -117.12 126.45 74.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.808 -1.196 . . . . 0.19 109.55 -168.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG12 ' HA ' ' B' ' 35' ' ' GLU . 3.0 m -97.68 148.58 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.118 -0.633 . . . . 0.22 111.13 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 59.9 mmt-85 -137.41 150.3 47.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.721 -0.672 . . . . 1.6000000000000001 110.515 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 0.4 OUTLIER -77.84 148.62 34.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.096 -0.502 . . . . 1.0900000000000001 110.059 172.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.941 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 35.8 t -86.8 20.98 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.847 0.832 . . . . 0.25 110.86 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 38.0 t70 68.51 -124.45 0.15 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.524 -0.762 . . . . 1.3200000000000001 110.191 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.468 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 2.0 pt-20 -142.9 -40.4 0.32 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.472 0.653 . . . . 2.0600000000000001 109.986 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' CD2' ' HG3' ' A' ' 12' ' ' GLU . 4.0 mm? -85.47 -0.66 55.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.769 . . . . 0.45000000000000001 110.395 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 10' ' ' VAL . . . 98.61 16.19 32.25 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 115.741 -0.663 . . . . 0.19 112.407 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.874 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 11.0 ptt180 -100.71 116.95 33.83 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.83 0.348 . . . . 1.5800000000000001 110.831 176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.69 HG12 HG12 ' B' ' 16' ' ' VAL . 4.5 p -82.82 127.44 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.765 -1.198 . . . . 0.17000000000000001 107.765 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.743 HG22 ' HB3' ' B' ' 15' ' ' ARG . 19.3 t -76.5 84.73 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.809 -0.756 . . . . 0.19 109.31 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CD1' HD13 ' B' ' 43' ' ' ILE . 2.8 tt -67.95 120.57 74.97 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 115.22 -0.9 . . . . 0.20000000000000001 109.117 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.4 142.84 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.455 2.103 . . . . 0.22 113.617 -173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -55.59 -29.79 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.066 -0.97 . . . . 0.51000000000000001 110.02 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.2 mt-10 -67.92 -44.23 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.3300000000000001 110.145 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.76 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -70.42 -43.01 70.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.38 -0.827 . . . . 0.34000000000000002 110.653 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.63 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.0 ppt_? -70.92 -13.75 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.525 0.678 . . . . 1.3799999999999999 109.181 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -82.74 -25.49 32.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.998 -1.001 . . . . 1.9399999999999999 109.375 171.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 88.4 m -70.43 -42.82 71.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.47999999999999998 109.815 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.76 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -85.54 -15.22 43.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.618 -0.719 . . . . 0.57999999999999996 109.781 177.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 17.42 78.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.351 -0.841 . . . . 0.41999999999999998 112.493 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.821 HD13 HD21 ' A' ' 34' ' ' LEU . 37.6 pt -77.85 -160.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.86 -0.422 . . . . 0.69999999999999996 109.86 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.04 177.37 10.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.31 110.77 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.924 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 11.8 pt-20 -69.4 -40.74 77.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.805 0.812 . . . . 2.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.73 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -78.92 0.86 25.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.244 -0.889 . . . . 0.67000000000000004 109.481 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.14 165.95 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.4 -0.818 . . . . 1.6499999999999999 109.779 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.9 154.99 24.38 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.071 -0.715 . . . . 0.26000000000000001 109.071 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.821 HD21 HD13 ' A' ' 28' ' ' ILE . 80.6 mt -129.95 130.97 45.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.671 -1.233 . . . . 0.27000000000000002 107.671 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.594 ' HA ' HG12 ' B' ' 7' ' ' VAL . 29.3 tt0 -89.38 98.01 11.52 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.991 -0.744 . . . . 1.1100000000000001 108.991 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.506 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 3.0 mp -89.57 135.4 26.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.968 -1.014 . . . . 0.12 112.611 -171.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 83.4 m-85 -130.65 -177.75 4.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.16 -1.382 . . . . 1.54 107.877 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.7 t -146.8 131.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.39 0.614 . . . . 0.26000000000000001 110.309 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.455 ' H ' HD11 ' A' ' 44' ' ' ILE . 15.2 t70 -104.95 104.61 14.4 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.914 -1.039 . . . . 1.74 109.278 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 t70 68.47 -71.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 O-C-N 124.165 0.916 . . . . 2.0099999999999998 111.106 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -143.47 8.45 1.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 1.6699999999999999 111.238 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 17.4 pttm -129.05 155.98 44.56 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 112.947 0.721 . . . . 0.75 112.947 -175.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.883 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.4 mt -93.03 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.118 -0.946 . . . . 0.16 111.147 -170.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.479 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -125.73 104.84 13.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.686 -0.487 . . . . 0.19 109.686 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.918 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -93.48 107.46 19.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.462 0.649 . . . . 0.13 110.321 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 26.0 ttmt -95.37 157.24 15.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.701 -1.222 . . . . 2.1099999999999999 107.701 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HA ' HD23 ' A' ' 34' ' ' LEU . 9.6 ptpp? -73.51 138.92 45.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.589 -0.893 . . . . 2.48 108.589 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HD1' HG11 ' B' ' 7' ' ' VAL . 72.5 t80 -60.89 143.99 53.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.227 -0.657 . . . . 3.3300000000000001 109.227 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.666 ' HD3' ' HD2' ' A' ' 50' ' ' PRO . 17.8 tppt? -67.18 112.07 8.93 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.621 -0.881 . . . . 1.8799999999999999 108.621 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.666 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 89.4 Cg_endo -75.97 34.19 0.42 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.914 2.409 . . . . 1.22 112.555 -171.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' LYS . 16.9 t30 -87.73 90.15 8.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.037 -0.983 . . . . 2.1400000000000001 109.413 174.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.2 mtm -91.78 113.76 26.12 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.755 -0.657 . . . . 3.1499999999999999 109.796 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.591 -0.719 . . . . 3.3500000000000001 110.353 -176.152 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.956 0.407 . . . . 3.6000000000000001 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.542 ' HE2' ' OG ' ' B' ' 3' ' ' SER . 15.5 ptmt -170.76 -144.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.817 -0.809 . . . . 2.04 108.817 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.563 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 57.2 p -51.04 132.63 27.68 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.698 0.761 . . . . 1.1699999999999999 110.842 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.735 ' HB ' HD13 ' B' ' 6' ' ' ILE . 7.4 p -99.74 -32.6 10.96 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.109 -0.951 . . . . 0.28000000000000003 110.195 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.81 40.44 64.45 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.321 -1.511 . . . . 0.28999999999999998 109.321 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.735 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -114.02 125.68 71.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 113.952 -1.124 . . . . 0.20000000000000001 109.709 -168.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.0 m -95.06 146.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.392 -0.523 . . . . 0.20000000000000001 110.883 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -136.42 155.29 50.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 1.9399999999999999 110.416 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.462 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.2 mmpp? -78.5 153.86 30.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.039 -0.528 . . . . 1.3700000000000001 109.773 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.924 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 25.3 t -92.38 19.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.815 0.817 . . . . 0.22 110.35 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 9.7 t70 65.43 -139.12 0.2 Allowed 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.29 -0.868 . . . . 1.1699999999999999 109.33 174.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.491 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -121.71 -47.57 2.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.46 0.648 . . . . 2.0899999999999999 110.528 176.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.09 -16.62 61.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.753 -0.658 . . . . 0.48999999999999999 111.392 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.13 12.16 7.11 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.755 -0.736 . . . . 0.17000000000000001 111.428 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.874 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -98.19 121.48 40.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.98 0.419 . . . . 1.72 111.466 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.69 HG12 HG12 ' A' ' 16' ' ' VAL . 9.9 p -83.27 125.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.028 -1.101 . . . . 0.17000000000000001 108.028 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' A' ' 15' ' ' ARG . 11.0 t -76.33 84.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 119.583 -0.847 . . . . 0.14000000000000001 109.042 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.447 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.4 tt -68.58 120.78 77.78 Favored Pre-proline 0 N--CA 1.437 -1.082 0 CA-C-N 115.268 -0.878 . . . . 0.16 108.985 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 18' ' ' ILE . 78.2 Cg_exo -51.79 142.97 40.14 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.267 1.978 . . . . 0.19 113.172 -173.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.4 pp -58.02 -26.69 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.69 -0.687 . . . . 0.42999999999999999 109.787 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.4 mt-10 -67.18 -44.15 80.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.599 -1.182 . . . . 1.27 110.228 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.762 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.0 mp -70.74 -42.99 69.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.677 -0.692 . . . . 0.52000000000000002 110.612 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.626 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.2 ppt_? -66.28 -23.8 66.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.703 -0.851 . . . . 1.2 108.703 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.7 OUTLIER -73.62 -29.32 62.29 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.557 -1.201 . . . . 2.1099999999999999 109.151 175.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 92.9 m -70.14 -42.03 73.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.754 -1.112 . . . . 0.51000000000000001 110.917 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.762 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -86.15 -16.6 37.38 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.684 -0.406 . . . . 0.58999999999999997 110.951 -178.213 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.23 50.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.787 -0.72 . . . . 0.52000000000000002 111.937 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.729 HD13 HD21 ' B' ' 34' ' ' LEU . 30.4 pt -100.18 -163.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.818 -0.438 . . . . 0.72999999999999998 109.818 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.501 ' H ' ' HB3' ' B' ' 32' ' ' ASP . . . -161.81 175.02 12.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.453 -0.34 . . . . 0.92000000000000004 110.653 -176.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.941 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 11.2 pt-20 -65.82 -37.68 86.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.708 0.766 . . . . 1.5 110.499 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -82.5 1.4 37.94 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.325 -0.852 . . . . 0.46000000000000002 109.458 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' B' ' 29' ' ' ALA . 33.7 t70 -93.84 148.62 21.96 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.77 -0.65 . . . . 2.0499999999999998 110.173 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.514 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -94.99 151.88 18.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.334 0.588 . . . . 0.25 109.972 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.729 HD21 HD13 ' B' ' 28' ' ' ILE . 82.0 mt -123.4 133.38 54.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.658 -1.238 . . . . 0.33000000000000002 107.658 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.766 ' HA ' HG12 ' A' ' 7' ' ' VAL . 27.3 tt0 -90.42 95.83 10.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.684 -0.858 . . . . 1.29 108.684 -175.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.468 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 3.1 mp -89.96 134.12 29.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.183 0.992 . . . . 0.14000000000000001 112.763 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.57 ' HE1' ' HG2' ' B' ' 35' ' ' GLU . 25.4 m-85 -132.09 -178.35 4.86 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.969 -1.469 . . . . 1.5900000000000001 107.758 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' B' ' 43' ' ' ILE . 8.8 t -147.51 132.24 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.19 110.142 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.464 ' H ' HD11 ' B' ' 44' ' ' ILE . 21.8 t70 -107.98 107.79 18.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.499 -0.773 . . . . 1.71 109.486 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 64.47 -69.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.802 1.314 . . . . 2.0800000000000001 112.08 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.84 12.07 1.43 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.62 -0.718 . . . . 2.3900000000000001 111.427 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 0.0 OUTLIER -137.77 157.05 47.25 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.232 -0.987 . . . . 0.82999999999999996 112.503 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.918 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 20.0 mt -92.5 139.29 18.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.768 -1.105 . . . . 0.46999999999999997 111.308 -168.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.464 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -123.2 104.86 14.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 0.17999999999999999 109.418 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.903 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 mp -94.04 107.5 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.387 0.613 . . . . 0.13 109.891 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' B' ' 35' ' ' GLU . 30.7 ttmt -94.53 159.03 15.27 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.427 -1.323 . . . . 1.98 107.427 172.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.609 ' HA ' HD23 ' B' ' 34' ' ' LEU . 18.1 ptpt -75.49 141.49 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.783 -1.191 . . . . 2.2000000000000002 107.783 171.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.563 ' CD1' HG11 ' A' ' 7' ' ' VAL . 26.1 t80 -67.3 144.19 56.02 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 119.726 -0.79 . . . . 3.3199999999999998 109.364 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.512 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 15.7 tppt? -66.81 121.19 76.54 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.507 -0.923 . . . . 2.21 108.507 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.512 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 97.9 Cg_endo -80.42 22.3 0.78 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.342 2.028 . . . . 1.25 112.118 -170.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -71.51 87.03 0.88 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.41 -0.814 . . . . 2.2599999999999998 109.429 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 44.6 mtm -92.31 109.18 20.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.366 -0.834 . . . . 3.3700000000000001 109.013 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.885 -0.579 . . . . 3.04 110.324 -178.892 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.379 0.609 . . . . 2.9900000000000002 110.375 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -170.72 -157.82 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.256 -0.883 . . . . 1.8600000000000001 109.479 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.558 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 31.2 t -51.58 142.85 13.41 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.726 0.774 . . . . 1.1499999999999999 111.196 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.866 ' HB ' HD13 ' A' ' 6' ' ' ILE . 23.2 p -119.84 -28.68 5.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.893 -1.048 . . . . 0.26000000000000001 111.052 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.05 39.91 93.05 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.012 -1.235 . . . . 0.35999999999999999 110.012 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.866 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -106.77 125.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.518 -0.841 . . . . 0.19 109.653 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.95 144.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 119.968 -0.693 . . . . 0.22 111.121 -176.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 36.7 mmt180 -135.38 158.64 43.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.938 -0.573 . . . . 1.6000000000000001 110.142 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.28 155.77 28.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.06 -0.518 . . . . 1.0900000000000001 110.527 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.831 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.9 t -89.28 15.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.973 0.892 . . . . 0.25 109.587 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 73.85 -108.34 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 114.879 -1.055 . . . . 1.3200000000000001 111.008 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.97 -42.17 0.07 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.649 0.738 . . . . 2.0600000000000001 109.961 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.0 mm? -84.38 -5.14 59.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.569 -0.741 . . . . 0.45000000000000001 110.392 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.81 18.39 10.76 Favored Glycine 0 CA--C 1.498 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.19 111.831 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.766 ' HB3' HG22 ' B' ' 17' ' ' VAL . 2.5 ptt180 -105.69 121.62 44.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.869 0.366 . . . . 1.5800000000000001 111.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.842 HG11 HD21 ' B' ' 45' ' ' LEU . 8.0 p -83.44 126.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.453 -0.943 . . . . 0.17000000000000001 108.453 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.778 HG22 ' HB3' ' B' ' 15' ' ' ARG . 18.7 t -76.49 85.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.873 -0.731 . . . . 0.19 109.515 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.8 tt -67.09 121.63 79.11 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 115.096 -0.956 . . . . 0.20000000000000001 109.458 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HG2' HD13 ' A' ' 22' ' ' LEU . 53.0 Cg_exo -54.79 146.16 57.14 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.462 2.108 . . . . 0.22 113.883 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.4 pp -53.56 -35.62 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.91 -1.041 . . . . 0.51000000000000001 110.88 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.562 ' HG3' HD12 ' A' ' 22' ' ' LEU . 3.7 pt-20 -72.65 -37.31 68.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.757 -1.111 . . . . 1.3300000000000001 110.546 -174.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.748 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -72.94 -42.2 63.7 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.698 -0.683 . . . . 0.34000000000000002 110.377 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -69.37 -17.34 63.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.05 -0.722 . . . . 1.3799999999999999 109.05 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -79.27 -29.78 42.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.3 -0.864 . . . . 1.9399999999999999 108.685 172.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 99.8 m -66.85 -41.71 86.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.47999999999999998 110.111 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.748 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.12 -19.18 40.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.056 -0.72 . . . . 0.57999999999999996 109.056 176.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.37 20.09 79.03 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.942 -1.026 . . . . 0.41999999999999998 112.148 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.854 HD13 HD21 ' A' ' 34' ' ' LEU . 42.2 pt -83.67 -158.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.074 0.464 . . . . 0.69999999999999996 110.085 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.593 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -160.84 -179.38 7.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.787 -0.642 . . . . 0.31 110.093 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.748 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 7.8 pt-20 -72.09 -28.37 63.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.473 0.654 . . . . 2.0 110.723 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.666 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 1.7 mmpt? -89.66 2.4 54.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.312 -0.858 . . . . 0.67000000000000004 109.02 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.593 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -84.15 163.71 19.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.395 -0.821 . . . . 1.6499999999999999 110.461 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.58 155.19 23.72 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.818 -0.808 . . . . 0.26000000000000001 108.818 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.854 HD21 HD13 ' A' ' 28' ' ' ILE . 96.0 mt -130.05 131.43 45.8 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.269 -1.011 . . . . 0.27000000000000002 108.269 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.629 ' HG3' HG12 ' B' ' 7' ' ' VAL . 40.1 tt0 -89.43 101.19 13.86 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.335 -0.987 . . . . 1.1100000000000001 108.335 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.541 HG13 ' HG ' ' A' ' 45' ' ' LEU . 3.3 mp -90.15 133.92 30.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.998 0.904 . . . . 0.12 112.776 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.412 ' C ' HG12 ' A' ' 44' ' ' ILE . 22.4 m-85 -124.73 -179.01 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.238 -1.346 . . . . 1.54 108.061 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.0 t -147.16 127.35 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.731 0.777 . . . . 0.26000000000000001 111.609 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.535 ' H ' HD11 ' A' ' 44' ' ' ILE . 21.5 t70 -99.09 103.86 15.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.051 -0.977 . . . . 1.74 108.851 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 -74.23 0.06 Allowed 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 124.091 0.87 . . . . 2.0099999999999998 110.981 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' O ' HD12 ' B' ' 26' ' ' LEU . 13.3 pt-20 -149.51 22.46 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.538 -0.756 . . . . 1.6699999999999999 110.571 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 14.5 pttm -126.66 157.14 39.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.341 0.591 . . . . 0.75 112.124 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.929 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 8.4 mt -93.25 139.9 17.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.238 -0.892 . . . . 0.16 111.456 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.535 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -128.24 104.01 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.795 -0.446 . . . . 0.19 109.795 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.964 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -94.33 108.58 20.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.532 0.682 . . . . 0.13 110.773 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' A' ' 35' ' ' GLU . 32.3 ttpt -98.61 155.44 17.3 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.326 -1.361 . . . . 2.1099999999999999 107.326 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HA ' HD23 ' A' ' 34' ' ' LEU . 18.9 ptpt -71.64 142.72 49.91 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.978 -0.749 . . . . 2.48 108.978 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HD1' HG11 ' B' ' 7' ' ' VAL . 47.6 t80 -63.94 144.47 57.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.602 -0.439 . . . . 3.3300000000000001 109.923 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 17.7 tppt? -68.34 112.37 10.77 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.231 -0.895 . . . . 1.8799999999999999 109.521 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 2.9 Cg_endo -82.37 20.57 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.925 2.417 . . . . 1.22 111.565 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -87.94 107.93 18.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.235 -0.893 . . . . 2.1400000000000001 110.108 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -131.64 122.07 25.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.598 -0.519 . . . . 3.1499999999999999 109.598 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.591 -0.718 . . . . 3.3500000000000001 110.784 -175.74 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.426 ' HB2' HG23 ' B' ' 25' ' ' THR . 19.5 ptp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.105 0.478 . . . . 3.6000000000000001 110.934 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.31 -159.03 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.552 -0.749 . . . . 2.04 109.562 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.434 ' HA ' ' N ' ' A' ' 38' ' ' VAL . 13.9 m -51.44 131.06 28.69 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.475 0.655 . . . . 1.1699999999999999 111.428 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.573 ' HB ' HD13 ' B' ' 6' ' ' ILE . 12.4 p -102.28 -30.71 10.92 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.139 -0.937 . . . . 0.28000000000000003 110.146 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.55 40.37 96.06 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.49 -1.444 . . . . 0.28999999999999998 109.49 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -110.61 126.1 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.354 -0.923 . . . . 0.20000000000000001 109.906 -168.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -94.88 143.09 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.106 -0.638 . . . . 0.20000000000000001 111.163 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.813 ' HE ' ' HG3' ' B' ' 19' ' ' PRO . 34.3 mmt180 -133.54 157.4 45.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 1.9399999999999999 109.773 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.527 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.5 mmpp? -79.32 157.24 27.73 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.39 0.431 . . . . 1.3700000000000001 110.168 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.748 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.3 t -89.8 12.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.158 0.98 . . . . 0.22 109.437 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.405 ' CG ' ' HG2' ' B' ' 12' ' ' GLU . 38.8 t70 74.77 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 114.435 -1.257 . . . . 1.1699999999999999 111.62 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.449 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.3 pt-20 -160.12 -45.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.279 0.561 . . . . 2.0899999999999999 110.082 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.449 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.05 -3.25 57.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.085 -0.507 . . . . 0.48999999999999999 110.909 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 14.24 17.56 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 120.77 -0.728 . . . . 0.17000000000000001 111.612 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.778 ' HB3' HG22 ' A' ' 17' ' ' VAL . 8.3 ptt180 -103.13 121.19 42.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.721 0.296 . . . . 1.72 111.568 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.752 HG11 HD21 ' A' ' 45' ' ' LEU . 9.7 p -83.21 125.68 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.346 -0.983 . . . . 0.17000000000000001 108.346 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 15' ' ' ARG . 16.3 t -76.12 85.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.948 -0.701 . . . . 0.14000000000000001 109.402 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.439 HD12 HD13 ' A' ' 43' ' ' ILE . 1.9 tt -67.62 121.26 78.47 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 115.101 -0.954 . . . . 0.16 109.242 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.813 ' HG3' ' HE ' ' B' ' 8' ' ' ARG . 51.2 Cg_exo -54.84 147.36 51.49 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.504 2.136 . . . . 0.19 113.293 -172.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.2 pp -59.34 -30.65 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.212 0.53 . . . . 0.42999999999999999 109.973 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.11 -42.97 93.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.688 -1.142 . . . . 1.27 109.99 -177.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.704 ' O ' HD22 ' B' ' 26' ' ' LEU . 7.1 mp -73.02 -42.62 63.01 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.262 -0.881 . . . . 0.52000000000000002 110.756 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.668 ' HB2' HG13 ' B' ' 28' ' ' ILE . 7.0 ppt_? -68.68 -20.04 64.42 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.933 -0.766 . . . . 1.2 108.933 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.569 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.9 OUTLIER -73.78 -30.94 63.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.483 -1.235 . . . . 2.1099999999999999 109.073 172.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 99.6 m -72.1 -39.03 69.21 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.67 -1.15 . . . . 0.51000000000000001 110.846 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.704 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -83.89 -19.28 35.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.58999999999999997 110.471 -178.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.18 25.47 55.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.983 -0.627 . . . . 0.52000000000000002 112.079 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.85 HD13 HD21 ' B' ' 34' ' ' LEU . 39.6 pt -99.72 -159.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.799 0.333 . . . . 0.72999999999999998 110.142 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.517 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -165.3 179.34 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.882 -0.599 . . . . 0.92000000000000004 109.657 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.831 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 13.1 pt-20 -69.47 -32.77 71.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.481 0.658 . . . . 1.5 111.044 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.551 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -85.48 1.64 48.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.521 -0.763 . . . . 0.46000000000000002 109.368 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 0.7 OUTLIER -88.16 160.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.44 -0.8 . . . . 2.0499999999999998 111.054 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 8' ' ' ARG . . . -108.75 155.84 20.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 0.25 109.233 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.85 HD21 HD13 ' B' ' 28' ' ' ILE . 98.8 mt -130.72 130.66 44.09 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.319 -0.993 . . . . 0.33000000000000002 108.319 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.654 ' HG3' HG12 ' A' ' 7' ' ' VAL . 40.1 tt0 -89.25 100.3 13.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.994 -1.113 . . . . 1.29 107.994 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.24 135.89 24.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.021 -0.99 . . . . 0.14000000000000001 112.477 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.501 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 41.0 m-85 -127.06 -178.89 4.59 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.154 -1.385 . . . . 1.5900000000000001 108.134 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.558 ' H ' ' CB ' ' A' ' 3' ' ' SER . 24.0 t -145.29 134.68 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.274 0.559 . . . . 0.19 110.846 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.524 ' N ' HD11 ' B' ' 44' ' ' ILE . 6.2 t70 -100.1 97.05 7.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.246 -0.888 . . . . 1.71 108.788 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.09 -65.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.232 0.958 . . . . 2.0800000000000001 111.398 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.523 ' O ' HD12 ' A' ' 26' ' ' LEU . 6.7 pt-20 -150.35 19.39 0.84 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.494 -0.776 . . . . 2.3900000000000001 111.205 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 52.8 pttt -130.18 156.96 43.71 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.256 -0.578 . . . . 0.82999999999999996 111.865 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.964 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 9.7 mt -92.7 139.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.534 -0.757 . . . . 0.46999999999999997 111.414 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.524 HD11 ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -128.08 104.64 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.684 -0.487 . . . . 0.17999999999999999 109.684 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.929 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.81 107.94 19.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.343 0.592 . . . . 0.13 110.689 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.552 ' HE2' ' HB3' ' B' ' 35' ' ' GLU . 30.4 ttpt -96.76 156.46 16.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.283 -1.377 . . . . 1.98 107.283 171.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.705 ' HA ' HD23 ' B' ' 34' ' ' LEU . 16.4 ptpt -74.93 139.5 43.09 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.734 -0.839 . . . . 2.2000000000000002 108.734 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -64.64 136.87 57.43 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.296 -0.561 . . . . 3.3199999999999998 109.794 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.446 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 15.6 tppt? -68.56 114.18 20.43 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.876 -0.602 . . . . 2.21 109.52 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.446 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 69.1 Cg_endo -82.52 21.4 0.99 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.784 2.323 . . . . 1.25 111.994 -174.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -77.31 99.15 5.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.286 -0.87 . . . . 2.2599999999999998 110.081 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -123.76 111.19 15.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.752 -0.658 . . . . 3.3700000000000001 109.806 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.675 -0.693 . . . . 3.04 110.635 -179.231 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.202 -0.296 . . . . 2.9900000000000002 110.202 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HE2' ' OG ' ' A' ' 3' ' ' SER . 17.1 ptmt -160.92 -123.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.238 -0.653 . . . . 1.8600000000000001 109.238 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.556 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 92.7 p -55.6 127.8 31.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.224 0.535 . . . . 1.1499999999999999 110.85 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.819 ' HB ' HD13 ' A' ' 6' ' ' ILE . 17.7 p -100.06 -35.92 9.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.438 -0.801 . . . . 0.26000000000000001 110.353 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.06 50.13 11.36 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.254 -1.539 . . . . 0.35999999999999999 109.254 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.819 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -122.42 125.32 72.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.447 -0.876 . . . . 0.19 109.83 -168.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.9 m -95.99 145.53 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.94 -0.704 . . . . 0.22 110.861 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.634 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 38.7 mmt180 -135.97 157.95 45.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 1.6000000000000001 110.442 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 2.5 mmpp? -78.63 153.61 30.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.266 -0.424 . . . . 1.0900000000000001 110.489 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.809 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.3 t -94.21 13.47 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.683 -0.69 . . . . 0.25 110.566 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 11.1 t70 66.2 -149.65 0.21 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.692 -0.686 . . . . 1.3200000000000001 110.037 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -115.75 -44.27 2.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.81 0.814 . . . . 2.0600000000000001 109.061 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.57 -16.87 62.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.691 -1.141 . . . . 0.45000000000000001 111.033 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.34 26.5 Favored Glycine 0 CA--C 1.495 -1.157 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.467 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.783 ' HD2' ' HG3' ' B' ' 15' ' ' ARG . 1.9 ptt85 -95.55 121.31 37.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 120.329 -0.548 . . . . 1.5800000000000001 111.465 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 9.7 p -82.55 131.05 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 108.261 -1.014 . . . . 0.17000000000000001 108.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 14.6 t -75.58 85.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 119.666 -0.814 . . . . 0.19 109.304 -176.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.9 tt -71.28 116.96 52.41 Favored Pre-proline 0 N--CA 1.429 -1.481 0 N-CA-C 108.047 -1.094 . . . . 0.20000000000000001 108.047 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.634 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 52.2 Cg_exo -54.17 138.82 72.05 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.046 1.831 . . . . 0.22 112.689 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.437 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.6 pp -56.2 -29.64 28.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.692 -0.685 . . . . 0.51000000000000001 109.945 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -66.34 -44.34 83.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.599 -1.182 . . . . 1.3300000000000001 110.011 -177.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.796 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -69.89 -45.13 68.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.384 -0.826 . . . . 0.34000000000000002 110.708 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -70.18 -13.8 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.694 0.759 . . . . 1.3799999999999999 108.966 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.0 tmt_? -82.83 -28.38 30.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.981 -1.009 . . . . 1.9399999999999999 109.397 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 92.0 m -69.72 -43.91 71.39 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.199 -0.909 . . . . 0.47999999999999998 109.919 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.38 -15.47 56.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.622 -0.717 . . . . 0.57999999999999996 109.2 177.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.65 21.8 76.29 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.051 -0.977 . . . . 0.41999999999999998 112.475 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.795 HD13 HD21 ' A' ' 34' ' ' LEU . 35.1 pt -83.91 -158.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.853 -0.795 . . . . 0.69999999999999996 108.853 171.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -154.8 179.34 9.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.136 -0.32 . . . . 0.31 110.136 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.979 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -77.97 -32.74 51.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.951 0.881 . . . . 2.0 109.126 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HE2' ' HA ' ' A' ' 31' ' ' LYS . 11.3 mmpt? -79.52 -0.01 31.55 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.026 -0.988 . . . . 0.67000000000000004 109.712 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -87.53 172.96 9.38 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.601 -0.727 . . . . 1.6499999999999999 109.16 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -120.95 150.92 40.36 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.613 -0.884 . . . . 0.26000000000000001 108.613 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.838 HD13 HD23 ' A' ' 45' ' ' LEU . 53.5 mt -124.75 128.97 49.59 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.73 -0.841 . . . . 0.27000000000000002 108.73 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.559 ' HA ' HG12 ' B' ' 7' ' ' VAL . 61.0 tt0 -88.57 97.65 11.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.952 -0.759 . . . . 1.1100000000000001 108.952 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.7 mp -89.89 135.98 24.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.739 -1.119 . . . . 0.12 112.792 -173.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 1.053 ' HE2' ' HE2' ' A' ' 46' ' ' LYS . 78.5 m-85 -130.11 -177.62 4.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.126 -1.397 . . . . 1.54 107.57 174.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 43' ' ' ILE . 6.4 t -147.05 133.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.391 0.615 . . . . 0.26000000000000001 110.798 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 22.4 t70 -99.09 95.18 6.94 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.079 -0.964 . . . . 1.74 108.671 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 65.52 -66.05 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.361 1.038 . . . . 2.0099999999999998 112.181 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -137.08 -3.2 2.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.674 -0.694 . . . . 1.6699999999999999 111.254 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 36.4 pttt -118.56 150.21 40.03 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.744 -0.783 . . . . 0.75 112.086 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.959 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 19.4 mt -92.64 138.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.003 -0.999 . . . . 0.16 110.814 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.32 106.76 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.489 -0.56 . . . . 0.19 109.489 -177.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.888 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -98.59 112.04 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.933 0.397 . . . . 0.13 110.657 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.053 ' HE2' ' HE2' ' A' ' 37' ' ' TYR . 38.0 mtmt -100.65 165.68 11.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.864 -1.162 . . . . 2.1099999999999999 107.864 167.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.0 ptpt -72.19 143.76 48.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.042 -1.466 . . . . 2.48 107.042 165.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 5.3 p90 -62.28 149.95 40.56 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.023 -0.671 . . . . 3.3300000000000001 111.026 -173.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HD3' ' HD2' ' A' ' 50' ' ' PRO . 17.7 tppt? -66.85 111.93 8.29 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 115.819 -0.628 . . . . 1.8799999999999999 110.352 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 95.4 Cg_endo -83.61 35.99 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.784 2.323 . . . . 1.22 111.594 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -73.61 87.84 1.66 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.646 -0.706 . . . . 2.1400000000000001 110.212 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.1 ptm -93.58 111.54 23.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.349 -0.841 . . . . 3.1499999999999999 109.372 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.249 1.037 0 CA-C-N 116.107 -0.497 . . . . 3.3500000000000001 110.405 -176.391 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mmm . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.583 -0.154 . . . . 3.6000000000000001 110.583 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.512 ' HE2' ' OG ' ' B' ' 3' ' ' SER . 13.2 ptmt 42.59 -145.17 0.07 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.207 1.003 . . . . 2.04 113.334 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.602 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 79.1 p -46.99 133.93 10.81 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 114.853 -1.067 . . . . 1.1699999999999999 112.115 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.796 ' HB ' HD13 ' B' ' 6' ' ' ILE . 16.2 p -104.64 -37.02 7.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.842 -1.072 . . . . 0.28000000000000003 110.253 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 77.1 46.25 10.59 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.394 -1.482 . . . . 0.28999999999999998 109.394 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.796 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.221 -0.989 . . . . 0.20000000000000001 109.945 -167.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.3 m -93.01 149.32 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.197 -0.601 . . . . 0.20000000000000001 110.582 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 13.3 mmt85 -139.76 156.76 46.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.184 -0.462 . . . . 1.9399999999999999 110.813 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.544 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 4.3 mmpp? -77.98 153.91 32.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.892 -0.595 . . . . 1.3700000000000001 110.153 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.979 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 19.5 t -96.12 15.74 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.54 -0.754 . . . . 0.22 110.489 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 13.8 t70 68.19 -146.88 0.13 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.627 -0.715 . . . . 1.1699999999999999 109.832 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.536 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -119.52 -44.93 2.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.984 0.897 . . . . 2.0899999999999999 108.682 175.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.69 -28.86 69.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.021 -1.445 . . . . 0.48999999999999999 110.715 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.9 0.14 9.08 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 120.557 -0.83 . . . . 0.17000000000000001 111.42 174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.783 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 5.6 ptt180 -92.48 121.41 33.91 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.913 0.387 . . . . 1.72 111.853 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.82 128.96 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.131 -1.063 . . . . 0.17000000000000001 108.131 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 10.0 t -75.77 85.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.556 -0.858 . . . . 0.14000000000000001 109.089 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.489 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.6 tt -70.19 115.66 36.67 Favored Pre-proline 0 N--CA 1.428 -1.539 0 N-CA-C 108.285 -1.006 . . . . 0.16 108.285 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.503 ' HB2' HD13 ' B' ' 22' ' ' LEU . 78.2 Cg_exo -50.09 138.99 35.37 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.304 2.003 . . . . 0.19 112.863 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.86 -30.89 23.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.684 -0.689 . . . . 0.42999999999999999 109.977 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.8 -42.94 90.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.621 -1.172 . . . . 1.27 110.555 -177.045 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.777 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -70.5 -46.81 62.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.017 -0.538 . . . . 0.52000000000000002 110.856 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.597 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.5 ppt_? -69.78 -15.07 63.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.39 0.614 . . . . 1.2 109.635 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -76.93 -32.55 57.42 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.057 -0.974 . . . . 2.1099999999999999 109.041 170.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.1 m -72.0 -39.86 68.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.167 -0.924 . . . . 0.51000000000000001 110.696 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.777 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -82.87 -14.58 54.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.863 -0.608 . . . . 0.58999999999999997 110.778 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.3 80.66 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.829 -0.7 . . . . 0.52000000000000002 112.592 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.702 HD13 HD21 ' B' ' 34' ' ' LEU . 38.0 pt -83.39 -158.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.72999999999999998 109.603 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 32' ' ' ASP . . . -158.51 175.17 14.02 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.878 0.371 . . . . 0.92000000000000004 110.92 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.809 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.6 pt-20 -72.41 -40.98 66.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.124 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.55 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 10.3 mmpt? -80.8 4.26 19.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.39 -0.823 . . . . 0.46000000000000002 109.616 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' B' ' 29' ' ' ALA . 17.6 t70 -85.77 -176.11 5.89 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.109 -0.7 . . . . 2.0499999999999998 109.109 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.564 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -135.25 146.17 48.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.673 -0.862 . . . . 0.25 108.673 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.857 HD13 HD23 ' B' ' 45' ' ' LEU . 53.0 mt -123.72 127.42 48.13 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.302 -0.629 . . . . 0.33000000000000002 109.302 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' B' ' 48' ' ' TYR . 27.8 tt0 -87.63 95.89 10.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.263 -1.014 . . . . 1.29 108.263 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 2.7 mp -89.87 136.62 23.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.543 -1.208 . . . . 0.14000000000000001 112.783 -173.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.434 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 77.6 m-85 -134.37 -177.99 4.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.083 -1.417 . . . . 1.5900000000000001 107.4 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' B' ' 43' ' ' ILE . 6.5 t -147.56 135.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.311 0.577 . . . . 0.19 111.182 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -104.58 105.85 16.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.344 -0.844 . . . . 1.71 109.204 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 61.15 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.269 0.981 . . . . 2.0800000000000001 111.035 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.62 14.99 2.15 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.632 -0.713 . . . . 2.3900000000000001 111.485 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 9.7 pttm -124.11 151.53 43.81 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 119.62 -0.832 . . . . 0.82999999999999996 112.077 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 4.9 mp -92.54 138.83 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.101 -0.954 . . . . 0.46999999999999997 111.612 -169.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 36' ' ' ILE . 0.1 OUTLIER -121.74 110.62 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.17999999999999999 109.546 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.959 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -103.54 109.18 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.13 110.992 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 42' ' ' LYS . 53.4 mtmt -105.66 165.19 11.34 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.665 -1.235 . . . . 1.98 107.665 168.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.458 ' HE2' HG22 ' B' ' 28' ' ' ILE . 16.4 ptpt -68.89 150.97 47.16 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.153 -1.054 . . . . 2.2000000000000002 108.153 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.631 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 35.9 p90 -59.3 153.46 18.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.324 -0.25 . . . . 3.3199999999999998 110.324 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.18 112.28 10.38 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 109.756 -0.461 . . . . 2.21 109.756 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -86.52 18.79 1.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.872 2.381 . . . . 1.25 111.637 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -71.9 99.83 2.3 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.045 -0.979 . . . . 2.2599999999999998 110.57 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 26.7 ptm -99.53 128.03 45.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.994 -1.003 . . . . 3.3700000000000001 109.047 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.878 -0.582 . . . . 3.04 110.456 -178.058 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.585 ' HB3' ' O ' ' B' ' 38' ' ' VAL . 97.7 p . . . . . 0 CA--C 1.506 -0.75 0 CA-C-O 121.278 0.561 . . . . 1.15 110.352 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.724 ' HB ' HD13 ' A' ' 6' ' ' ILE . 10.6 p -103.21 -35.94 8.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.728 -0.669 . . . . 0.26 110.654 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.03 46.51 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.063 -1.615 . . . . 0.36 109.063 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.724 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -118.25 126.15 74.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 113.989 -1.105 . . . . 0.19 109.731 -167.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.51 148.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.995 -0.682 . . . . 0.22 110.756 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.82 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 32.2 mmt180 -137.26 157.3 46.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 1.6 110.301 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 8.6 mmpt? -80.06 154.61 28.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.036 -0.529 . . . . 1.09 109.841 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.926 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t -88.57 14.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.21 1.005 . . . . 0.25 109.677 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 12' ' ' GLU . 24.4 t70 73.32 -91.81 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.237 -1.347 . . . . 1.32 112.558 167.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.519 ' HG2' ' OD2' ' A' ' 11' ' ' ASP . 4.8 pt-20 -161.12 -54.24 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 2.06 111.746 -174.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.4 mm? -85.01 -9.88 57.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.217 -0.447 . . . . 0.45 110.715 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.428 ' HA2' HG12 ' A' ' 10' ' ' VAL . . . 114.23 14.18 9.29 Favored Glycine 0 CA--C 1.499 -0.918 0 C-N-CA 120.726 -0.75 . . . . 0.19 111.351 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.8 ' HB3' HG22 ' B' ' 17' ' ' VAL . 19.4 ptt180 -97.6 117.08 31.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.575 -0.313 . . . . 1.58 110.536 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.691 HG12 HG12 ' B' ' 16' ' ' VAL . 9.8 p -82.92 127.04 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.374 -0.973 . . . . 0.17 108.374 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' B' ' 15' ' ' ARG . 19.6 t -75.63 84.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.742 -0.783 . . . . 0.19 109.127 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.451 ' CD1' HD13 ' B' ' 43' ' ' ILE . 2.1 tt -68.47 118.44 59.92 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-N 115.036 -0.984 . . . . 0.2 108.797 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.82 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 74.1 Cg_exo -52.0 143.45 40.41 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.341 2.027 . . . . 0.22 113.209 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.429 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -57.42 -32.85 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 115.528 -0.76 . . . . 0.51 110.008 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -67.0 -41.84 86.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.708 -1.133 . . . . 1.33 110.295 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.655 ' O ' HD22 ' A' ' 26' ' ' LEU . 4.1 mp -68.74 -47.85 65.23 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.549 -0.75 . . . . 0.34 110.578 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 2.0 ppt_? -70.11 -11.07 60.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.748 -0.781 . . . . 1.38 109.769 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 12.7 ttt180 -80.87 -31.88 35.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.622 -0.717 . . . . 1.94 109.456 171.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.4 m -67.57 -43.17 81.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.117 -0.947 . . . . 0.48 110.058 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.655 HD22 ' O ' ' A' ' 22' ' ' LEU . 1.1 mm? -86.54 -9.21 56.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.599 -0.728 . . . . 0.58 109.942 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.54 91.76 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.796 -0.638 . . . . 0.42 112.696 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 1.056 HD13 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.47 -176.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.939 0.496 . . . . 0.7 109.705 173.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 175.73 10.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.263 -0.426 . . . . 0.31 110.444 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.834 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.4 pt-20 -67.87 -37.85 82.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.53 0.681 . . . . 2.0 111.25 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.63 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 10.9 mmpt? -80.75 -3.25 50.21 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.583 -0.735 . . . . 0.67 109.652 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.52 171.89 12.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.549 -0.75 . . . . 1.65 110.111 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -117.75 158.12 25.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.38 -0.827 . . . . 0.26 108.986 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.056 HD21 HD13 ' A' ' 28' ' ' ILE . 61.8 mt -131.01 127.81 39.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.547 -0.909 . . . . 0.27 108.547 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.613 ' HA ' HG12 ' B' ' 7' ' ' VAL . 30.7 tt0 -89.09 96.46 10.73 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.736 -0.839 . . . . 1.11 108.736 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.8 mp -90.25 136.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.857 -1.065 . . . . 0.12 112.789 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 16.4 m-85 -132.68 -178.05 4.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.278 -1.328 . . . . 1.54 107.455 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.6 t -147.7 129.66 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.688 0.756 . . . . 0.26 111.259 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 44' ' ' ILE . 17.5 t70 -92.51 87.27 5.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.702 -1.135 . . . . 1.74 108.718 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.8 t70 61.46 -67.42 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.662 -1.154 . . . . 2.01 112.394 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -120.9 -9.19 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.681 -0.691 . . . . 1.67 111.916 -172.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 38' ' ' VAL . 20.3 pttm -127.65 154.9 44.72 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.727 1.01 . . . . 0.75 113.727 -173.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.912 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 25.7 mt -92.27 139.04 18.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.548 -1.205 . . . . 0.16 110.924 -170.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.534 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -124.5 105.62 15.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.9 -0.408 . . . . 0.19 109.9 -177.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.942 HD13 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -97.6 109.09 21.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.223 0.535 . . . . 0.13 110.733 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -98.04 157.19 16.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.186 -1.412 . . . . 2.11 107.186 168.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.817 ' HA ' HD23 ' A' ' 34' ' ' LEU . 17.5 ptmt -75.76 148.32 38.59 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 2.48 108.395 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HD1' HG11 ' B' ' 7' ' ' VAL . 76.9 t80 . . . . . 0 C--N 1.319 -0.72 0 C-N-CA 120.798 -0.361 . . . . 3.33 110.091 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.544 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 94.2 p . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.364 0.602 . . . . 1.17 109.938 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.749 ' HB ' HD13 ' B' ' 6' ' ' ILE . 8.1 p -102.8 -37.02 8.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.395 -0.82 . . . . 0.28 110.746 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.6 44.15 41.26 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 108.973 -1.651 . . . . 0.29 108.973 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.749 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.94 125.97 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.038 -1.081 . . . . 0.2 109.692 -168.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.2 m -93.91 149.6 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.168 -0.613 . . . . 0.2 110.822 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.42 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 21.6 mmt180 -139.38 156.34 47.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.874 -0.603 . . . . 1.94 110.323 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 7.1 mmpt? -80.26 154.08 28.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.629 -0.714 . . . . 1.37 110.011 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.834 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 22.1 t -89.82 17.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.029 0.919 . . . . 0.22 110.025 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t70 71.65 -109.84 0.05 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.682 -1.144 . . . . 1.17 110.441 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.0 pt-20 -151.63 -42.23 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.337 0.589 . . . . 2.09 111.043 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.47 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.25 -6.39 59.39 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.519 -0.472 . . . . 0.49 111.42 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.97 11.21 16.84 Favored Glycine 0 CA--C 1.497 -1.073 0 N-CA-C 110.975 -0.85 . . . . 0.17 110.975 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.726 ' HB3' HG22 ' A' ' 17' ' ' VAL . 5.3 ptt180 -99.13 119.87 38.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.527 -0.337 . . . . 1.72 111.277 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.691 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -82.85 127.5 39.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.277 -1.009 . . . . 0.17 108.277 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.8 HG22 ' HB3' ' A' ' 15' ' ' ARG . 23.1 t -75.74 85.24 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 119.576 -0.85 . . . . 0.14 109.013 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.473 ' CD1' HD13 ' A' ' 43' ' ' ILE . 1.9 tt -68.73 117.47 51.18 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 115.331 -0.85 . . . . 0.16 108.989 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.474 ' HB2' HD13 ' B' ' 22' ' ' LEU . 74.2 Cg_exo -50.68 140.74 36.43 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.605 2.203 . . . . 0.19 113.087 -171.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.5 pp -53.17 -32.14 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.43 110.776 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -66.67 -44.64 81.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.299 -0.864 . . . . 1.27 110.191 -176.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.792 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.6 mp -67.42 -46.9 71.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.552 -0.749 . . . . 0.52 110.559 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 6.5 ppt_? -68.49 -18.12 64.32 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.065 -0.654 . . . . 1.2 109.342 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.645 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 2.6 ttt180 -72.34 -31.61 65.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.098 -0.956 . . . . 2.11 109.054 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 25.3 m -73.71 -43.44 59.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.043 -0.98 . . . . 0.51 110.699 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.792 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.3 OUTLIER -89.05 -1.36 58.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.614 -0.434 . . . . 0.59 111.467 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.1 35.55 71.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.643 -0.789 . . . . 0.52 112.661 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 1.048 HD13 HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -102.06 -178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 0.73 110.642 176.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -150.41 173.57 13.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.92 109.348 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.926 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.5 pm0 -76.94 -21.56 54.62 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.458 0.647 . . . . 1.5 110.413 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.506 ' HG2' ' HG2' ' B' ' 30' ' ' GLU . 8.3 mmpt? -93.34 0.37 56.9 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.926 -0.768 . . . . 0.46 108.926 176.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.456 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 1.5 t0 -84.33 -179.5 7.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.0 -1.0 . . . . 2.05 110.128 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.03 156.79 41.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.353 -0.84 . . . . 0.25 108.897 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 1.048 HD21 HD13 ' B' ' 28' ' ' ILE . 37.8 mt -131.16 126.98 37.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.585 -0.894 . . . . 0.33 108.585 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.543 ' HG3' HG12 ' A' ' 7' ' ' VAL . 31.9 tt0 -88.33 96.38 10.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.482 -0.933 . . . . 1.29 108.482 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.426 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.43 136.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.739 -1.118 . . . . 0.14 112.962 -171.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.436 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 23.6 m-85 -132.22 -178.35 4.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.218 -1.356 . . . . 1.59 107.671 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.684 HG22 ' HA ' ' B' ' 43' ' ' ILE . 6.9 t -147.56 133.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 0.19 110.521 174.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.49 ' H ' HD11 ' B' ' 44' ' ' ILE . 30.1 t70 -101.89 93.9 5.52 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.64 -0.874 . . . . 1.71 108.64 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.72 -70.46 0.06 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 124.751 1.282 . . . . 2.08 112.014 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -123.75 -2.86 8.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.164 -0.925 . . . . 2.39 111.501 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 42.3 pttt -133.14 152.45 51.95 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 119.291 -0.964 . . . . 0.83 113.29 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 28.5 mt -92.6 139.12 18.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.954 -1.021 . . . . 0.47 110.894 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.49 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.91 105.73 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.74 -0.467 . . . . 0.18 109.74 -176.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -97.97 109.03 21.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.062 0.458 . . . . 0.13 110.831 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' B' ' 35' ' ' GLU . 7.6 mtmp? -100.46 154.84 18.21 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.412 -1.329 . . . . 1.98 107.412 168.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.741 ' HE3' HG23 ' B' ' 28' ' ' ILE . 1.3 ptmt -75.58 140.62 42.77 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.761 -0.829 . . . . 2.2 108.761 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 t80 . . . . . 0 C--N 1.319 -0.746 0 CA-C-O 121.035 0.445 . . . . 3.32 110.289 -178.384 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.52 ' HA ' ' N ' ' B' ' 38' ' ' VAL . 77.3 p . . . . . 0 N--CA 1.439 -1.023 0 CA-C-O 121.175 0.512 . . . . 1.15 110.405 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.807 ' HB ' HD13 ' A' ' 6' ' ' ILE . 17.6 p -96.09 -32.42 12.54 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.26 110.624 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' B' ' 37' ' ' TYR . . . 70.0 33.64 70.19 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.612 -1.395 . . . . 0.36 109.612 -172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.807 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -104.2 123.02 57.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.181 -1.009 . . . . 0.19 109.887 -169.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.756 HG12 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -91.34 146.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.969 -0.692 . . . . 0.22 110.669 -177.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 21.3 mmt180 -138.26 154.11 49.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.469 -0.787 . . . . 1.6 110.112 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 5.8 mmpt? -80.36 151.75 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.973 -0.558 . . . . 1.09 109.772 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.865 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 24.9 t -94.47 15.9 2.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.806 0.813 . . . . 0.25 110.554 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 13.5 t70 66.29 -147.28 0.19 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.396 -0.82 . . . . 1.32 110.111 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.537 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.85 -41.76 2.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.593 -0.891 . . . . 2.06 108.593 176.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -10.8 60.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.728 -1.124 . . . . 0.45 111.011 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.19 11.38 34.14 Favored Glycine 0 CA--C 1.494 -1.243 0 C-N-CA 120.709 -0.758 . . . . 0.19 112.054 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 8.9 ptp180 -103.88 118.94 37.87 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.047 0.451 . . . . 1.58 111.323 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 8.9 p -82.81 129.6 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.933 -0.766 . . . . 0.17 108.933 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' B' ' 15' ' ' ARG . 3.5 t -75.89 84.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.975 -0.69 . . . . 0.19 109.455 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.488 ' CD1' HD13 ' B' ' 43' ' ' ILE . 1.9 tt -69.27 121.27 81.43 Favored Pre-proline 0 N--CA 1.435 -1.184 0 CA-C-N 115.1 -0.955 . . . . 0.2 109.27 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 55.0 Cg_exo -54.61 143.67 67.44 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.246 1.964 . . . . 0.22 112.969 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -59.02 -28.88 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.51 109.857 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -65.91 -44.63 84.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.946 -1.025 . . . . 1.33 110.286 -175.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.675 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.9 mp -69.17 -44.82 71.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.642 -0.708 . . . . 0.34 110.34 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.681 ' HB2' HG13 ' A' ' 28' ' ' ILE . 4.6 ppt_? -71.05 -10.88 60.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.443 0.639 . . . . 1.38 109.62 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.56 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.8 -30.52 32.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.11 -0.95 . . . . 1.94 108.916 171.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -67.35 -41.95 84.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.303 -0.862 . . . . 0.48 109.851 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.675 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -86.64 -11.85 50.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.647 -0.706 . . . . 0.58 110.08 176.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.01 77.56 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.477 -0.783 . . . . 0.42 112.771 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.747 HD13 HD21 ' A' ' 34' ' ' LEU . 36.9 pt -88.12 -157.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 0.7 109.818 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB1' ' OE2' ' A' ' 30' ' ' GLU . . . -161.45 -174.97 4.52 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.917 -0.401 . . . . 0.31 109.917 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.947 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.6 pm0 -79.87 -27.97 40.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.886 0.851 . . . . 2.0 109.922 -176.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.441 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 8.1 mmpt? -80.02 -2.09 42.6 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.138 -0.937 . . . . 0.67 109.697 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.79 177.36 8.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.944 -0.571 . . . . 1.65 110.026 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.77 141.16 52.29 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.856 -1.165 . . . . 0.26 107.856 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.801 HD23 ' HA ' ' A' ' 47' ' ' LYS . 47.8 mt -118.09 127.68 54.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.196 -0.668 . . . . 0.27 109.196 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.761 ' HG3' HG12 ' B' ' 7' ' ' VAL . 17.9 tt0 -89.18 99.22 12.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.928 -1.138 . . . . 1.11 107.928 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.497 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.9 mp -89.38 135.34 26.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.551 -1.204 . . . . 0.12 112.324 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.496 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 4.2 m-85 -128.74 -178.55 4.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.174 -1.375 . . . . 1.54 107.582 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 43' ' ' ILE . 3.8 t -148.34 136.77 14.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.659 -0.497 . . . . 0.26 109.659 172.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.417 ' H ' HD11 ' A' ' 44' ' ' ILE . 65.0 m-20 -115.78 116.8 28.66 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.458 -0.571 . . . . 1.74 109.458 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 60.79 -79.37 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 124.231 0.957 . . . . 2.01 111.177 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -141.25 20.82 2.25 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.191 -0.913 . . . . 1.67 111.274 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 55.4 pttt -135.63 152.29 51.09 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 112.908 0.707 . . . . 0.75 112.908 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 40.1 mt -92.26 139.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.812 -1.085 . . . . 0.16 110.745 -172.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -126.34 106.0 15.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.074 -0.343 . . . . 0.19 110.074 -175.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.934 HD13 HD13 ' B' ' 45' ' ' LEU . 11.2 mp -97.51 109.48 22.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.843 0.354 . . . . 0.13 110.523 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 37' ' ' TYR . 31.7 ttmt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.659 -0.867 . . . . 2.11 108.659 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.801 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -50.28 142.59 9.84 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.834 0.35 . . . . 2.48 111.282 -173.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.532 ' CD1' HG11 ' B' ' 7' ' ' VAL . 52.7 t80 . . . . . 0 N--CA 1.448 -0.566 0 CA-C-N 115.905 -0.588 . . . . 3.33 109.68 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.536 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 91.2 p . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 121.563 0.697 . . . . 1.17 109.406 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.532 ' HB ' ' HB ' ' B' ' 6' ' ' ILE . 3.1 p -93.88 -36.77 12.06 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.312 -0.858 . . . . 0.28 110.563 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 68.78 38.01 84.91 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 108.954 -1.658 . . . . 0.29 108.954 -170.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -111.82 124.8 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.925 -1.138 . . . . 0.2 109.689 -167.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.761 HG12 ' HG3' ' A' ' 35' ' ' GLU . 1.4 m -94.18 146.41 6.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.07 -0.652 . . . . 0.2 110.833 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.603 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 10.4 mmt180 -138.21 153.53 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 1.94 110.305 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -79.67 148.66 31.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 1.37 109.843 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.947 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 13.2 t -91.71 15.84 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.603 0.716 . . . . 0.22 110.635 -174.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 7.4 t70 70.17 -148.43 0.1 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-N 115.289 -0.869 . . . . 1.17 110.002 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -121.11 -41.16 2.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.531 -0.915 . . . . 2.09 108.531 175.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.77 -10.54 59.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.563 -1.199 . . . . 0.49 111.473 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.52 5.48 36.64 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.643 -0.789 . . . . 0.17 111.982 172.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 11.3 ptp180 -101.02 118.55 37.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.079 0.466 . . . . 1.72 111.232 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.84 129.47 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.783 -0.821 . . . . 0.17 108.783 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 15' ' ' ARG . 4.0 t -76.0 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.932 -0.707 . . . . 0.14 109.361 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.3 tt -70.03 120.8 80.28 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.892 -1.049 . . . . 0.16 109.412 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.603 ' HD3' ' HG3' ' B' ' 8' ' ' ARG . 73.6 Cg_exo -52.56 142.37 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.493 2.129 . . . . 0.19 113.197 -175.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.467 ' HA ' ' HG3' ' B' ' 23' ' ' ARG . 2.3 pp -57.39 -27.46 28.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.517 -0.765 . . . . 0.43 109.988 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' B' ' 21' ' ' GLU . 3.5 mt-10 -65.89 -47.26 75.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.159 -0.928 . . . . 1.27 110.391 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.733 ' O ' HD22 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -66.42 -45.31 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.546 -0.462 . . . . 0.52 110.799 178.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.809 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.4 ppt_? -69.36 -15.79 63.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.567 0.699 . . . . 1.2 109.699 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -80.93 -24.01 38.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.949 -1.023 . . . . 2.11 109.298 172.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 57.0 m -71.62 -42.41 67.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.713 -0.676 . . . . 0.51 110.399 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.733 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.8 OUTLIER -87.79 -16.1 35.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.142 -0.481 . . . . 0.59 111.841 -178.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 6.14 79.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.086 -0.578 . . . . 0.52 112.984 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.809 HG13 ' HB2' ' B' ' 23' ' ' ARG . 39.8 pt -78.34 -153.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.321 0.248 . . . . 0.73 110.372 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.44 -105.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.585 0.958 . . . . 0.92 113.585 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.865 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 9.4 pt-20 -154.7 -39.34 0.09 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.094 -1.817 . . . . 1.5 106.094 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.5 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 7.4 mmpt? -75.1 -6.53 50.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 113.527 -1.669 . . . . 0.46 108.967 172.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.586 ' CG ' ' HB ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -77.6 168.65 19.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.072 -0.967 . . . . 2.05 109.492 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.404 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -120.43 142.44 49.23 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.495 -0.928 . . . . 0.25 108.495 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.819 HD13 HD23 ' B' ' 45' ' ' LEU . 33.7 mt -119.93 125.73 49.16 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.773 -0.825 . . . . 0.33 108.773 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.756 ' HG3' HG12 ' A' ' 7' ' ' VAL . 29.2 tt0 -88.77 100.36 13.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.072 -1.085 . . . . 1.29 108.072 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.428 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.19 134.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.729 -1.123 . . . . 0.14 112.694 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.468 ' CD1' ' HA2' ' A' ' 5' ' ' GLY . 16.9 m-85 -124.29 -179.14 4.33 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.01 -1.45 . . . . 1.59 107.804 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' B' ' 43' ' ' ILE . 9.5 t -148.93 134.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.67 -0.493 . . . . 0.19 109.67 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.91 94.01 4.73 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.391 -0.368 . . . . 1.71 110.683 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 67.04 -13.31 0.2 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.23 -1.35 . . . . 2.08 113.975 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -179.91 -15.46 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.393 -0.367 . . . . 2.39 111.548 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 50.1 pttt -137.84 156.12 48.27 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 119.251 -0.98 . . . . 0.83 113.381 -172.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.912 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -92.38 139.65 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.596 -1.184 . . . . 0.47 110.445 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.428 HD13 ' C ' ' B' ' 43' ' ' ILE . 0.1 OUTLIER -127.01 104.11 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.215 -0.291 . . . . 0.18 110.215 -175.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.12 108.59 20.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.081 0.467 . . . . 0.13 110.331 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -114.74 127.23 55.63 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.761 ' HA ' HD23 ' B' ' 34' ' ' LEU . 14.6 ptpt -46.07 139.04 4.74 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.456 0.472 . . . . 2.2 110.697 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.536 ' CD1' HG11 ' A' ' 7' ' ' VAL . 55.1 t80 . . . . . 0 C--N 1.32 -0.684 0 N-CA-C 109.847 -0.427 . . . . 3.32 109.847 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.596 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 35.3 t . . . . . 0 CA--C 1.496 -1.102 0 CA-C-O 121.685 0.755 . . . . 1.15 110.836 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.76 ' HB ' HD13 ' A' ' 6' ' ' ILE . 21.9 p -118.84 -27.26 5.84 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.615 -1.175 . . . . 0.26 110.481 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.54 44.38 92.98 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.788 -1.325 . . . . 0.36 109.788 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.76 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -115.3 126.02 72.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.463 -0.868 . . . . 0.19 109.992 -170.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.4 m -92.79 146.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.107 -0.637 . . . . 0.22 110.382 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 31.3 mmt180 -137.84 154.93 49.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.118 -0.492 . . . . 1.6 109.929 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 6.7 mmpt? -80.62 154.42 27.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.249 -0.432 . . . . 1.09 109.933 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.867 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.7 t -91.06 16.83 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.792 0.806 . . . . 0.25 110.228 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 26.2 t70 66.94 -133.34 0.14 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.412 -0.813 . . . . 1.32 109.584 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.463 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -131.19 -37.13 1.27 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.253 0.549 . . . . 2.06 110.438 177.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 13' ' ' LEU . 3.8 mm? -87.09 6.26 33.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.177 -0.465 . . . . 0.45 111.529 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.42 18.14 31.74 Favored Glycine 0 CA--C 1.496 -1.114 0 C-N-CA 121.056 -0.592 . . . . 0.19 112.15 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' B' ' 17' ' ' VAL . 10.1 ptt180 -106.12 120.13 41.02 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.849 0.357 . . . . 1.58 111.234 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.767 HG12 HG12 ' B' ' 16' ' ' VAL . 9.6 p -82.96 126.75 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.191 -1.04 . . . . 0.17 108.191 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' B' ' 15' ' ' ARG . 21.5 t -75.41 85.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.891 -0.724 . . . . 0.19 109.154 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 HD13 ' B' ' 43' ' ' ILE . 1.2 tt -69.79 124.46 90.66 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 115.063 -0.971 . . . . 0.2 108.967 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 50.9 Cg_exo -54.13 145.15 55.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.239 1.959 . . . . 0.22 112.965 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.31 -32.15 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.51 109.946 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.0 pt-20 -70.43 -34.38 72.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.697 -1.138 . . . . 1.33 110.771 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.75 ' O ' HD22 ' A' ' 26' ' ' LEU . 6.0 mp -74.17 -44.63 52.74 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.269 -0.573 . . . . 0.34 110.542 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.706 ' HB2' HG13 ' A' ' 28' ' ' ILE . 2.2 ppt_? -70.12 -12.91 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 1.38 109.407 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.1 ttt180 -82.74 -27.07 31.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.894 -1.048 . . . . 1.94 109.431 171.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 96.7 m -69.68 -42.8 73.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.36 -0.836 . . . . 0.48 109.681 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.15 -18.58 45.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.202 -0.666 . . . . 0.58 109.202 177.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.69 81.99 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.286 -0.87 . . . . 0.42 112.202 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.706 HG13 ' HB2' ' A' ' 23' ' ' ARG . 46.5 pt -83.11 -153.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.645 -0.502 . . . . 0.7 109.645 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.504 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -162.47 -168.61 1.88 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.403 -0.362 . . . . 0.31 110.036 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.942 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -82.93 -30.81 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.645 0.736 . . . . 2.0 109.798 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 11.8 mmpt? -77.04 -6.26 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.578 -0.737 . . . . 0.67 109.918 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -84.48 162.73 19.8 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.916 -0.584 . . . . 1.65 110.829 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.554 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -107.69 157.45 18.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.576 -0.738 . . . . 0.26 109.511 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.817 HD13 HD23 ' A' ' 45' ' ' LEU . 52.1 mt -129.93 130.5 45.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.516 -0.92 . . . . 0.27 108.516 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.653 ' HG3' HG12 ' B' ' 7' ' ' VAL . 19.9 tt0 -88.82 96.24 10.61 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.486 -0.931 . . . . 1.11 108.486 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.412 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -89.78 137.19 21.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.0 -1.0 . . . . 0.12 112.942 -171.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.412 ' C ' HG12 ' A' ' 44' ' ' ILE . 7.2 m-85 -130.8 -177.99 4.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.201 -1.363 . . . . 1.54 107.916 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 43' ' ' ILE . 12.8 t -147.25 130.52 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.26 111.029 174.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.457 ' H ' HD11 ' A' ' 44' ' ' ILE . 31.7 t70 -115.16 121.93 44.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.784 -0.643 . . . . 1.74 109.527 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.87 -73.82 0.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 124.177 0.923 . . . . 2.01 110.784 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.5 17.88 0.4 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.176 -0.92 . . . . 1.67 110.281 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -133.06 157.06 46.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.372 0.606 . . . . 0.75 112.32 -174.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.922 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.1 mt -92.88 139.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.832 -1.076 . . . . 0.16 111.652 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.457 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -124.0 104.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.149 -0.478 . . . . 0.19 109.775 -178.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.899 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -95.86 107.68 19.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.481 0.658 . . . . 0.13 110.488 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -97.93 159.0 15.21 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.142 -1.429 . . . . 2.11 107.142 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD23 ' A' ' 34' ' ' LEU . 3.9 ptpp? -74.17 145.18 44.44 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.134 -1.061 . . . . 2.48 108.134 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 p90 . . . . . 0 C--N 1.32 -0.681 0 N-CA-C 110.02 -0.363 . . . . 3.33 110.02 -177.488 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.443 ' HA ' ' N ' ' A' ' 38' ' ' VAL . 3.5 m . . . . . 0 CA--C 1.507 -0.705 0 CA-C-O 121.495 0.664 . . . . 1.17 111.551 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.425 ' HB ' HD13 ' B' ' 6' ' ' ILE . 17.0 p -110.64 -30.38 7.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.895 -1.048 . . . . 0.28 109.936 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 67.97 44.44 78.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.662 -1.375 . . . . 0.29 109.662 -173.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.425 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -118.28 125.98 74.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.099 -1.05 . . . . 0.2 109.826 -167.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 m -93.88 142.43 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.035 -0.666 . . . . 0.2 110.831 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 71.8 mmt-85 -134.36 155.15 50.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.472 -0.331 . . . . 1.94 110.957 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.554 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 7.6 mmpt? -80.7 152.59 28.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.772 -0.649 . . . . 1.37 110.003 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.942 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.7 t -94.36 19.35 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.687 0.756 . . . . 0.22 110.743 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 14.3 t70 64.69 -145.14 0.25 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.604 -0.725 . . . . 1.17 109.692 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.502 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -116.92 -43.06 2.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.482 0.658 . . . . 2.09 109.716 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.94 -15.07 61.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.967 -1.015 . . . . 0.49 111.197 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.46 13.64 11.5 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.751 -0.738 . . . . 0.17 111.716 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.716 ' HB3' HG22 ' A' ' 17' ' ' VAL . 3.8 ptt180 -99.78 121.69 41.65 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 120.836 0.351 . . . . 1.72 111.389 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.767 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.31 126.81 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.128 -1.064 . . . . 0.17 108.128 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 15' ' ' ARG . 21.4 t -76.07 84.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.58 -0.848 . . . . 0.14 109.314 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.472 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.5 tt -69.28 122.08 84.23 Favored Pre-proline 0 N--CA 1.436 -1.16 0 CA-C-N 114.743 -1.117 . . . . 0.16 109.15 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.426 ' HB2' ' CD1' ' B' ' 22' ' ' LEU . 69.8 Cg_exo -51.58 139.25 47.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.194 1.929 . . . . 0.19 113.224 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -53.18 -29.71 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.43 110.831 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 1.8 mt-10 -67.18 -41.15 86.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.969 . . . . 1.27 110.334 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.714 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.5 mp -70.9 -42.65 69.66 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.851 -0.613 . . . . 0.52 110.855 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.699 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.9 ppt_? -67.79 -22.7 65.17 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.659 -0.867 . . . . 1.2 108.659 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -71.4 -31.64 67.5 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.748 -1.115 . . . . 2.11 108.504 174.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 96.8 m -70.52 -38.4 74.25 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.813 -1.085 . . . . 0.51 110.795 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.714 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -84.29 -20.14 32.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.482 -0.487 . . . . 0.59 110.706 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.74 8.12 67.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.034 -0.603 . . . . 0.52 112.061 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.699 HG13 ' HB2' ' B' ' 23' ' ' ARG . 44.0 pt -88.81 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.73 110.181 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.649 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -164.69 -177.28 4.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.795 -0.639 . . . . 0.92 109.838 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.867 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -69.22 -34.8 75.41 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.567 0.699 . . . . 1.5 110.676 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.1 mmpt? -79.13 -5.38 54.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.528 -0.76 . . . . 0.46 109.951 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.615 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 1.8 m-20 -86.89 160.39 18.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.478 -0.783 . . . . 2.05 111.306 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.485 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -108.03 155.86 19.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.525 -0.762 . . . . 0.25 109.521 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.811 HD13 HD23 ' B' ' 45' ' ' LEU . 26.2 mt -130.15 129.15 43.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.101 -1.074 . . . . 0.33 108.101 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.678 ' HG3' HG12 ' A' ' 7' ' ' VAL . 23.9 tt0 -88.75 99.62 12.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.626 -0.879 . . . . 1.29 108.626 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.16 138.06 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.541 -1.208 . . . . 0.14 112.775 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.502 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 11.6 m-85 -130.18 -177.6 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.325 -1.307 . . . . 1.59 108.156 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.596 ' H ' ' CB ' ' A' ' 3' ' ' SER . 9.9 t -145.63 135.98 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.024 0.44 . . . . 0.19 110.271 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.454 ' N ' HD11 ' B' ' 44' ' ' ILE . 15.4 t70 -117.33 115.03 24.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.478 -0.783 . . . . 1.71 109.473 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t0 69.73 -69.47 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 124.347 1.03 . . . . 2.08 110.569 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.81 20.82 0.21 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.135 -0.939 . . . . 2.39 110.207 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 44.1 pttt -133.67 156.85 47.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.195 0.521 . . . . 0.83 112.035 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.7 mt -93.17 139.31 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.283 -0.872 . . . . 0.47 111.393 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.454 HD11 ' N ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.11 104.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.18 109.885 -177.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.922 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.8 mp -94.64 108.42 20.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.134 0.493 . . . . 0.13 110.644 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 35' ' ' GLU . 34.3 ttpt -101.22 157.08 17.04 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.39 -1.337 . . . . 1.98 107.39 171.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.598 ' HA ' HD23 ' B' ' 34' ' ' LEU . 17.5 ptpt -65.79 148.98 50.9 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.601 -0.888 . . . . 2.2 108.601 172.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 109.031 -0.729 . . . . 3.32 109.031 176.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.642 ' HB2' ' O ' ' B' ' 38' ' ' VAL . 4.0 t . . . . . 0 CA--C 1.498 -1.042 0 CA-C-O 121.389 0.614 . . . . 1.15 109.99 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.889 ' HB ' HD13 ' A' ' 6' ' ' ILE . 41.2 p -135.77 -34.51 0.82 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.042 -0.981 . . . . 0.26 111.035 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.56 24.89 71.5 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.591 -1.403 . . . . 0.36 109.591 -174.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.889 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.3 mp -89.97 125.73 42.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.062 -1.069 . . . . 0.19 110.061 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.802 HG12 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -95.15 147.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.019 -0.673 . . . . 0.22 110.471 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -141.25 157.23 45.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.196 -0.456 . . . . 1.6 110.416 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.502 ' CE ' ' HB2' ' B' ' 33' ' ' ALA . 9.4 mmpt? -80.33 158.03 26.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.689 -0.687 . . . . 1.09 110.18 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.94 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.2 t -97.2 18.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.763 0.792 . . . . 0.25 110.392 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 15' ' ' ARG . 1.1 t70 66.35 -135.62 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.357 1.075 . . . . 1.32 110.472 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -130.25 -47.96 1.09 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.314 -1.766 . . . . 2.06 108.455 177.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.4 mm? -67.04 -22.05 65.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.245 -1.343 . . . . 0.45 110.55 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.11 14.33 7.84 Favored Glycine 0 CA--C 1.499 -0.968 0 C-N-CA 120.898 -0.668 . . . . 0.19 111.55 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.696 ' HB3' HG22 ' B' ' 17' ' ' VAL . 18.3 ptt180 -100.83 120.24 39.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.176 0.513 . . . . 1.58 111.617 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.784 HG11 HD21 ' B' ' 45' ' ' LEU . 7.8 p -84.07 128.15 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 108.372 -0.973 . . . . 0.17 108.372 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG22 ' HB3' ' B' ' 15' ' ' ARG . 13.8 t -76.53 84.44 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.685 -0.806 . . . . 0.19 109.442 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 HD13 ' B' ' 43' ' ' ILE . 0.9 OUTLIER -67.07 124.63 89.33 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.86 -1.064 . . . . 0.2 109.293 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HG2' HD13 ' A' ' 22' ' ' LEU . 50.8 Cg_exo -55.91 139.45 84.38 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.333 2.022 . . . . 0.22 113.329 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.664 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.2 pp -50.52 -35.91 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.697 -1.138 . . . . 0.51 111.107 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HG3' HD12 ' A' ' 22' ' ' LEU . 3.6 pt-20 -69.91 -36.21 75.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.817 -1.083 . . . . 1.33 110.727 -174.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.728 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -72.58 -43.73 62.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.827 -0.624 . . . . 0.34 110.921 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.664 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -67.26 -20.92 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.656 -0.868 . . . . 1.38 108.656 178.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -24.87 41.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.703 -1.135 . . . . 1.94 109.57 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 97.5 m -70.67 -42.25 70.98 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.37 -0.832 . . . . 0.48 109.895 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.07 -19.7 39.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.58 109.28 178.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.57 17.8 78.52 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.244 -0.889 . . . . 0.42 112.126 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.867 HD13 HD21 ' A' ' 34' ' ' LEU . 44.2 pt -81.1 -156.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.283 -0.636 . . . . 0.7 109.283 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -161.68 176.5 10.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.31 111.243 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.798 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.0 pt-20 -65.21 -41.05 94.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.852 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.693 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 7.4 mmpt? -76.39 -1.44 26.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.52 -0.764 . . . . 0.67 109.785 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -85.55 176.16 8.38 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.902 -0.59 . . . . 1.65 109.898 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' B' ' 8' ' ' ARG . . . -126.84 145.33 50.69 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.558 -0.905 . . . . 0.26 108.558 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 28' ' ' ILE . 84.5 mt -123.51 130.61 52.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.501 -0.926 . . . . 0.27 108.501 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.653 ' HG3' HG12 ' B' ' 7' ' ' VAL . 24.4 tt0 -88.6 101.32 13.85 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.705 -1.221 . . . . 1.11 107.705 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.433 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -88.91 135.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.576 -1.193 . . . . 0.12 112.254 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.5 ' HB3' ' OG ' ' B' ' 3' ' ' SER . 4.6 m-85 -127.06 -179.55 4.91 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.397 -1.274 . . . . 1.54 107.979 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 ' HA ' ' A' ' 43' ' ' ILE . 9.7 t -147.3 136.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.26 110.101 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 36.3 t70 -119.82 118.83 31.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.641 -0.709 . . . . 1.74 109.098 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.83 -83.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.734 0.646 . . . . 2.01 110.576 -172.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -143.97 18.15 1.78 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.007 -0.997 . . . . 1.67 109.915 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 16.0 pttm -125.82 151.44 46.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.085 -0.646 . . . . 0.75 112.345 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.89 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 17.6 mt -92.37 138.82 19.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.653 -1.158 . . . . 0.16 110.715 -171.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.446 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -125.55 103.11 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.639 -0.504 . . . . 0.19 109.639 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.949 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -92.12 109.15 20.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.001 0.429 . . . . 0.13 110.424 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLU . 39.8 ttmt -107.15 159.62 16.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.035 -1.469 . . . . 2.11 107.035 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.743 ' HA ' HD23 ' A' ' 34' ' ' LEU . 8.4 ptpp? -66.59 150.75 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.622 -0.881 . . . . 2.48 108.622 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 29.5 p90 . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 109.901 -0.407 . . . . 3.33 109.901 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 2.4 t . . . . . 0 CA--C 1.5 -0.97 0 CA-C-O 122.004 0.907 . . . . 1.17 110.013 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.894 ' HB ' HD13 ' B' ' 6' ' ' ILE . 25.0 p -137.86 -39.66 0.56 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.312 -1.313 . . . . 0.28 110.175 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 74.88 28.55 62.52 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.342 -1.503 . . . . 0.29 109.342 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.894 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -96.7 125.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.939 -1.131 . . . . 0.2 110.049 -173.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -93.59 148.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.235 -0.586 . . . . 0.2 111.084 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' HD3' ' B' ' 8' ' ' ARG . 16.4 mmt85 -140.15 154.87 47.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 1.94 110.593 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -79.99 153.71 28.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.085 -0.507 . . . . 1.37 110.082 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.798 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.6 t -93.0 18.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.764 0.792 . . . . 0.22 110.527 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 23.1 t70 67.18 -136.74 0.12 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.525 -0.761 . . . . 1.17 110.163 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.547 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -131.56 -42.33 1.04 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.76 -1.109 . . . . 2.09 109.11 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.423 HD22 ' N ' ' B' ' 13' ' ' LEU . 3.8 mm? -73.86 -24.21 59.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.038 -0.983 . . . . 0.49 110.077 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.05 16.38 4.42 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 120.716 -0.754 . . . . 0.17 111.751 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.675 ' HB3' HG22 ' A' ' 17' ' ' VAL . 10.6 ptt180 -103.73 121.41 42.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.939 0.4 . . . . 1.72 111.897 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.75 128.15 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.335 -0.987 . . . . 0.17 108.335 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 15' ' ' ARG . 17.3 t -76.41 84.75 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 119.673 -0.811 . . . . 0.14 109.507 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.491 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.3 tt -71.08 121.6 84.62 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.145 -0.934 . . . . 0.16 109.209 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' B' ' 22' ' ' LEU . 70.9 Cg_exo -51.68 140.18 46.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.256 1.971 . . . . 0.19 113.131 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -57.36 -26.59 26.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.67 -0.696 . . . . 0.43 110.13 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.5 mt-10 -66.77 -41.68 87.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.671 -1.149 . . . . 1.27 110.448 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.728 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -71.88 -43.55 65.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.675 -0.693 . . . . 0.52 110.34 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.673 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.4 ppt_? -69.3 -17.95 63.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.355 0.598 . . . . 1.2 109.71 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -75.99 -31.11 58.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.817 -1.083 . . . . 2.11 108.474 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 93.2 m -68.09 -41.14 82.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.144 -0.935 . . . . 0.51 110.516 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.728 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 -19.69 35.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.59 111.266 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.93 7.15 78.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.886 -0.673 . . . . 0.52 112.261 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.881 HD13 HD21 ' B' ' 34' ' ' LEU . 42.9 pt -80.9 -156.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.948 0.404 . . . . 0.73 110.294 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -160.25 179.35 8.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.369 -0.378 . . . . 0.92 110.97 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.94 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -74.98 -37.48 61.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.585 0.707 . . . . 1.5 109.986 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.9 mmpt? -77.14 -2.62 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.732 -0.667 . . . . 0.46 109.884 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.448 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 20.7 t70 -84.12 -178.83 7.07 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.104 -0.498 . . . . 2.05 109.852 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.502 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . . . -133.86 144.28 48.83 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.044 -0.724 . . . . 0.25 109.044 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.881 HD21 HD13 ' B' ' 28' ' ' ILE . 92.0 mt -124.67 130.08 51.73 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.755 -0.831 . . . . 0.33 108.755 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.802 ' HG3' HG12 ' A' ' 7' ' ' VAL . 21.7 tt0 -88.33 103.12 15.53 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 107.62 -1.252 . . . . 1.29 107.62 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.446 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.35 133.82 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.273 -1.331 . . . . 0.14 112.588 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.511 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 5.4 m-85 -126.39 -178.99 4.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.716 -1.129 . . . . 1.59 108.152 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 3' ' ' SER . 8.7 t -147.58 137.91 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.399 0.618 . . . . 0.19 110.871 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.9 t70 -119.46 121.98 40.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.604 -0.726 . . . . 1.71 109.156 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 -87.11 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.798 0.686 . . . . 2.08 110.354 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.43 29.81 1.26 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.262 -0.881 . . . . 2.39 109.649 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 34.7 pttt -127.66 149.45 50.19 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.432 0.634 . . . . 0.83 111.479 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.883 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.5 mt -92.8 139.26 18.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.995 -1.002 . . . . 0.47 110.943 -170.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.405 HG12 ' C ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER -125.07 103.69 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.856 -0.424 . . . . 0.18 109.856 -176.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 45' ' ' LEU . 10.9 mp -95.24 109.57 21.67 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.852 0.358 . . . . 0.13 110.494 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' B' ' 35' ' ' GLU . 29.3 ttmt -112.38 153.87 26.64 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 108.047 -1.094 . . . . 1.98 108.047 171.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.784 ' HA ' HD23 ' B' ' 34' ' ' LEU . 9.9 ptpp? -58.49 144.08 43.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.501 -0.555 . . . . 2.2 109.501 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.489 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 3.4 p90 . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 3.32 109.605 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.573 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 98.7 p . . . . . 0 CA--C 1.511 -0.543 0 CA-C-O 121.679 0.752 . . . . 1.15 111.81 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.729 ' HB ' HD13 ' A' ' 6' ' ' ILE . 15.2 p -100.06 -34.04 10.23 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.824 -1.08 . . . . 0.26 110.344 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.67 43.68 51.11 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.222 -1.551 . . . . 0.36 109.222 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.729 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -117.12 126.45 74.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.808 -1.196 . . . . 0.19 109.55 -168.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG12 ' HA ' ' B' ' 35' ' ' GLU . 3.0 m -97.68 148.58 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.118 -0.633 . . . . 0.22 111.13 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 59.9 mmt-85 -137.41 150.3 47.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.721 -0.672 . . . . 1.6 110.515 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 0.4 OUTLIER -77.84 148.62 34.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.096 -0.502 . . . . 1.09 110.059 172.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.941 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 35.8 t -86.8 20.98 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.847 0.832 . . . . 0.25 110.86 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 38.0 t70 68.51 -124.45 0.15 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.524 -0.762 . . . . 1.32 110.191 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.468 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 2.0 pt-20 -142.9 -40.4 0.32 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.472 0.653 . . . . 2.06 109.986 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' CD2' ' HG3' ' A' ' 12' ' ' GLU . 4.0 mm? -85.47 -0.66 55.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.769 . . . . 0.45 110.395 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 10' ' ' VAL . . . 98.61 16.19 32.25 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 115.741 -0.663 . . . . 0.19 112.407 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.874 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 11.0 ptt180 -100.71 116.95 33.83 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.83 0.348 . . . . 1.58 110.831 176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.69 HG12 HG12 ' B' ' 16' ' ' VAL . 4.5 p -82.82 127.44 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.765 -1.198 . . . . 0.17 107.765 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.743 HG22 ' HB3' ' B' ' 15' ' ' ARG . 19.3 t -76.5 84.73 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.809 -0.756 . . . . 0.19 109.31 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CD1' HD13 ' B' ' 43' ' ' ILE . 2.8 tt -67.95 120.57 74.97 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 115.22 -0.9 . . . . 0.2 109.117 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.4 142.84 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.455 2.103 . . . . 0.22 113.617 -173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -55.59 -29.79 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.066 -0.97 . . . . 0.51 110.02 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.2 mt-10 -67.92 -44.23 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.33 110.145 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.76 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -70.42 -43.01 70.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.38 -0.827 . . . . 0.34 110.653 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.63 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.0 ppt_? -70.92 -13.75 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.525 0.678 . . . . 1.38 109.181 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -82.74 -25.49 32.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.998 -1.001 . . . . 1.94 109.375 171.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 88.4 m -70.43 -42.82 71.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.48 109.815 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.76 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -85.54 -15.22 43.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.618 -0.719 . . . . 0.58 109.781 177.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 17.42 78.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.351 -0.841 . . . . 0.42 112.493 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.821 HD13 HD21 ' A' ' 34' ' ' LEU . 37.6 pt -77.85 -160.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.86 -0.422 . . . . 0.7 109.86 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.04 177.37 10.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.31 110.77 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.924 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 11.8 pt-20 -69.4 -40.74 77.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.805 0.812 . . . . 2.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.73 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -78.92 0.86 25.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.244 -0.889 . . . . 0.67 109.481 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.14 165.95 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.4 -0.818 . . . . 1.65 109.779 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.9 154.99 24.38 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.071 -0.715 . . . . 0.26 109.071 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.821 HD21 HD13 ' A' ' 28' ' ' ILE . 80.6 mt -129.95 130.97 45.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.671 -1.233 . . . . 0.27 107.671 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.594 ' HA ' HG12 ' B' ' 7' ' ' VAL . 29.3 tt0 -89.38 98.01 11.52 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.991 -0.744 . . . . 1.11 108.991 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.506 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 3.0 mp -89.57 135.4 26.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.968 -1.014 . . . . 0.12 112.611 -171.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 83.4 m-85 -130.65 -177.75 4.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.16 -1.382 . . . . 1.54 107.877 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.7 t -146.8 131.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.39 0.614 . . . . 0.26 110.309 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.455 ' H ' HD11 ' A' ' 44' ' ' ILE . 15.2 t70 -104.95 104.61 14.4 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.914 -1.039 . . . . 1.74 109.278 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 t70 68.47 -71.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 O-C-N 124.165 0.916 . . . . 2.01 111.106 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -143.47 8.45 1.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 1.67 111.238 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 17.4 pttm -129.05 155.98 44.56 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 112.947 0.721 . . . . 0.75 112.947 -175.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.883 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.4 mt -93.03 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.118 -0.946 . . . . 0.16 111.147 -170.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.479 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -125.73 104.84 13.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.686 -0.487 . . . . 0.19 109.686 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.918 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -93.48 107.46 19.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.462 0.649 . . . . 0.13 110.321 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 26.0 ttmt -95.37 157.24 15.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.701 -1.222 . . . . 2.11 107.701 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HA ' HD23 ' A' ' 34' ' ' LEU . 9.6 ptpp? -73.51 138.92 45.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.589 -0.893 . . . . 2.48 108.589 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HD1' HG11 ' B' ' 7' ' ' VAL . 72.5 t80 . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 109.227 -0.657 . . . . 3.33 109.227 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.563 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 57.2 p . . . . . 0 CA--C 1.51 -0.575 0 CA-C-O 121.698 0.761 . . . . 1.17 110.842 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.735 ' HB ' HD13 ' B' ' 6' ' ' ILE . 7.4 p -99.74 -32.6 10.96 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.109 -0.951 . . . . 0.28 110.195 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.81 40.44 64.45 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.321 -1.511 . . . . 0.29 109.321 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.735 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -114.02 125.68 71.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 113.952 -1.124 . . . . 0.2 109.709 -168.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.0 m -95.06 146.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.392 -0.523 . . . . 0.2 110.883 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -136.42 155.29 50.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 1.94 110.416 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.462 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.2 mmpp? -78.5 153.86 30.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.039 -0.528 . . . . 1.37 109.773 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.924 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 25.3 t -92.38 19.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.815 0.817 . . . . 0.22 110.35 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 9.7 t70 65.43 -139.12 0.2 Allowed 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.29 -0.868 . . . . 1.17 109.33 174.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.491 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -121.71 -47.57 2.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.46 0.648 . . . . 2.09 110.528 176.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.09 -16.62 61.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.753 -0.658 . . . . 0.49 111.392 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.13 12.16 7.11 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.755 -0.736 . . . . 0.17 111.428 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.874 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -98.19 121.48 40.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.98 0.419 . . . . 1.72 111.466 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.69 HG12 HG12 ' A' ' 16' ' ' VAL . 9.9 p -83.27 125.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.028 -1.101 . . . . 0.17 108.028 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' A' ' 15' ' ' ARG . 11.0 t -76.33 84.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 119.583 -0.847 . . . . 0.14 109.042 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.447 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.4 tt -68.58 120.78 77.78 Favored Pre-proline 0 N--CA 1.437 -1.082 0 CA-C-N 115.268 -0.878 . . . . 0.16 108.985 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 18' ' ' ILE . 78.2 Cg_exo -51.79 142.97 40.14 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.267 1.978 . . . . 0.19 113.172 -173.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.4 pp -58.02 -26.69 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.69 -0.687 . . . . 0.43 109.787 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.4 mt-10 -67.18 -44.15 80.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.599 -1.182 . . . . 1.27 110.228 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.762 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.0 mp -70.74 -42.99 69.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.677 -0.692 . . . . 0.52 110.612 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.626 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.2 ppt_? -66.28 -23.8 66.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.703 -0.851 . . . . 1.2 108.703 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.7 OUTLIER -73.62 -29.32 62.29 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.557 -1.201 . . . . 2.11 109.151 175.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 92.9 m -70.14 -42.03 73.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.754 -1.112 . . . . 0.51 110.917 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.762 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -86.15 -16.6 37.38 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.684 -0.406 . . . . 0.59 110.951 -178.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.23 50.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.787 -0.72 . . . . 0.52 111.937 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.729 HD13 HD21 ' B' ' 34' ' ' LEU . 30.4 pt -100.18 -163.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.818 -0.438 . . . . 0.73 109.818 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.501 ' H ' ' HB3' ' B' ' 32' ' ' ASP . . . -161.81 175.02 12.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.453 -0.34 . . . . 0.92 110.653 -176.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.941 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 11.2 pt-20 -65.82 -37.68 86.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.708 0.766 . . . . 1.5 110.499 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -82.5 1.4 37.94 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.325 -0.852 . . . . 0.46 109.458 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' B' ' 29' ' ' ALA . 33.7 t70 -93.84 148.62 21.96 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.77 -0.65 . . . . 2.05 110.173 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.514 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -94.99 151.88 18.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.334 0.588 . . . . 0.25 109.972 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.729 HD21 HD13 ' B' ' 28' ' ' ILE . 82.0 mt -123.4 133.38 54.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.658 -1.238 . . . . 0.33 107.658 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.766 ' HA ' HG12 ' A' ' 7' ' ' VAL . 27.3 tt0 -90.42 95.83 10.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.684 -0.858 . . . . 1.29 108.684 -175.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.468 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 3.1 mp -89.96 134.12 29.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.183 0.992 . . . . 0.14 112.763 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.57 ' HE1' ' HG2' ' B' ' 35' ' ' GLU . 25.4 m-85 -132.09 -178.35 4.86 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.969 -1.469 . . . . 1.59 107.758 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' B' ' 43' ' ' ILE . 8.8 t -147.51 132.24 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.19 110.142 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.464 ' H ' HD11 ' B' ' 44' ' ' ILE . 21.8 t70 -107.98 107.79 18.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.499 -0.773 . . . . 1.71 109.486 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 64.47 -69.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.802 1.314 . . . . 2.08 112.08 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.84 12.07 1.43 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.62 -0.718 . . . . 2.39 111.427 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 0.0 OUTLIER -137.77 157.05 47.25 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.232 -0.987 . . . . 0.83 112.503 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.918 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 20.0 mt -92.5 139.29 18.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.768 -1.105 . . . . 0.47 111.308 -168.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.464 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -123.2 104.86 14.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 0.18 109.418 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.903 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 mp -94.04 107.5 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.387 0.613 . . . . 0.13 109.891 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' B' ' 35' ' ' GLU . 30.7 ttmt -94.53 159.03 15.27 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.427 -1.323 . . . . 1.98 107.427 172.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.609 ' HA ' HD23 ' B' ' 34' ' ' LEU . 18.1 ptpt -75.49 141.49 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.783 -1.191 . . . . 2.2 107.783 171.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.563 ' CD1' HG11 ' A' ' 7' ' ' VAL . 26.1 t80 . . . . . 0 N--CA 1.441 -0.916 0 C-N-CA 119.726 -0.79 . . . . 3.32 109.364 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.558 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 31.2 t . . . . . 0 CA--C 1.501 -0.927 0 CA-C-O 121.726 0.774 . . . . 1.15 111.196 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.866 ' HB ' HD13 ' A' ' 6' ' ' ILE . 23.2 p -119.84 -28.68 5.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.893 -1.048 . . . . 0.26 111.052 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.05 39.91 93.05 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.012 -1.235 . . . . 0.36 110.012 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.866 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -106.77 125.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.518 -0.841 . . . . 0.19 109.653 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.95 144.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 119.968 -0.693 . . . . 0.22 111.121 -176.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 36.7 mmt180 -135.38 158.64 43.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.938 -0.573 . . . . 1.6 110.142 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.28 155.77 28.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.06 -0.518 . . . . 1.09 110.527 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.831 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.9 t -89.28 15.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.973 0.892 . . . . 0.25 109.587 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 73.85 -108.34 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 114.879 -1.055 . . . . 1.32 111.008 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.97 -42.17 0.07 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.649 0.738 . . . . 2.06 109.961 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.0 mm? -84.38 -5.14 59.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.569 -0.741 . . . . 0.45 110.392 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.81 18.39 10.76 Favored Glycine 0 CA--C 1.498 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.19 111.831 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.766 ' HB3' HG22 ' B' ' 17' ' ' VAL . 2.5 ptt180 -105.69 121.62 44.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.869 0.366 . . . . 1.58 111.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.842 HG11 HD21 ' B' ' 45' ' ' LEU . 8.0 p -83.44 126.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.453 -0.943 . . . . 0.17 108.453 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.778 HG22 ' HB3' ' B' ' 15' ' ' ARG . 18.7 t -76.49 85.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.873 -0.731 . . . . 0.19 109.515 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.8 tt -67.09 121.63 79.11 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 115.096 -0.956 . . . . 0.2 109.458 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HG2' HD13 ' A' ' 22' ' ' LEU . 53.0 Cg_exo -54.79 146.16 57.14 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.462 2.108 . . . . 0.22 113.883 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.4 pp -53.56 -35.62 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.91 -1.041 . . . . 0.51 110.88 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.562 ' HG3' HD12 ' A' ' 22' ' ' LEU . 3.7 pt-20 -72.65 -37.31 68.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.757 -1.111 . . . . 1.33 110.546 -174.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.748 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -72.94 -42.2 63.7 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.698 -0.683 . . . . 0.34 110.377 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -69.37 -17.34 63.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.05 -0.722 . . . . 1.38 109.05 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.457 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -79.27 -29.78 42.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.3 -0.864 . . . . 1.94 108.685 172.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 99.8 m -66.85 -41.71 86.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.48 110.111 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.748 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.12 -19.18 40.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.056 -0.72 . . . . 0.58 109.056 176.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.37 20.09 79.03 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.942 -1.026 . . . . 0.42 112.148 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.854 HD13 HD21 ' A' ' 34' ' ' LEU . 42.2 pt -83.67 -158.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.074 0.464 . . . . 0.7 110.085 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.593 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -160.84 -179.38 7.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.787 -0.642 . . . . 0.31 110.093 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.748 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 7.8 pt-20 -72.09 -28.37 63.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.473 0.654 . . . . 2.0 110.723 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.666 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 1.7 mmpt? -89.66 2.4 54.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.312 -0.858 . . . . 0.67 109.02 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.593 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -84.15 163.71 19.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.395 -0.821 . . . . 1.65 110.461 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.58 155.19 23.72 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.818 -0.808 . . . . 0.26 108.818 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.854 HD21 HD13 ' A' ' 28' ' ' ILE . 96.0 mt -130.05 131.43 45.8 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.269 -1.011 . . . . 0.27 108.269 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.629 ' HG3' HG12 ' B' ' 7' ' ' VAL . 40.1 tt0 -89.43 101.19 13.86 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.335 -0.987 . . . . 1.11 108.335 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.541 HG13 ' HG ' ' A' ' 45' ' ' LEU . 3.3 mp -90.15 133.92 30.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.998 0.904 . . . . 0.12 112.776 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.412 ' C ' HG12 ' A' ' 44' ' ' ILE . 22.4 m-85 -124.73 -179.01 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.238 -1.346 . . . . 1.54 108.061 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.0 t -147.16 127.35 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.731 0.777 . . . . 0.26 111.609 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.535 ' H ' HD11 ' A' ' 44' ' ' ILE . 21.5 t70 -99.09 103.86 15.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.051 -0.977 . . . . 1.74 108.851 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 -74.23 0.06 Allowed 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 124.091 0.87 . . . . 2.01 110.981 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' O ' HD12 ' B' ' 26' ' ' LEU . 13.3 pt-20 -149.51 22.46 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.538 -0.756 . . . . 1.67 110.571 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 14.5 pttm -126.66 157.14 39.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.341 0.591 . . . . 0.75 112.124 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.929 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 8.4 mt -93.25 139.9 17.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.238 -0.892 . . . . 0.16 111.456 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.535 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -128.24 104.01 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.795 -0.446 . . . . 0.19 109.795 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.964 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -94.33 108.58 20.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.532 0.682 . . . . 0.13 110.773 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' A' ' 35' ' ' GLU . 32.3 ttpt -98.61 155.44 17.3 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.326 -1.361 . . . . 2.11 107.326 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HA ' HD23 ' A' ' 34' ' ' LEU . 18.9 ptpt -71.64 142.72 49.91 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.978 -0.749 . . . . 2.48 108.978 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HD1' HG11 ' B' ' 7' ' ' VAL . 47.6 t80 . . . . . 0 C--N 1.321 -0.651 0 C-N-CA 120.602 -0.439 . . . . 3.33 109.923 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.434 ' HA ' ' N ' ' A' ' 38' ' ' VAL . 13.9 m . . . . . 0 CA--C 1.508 -0.65 0 CA-C-O 121.475 0.655 . . . . 1.17 111.428 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.573 ' HB ' HD13 ' B' ' 6' ' ' ILE . 12.4 p -102.28 -30.71 10.92 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.139 -0.937 . . . . 0.28 110.146 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.55 40.37 96.06 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.49 -1.444 . . . . 0.29 109.49 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -110.61 126.1 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.354 -0.923 . . . . 0.2 109.906 -168.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -94.88 143.09 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.106 -0.638 . . . . 0.2 111.163 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.813 ' HE ' ' HG3' ' B' ' 19' ' ' PRO . 34.3 mmt180 -133.54 157.4 45.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 1.94 109.773 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.527 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.5 mmpp? -79.32 157.24 27.73 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.39 0.431 . . . . 1.37 110.168 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.748 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.3 t -89.8 12.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.158 0.98 . . . . 0.22 109.437 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.405 ' CG ' ' HG2' ' B' ' 12' ' ' GLU . 38.8 t70 74.77 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 114.435 -1.257 . . . . 1.17 111.62 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.449 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.3 pt-20 -160.12 -45.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.279 0.561 . . . . 2.09 110.082 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.449 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.05 -3.25 57.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.085 -0.507 . . . . 0.49 110.909 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 14.24 17.56 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 120.77 -0.728 . . . . 0.17 111.612 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.778 ' HB3' HG22 ' A' ' 17' ' ' VAL . 8.3 ptt180 -103.13 121.19 42.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.721 0.296 . . . . 1.72 111.568 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.752 HG11 HD21 ' A' ' 45' ' ' LEU . 9.7 p -83.21 125.68 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.346 -0.983 . . . . 0.17 108.346 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 15' ' ' ARG . 16.3 t -76.12 85.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.948 -0.701 . . . . 0.14 109.402 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.439 HD12 HD13 ' A' ' 43' ' ' ILE . 1.9 tt -67.62 121.26 78.47 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 115.101 -0.954 . . . . 0.16 109.242 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.813 ' HG3' ' HE ' ' B' ' 8' ' ' ARG . 51.2 Cg_exo -54.84 147.36 51.49 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.504 2.136 . . . . 0.19 113.293 -172.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.2 pp -59.34 -30.65 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.212 0.53 . . . . 0.43 109.973 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.11 -42.97 93.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.688 -1.142 . . . . 1.27 109.99 -177.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.704 ' O ' HD22 ' B' ' 26' ' ' LEU . 7.1 mp -73.02 -42.62 63.01 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.262 -0.881 . . . . 0.52 110.756 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.668 ' HB2' HG13 ' B' ' 28' ' ' ILE . 7.0 ppt_? -68.68 -20.04 64.42 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.933 -0.766 . . . . 1.2 108.933 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.569 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.9 OUTLIER -73.78 -30.94 63.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.483 -1.235 . . . . 2.11 109.073 172.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 99.6 m -72.1 -39.03 69.21 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.67 -1.15 . . . . 0.51 110.846 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.704 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -83.89 -19.28 35.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.59 110.471 -178.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.18 25.47 55.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.983 -0.627 . . . . 0.52 112.079 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.85 HD13 HD21 ' B' ' 34' ' ' LEU . 39.6 pt -99.72 -159.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.799 0.333 . . . . 0.73 110.142 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.517 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -165.3 179.34 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.882 -0.599 . . . . 0.92 109.657 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.831 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 13.1 pt-20 -69.47 -32.77 71.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.481 0.658 . . . . 1.5 111.044 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.551 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -85.48 1.64 48.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.521 -0.763 . . . . 0.46 109.368 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 0.7 OUTLIER -88.16 160.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.44 -0.8 . . . . 2.05 111.054 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 8' ' ' ARG . . . -108.75 155.84 20.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 0.25 109.233 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.85 HD21 HD13 ' B' ' 28' ' ' ILE . 98.8 mt -130.72 130.66 44.09 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.319 -0.993 . . . . 0.33 108.319 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.654 ' HG3' HG12 ' A' ' 7' ' ' VAL . 40.1 tt0 -89.25 100.3 13.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.994 -1.113 . . . . 1.29 107.994 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.24 135.89 24.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.021 -0.99 . . . . 0.14 112.477 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.501 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 41.0 m-85 -127.06 -178.89 4.59 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.154 -1.385 . . . . 1.59 108.134 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.558 ' H ' ' CB ' ' A' ' 3' ' ' SER . 24.0 t -145.29 134.68 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.274 0.559 . . . . 0.19 110.846 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.524 ' N ' HD11 ' B' ' 44' ' ' ILE . 6.2 t70 -100.1 97.05 7.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.246 -0.888 . . . . 1.71 108.788 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.09 -65.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.232 0.958 . . . . 2.08 111.398 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.523 ' O ' HD12 ' A' ' 26' ' ' LEU . 6.7 pt-20 -150.35 19.39 0.84 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.494 -0.776 . . . . 2.39 111.205 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 52.8 pttt -130.18 156.96 43.71 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.256 -0.578 . . . . 0.83 111.865 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.964 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 9.7 mt -92.7 139.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.534 -0.757 . . . . 0.47 111.414 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.524 HD11 ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -128.08 104.64 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.684 -0.487 . . . . 0.18 109.684 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.929 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.81 107.94 19.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.343 0.592 . . . . 0.13 110.689 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.552 ' HE2' ' HB3' ' B' ' 35' ' ' GLU . 30.4 ttpt -96.76 156.46 16.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.283 -1.377 . . . . 1.98 107.283 171.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.705 ' HA ' HD23 ' B' ' 34' ' ' LEU . 16.4 ptpt -74.93 139.5 43.09 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.734 -0.839 . . . . 2.2 108.734 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 . . . . . 0 C--N 1.322 -0.616 0 C-N-CA 120.296 -0.561 . . . . 3.32 109.794 179.082 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.556 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 92.7 p . . . . . 0 CA--C 1.504 -0.824 0 CA-C-O 121.224 0.535 . . . . 1.15 110.85 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.819 ' HB ' HD13 ' A' ' 6' ' ' ILE . 17.7 p -100.06 -35.92 9.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.438 -0.801 . . . . 0.26 110.353 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.06 50.13 11.36 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.254 -1.539 . . . . 0.36 109.254 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.819 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -122.42 125.32 72.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.447 -0.876 . . . . 0.19 109.83 -168.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.9 m -95.99 145.53 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.94 -0.704 . . . . 0.22 110.861 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.634 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 38.7 mmt180 -135.97 157.95 45.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 1.6 110.442 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 2.5 mmpp? -78.63 153.61 30.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.266 -0.424 . . . . 1.09 110.489 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.809 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.3 t -94.21 13.47 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.683 -0.69 . . . . 0.25 110.566 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 11.1 t70 66.2 -149.65 0.21 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.692 -0.686 . . . . 1.32 110.037 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -115.75 -44.27 2.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.81 0.814 . . . . 2.06 109.061 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.57 -16.87 62.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.691 -1.141 . . . . 0.45 111.033 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.34 26.5 Favored Glycine 0 CA--C 1.495 -1.157 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.467 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.783 ' HD2' ' HG3' ' B' ' 15' ' ' ARG . 1.9 ptt85 -95.55 121.31 37.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 120.329 -0.548 . . . . 1.58 111.465 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 9.7 p -82.55 131.05 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 108.261 -1.014 . . . . 0.17 108.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 14.6 t -75.58 85.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 119.666 -0.814 . . . . 0.19 109.304 -176.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.9 tt -71.28 116.96 52.41 Favored Pre-proline 0 N--CA 1.429 -1.481 0 N-CA-C 108.047 -1.094 . . . . 0.2 108.047 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.634 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 52.2 Cg_exo -54.17 138.82 72.05 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.046 1.831 . . . . 0.22 112.689 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.437 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.6 pp -56.2 -29.64 28.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.692 -0.685 . . . . 0.51 109.945 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -66.34 -44.34 83.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.599 -1.182 . . . . 1.33 110.011 -177.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.796 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -69.89 -45.13 68.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.384 -0.826 . . . . 0.34 110.708 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -70.18 -13.8 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.694 0.759 . . . . 1.38 108.966 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.0 tmt_? -82.83 -28.38 30.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.981 -1.009 . . . . 1.94 109.397 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 92.0 m -69.72 -43.91 71.39 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.199 -0.909 . . . . 0.48 109.919 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.38 -15.47 56.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.622 -0.717 . . . . 0.58 109.2 177.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.65 21.8 76.29 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.051 -0.977 . . . . 0.42 112.475 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.795 HD13 HD21 ' A' ' 34' ' ' LEU . 35.1 pt -83.91 -158.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.853 -0.795 . . . . 0.7 108.853 171.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -154.8 179.34 9.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.136 -0.32 . . . . 0.31 110.136 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.979 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -77.97 -32.74 51.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.951 0.881 . . . . 2.0 109.126 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 11.3 mmpt? -79.52 -0.01 31.55 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.026 -0.988 . . . . 0.67 109.712 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -87.53 172.96 9.38 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.601 -0.727 . . . . 1.65 109.16 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -120.95 150.92 40.36 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.613 -0.884 . . . . 0.26 108.613 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.838 HD13 HD23 ' A' ' 45' ' ' LEU . 53.5 mt -124.75 128.97 49.59 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.73 -0.841 . . . . 0.27 108.73 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.559 ' HA ' HG12 ' B' ' 7' ' ' VAL . 61.0 tt0 -88.57 97.65 11.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.952 -0.759 . . . . 1.11 108.952 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.7 mp -89.89 135.98 24.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.739 -1.119 . . . . 0.12 112.792 -173.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 1.053 ' HE2' ' HE2' ' A' ' 46' ' ' LYS . 78.5 m-85 -130.11 -177.62 4.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.126 -1.397 . . . . 1.54 107.57 174.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 43' ' ' ILE . 6.4 t -147.05 133.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.391 0.615 . . . . 0.26 110.798 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 22.4 t70 -99.09 95.18 6.94 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.079 -0.964 . . . . 1.74 108.671 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 65.52 -66.05 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.361 1.038 . . . . 2.01 112.181 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -137.08 -3.2 2.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.674 -0.694 . . . . 1.67 111.254 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 36.4 pttt -118.56 150.21 40.03 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.744 -0.783 . . . . 0.75 112.086 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.959 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 19.4 mt -92.64 138.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.003 -0.999 . . . . 0.16 110.814 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.32 106.76 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.489 -0.56 . . . . 0.19 109.489 -177.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.888 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -98.59 112.04 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.933 0.397 . . . . 0.13 110.657 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.053 ' HE2' ' HE2' ' A' ' 37' ' ' TYR . 38.0 mtmt -100.65 165.68 11.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.864 -1.162 . . . . 2.11 107.864 167.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.0 ptpt -72.19 143.76 48.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.042 -1.466 . . . . 2.48 107.042 165.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 5.3 p90 . . . . . 0 C--N 1.322 -0.594 0 C-N-CA 120.023 -0.671 . . . . 3.33 111.026 -173.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . 0.602 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 79.1 p . . . . . 0 CA--C 1.503 -0.831 0 CA-C-O 121.574 0.702 . . . . 1.17 112.115 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.796 ' HB ' HD13 ' B' ' 6' ' ' ILE . 16.2 p -104.64 -37.02 7.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.842 -1.072 . . . . 0.28 110.253 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 77.1 46.25 10.59 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.394 -1.482 . . . . 0.29 109.394 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.796 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.221 -0.989 . . . . 0.2 109.945 -167.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.3 m -93.01 149.32 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.197 -0.601 . . . . 0.2 110.582 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 13.3 mmt85 -139.76 156.76 46.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.184 -0.462 . . . . 1.94 110.813 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.544 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 4.3 mmpp? -77.98 153.91 32.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.892 -0.595 . . . . 1.37 110.153 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.979 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 19.5 t -96.12 15.74 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.54 -0.754 . . . . 0.22 110.489 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 13.8 t70 68.19 -146.88 0.13 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.627 -0.715 . . . . 1.17 109.832 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.536 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -119.52 -44.93 2.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.984 0.897 . . . . 2.09 108.682 175.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.69 -28.86 69.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.021 -1.445 . . . . 0.49 110.715 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.9 0.14 9.08 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 120.557 -0.83 . . . . 0.17 111.42 174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.783 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 5.6 ptt180 -92.48 121.41 33.91 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.913 0.387 . . . . 1.72 111.853 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.82 128.96 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.131 -1.063 . . . . 0.17 108.131 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 10.0 t -75.77 85.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.556 -0.858 . . . . 0.14 109.089 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.489 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.6 tt -70.19 115.66 36.67 Favored Pre-proline 0 N--CA 1.428 -1.539 0 N-CA-C 108.285 -1.006 . . . . 0.16 108.285 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.503 ' HB2' HD13 ' B' ' 22' ' ' LEU . 78.2 Cg_exo -50.09 138.99 35.37 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.304 2.003 . . . . 0.19 112.863 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.86 -30.89 23.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.684 -0.689 . . . . 0.43 109.977 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.8 -42.94 90.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.621 -1.172 . . . . 1.27 110.555 -177.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.777 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -70.5 -46.81 62.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.017 -0.538 . . . . 0.52 110.856 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.597 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.5 ppt_? -69.78 -15.07 63.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.39 0.614 . . . . 1.2 109.635 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -76.93 -32.55 57.42 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.057 -0.974 . . . . 2.11 109.041 170.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.1 m -72.0 -39.86 68.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.167 -0.924 . . . . 0.51 110.696 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.777 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -82.87 -14.58 54.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.863 -0.608 . . . . 0.59 110.778 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.3 80.66 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.829 -0.7 . . . . 0.52 112.592 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.702 HD13 HD21 ' B' ' 34' ' ' LEU . 38.0 pt -83.39 -158.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.73 109.603 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 32' ' ' ASP . . . -158.51 175.17 14.02 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.878 0.371 . . . . 0.92 110.92 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.809 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.6 pt-20 -72.41 -40.98 66.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.124 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.55 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 10.3 mmpt? -80.8 4.26 19.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.39 -0.823 . . . . 0.46 109.616 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' B' ' 29' ' ' ALA . 17.6 t70 -85.77 -176.11 5.89 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.109 -0.7 . . . . 2.05 109.109 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.564 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -135.25 146.17 48.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.673 -0.862 . . . . 0.25 108.673 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.857 HD13 HD23 ' B' ' 45' ' ' LEU . 53.0 mt -123.72 127.42 48.13 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.302 -0.629 . . . . 0.33 109.302 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' B' ' 48' ' ' TYR . 27.8 tt0 -87.63 95.89 10.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.263 -1.014 . . . . 1.29 108.263 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 2.7 mp -89.87 136.62 23.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.543 -1.208 . . . . 0.14 112.783 -173.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.434 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 77.6 m-85 -134.37 -177.99 4.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.083 -1.417 . . . . 1.59 107.4 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' B' ' 43' ' ' ILE . 6.5 t -147.56 135.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.311 0.577 . . . . 0.19 111.182 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -104.58 105.85 16.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.344 -0.844 . . . . 1.71 109.204 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 61.15 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.269 0.981 . . . . 2.08 111.035 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.62 14.99 2.15 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.632 -0.713 . . . . 2.39 111.485 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 9.7 pttm -124.11 151.53 43.81 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 119.62 -0.832 . . . . 0.83 112.077 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 4.9 mp -92.54 138.83 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.101 -0.954 . . . . 0.47 111.612 -169.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 36' ' ' ILE . 0.1 OUTLIER -121.74 110.62 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.18 109.546 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.959 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -103.54 109.18 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.13 110.992 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 42' ' ' LYS . 53.4 mtmt -105.66 165.19 11.34 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.665 -1.235 . . . . 1.98 107.665 168.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.458 ' HE2' HG22 ' B' ' 28' ' ' ILE . 16.4 ptpt -68.89 150.97 47.16 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.153 -1.054 . . . . 2.2 108.153 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.631 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 35.9 p90 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 110.324 -0.25 . . . . 3.32 110.324 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 121.294 0.569 . . . . 2.99 110.544 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HE2' ' OG ' ' A' ' 3' ' ' SER . 17.9 ptmt -163.3 -124.51 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.438 -0.801 . . . . 1.86 108.897 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.585 ' HB3' ' O ' ' B' ' 38' ' ' VAL . 97.7 p -54.19 130.92 40.21 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.278 0.561 . . . . 1.15 110.352 170.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.724 ' HB ' HD13 ' A' ' 6' ' ' ILE . 10.6 p -103.21 -35.94 8.28 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.728 -0.669 . . . . 0.26 110.654 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.94 42.03 46.51 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.063 -1.615 . . . . 0.36 109.063 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.724 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -118.25 126.15 74.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 113.989 -1.105 . . . . 0.19 109.731 -167.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.715 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.51 148.48 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.995 -0.682 . . . . 0.22 110.756 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.82 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 32.2 mmt180 -137.26 157.3 46.94 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.029 -0.532 . . . . 1.6 110.301 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 8.6 mmpt? -80.06 154.61 28.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.036 -0.529 . . . . 1.09 109.841 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.926 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t -88.57 14.06 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 122.21 1.005 . . . . 0.25 109.677 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 12' ' ' GLU . 24.4 t70 73.32 -91.81 0.02 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.237 -1.347 . . . . 1.32 112.558 167.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.519 ' HG2' ' OD2' ' A' ' 11' ' ' ASP . 4.8 pt-20 -161.12 -54.24 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.794 0.33 . . . . 2.06 111.746 -174.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.4 mm? -85.01 -9.88 57.58 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.217 -0.447 . . . . 0.45 110.715 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.428 ' HA2' HG12 ' A' ' 10' ' ' VAL . . . 114.23 14.18 9.29 Favored Glycine 0 CA--C 1.499 -0.918 0 C-N-CA 120.726 -0.75 . . . . 0.19 111.351 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.8 ' HB3' HG22 ' B' ' 17' ' ' VAL . 19.4 ptt180 -97.6 117.08 31.07 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.575 -0.313 . . . . 1.58 110.536 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.691 HG12 HG12 ' B' ' 16' ' ' VAL . 9.8 p -82.92 127.04 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.374 -0.973 . . . . 0.17 108.374 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' B' ' 15' ' ' ARG . 19.6 t -75.63 84.87 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 119.742 -0.783 . . . . 0.19 109.127 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.451 ' CD1' HD13 ' B' ' 43' ' ' ILE . 2.1 tt -68.47 118.44 59.92 Favored Pre-proline 0 N--CA 1.437 -1.091 0 CA-C-N 115.036 -0.984 . . . . 0.2 108.797 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.82 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 74.1 Cg_exo -52.0 143.45 40.41 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.341 2.027 . . . . 0.22 113.209 -172.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.429 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -57.42 -32.85 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 CA-C-N 115.528 -0.76 . . . . 0.51 110.008 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -67.0 -41.84 86.0 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.708 -1.133 . . . . 1.33 110.295 -177.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.655 ' O ' HD22 ' A' ' 26' ' ' LEU . 4.1 mp -68.74 -47.85 65.23 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.549 -0.75 . . . . 0.34 110.578 178.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HG3' ' HA ' ' A' ' 20' ' ' ILE . 2.0 ppt_? -70.11 -11.07 60.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.748 -0.781 . . . . 1.38 109.769 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 12.7 ttt180 -80.87 -31.88 35.17 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.622 -0.717 . . . . 1.94 109.456 171.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.4 m -67.57 -43.17 81.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.117 -0.947 . . . . 0.48 110.058 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.655 HD22 ' O ' ' A' ' 22' ' ' LEU . 1.1 mm? -86.54 -9.21 56.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.599 -0.728 . . . . 0.58 109.942 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.21 35.54 91.76 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.796 -0.638 . . . . 0.42 112.696 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 1.056 HD13 HD21 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -91.47 -176.24 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 122.939 0.496 . . . . 0.7 109.705 173.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.41 175.73 10.88 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.263 -0.426 . . . . 0.31 110.444 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.834 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.4 pt-20 -67.87 -37.85 82.33 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.53 0.681 . . . . 2.0 111.25 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.63 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 10.9 mmpt? -80.75 -3.25 50.21 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.583 -0.735 . . . . 0.67 109.652 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.52 171.89 12.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.549 -0.75 . . . . 1.65 110.111 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.533 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -117.75 158.12 25.31 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.38 -0.827 . . . . 0.26 108.986 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.056 HD21 HD13 ' A' ' 28' ' ' ILE . 61.8 mt -131.01 127.81 39.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.547 -0.909 . . . . 0.27 108.547 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.613 ' HA ' HG12 ' B' ' 7' ' ' VAL . 30.7 tt0 -89.09 96.46 10.73 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.736 -0.839 . . . . 1.11 108.736 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.8 mp -90.25 136.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.857 -1.065 . . . . 0.12 112.789 -172.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.546 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 16.4 m-85 -132.68 -178.05 4.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.278 -1.328 . . . . 1.54 107.455 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.6 t -147.7 129.66 6.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.688 0.756 . . . . 0.26 111.259 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.534 ' H ' HD11 ' A' ' 44' ' ' ILE . 17.5 t70 -92.51 87.27 5.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.702 -1.135 . . . . 1.74 108.718 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.8 t70 61.46 -67.42 0.06 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.662 -1.154 . . . . 2.01 112.394 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -120.9 -9.19 9.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.681 -0.691 . . . . 1.67 111.916 -172.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' O ' HG13 ' A' ' 38' ' ' VAL . 20.3 pttm -127.65 154.9 44.72 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 113.727 1.01 . . . . 0.75 113.727 -173.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.912 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 25.7 mt -92.27 139.04 18.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.548 -1.205 . . . . 0.16 110.924 -170.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.534 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -124.5 105.62 15.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.9 -0.408 . . . . 0.19 109.9 -177.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.942 HD13 HD13 ' B' ' 45' ' ' LEU . 11.0 mp -97.6 109.09 21.91 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.223 0.535 . . . . 0.13 110.733 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -98.04 157.19 16.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.186 -1.412 . . . . 2.11 107.186 168.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.817 ' HA ' HD23 ' A' ' 34' ' ' LEU . 17.5 ptmt -75.76 148.32 38.59 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.395 -0.965 . . . . 2.48 108.395 175.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' HD1' HG11 ' B' ' 7' ' ' VAL . 76.9 t80 -64.42 144.97 56.79 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.798 -0.361 . . . . 3.33 110.091 178.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 10.2 tppt? -68.75 115.34 29.77 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.759 -0.655 . . . . 1.88 109.551 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.74 41.25 0.79 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.903 2.402 . . . . 1.22 112.584 -174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -82.77 97.13 8.43 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.261 -0.882 . . . . 2.14 109.909 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -109.86 117.95 35.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.741 -0.663 . . . . 3.15 109.945 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.465 -0.779 . . . . 3.35 110.165 -178.789 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.243 0.544 . . . . 3.6 111.318 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.578 ' HE2' ' OG ' ' B' ' 3' ' ' SER . 17.4 ptmt -168.98 -120.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.19 -0.914 . . . . 2.04 108.947 173.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.578 ' OG ' ' HE2' ' B' ' 2' ' ' LYS . 94.2 p -58.86 129.99 44.81 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.364 0.602 . . . . 1.17 109.938 169.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.749 ' HB ' HD13 ' B' ' 6' ' ' ILE . 8.1 p -102.8 -37.02 8.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.395 -0.82 . . . . 0.28 110.746 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.6 44.15 41.26 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 108.973 -1.651 . . . . 0.29 108.973 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.749 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.94 125.97 74.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.038 -1.081 . . . . 0.2 109.692 -168.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.2 m -93.91 149.6 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.168 -0.613 . . . . 0.2 110.822 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.42 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 21.6 mmt180 -139.38 156.34 47.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.874 -0.603 . . . . 1.94 110.323 175.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 7.1 mmpt? -80.26 154.08 28.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.629 -0.714 . . . . 1.37 110.011 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.834 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 22.1 t -89.82 17.27 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 122.029 0.919 . . . . 0.22 110.025 -177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 30.5 t70 71.65 -109.84 0.05 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.682 -1.144 . . . . 1.17 110.441 169.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.47 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.0 pt-20 -151.63 -42.23 0.11 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.337 0.589 . . . . 2.09 111.043 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.47 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.25 -6.39 59.39 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.519 -0.472 . . . . 0.49 111.42 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.97 11.21 16.84 Favored Glycine 0 CA--C 1.497 -1.073 0 N-CA-C 110.975 -0.85 . . . . 0.17 110.975 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.726 ' HB3' HG22 ' A' ' 17' ' ' VAL . 5.3 ptt180 -99.13 119.87 38.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.527 -0.337 . . . . 1.72 111.277 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.691 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -82.85 127.5 39.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.277 -1.009 . . . . 0.17 108.277 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.8 HG22 ' HB3' ' A' ' 15' ' ' ARG . 23.1 t -75.74 85.24 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 119.576 -0.85 . . . . 0.14 109.013 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.473 ' CD1' HD13 ' A' ' 43' ' ' ILE . 1.9 tt -68.73 117.47 51.18 Favored Pre-proline 0 N--CA 1.438 -1.03 0 CA-C-N 115.331 -0.85 . . . . 0.16 108.989 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.474 ' HB2' HD13 ' B' ' 22' ' ' LEU . 74.2 Cg_exo -50.68 140.74 36.43 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.605 2.203 . . . . 0.19 113.087 -171.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.418 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.5 pp -53.17 -32.14 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.43 110.776 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.5 OUTLIER -66.67 -44.64 81.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.299 -0.864 . . . . 1.27 110.191 -176.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.792 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.6 mp -67.42 -46.9 71.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.552 -0.749 . . . . 0.52 110.559 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 6.5 ppt_? -68.49 -18.12 64.32 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.065 -0.654 . . . . 1.2 109.342 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.645 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 2.6 ttt180 -72.34 -31.61 65.79 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.098 -0.956 . . . . 2.11 109.054 172.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 25.3 m -73.71 -43.44 59.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.043 -0.98 . . . . 0.51 110.699 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.792 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.3 OUTLIER -89.05 -1.36 58.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.614 -0.434 . . . . 0.59 111.467 -176.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.1 35.55 71.18 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.643 -0.789 . . . . 0.52 112.661 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 1.048 HD13 HD21 ' B' ' 34' ' ' LEU . 0.0 OUTLIER -102.06 -178.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.171 0.51 . . . . 0.73 110.642 176.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -150.41 173.57 13.88 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.92 109.348 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.926 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 1.5 pm0 -76.94 -21.56 54.62 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.458 0.647 . . . . 1.5 110.413 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.506 ' HG2' ' HG2' ' B' ' 30' ' ' GLU . 8.3 mmpt? -93.34 0.37 56.9 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.926 -0.768 . . . . 0.46 108.926 176.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.456 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 1.5 t0 -84.33 -179.5 7.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.0 -1.0 . . . . 2.05 110.128 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.03 156.79 41.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.353 -0.84 . . . . 0.25 108.897 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 1.048 HD21 HD13 ' B' ' 28' ' ' ILE . 37.8 mt -131.16 126.98 37.06 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.585 -0.894 . . . . 0.33 108.585 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.543 ' HG3' HG12 ' A' ' 7' ' ' VAL . 31.9 tt0 -88.33 96.38 10.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.482 -0.933 . . . . 1.29 108.482 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.426 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.43 136.62 23.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.739 -1.118 . . . . 0.14 112.962 -171.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.436 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 23.6 m-85 -132.22 -178.35 4.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.218 -1.356 . . . . 1.59 107.671 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.684 HG22 ' HA ' ' B' ' 43' ' ' ILE . 6.9 t -147.56 133.4 12.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.161 0.505 . . . . 0.19 110.521 174.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.49 ' H ' HD11 ' B' ' 44' ' ' ILE . 30.1 t70 -101.89 93.9 5.52 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.64 -0.874 . . . . 1.71 108.64 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.72 -70.46 0.06 Allowed 'General case' 0 N--CA 1.462 0.15 0 O-C-N 124.751 1.282 . . . . 2.08 112.014 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -123.75 -2.86 8.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.164 -0.925 . . . . 2.39 111.501 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 42.3 pttt -133.14 152.45 51.95 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 119.291 -0.964 . . . . 0.83 113.29 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.878 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 28.5 mt -92.6 139.12 18.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 114.954 -1.021 . . . . 0.47 110.894 -173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.49 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.91 105.73 15.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.74 -0.467 . . . . 0.18 109.74 -176.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.942 HD13 HD13 ' A' ' 45' ' ' LEU . 11.0 mp -97.97 109.03 21.86 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.062 0.458 . . . . 0.13 110.831 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' B' ' 35' ' ' GLU . 7.6 mtmp? -100.46 154.84 18.21 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 107.412 -1.329 . . . . 1.98 107.412 168.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.741 ' HE3' HG23 ' B' ' 28' ' ' ILE . 1.3 ptmt -75.58 140.62 42.77 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.761 -0.829 . . . . 2.2 108.761 176.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -60.67 147.93 40.33 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.035 0.445 . . . . 3.32 110.289 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.514 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 17.4 tppt? -65.74 119.12 58.04 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.413 -0.812 . . . . 2.21 109.385 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.514 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 89.3 Cg_endo -80.24 27.08 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.508 2.139 . . . . 1.25 111.763 -173.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -71.31 102.52 2.61 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.245 -0.888 . . . . 2.26 110.283 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 13.8 ptt? -111.25 111.48 22.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.8 -0.636 . . . . 3.37 110.085 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.471 -0.776 . . . . 3.04 110.45 -177.682 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.0 ttp . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.597 0.713 . . . . 2.99 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.6 ' CG ' ' H ' ' A' ' 3' ' ' SER . 6.6 tttp -146.6 -133.77 0.08 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.279 -1.378 . . . . 1.86 107.279 175.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.6 ' H ' ' CG ' ' A' ' 2' ' ' LYS . 77.3 p -62.93 127.89 33.36 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.175 0.512 . . . . 1.15 110.405 170.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.807 ' HB ' HD13 ' A' ' 6' ' ' ILE . 17.6 p -96.09 -32.42 12.54 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.235 -0.893 . . . . 0.26 110.624 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' B' ' 37' ' ' TYR . . . 70.0 33.64 70.19 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.612 -1.395 . . . . 0.36 109.612 -172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.807 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -104.2 123.02 57.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 114.181 -1.009 . . . . 0.19 109.887 -169.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.756 HG12 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -91.34 146.46 6.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.969 -0.692 . . . . 0.22 110.669 -177.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 21.3 mmt180 -138.26 154.11 49.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.469 -0.787 . . . . 1.6 110.112 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 5.8 mmpt? -80.36 151.75 29.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.973 -0.558 . . . . 1.09 109.772 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.865 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 24.9 t -94.47 15.9 2.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.806 0.813 . . . . 0.25 110.554 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 13.5 t70 66.29 -147.28 0.19 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.396 -0.82 . . . . 1.32 110.111 174.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.537 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -120.85 -41.76 2.54 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.593 -0.891 . . . . 2.06 108.593 176.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -10.8 60.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.728 -1.124 . . . . 0.45 111.011 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.19 11.38 34.14 Favored Glycine 0 CA--C 1.494 -1.243 0 C-N-CA 120.709 -0.758 . . . . 0.19 112.054 172.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 8.9 ptp180 -103.88 118.94 37.87 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.047 0.451 . . . . 1.58 111.323 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 8.9 p -82.81 129.6 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.933 -0.766 . . . . 0.17 108.933 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' B' ' 15' ' ' ARG . 3.5 t -75.89 84.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 119.975 -0.69 . . . . 0.19 109.455 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.488 ' CD1' HD13 ' B' ' 43' ' ' ILE . 1.9 tt -69.27 121.27 81.43 Favored Pre-proline 0 N--CA 1.435 -1.184 0 CA-C-N 115.1 -0.955 . . . . 0.2 109.27 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 55.0 Cg_exo -54.61 143.67 67.44 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.246 1.964 . . . . 0.22 112.969 -174.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.5 pp -59.02 -28.88 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.51 109.857 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -65.91 -44.63 84.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.946 -1.025 . . . . 1.33 110.286 -175.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.675 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.9 mp -69.17 -44.82 71.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.642 -0.708 . . . . 0.34 110.34 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.681 ' HB2' HG13 ' A' ' 28' ' ' ILE . 4.6 ppt_? -71.05 -10.88 60.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.443 0.639 . . . . 1.38 109.62 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.56 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -81.8 -30.52 32.2 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.11 -0.95 . . . . 1.94 108.916 171.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.2 m -67.35 -41.95 84.32 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.303 -0.862 . . . . 0.48 109.851 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.675 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -86.64 -11.85 50.15 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.647 -0.706 . . . . 0.58 110.08 176.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.2 23.01 77.56 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.477 -0.783 . . . . 0.42 112.771 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.747 HD13 HD21 ' A' ' 34' ' ' LEU . 36.9 pt -88.12 -157.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 0.7 109.818 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB1' ' OE2' ' A' ' 30' ' ' GLU . . . -161.45 -174.97 4.52 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.917 -0.401 . . . . 0.31 109.917 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.947 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.6 pm0 -79.87 -27.97 40.01 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.886 0.851 . . . . 2.0 109.922 -176.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.441 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 8.1 mmpt? -80.02 -2.09 42.6 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.138 -0.937 . . . . 0.67 109.697 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -83.79 177.36 8.38 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.944 -0.571 . . . . 1.65 110.026 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -123.77 141.16 52.29 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 107.856 -1.165 . . . . 0.26 107.856 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.801 HD23 ' HA ' ' A' ' 47' ' ' LYS . 47.8 mt -118.09 127.68 54.02 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.196 -0.668 . . . . 0.27 109.196 -177.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.761 ' HG3' HG12 ' B' ' 7' ' ' VAL . 17.9 tt0 -89.18 99.22 12.25 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.928 -1.138 . . . . 1.11 107.928 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.497 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.9 mp -89.38 135.34 26.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.551 -1.204 . . . . 0.12 112.324 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.496 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 4.2 m-85 -128.74 -178.55 4.65 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.174 -1.375 . . . . 1.54 107.582 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 43' ' ' ILE . 3.8 t -148.34 136.77 14.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.659 -0.497 . . . . 0.26 109.659 172.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.417 ' H ' HD11 ' A' ' 44' ' ' ILE . 65.0 m-20 -115.78 116.8 28.66 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.458 -0.571 . . . . 1.74 109.458 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 60.79 -79.37 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 O-C-N 124.231 0.957 . . . . 2.01 111.177 -176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -141.25 20.82 2.25 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.191 -0.913 . . . . 1.67 111.274 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 55.4 pttt -135.63 152.29 51.09 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 112.908 0.707 . . . . 0.75 112.908 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.984 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 40.1 mt -92.26 139.55 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.812 -1.085 . . . . 0.16 110.745 -172.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -126.34 106.0 15.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.074 -0.343 . . . . 0.19 110.074 -175.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.934 HD13 HD13 ' B' ' 45' ' ' LEU . 11.2 mp -97.51 109.48 22.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.843 0.354 . . . . 0.13 110.523 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HB3' ' HE2' ' A' ' 37' ' ' TYR . 31.7 ttmt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.659 -0.867 . . . . 2.11 108.659 173.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.801 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -50.28 142.59 9.84 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 120.834 0.35 . . . . 2.48 111.282 -173.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.532 ' CD1' HG11 ' B' ' 7' ' ' VAL . 52.7 t80 -59.86 148.07 36.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.905 -0.588 . . . . 3.33 109.68 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 11.6 tppt? -66.91 113.31 12.65 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.643 -0.708 . . . . 1.88 109.474 -175.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -79.79 19.56 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.764 2.309 . . . . 1.22 112.179 -172.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.11 95.36 5.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.286 -0.87 . . . . 2.14 109.895 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 21.4 ptp -149.14 143.55 26.05 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.561 -1.199 . . . . 3.15 108.367 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.595 -0.717 . . . . 3.35 110.85 -175.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.2 ttp . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 121.068 0.461 . . . . 3.6 110.107 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.547 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 11.4 ttpp -136.91 -104.25 0.2 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.689 -0.856 . . . . 2.04 108.689 171.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.536 ' HB3' ' O ' ' A' ' 38' ' ' VAL . 91.2 p -82.03 131.51 35.25 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.563 0.697 . . . . 1.17 109.406 174.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.532 ' HB ' ' HB ' ' B' ' 6' ' ' ILE . 3.1 p -93.88 -36.77 12.06 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.312 -0.858 . . . . 0.28 110.563 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 68.78 38.01 84.91 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 108.954 -1.658 . . . . 0.29 108.954 -170.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -111.82 124.8 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.925 -1.138 . . . . 0.2 109.689 -167.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.761 HG12 ' HG3' ' A' ' 35' ' ' GLU . 1.4 m -94.18 146.41 6.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.07 -0.652 . . . . 0.2 110.833 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.603 ' HG3' ' HD3' ' B' ' 19' ' ' PRO . 10.4 mmt180 -138.21 153.53 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 1.94 110.305 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -79.67 148.66 31.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.983 -0.553 . . . . 1.37 109.843 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.947 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 13.2 t -91.71 15.84 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.603 0.716 . . . . 0.22 110.635 -174.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 7.4 t70 70.17 -148.43 0.1 Allowed 'General case' 0 CA--C 1.523 -0.086 0 CA-C-N 115.289 -0.869 . . . . 1.17 110.002 173.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.451 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -121.11 -41.16 2.55 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.531 -0.915 . . . . 2.09 108.531 175.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.77 -10.54 59.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.563 -1.199 . . . . 0.49 111.473 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.52 5.48 36.64 Favored Glycine 0 CA--C 1.497 -1.081 0 C-N-CA 120.643 -0.789 . . . . 0.17 111.982 172.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.744 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 11.3 ptp180 -101.02 118.55 37.23 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 121.079 0.466 . . . . 1.72 111.232 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.84 129.47 37.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.783 -0.821 . . . . 0.17 108.783 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 15' ' ' ARG . 4.0 t -76.0 85.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.932 -0.707 . . . . 0.14 109.361 -176.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.48 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.3 tt -70.03 120.8 80.28 Favored Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-N 114.892 -1.049 . . . . 0.16 109.412 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.603 ' HD3' ' HG3' ' B' ' 8' ' ' ARG . 73.6 Cg_exo -52.56 142.37 49.45 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.493 2.129 . . . . 0.19 113.197 -175.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.467 ' HA ' ' HG3' ' B' ' 23' ' ' ARG . 2.3 pp -57.39 -27.46 28.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 CA-C-N 115.517 -0.765 . . . . 0.43 109.988 177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' B' ' 21' ' ' GLU . 3.5 mt-10 -65.89 -47.26 75.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.159 -0.928 . . . . 1.27 110.391 -175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.733 ' O ' HD22 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -66.42 -45.31 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 120.546 -0.462 . . . . 0.52 110.799 178.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.809 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.4 ppt_? -69.36 -15.79 63.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.567 0.699 . . . . 1.2 109.699 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -80.93 -24.01 38.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.949 -1.023 . . . . 2.11 109.298 172.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 57.0 m -71.62 -42.41 67.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.713 -0.676 . . . . 0.51 110.399 175.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.733 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.8 OUTLIER -87.79 -16.1 35.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.142 -0.481 . . . . 0.59 111.841 -178.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 6.14 79.83 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.086 -0.578 . . . . 0.52 112.984 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.809 HG13 ' HB2' ' B' ' 23' ' ' ARG . 39.8 pt -78.34 -153.45 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 122.321 0.248 . . . . 0.73 110.372 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.44 -105.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 113.585 0.958 . . . . 0.92 113.585 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.865 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 9.4 pt-20 -154.7 -39.34 0.09 Allowed 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.094 -1.817 . . . . 1.5 106.094 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.5 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 7.4 mmpt? -75.1 -6.53 50.0 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 113.527 -1.669 . . . . 0.46 108.967 172.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.586 ' CG ' ' HB ' ' B' ' 28' ' ' ILE . 0.5 OUTLIER -77.6 168.65 19.63 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.072 -0.967 . . . . 2.05 109.492 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.404 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -120.43 142.44 49.23 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.495 -0.928 . . . . 0.25 108.495 176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.819 HD13 HD23 ' B' ' 45' ' ' LEU . 33.7 mt -119.93 125.73 49.16 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.773 -0.825 . . . . 0.33 108.773 -176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.756 ' HG3' HG12 ' A' ' 7' ' ' VAL . 29.2 tt0 -88.77 100.36 13.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.072 -1.085 . . . . 1.29 108.072 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.428 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.19 134.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.729 -1.123 . . . . 0.14 112.694 -172.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.468 ' CD1' ' HA2' ' A' ' 5' ' ' GLY . 16.9 m-85 -124.29 -179.14 4.33 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.01 -1.45 . . . . 1.59 107.804 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' B' ' 43' ' ' ILE . 9.5 t -148.93 134.48 11.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.67 -0.493 . . . . 0.19 109.67 173.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.91 94.01 4.73 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.391 -0.368 . . . . 1.71 110.683 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 67.04 -13.31 0.2 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.23 -1.35 . . . . 2.08 113.975 164.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -179.91 -15.46 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.393 -0.367 . . . . 2.39 111.548 -168.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 50.1 pttt -137.84 156.12 48.27 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 119.251 -0.98 . . . . 0.83 113.381 -172.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.912 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 39.1 mt -92.38 139.65 17.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.596 -1.184 . . . . 0.47 110.445 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.428 HD13 ' C ' ' B' ' 43' ' ' ILE . 0.1 OUTLIER -127.01 104.11 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 110.215 -0.291 . . . . 0.18 110.215 -175.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.984 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.12 108.59 20.06 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.081 0.467 . . . . 0.13 110.331 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -114.74 127.23 55.63 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.229 -1.026 . . . . 1.98 108.229 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.761 ' HA ' HD23 ' B' ' 34' ' ' LEU . 14.6 ptpt -46.07 139.04 4.74 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.456 0.472 . . . . 2.2 110.697 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.536 ' CD1' HG11 ' A' ' 7' ' ' VAL . 55.1 t80 -61.3 143.27 55.97 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.847 -0.427 . . . . 3.32 109.847 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.49 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 16.9 tppt? -67.31 116.0 32.07 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.178 -0.675 . . . . 2.21 109.178 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.49 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 82.9 Cg_endo -81.08 22.62 0.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.519 2.146 . . . . 1.25 111.915 -172.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.57 85.48 3.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.476 -0.784 . . . . 2.26 110.221 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 17.3 ptp -140.85 110.79 6.53 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.976 -1.011 . . . . 3.37 109.111 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 24.8 p . . . . . 0 C--N 1.314 -0.948 0 CA-C-N 115.663 -0.699 . . . . 3.04 110.713 -174.306 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mmm . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.344 -0.613 . . . . 2.99 109.344 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.795 ' HG2' ' H ' ' A' ' 3' ' ' SER . 17.6 tttt 63.22 -151.08 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.676 -0.49 . . . . 1.86 109.676 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.795 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 35.3 t -56.43 146.5 24.27 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.685 0.755 . . . . 1.15 110.836 175.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.76 ' HB ' HD13 ' A' ' 6' ' ' ILE . 21.9 p -118.84 -27.26 5.84 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 114.615 -1.175 . . . . 0.26 110.481 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.54 44.38 92.98 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.788 -1.325 . . . . 0.36 109.788 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.76 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -115.3 126.02 72.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.463 -0.868 . . . . 0.19 109.992 -170.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.4 m -92.79 146.13 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.107 -0.637 . . . . 0.22 110.382 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' NE ' ' HG3' ' A' ' 19' ' ' PRO . 31.3 mmt180 -137.84 154.93 49.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.118 -0.492 . . . . 1.6 109.929 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 6.7 mmpt? -80.62 154.42 27.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.249 -0.432 . . . . 1.09 109.933 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.867 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.7 t -91.06 16.83 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.792 0.806 . . . . 0.25 110.228 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 26.2 t70 66.94 -133.34 0.14 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.412 -0.813 . . . . 1.32 109.584 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.463 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -131.19 -37.13 1.27 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.253 0.549 . . . . 2.06 110.438 177.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 13' ' ' LEU . 3.8 mm? -87.09 6.26 33.55 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.177 -0.465 . . . . 0.45 111.529 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.42 18.14 31.74 Favored Glycine 0 CA--C 1.496 -1.114 0 C-N-CA 121.056 -0.592 . . . . 0.19 112.15 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' B' ' 17' ' ' VAL . 10.1 ptt180 -106.12 120.13 41.02 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.849 0.357 . . . . 1.58 111.234 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.767 HG12 HG12 ' B' ' 16' ' ' VAL . 9.6 p -82.96 126.75 40.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.191 -1.04 . . . . 0.17 108.191 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' B' ' 15' ' ' ARG . 21.5 t -75.41 85.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 119.891 -0.724 . . . . 0.19 109.154 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.456 HD12 HD13 ' B' ' 43' ' ' ILE . 1.2 tt -69.79 124.46 90.66 Favored Pre-proline 0 N--CA 1.437 -1.11 0 CA-C-N 115.063 -0.971 . . . . 0.2 108.967 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HG3' ' NE ' ' A' ' 8' ' ' ARG . 50.9 Cg_exo -54.13 145.15 55.2 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.239 1.959 . . . . 0.22 112.965 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.31 -32.15 44.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.458 -0.792 . . . . 0.51 109.946 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.0 pt-20 -70.43 -34.38 72.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.697 -1.138 . . . . 1.33 110.771 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.75 ' O ' HD22 ' A' ' 26' ' ' LEU . 6.0 mp -74.17 -44.63 52.74 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.269 -0.573 . . . . 0.34 110.542 177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.706 ' HB2' HG13 ' A' ' 28' ' ' ILE . 2.2 ppt_? -70.12 -12.91 61.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.538 0.685 . . . . 1.38 109.407 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.1 ttt180 -82.74 -27.07 31.34 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.894 -1.048 . . . . 1.94 109.431 171.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 96.7 m -69.68 -42.8 73.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.36 -0.836 . . . . 0.48 109.681 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.15 -18.58 45.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.202 -0.666 . . . . 0.58 109.202 177.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.16 14.69 81.99 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.286 -0.87 . . . . 0.42 112.202 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.706 HG13 ' HB2' ' A' ' 23' ' ' ARG . 46.5 pt -83.11 -153.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.645 -0.502 . . . . 0.7 109.645 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.504 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -162.47 -168.61 1.88 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.403 -0.362 . . . . 0.31 110.036 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.942 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -82.93 -30.81 28.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.645 0.736 . . . . 2.0 109.798 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.624 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 11.8 mmpt? -77.04 -6.26 52.03 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.578 -0.737 . . . . 0.67 109.918 175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.7 OUTLIER -84.48 162.73 19.8 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.916 -0.584 . . . . 1.65 110.829 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.554 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -107.69 157.45 18.09 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.576 -0.738 . . . . 0.26 109.511 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.817 HD13 HD23 ' A' ' 45' ' ' LEU . 52.1 mt -129.93 130.5 45.2 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.516 -0.92 . . . . 0.27 108.516 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.653 ' HG3' HG12 ' B' ' 7' ' ' VAL . 19.9 tt0 -88.82 96.24 10.61 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.486 -0.931 . . . . 1.11 108.486 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.412 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -89.78 137.19 21.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.0 -1.0 . . . . 0.12 112.942 -171.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.412 ' C ' HG12 ' A' ' 44' ' ' ILE . 7.2 m-85 -130.8 -177.99 4.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.201 -1.363 . . . . 1.54 107.916 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 43' ' ' ILE . 12.8 t -147.25 130.52 8.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.436 0.636 . . . . 0.26 111.029 174.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.457 ' H ' HD11 ' A' ' 44' ' ' ILE . 31.7 t70 -115.16 121.93 44.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.784 -0.643 . . . . 1.74 109.527 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 t70 67.87 -73.82 0.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 O-C-N 124.177 0.923 . . . . 2.01 110.784 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.5 17.88 0.4 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.176 -0.92 . . . . 1.67 110.281 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -133.06 157.06 46.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.372 0.606 . . . . 0.75 112.32 -174.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.922 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.1 mt -92.88 139.77 17.47 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 114.832 -1.076 . . . . 0.16 111.652 -166.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.457 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -124.0 104.36 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.149 -0.478 . . . . 0.19 109.775 -178.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.899 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -95.86 107.68 19.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.481 0.658 . . . . 0.13 110.488 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -97.93 159.0 15.21 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.142 -1.429 . . . . 2.11 107.142 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD23 ' A' ' 34' ' ' LEU . 3.9 ptpp? -74.17 145.18 44.44 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.134 -1.061 . . . . 2.48 108.134 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -59.83 143.98 49.77 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.02 -0.363 . . . . 3.33 110.02 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 20.0 mmmt -68.92 115.44 31.29 Favored Pre-proline 0 N--CA 1.442 -0.826 0 CA-C-O 121.148 0.499 . . . . 1.88 110.415 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.47 62.6 7.34 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 122.883 2.389 . . . . 1.22 111.065 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -73.04 94.43 1.89 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.785 -1.098 . . . . 2.14 110.914 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.2 ptm -120.3 121.02 37.74 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.391 -0.822 . . . . 3.15 109.085 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.25 1.122 0 CA-C-O 118.645 -0.693 . . . . 3.35 110.309 -177.142 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mmm . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.897 -0.409 . . . . 3.6 109.897 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.624 ' HG2' ' H ' ' B' ' 3' ' ' SER . 27.5 ttpt 62.93 -148.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.447 -0.575 . . . . 2.04 109.447 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.624 ' H ' ' HG2' ' B' ' 2' ' ' LYS . 3.5 m -50.76 138.1 19.1 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 121.495 0.664 . . . . 1.17 111.551 175.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.425 ' HB ' HD13 ' B' ' 6' ' ' ILE . 17.0 p -110.64 -30.38 7.63 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 114.895 -1.048 . . . . 0.28 109.936 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.4 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 67.97 44.44 78.38 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.662 -1.375 . . . . 0.29 109.662 -173.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.425 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -118.28 125.98 74.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.099 -1.05 . . . . 0.2 109.826 -167.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.728 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 m -93.88 142.43 13.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.035 -0.666 . . . . 0.2 110.831 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 71.8 mmt-85 -134.36 155.15 50.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.472 -0.331 . . . . 1.94 110.957 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.554 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 7.6 mmpt? -80.7 152.59 28.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.772 -0.649 . . . . 1.37 110.003 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.942 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.7 t -94.36 19.35 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.687 0.756 . . . . 0.22 110.743 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 14.3 t70 64.69 -145.14 0.25 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.604 -0.725 . . . . 1.17 109.692 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.502 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -116.92 -43.06 2.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.482 0.658 . . . . 2.09 109.716 176.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.94 -15.07 61.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.967 -1.015 . . . . 0.49 111.197 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.46 13.64 11.5 Favored Glycine 0 C--O 1.216 -1.013 0 C-N-CA 120.751 -0.738 . . . . 0.17 111.716 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.716 ' HB3' HG22 ' A' ' 17' ' ' VAL . 3.8 ptt180 -99.78 121.69 41.65 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-O 120.836 0.351 . . . . 1.72 111.389 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.767 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.31 126.81 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 N-CA-C 108.128 -1.064 . . . . 0.17 108.128 178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 15' ' ' ARG . 21.4 t -76.07 84.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.58 -0.848 . . . . 0.14 109.314 -177.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.472 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.5 tt -69.28 122.08 84.23 Favored Pre-proline 0 N--CA 1.436 -1.16 0 CA-C-N 114.743 -1.117 . . . . 0.16 109.15 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.426 ' HB2' ' CD1' ' B' ' 22' ' ' LEU . 69.8 Cg_exo -51.58 139.25 47.72 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.194 1.929 . . . . 0.19 113.224 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.502 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -53.18 -29.71 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.862 . . . . 0.43 110.831 177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 1.8 mt-10 -67.18 -41.15 86.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.069 -0.969 . . . . 1.27 110.334 -176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.714 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.5 mp -70.9 -42.65 69.66 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.851 -0.613 . . . . 0.52 110.855 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.699 ' HB2' HG13 ' B' ' 28' ' ' ILE . 5.9 ppt_? -67.79 -22.7 65.17 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.659 -0.867 . . . . 1.2 108.659 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -71.4 -31.64 67.5 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.748 -1.115 . . . . 2.11 108.504 174.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 96.8 m -70.52 -38.4 74.25 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.813 -1.085 . . . . 0.51 110.795 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.714 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -84.29 -20.14 32.63 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.482 -0.487 . . . . 0.59 110.706 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.74 8.12 67.9 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.034 -0.603 . . . . 0.52 112.061 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.699 HG13 ' HB2' ' B' ' 23' ' ' ARG . 44.0 pt -88.81 -157.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.987 0.422 . . . . 0.73 110.181 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.649 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -164.69 -177.28 4.69 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.795 -0.639 . . . . 0.92 109.838 -176.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.867 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -69.22 -34.8 75.41 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.567 0.699 . . . . 1.5 110.676 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.646 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.1 mmpt? -79.13 -5.38 54.02 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.528 -0.76 . . . . 0.46 109.951 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.615 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 1.8 m-20 -86.89 160.39 18.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.478 -0.783 . . . . 2.05 111.306 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.485 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -108.03 155.86 19.89 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.525 -0.762 . . . . 0.25 109.521 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.811 HD13 HD23 ' B' ' 45' ' ' LEU . 26.2 mt -130.15 129.15 43.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.101 -1.074 . . . . 0.33 108.101 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.678 ' HG3' HG12 ' A' ' 7' ' ' VAL . 23.9 tt0 -88.75 99.62 12.49 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 108.626 -0.879 . . . . 1.29 108.626 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mp -90.16 138.06 20.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.541 -1.208 . . . . 0.14 112.775 -171.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.502 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 11.6 m-85 -130.18 -177.6 4.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.325 -1.307 . . . . 1.59 108.156 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.596 ' H ' ' CB ' ' A' ' 3' ' ' SER . 9.9 t -145.63 135.98 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.024 0.44 . . . . 0.19 110.271 172.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.454 ' N ' HD11 ' B' ' 44' ' ' ILE . 15.4 t70 -117.33 115.03 24.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.478 -0.783 . . . . 1.71 109.473 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 24.5 t0 69.73 -69.47 0.17 Allowed 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 124.347 1.03 . . . . 2.08 110.569 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -158.81 20.82 0.21 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.135 -0.939 . . . . 2.39 110.207 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 44.1 pttt -133.67 156.85 47.17 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 121.195 0.521 . . . . 0.83 112.035 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 22.7 mt -93.17 139.31 18.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.283 -0.872 . . . . 0.47 111.393 -170.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.454 HD11 ' N ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -124.11 104.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.078 -0.51 . . . . 0.18 109.885 -177.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.922 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 10.8 mp -94.64 108.42 20.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.134 0.493 . . . . 0.13 110.644 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 35' ' ' GLU . 34.3 ttpt -101.22 157.08 17.04 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.39 -1.337 . . . . 1.98 107.39 171.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.598 ' HA ' HD23 ' B' ' 34' ' ' LEU . 17.5 ptpt -65.79 148.98 50.9 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.601 -0.888 . . . . 2.2 108.601 172.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.83 144.79 56.24 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.031 -0.729 . . . . 3.32 109.031 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt -68.3 115.21 26.99 Favored Pre-proline 0 CA--C 1.505 -0.78 0 CA-C-O 121.515 0.674 . . . . 2.21 109.954 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -83.85 55.34 4.76 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.943 2.429 . . . . 1.25 111.448 -173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -69.62 105.44 2.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.876 -1.056 . . . . 2.26 110.919 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 23.0 ptm -124.1 112.26 16.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.468 -0.787 . . . . 3.37 109.602 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.773 -0.632 . . . . 3.04 111.019 -177.747 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.885 0.374 . . . . 2.99 111.204 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.644 ' HA ' HG21 ' A' ' 25' ' ' THR . 20.9 tttt 64.68 -151.01 0.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.095 -0.957 . . . . 1.86 110.833 175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.644 ' H ' ' HG2' ' A' ' 2' ' ' LYS . 4.0 t -55.61 145.43 23.45 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.389 0.614 . . . . 1.15 109.99 175.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.889 ' HB ' HD13 ' A' ' 6' ' ' ILE . 41.2 p -135.77 -34.51 0.82 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.042 -0.981 . . . . 0.26 111.035 -174.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.56 24.89 71.5 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 109.591 -1.403 . . . . 0.36 109.591 -174.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.889 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.3 mp -89.97 125.73 42.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 114.062 -1.069 . . . . 0.19 110.061 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.802 HG12 ' HG3' ' B' ' 35' ' ' GLU . 1.0 OUTLIER -95.15 147.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.019 -0.673 . . . . 0.22 110.471 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -141.25 157.23 45.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.196 -0.456 . . . . 1.6 110.416 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.502 ' CE ' ' HB2' ' B' ' 33' ' ' ALA . 9.4 mmpt? -80.33 158.03 26.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.689 -0.687 . . . . 1.09 110.18 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.94 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.2 t -97.2 18.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.763 0.792 . . . . 0.25 110.392 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 15' ' ' ARG . 1.1 t70 66.35 -135.62 0.16 Allowed 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.357 1.075 . . . . 1.32 110.472 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -130.25 -47.96 1.09 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.314 -1.766 . . . . 2.06 108.455 177.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 13' ' ' LEU . 3.4 mm? -67.04 -22.05 65.89 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.245 -1.343 . . . . 0.45 110.55 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.11 14.33 7.84 Favored Glycine 0 CA--C 1.499 -0.968 0 C-N-CA 120.898 -0.668 . . . . 0.19 111.55 175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.696 ' HB3' HG22 ' B' ' 17' ' ' VAL . 18.3 ptt180 -100.83 120.24 39.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.176 0.513 . . . . 1.58 111.617 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.784 HG11 HD21 ' B' ' 45' ' ' LEU . 7.8 p -84.07 128.15 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 N-CA-C 108.372 -0.973 . . . . 0.17 108.372 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG22 ' HB3' ' B' ' 15' ' ' ARG . 13.8 t -76.53 84.44 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.685 -0.806 . . . . 0.19 109.442 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.461 HD12 HD13 ' B' ' 43' ' ' ILE . 0.9 OUTLIER -67.07 124.63 89.33 Favored Pre-proline 0 N--CA 1.436 -1.165 0 CA-C-N 114.86 -1.064 . . . . 0.2 109.293 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HG2' HD13 ' A' ' 22' ' ' LEU . 50.8 Cg_exo -55.91 139.45 84.38 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.333 2.022 . . . . 0.22 113.329 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.664 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.2 pp -50.52 -35.91 13.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.697 -1.138 . . . . 0.51 111.107 176.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HG3' HD12 ' A' ' 22' ' ' LEU . 3.6 pt-20 -69.91 -36.21 75.2 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.817 -1.083 . . . . 1.33 110.727 -174.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.728 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -72.58 -43.73 62.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.827 -0.624 . . . . 0.34 110.921 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.664 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -67.26 -20.92 65.73 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.656 -0.868 . . . . 1.38 108.656 178.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.53 -24.87 41.91 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.703 -1.135 . . . . 1.94 109.57 175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 2' ' ' LYS . 97.5 m -70.67 -42.25 70.98 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.37 -0.832 . . . . 0.48 109.895 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.07 -19.7 39.7 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.58 109.28 178.023 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.57 17.8 78.52 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.244 -0.889 . . . . 0.42 112.126 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.867 HD13 HD21 ' A' ' 34' ' ' LEU . 44.2 pt -81.1 -156.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.283 -0.636 . . . . 0.7 109.283 173.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.515 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -161.68 176.5 10.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.31 111.243 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.798 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 10.0 pt-20 -65.21 -41.05 94.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.313 -0.858 . . . . 2.0 110.852 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.693 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 7.4 mmpt? -76.39 -1.44 26.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.52 -0.764 . . . . 0.67 109.785 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -85.55 176.16 8.38 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.902 -0.59 . . . . 1.65 109.898 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' B' ' 8' ' ' ARG . . . -126.84 145.33 50.69 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.558 -0.905 . . . . 0.26 108.558 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.867 HD21 HD13 ' A' ' 28' ' ' ILE . 84.5 mt -123.51 130.61 52.94 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.501 -0.926 . . . . 0.27 108.501 -177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.653 ' HG3' HG12 ' B' ' 7' ' ' VAL . 24.4 tt0 -88.6 101.32 13.85 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.705 -1.221 . . . . 1.11 107.705 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.433 HG13 ' HG ' ' A' ' 45' ' ' LEU . 2.7 mp -88.91 135.11 26.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 114.576 -1.193 . . . . 0.12 112.254 -172.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.5 ' HB3' ' OG ' ' B' ' 3' ' ' SER . 4.6 m-85 -127.06 -179.55 4.91 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.397 -1.274 . . . . 1.54 107.979 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.59 HG22 ' HA ' ' A' ' 43' ' ' ILE . 9.7 t -147.3 136.96 16.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.196 0.522 . . . . 0.26 110.101 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 36.3 t70 -119.82 118.83 31.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.641 -0.709 . . . . 1.74 109.098 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 64.83 -83.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.734 0.646 . . . . 2.01 110.576 -172.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -143.97 18.15 1.78 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.007 -0.997 . . . . 1.67 109.915 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 16.0 pttm -125.82 151.44 46.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 120.085 -0.646 . . . . 0.75 112.345 -176.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.89 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 17.6 mt -92.37 138.82 19.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.653 -1.158 . . . . 0.16 110.715 -171.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.446 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -125.55 103.11 11.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.639 -0.504 . . . . 0.19 109.639 -177.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.949 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -92.12 109.15 20.51 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.001 0.429 . . . . 0.13 110.424 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 35' ' ' GLU . 39.8 ttmt -107.15 159.62 16.19 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.035 -1.469 . . . . 2.11 107.035 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.743 ' HA ' HD23 ' A' ' 34' ' ' LEU . 8.4 ptpp? -66.59 150.75 48.55 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.622 -0.881 . . . . 2.48 108.622 175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 29.5 p90 -60.16 159.44 9.67 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.901 -0.407 . . . . 3.33 109.901 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 8.8 tppt? -69.01 111.86 9.78 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.655 -0.498 . . . . 1.88 109.655 -177.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.98 13.61 2.31 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.438 2.092 . . . . 1.22 112.339 -173.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -77.48 108.31 10.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.565 -0.743 . . . . 2.14 110.384 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 65.8 mtm -114.25 130.04 56.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.417 -0.811 . . . . 3.15 109.041 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.306 -0.854 . . . . 3.35 110.355 -176.859 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 110.198 -0.297 . . . . 3.6 110.198 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.858 ' HG2' ' H ' ' B' ' 3' ' ' SER . 25.1 ttpt 66.01 -155.37 0.26 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 123.528 0.517 . . . . 2.04 109.769 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.858 ' H ' ' HG2' ' B' ' 2' ' ' LYS . 2.4 t -55.18 154.55 5.64 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.004 0.907 . . . . 1.17 110.013 172.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.894 ' HB ' HD13 ' B' ' 6' ' ' ILE . 25.0 p -137.86 -39.66 0.56 Allowed 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.312 -1.313 . . . . 0.28 110.175 -175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 74.88 28.55 62.52 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.342 -1.503 . . . . 0.29 109.342 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.894 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -96.7 125.54 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 113.939 -1.131 . . . . 0.2 110.049 -173.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -93.59 148.15 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.235 -0.586 . . . . 0.2 111.084 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' HD3' ' B' ' 8' ' ' ARG . 16.4 mmt85 -140.15 154.87 47.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.966 -0.561 . . . . 1.94 110.593 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -79.99 153.71 28.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.085 -0.507 . . . . 1.37 110.082 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.798 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.6 t -93.0 18.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.764 0.792 . . . . 0.22 110.527 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 23.1 t70 67.18 -136.74 0.12 Allowed 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.525 -0.761 . . . . 1.17 110.163 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.547 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -131.56 -42.33 1.04 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.76 -1.109 . . . . 2.09 109.11 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.423 HD22 ' N ' ' B' ' 13' ' ' LEU . 3.8 mm? -73.86 -24.21 59.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.038 -0.983 . . . . 0.49 110.077 179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 121.05 16.38 4.42 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 120.716 -0.754 . . . . 0.17 111.751 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.675 ' HB3' HG22 ' A' ' 17' ' ' VAL . 10.6 ptt180 -103.73 121.41 42.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.939 0.4 . . . . 1.72 111.897 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.727 HG12 HG12 ' A' ' 16' ' ' VAL . 9.0 p -83.75 128.15 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 N-CA-C 108.335 -0.987 . . . . 0.17 108.335 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 15' ' ' ARG . 17.3 t -76.41 84.75 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 119.673 -0.811 . . . . 0.14 109.507 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.491 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.3 tt -71.08 121.6 84.62 Favored Pre-proline 0 N--CA 1.439 -0.992 0 CA-C-N 115.145 -0.934 . . . . 0.16 109.209 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' B' ' 22' ' ' LEU . 70.9 Cg_exo -51.68 140.18 46.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.256 1.971 . . . . 0.19 113.131 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.6 pp -57.36 -26.59 26.52 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 115.67 -0.696 . . . . 0.43 110.13 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.5 mt-10 -66.77 -41.68 87.32 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.671 -1.149 . . . . 1.27 110.448 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.728 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -71.88 -43.55 65.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.675 -0.693 . . . . 0.52 110.34 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.673 ' HB2' HG13 ' B' ' 28' ' ' ILE . 6.4 ppt_? -69.3 -17.95 63.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.355 0.598 . . . . 1.2 109.71 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.0 OUTLIER -75.99 -31.11 58.82 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.817 -1.083 . . . . 2.11 108.474 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 93.2 m -68.09 -41.14 82.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.144 -0.935 . . . . 0.51 110.516 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.728 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 -19.69 35.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.59 111.266 -177.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.93 7.15 78.34 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.886 -0.673 . . . . 0.52 112.261 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.881 HD13 HD21 ' B' ' 34' ' ' LEU . 42.9 pt -80.9 -156.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.948 0.404 . . . . 0.73 110.294 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' B' ' 23' ' ' ARG . . . -160.25 179.35 8.76 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.369 -0.378 . . . . 0.92 110.97 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.94 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 5.4 pt-20 -74.98 -37.48 61.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.585 0.707 . . . . 1.5 109.986 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.643 ' HE2' ' HA ' ' B' ' 31' ' ' LYS . 10.9 mmpt? -77.14 -2.62 35.26 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.732 -0.667 . . . . 0.46 109.884 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.448 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 20.7 t70 -84.12 -178.83 7.07 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.104 -0.498 . . . . 2.05 109.852 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.502 ' HB2' ' CE ' ' A' ' 9' ' ' LYS . . . -133.86 144.28 48.83 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.044 -0.724 . . . . 0.25 109.044 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.881 HD21 HD13 ' B' ' 28' ' ' ILE . 92.0 mt -124.67 130.08 51.73 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.755 -0.831 . . . . 0.33 108.755 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.802 ' HG3' HG12 ' A' ' 7' ' ' VAL . 21.7 tt0 -88.33 103.12 15.53 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 107.62 -1.252 . . . . 1.29 107.62 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.446 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 2.8 mp -90.35 133.82 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.273 -1.331 . . . . 0.14 112.588 -173.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.511 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 5.4 m-85 -126.39 -178.99 4.54 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.716 -1.129 . . . . 1.59 108.152 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 3' ' ' SER . 8.7 t -147.58 137.91 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.399 0.618 . . . . 0.19 110.871 173.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.438 ' HB3' ' HE2' ' B' ' 42' ' ' LYS . 23.9 t70 -119.46 121.98 40.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.604 -0.726 . . . . 1.71 109.156 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 -87.11 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.798 0.686 . . . . 2.08 110.354 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.43 29.81 1.26 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.262 -0.881 . . . . 2.39 109.649 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 34.7 pttt -127.66 149.45 50.19 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.432 0.634 . . . . 0.83 111.479 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.883 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 25.5 mt -92.8 139.26 18.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.995 -1.002 . . . . 0.47 110.943 -170.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.405 HG12 ' C ' ' B' ' 37' ' ' TYR . 0.1 OUTLIER -125.07 103.69 12.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.856 -0.424 . . . . 0.18 109.856 -176.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.949 HD13 HD13 ' A' ' 45' ' ' LEU . 10.9 mp -95.24 109.57 21.67 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.852 0.358 . . . . 0.13 110.494 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' B' ' 35' ' ' GLU . 29.3 ttmt -112.38 153.87 26.64 Favored 'General case' 0 C--O 1.211 -0.955 0 N-CA-C 108.047 -1.094 . . . . 1.98 108.047 171.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.784 ' HA ' HD23 ' B' ' 34' ' ' LEU . 9.9 ptpp? -58.49 144.08 43.56 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.501 -0.555 . . . . 2.2 109.501 177.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.489 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 3.4 p90 -60.74 151.58 29.1 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.605 -0.517 . . . . 3.32 109.605 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' B' ' 49' ' ' LYS . 0.1 OUTLIER -67.26 112.11 9.12 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.863 0.363 . . . . 2.21 110.128 -174.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.408 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 74.3 Cg_endo -85.44 23.46 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.098 2.532 . . . . 1.25 112.43 -173.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -77.54 90.28 3.9 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.678 -0.692 . . . . 2.26 110.455 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 64.4 mtt -93.19 116.76 29.33 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.698 -0.683 . . . . 3.37 109.365 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 38.5 p . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.585 -0.721 . . . . 3.04 110.571 -179.783 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mmt . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 120.904 0.383 . . . . 2.99 111.555 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HE2' ' OG ' ' A' ' 3' ' ' SER . 17.8 ptmt -151.92 -140.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.794 -0.817 . . . . 1.86 108.794 172.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.573 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 98.7 p -45.53 132.2 8.3 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.679 0.752 . . . . 1.15 111.81 176.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.729 ' HB ' HD13 ' A' ' 6' ' ' ILE . 15.2 p -100.06 -34.04 10.23 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.824 -1.08 . . . . 0.26 110.344 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.67 43.68 51.11 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 109.222 -1.551 . . . . 0.36 109.222 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.729 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -117.12 126.45 74.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.808 -1.196 . . . . 0.19 109.55 -168.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG12 ' HA ' ' B' ' 35' ' ' GLU . 3.0 m -97.68 148.58 5.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 C-N-CA 120.118 -0.633 . . . . 0.22 111.13 -176.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 59.9 mmt-85 -137.41 150.3 47.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.721 -0.672 . . . . 1.6 110.515 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 0.4 OUTLIER -77.84 148.62 34.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.096 -0.502 . . . . 1.09 110.059 172.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.941 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 35.8 t -86.8 20.98 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.847 0.832 . . . . 0.25 110.86 -177.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 38.0 t70 68.51 -124.45 0.15 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 115.524 -0.762 . . . . 1.32 110.191 172.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.468 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 2.0 pt-20 -142.9 -40.4 0.32 Allowed 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.472 0.653 . . . . 2.06 109.986 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' CD2' ' HG3' ' A' ' 12' ' ' GLU . 4.0 mm? -85.47 -0.66 55.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.507 -0.769 . . . . 0.45 110.395 178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 10' ' ' VAL . . . 98.61 16.19 32.25 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-N 115.741 -0.663 . . . . 0.19 112.407 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.874 ' HG3' ' HG3' ' B' ' 15' ' ' ARG . 11.0 ptt180 -100.71 116.95 33.83 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.83 0.348 . . . . 1.58 110.831 176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.69 HG12 HG12 ' B' ' 16' ' ' VAL . 4.5 p -82.82 127.44 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.765 -1.198 . . . . 0.17 107.765 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.743 HG22 ' HB3' ' B' ' 15' ' ' ARG . 19.3 t -76.5 84.73 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.809 -0.756 . . . . 0.19 109.31 -176.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' CD1' HD13 ' B' ' 43' ' ' ILE . 2.8 tt -67.95 120.57 74.97 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-N 115.22 -0.9 . . . . 0.2 109.117 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -50.4 142.84 28.79 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.455 2.103 . . . . 0.22 113.617 -173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -55.59 -29.79 25.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.066 -0.97 . . . . 0.51 110.02 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 2.2 mt-10 -67.92 -44.23 77.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.33 110.145 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.76 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.1 mp -70.42 -43.01 70.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.38 -0.827 . . . . 0.34 110.653 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.63 ' HB2' HG13 ' A' ' 28' ' ' ILE . 7.0 ppt_? -70.92 -13.75 62.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.525 0.678 . . . . 1.38 109.181 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -82.74 -25.49 32.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.998 -1.001 . . . . 1.94 109.375 171.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 88.4 m -70.43 -42.82 71.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.48 109.815 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.76 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.3 OUTLIER -85.54 -15.22 43.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.618 -0.719 . . . . 0.58 109.781 177.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 17.42 78.78 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.351 -0.841 . . . . 0.42 112.493 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.821 HD13 HD21 ' A' ' 34' ' ' LEU . 37.6 pt -77.85 -160.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.86 -0.422 . . . . 0.7 109.86 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.04 177.37 10.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.853 0.359 . . . . 0.31 110.77 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.924 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 11.8 pt-20 -69.4 -40.74 77.16 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.805 0.812 . . . . 2.0 110.665 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.73 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -78.92 0.86 25.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.244 -0.889 . . . . 0.67 109.481 -179.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -89.14 165.95 14.15 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.4 -0.818 . . . . 1.65 109.779 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.9 154.99 24.38 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.071 -0.715 . . . . 0.26 109.071 176.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.821 HD21 HD13 ' A' ' 28' ' ' ILE . 80.6 mt -129.95 130.97 45.75 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.671 -1.233 . . . . 0.27 107.671 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.594 ' HA ' HG12 ' B' ' 7' ' ' VAL . 29.3 tt0 -89.38 98.01 11.52 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.991 -0.744 . . . . 1.11 108.991 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.506 ' CG1' ' HG ' ' A' ' 45' ' ' LEU . 3.0 mp -89.57 135.4 26.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.968 -1.014 . . . . 0.12 112.611 -171.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' B' ' 3' ' ' SER . 83.4 m-85 -130.65 -177.75 4.49 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.16 -1.382 . . . . 1.54 107.877 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 43' ' ' ILE . 7.7 t -146.8 131.56 11.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.39 0.614 . . . . 0.26 110.309 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.455 ' H ' HD11 ' A' ' 44' ' ' ILE . 15.2 t70 -104.95 104.61 14.4 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.914 -1.039 . . . . 1.74 109.278 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 t70 68.47 -71.16 0.12 Allowed 'General case' 0 C--N 1.331 -0.236 0 O-C-N 124.165 0.916 . . . . 2.01 111.106 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -143.47 8.45 1.56 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.536 -0.756 . . . . 1.67 111.238 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 17.4 pttm -129.05 155.98 44.56 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 112.947 0.721 . . . . 0.75 112.947 -175.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.883 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 18.4 mt -93.03 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.118 -0.946 . . . . 0.16 111.147 -170.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.479 HD13 ' C ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -125.73 104.84 13.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.686 -0.487 . . . . 0.19 109.686 -178.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.918 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 10.9 mp -93.48 107.46 19.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.462 0.649 . . . . 0.13 110.321 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 26.0 ttmt -95.37 157.24 15.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.701 -1.222 . . . . 2.11 107.701 173.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.715 ' HA ' HD23 ' A' ' 34' ' ' LEU . 9.6 ptpp? -73.51 138.92 45.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.589 -0.893 . . . . 2.48 108.589 171.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HD1' HG11 ' B' ' 7' ' ' VAL . 72.5 t80 -60.89 143.99 53.82 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.227 -0.657 . . . . 3.33 109.227 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.666 ' HD3' ' HD2' ' A' ' 50' ' ' PRO . 17.8 tppt? -67.18 112.07 8.93 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.621 -0.881 . . . . 1.88 108.621 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.666 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 89.4 Cg_endo -75.97 34.19 0.42 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.914 2.409 . . . . 1.22 112.555 -171.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' LYS . 16.9 t30 -87.73 90.15 8.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.037 -0.983 . . . . 2.14 109.413 174.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.2 mtm -91.78 113.76 26.12 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.755 -0.657 . . . . 3.15 109.796 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.591 -0.719 . . . . 3.35 110.353 -176.152 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.956 0.407 . . . . 3.6 110.021 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.542 ' HE2' ' OG ' ' B' ' 3' ' ' SER . 15.5 ptmt -170.76 -144.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.817 -0.809 . . . . 2.04 108.817 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.563 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 57.2 p -51.04 132.63 27.68 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.698 0.761 . . . . 1.17 110.842 173.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.735 ' HB ' HD13 ' B' ' 6' ' ' ILE . 7.4 p -99.74 -32.6 10.96 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.109 -0.951 . . . . 0.28 110.195 177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.81 40.44 64.45 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.321 -1.511 . . . . 0.29 109.321 -172.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.735 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.1 mp -114.02 125.68 71.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 113.952 -1.124 . . . . 0.2 109.709 -168.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.67 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.0 m -95.06 146.34 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.392 -0.523 . . . . 0.2 110.883 -177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 64.9 mmt-85 -136.42 155.29 50.22 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.799 -0.637 . . . . 1.94 110.416 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.462 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.2 mmpp? -78.5 153.86 30.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.039 -0.528 . . . . 1.37 109.773 174.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.924 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 25.3 t -92.38 19.04 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.815 0.817 . . . . 0.22 110.35 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' B' ' 15' ' ' ARG . 9.7 t70 65.43 -139.12 0.2 Allowed 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 115.29 -0.868 . . . . 1.17 109.33 174.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.491 ' HA ' ' OE2' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -121.71 -47.57 2.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.46 0.648 . . . . 2.09 110.528 176.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.09 -16.62 61.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.753 -0.658 . . . . 0.49 111.392 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 119.13 12.16 7.11 Favored Glycine 0 CA--C 1.499 -0.952 0 C-N-CA 120.755 -0.736 . . . . 0.17 111.428 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.874 ' HG3' ' HG3' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -98.19 121.48 40.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 120.98 0.419 . . . . 1.72 111.466 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.69 HG12 HG12 ' A' ' 16' ' ' VAL . 9.9 p -83.27 125.78 40.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.028 -1.101 . . . . 0.17 108.028 177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' A' ' 15' ' ' ARG . 11.0 t -76.33 84.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 119.583 -0.847 . . . . 0.14 109.042 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.447 ' CD1' HD13 ' A' ' 43' ' ' ILE . 2.4 tt -68.58 120.78 77.78 Favored Pre-proline 0 N--CA 1.437 -1.082 0 CA-C-N 115.268 -0.878 . . . . 0.16 108.985 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 18' ' ' ILE . 78.2 Cg_exo -51.79 142.97 40.14 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.267 1.978 . . . . 0.19 113.172 -173.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.4 pp -58.02 -26.69 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.69 -0.687 . . . . 0.43 109.787 179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 2.4 mt-10 -67.18 -44.15 80.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.599 -1.182 . . . . 1.27 110.228 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.762 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.0 mp -70.74 -42.99 69.77 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.677 -0.692 . . . . 0.52 110.612 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.626 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.2 ppt_? -66.28 -23.8 66.46 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.703 -0.851 . . . . 1.2 108.703 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.7 OUTLIER -73.62 -29.32 62.29 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.557 -1.201 . . . . 2.11 109.151 175.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 92.9 m -70.14 -42.03 73.09 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.754 -1.112 . . . . 0.51 110.917 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.762 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -86.15 -16.6 37.38 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.684 -0.406 . . . . 0.59 110.951 -178.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.37 29.23 50.4 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.787 -0.72 . . . . 0.52 111.937 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.729 HD13 HD21 ' B' ' 34' ' ' LEU . 30.4 pt -100.18 -163.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.818 -0.438 . . . . 0.73 109.818 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.501 ' H ' ' HB3' ' B' ' 32' ' ' ASP . . . -161.81 175.02 12.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.453 -0.34 . . . . 0.92 110.653 -176.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.941 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 11.2 pt-20 -65.82 -37.68 86.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.708 0.766 . . . . 1.5 110.499 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.544 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -82.5 1.4 37.94 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.325 -0.852 . . . . 0.46 109.458 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.501 ' HB3' ' H ' ' B' ' 29' ' ' ALA . 33.7 t70 -93.84 148.62 21.96 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.77 -0.65 . . . . 2.05 110.173 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.514 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -94.99 151.88 18.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.334 0.588 . . . . 0.25 109.972 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.729 HD21 HD13 ' B' ' 28' ' ' ILE . 82.0 mt -123.4 133.38 54.09 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.658 -1.238 . . . . 0.33 107.658 178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.766 ' HA ' HG12 ' A' ' 7' ' ' VAL . 27.3 tt0 -90.42 95.83 10.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.684 -0.858 . . . . 1.29 108.684 -175.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.468 ' CG1' ' HG ' ' B' ' 45' ' ' LEU . 3.1 mp -89.96 134.12 29.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 122.183 0.992 . . . . 0.14 112.763 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.57 ' HE1' ' HG2' ' B' ' 35' ' ' GLU . 25.4 m-85 -132.09 -178.35 4.86 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.969 -1.469 . . . . 1.59 107.758 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.636 HG22 ' HA ' ' B' ' 43' ' ' ILE . 8.8 t -147.51 132.24 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.19 110.142 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.464 ' H ' HD11 ' B' ' 44' ' ' ILE . 21.8 t70 -107.98 107.79 18.64 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.499 -0.773 . . . . 1.71 109.486 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 10.6 t70 64.47 -69.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.802 1.314 . . . . 2.08 112.08 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.84 12.07 1.43 Allowed 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.62 -0.718 . . . . 2.39 111.427 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 0.0 OUTLIER -137.77 157.05 47.25 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 119.232 -0.987 . . . . 0.83 112.503 -178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.918 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 20.0 mt -92.5 139.29 18.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.768 -1.105 . . . . 0.47 111.308 -168.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.464 HD11 ' H ' ' B' ' 39' ' ' ASP . 0.1 OUTLIER -123.2 104.86 14.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 0.18 109.418 -178.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.903 HD13 HD13 ' A' ' 45' ' ' LEU . 10.7 mp -94.04 107.5 19.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.387 0.613 . . . . 0.13 109.891 177.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' B' ' 35' ' ' GLU . 30.7 ttmt -94.53 159.03 15.27 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.427 -1.323 . . . . 1.98 107.427 172.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.609 ' HA ' HD23 ' B' ' 34' ' ' LEU . 18.1 ptpt -75.49 141.49 43.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.783 -1.191 . . . . 2.2 107.783 171.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.563 ' CD1' HG11 ' A' ' 7' ' ' VAL . 26.1 t80 -67.3 144.19 56.02 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 119.726 -0.79 . . . . 3.32 109.364 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.512 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 15.7 tppt? -66.81 121.19 76.54 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 108.507 -0.923 . . . . 2.21 108.507 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.512 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 97.9 Cg_endo -80.42 22.3 0.78 Allowed 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.342 2.028 . . . . 1.25 112.118 -170.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -71.51 87.03 0.88 Allowed 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.41 -0.814 . . . . 2.26 109.429 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 44.6 mtm -92.31 109.18 20.55 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.366 -0.834 . . . . 3.37 109.013 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.885 -0.579 . . . . 3.04 110.324 -178.892 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptp . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.379 0.609 . . . . 2.99 110.375 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -170.72 -157.82 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.256 -0.883 . . . . 1.86 109.479 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.558 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 31.2 t -51.58 142.85 13.41 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.726 0.774 . . . . 1.15 111.196 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.866 ' HB ' HD13 ' A' ' 6' ' ' ILE . 23.2 p -119.84 -28.68 5.16 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-N 114.893 -1.048 . . . . 0.26 111.052 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.05 39.91 93.05 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.012 -1.235 . . . . 0.36 110.012 -171.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.866 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.1 mp -106.77 125.96 62.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.518 -0.841 . . . . 0.19 109.653 -171.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.709 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.5 m -94.95 144.6 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 119.968 -0.693 . . . . 0.22 111.121 -176.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 36.7 mmt180 -135.38 158.64 43.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.938 -0.573 . . . . 1.6 110.142 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.28 155.77 28.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.06 -0.518 . . . . 1.09 110.527 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.831 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.9 t -89.28 15.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.973 0.892 . . . . 0.25 109.587 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 73.85 -108.34 0.03 OUTLIER 'General case' 0 CA--C 1.527 0.071 0 CA-C-N 114.879 -1.055 . . . . 1.32 111.008 168.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.97 -42.17 0.07 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.649 0.738 . . . . 2.06 109.961 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 13' ' ' LEU . 4.0 mm? -84.38 -5.14 59.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.569 -0.741 . . . . 0.45 110.392 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.81 18.39 10.76 Favored Glycine 0 CA--C 1.498 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.19 111.831 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.766 ' HB3' HG22 ' B' ' 17' ' ' VAL . 2.5 ptt180 -105.69 121.62 44.38 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.869 0.366 . . . . 1.58 111.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.842 HG11 HD21 ' B' ' 45' ' ' LEU . 8.0 p -83.44 126.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.453 -0.943 . . . . 0.17 108.453 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.778 HG22 ' HB3' ' B' ' 15' ' ' ARG . 18.7 t -76.49 85.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 119.873 -0.731 . . . . 0.19 109.515 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.8 tt -67.09 121.63 79.11 Favored Pre-proline 0 N--CA 1.438 -1.027 0 CA-C-N 115.096 -0.956 . . . . 0.2 109.458 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HG2' HD13 ' A' ' 22' ' ' LEU . 53.0 Cg_exo -54.79 146.16 57.14 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 122.462 2.108 . . . . 0.22 113.883 -172.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.567 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 2.4 pp -53.56 -35.62 26.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.91 -1.041 . . . . 0.51 110.88 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.562 ' HG3' HD12 ' A' ' 22' ' ' LEU . 3.7 pt-20 -72.65 -37.31 68.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.757 -1.111 . . . . 1.33 110.546 -174.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.748 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -72.94 -42.2 63.7 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.698 -0.683 . . . . 0.34 110.377 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.567 ' HG3' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -69.37 -17.34 63.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.05 -0.722 . . . . 1.38 109.05 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.457 ' O ' ' HD3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -79.27 -29.78 42.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.3 -0.864 . . . . 1.94 108.685 172.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 99.8 m -66.85 -41.71 86.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.317 -0.856 . . . . 0.48 110.111 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.748 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.12 -19.18 40.6 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.056 -0.72 . . . . 0.58 109.056 176.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.37 20.09 79.03 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.942 -1.026 . . . . 0.42 112.148 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.854 HD13 HD21 ' A' ' 34' ' ' LEU . 42.2 pt -83.67 -158.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.074 0.464 . . . . 0.7 110.085 174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.593 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -160.84 -179.38 7.52 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.787 -0.642 . . . . 0.31 110.093 -178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.748 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 7.8 pt-20 -72.09 -28.37 63.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.473 0.654 . . . . 2.0 110.723 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.666 ' HG2' ' HG3' ' A' ' 30' ' ' GLU . 1.7 mmpt? -89.66 2.4 54.81 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.312 -0.858 . . . . 0.67 109.02 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.593 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -84.15 163.71 19.61 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.395 -0.821 . . . . 1.65 110.461 179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB2' ' CE ' ' B' ' 9' ' ' LYS . . . -111.58 155.19 23.72 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.818 -0.808 . . . . 0.26 108.818 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.854 HD21 HD13 ' A' ' 28' ' ' ILE . 96.0 mt -130.05 131.43 45.8 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.269 -1.011 . . . . 0.27 108.269 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.629 ' HG3' HG12 ' B' ' 7' ' ' VAL . 40.1 tt0 -89.43 101.19 13.86 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 108.335 -0.987 . . . . 1.11 108.335 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.541 HG13 ' HG ' ' A' ' 45' ' ' LEU . 3.3 mp -90.15 133.92 30.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.998 0.904 . . . . 0.12 112.776 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.412 ' C ' HG12 ' A' ' 44' ' ' ILE . 22.4 m-85 -124.73 -179.01 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.238 -1.346 . . . . 1.54 108.061 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.0 t -147.16 127.35 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.731 0.777 . . . . 0.26 111.609 177.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.535 ' H ' HD11 ' A' ' 44' ' ' ILE . 21.5 t70 -99.09 103.86 15.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.051 -0.977 . . . . 1.74 108.851 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 -74.23 0.06 Allowed 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 124.091 0.87 . . . . 2.01 110.981 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' O ' HD12 ' B' ' 26' ' ' LEU . 13.3 pt-20 -149.51 22.46 0.92 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.538 -0.756 . . . . 1.67 110.571 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 14.5 pttm -126.66 157.14 39.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-O 121.341 0.591 . . . . 0.75 112.124 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.929 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 8.4 mt -93.25 139.9 17.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.238 -0.892 . . . . 0.16 111.456 -167.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.535 HD11 ' H ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -128.24 104.01 10.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.795 -0.446 . . . . 0.19 109.795 -179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.964 ' HB2' ' HB ' ' B' ' 43' ' ' ILE . 11.1 mp -94.33 108.58 20.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.532 0.682 . . . . 0.13 110.773 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' A' ' 35' ' ' GLU . 32.3 ttpt -98.61 155.44 17.3 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.326 -1.361 . . . . 2.11 107.326 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.739 ' HA ' HD23 ' A' ' 34' ' ' LEU . 18.9 ptpt -71.64 142.72 49.91 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.978 -0.749 . . . . 2.48 108.978 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' HD1' HG11 ' B' ' 7' ' ' VAL . 47.6 t80 -63.94 144.47 57.05 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.602 -0.439 . . . . 3.33 109.923 177.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 17.7 tppt? -68.34 112.37 10.77 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.231 -0.895 . . . . 1.88 109.521 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 2.9 Cg_endo -82.37 20.57 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.925 2.417 . . . . 1.22 111.565 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -87.94 107.93 18.95 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.235 -0.893 . . . . 2.14 110.108 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -131.64 122.07 25.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.598 -0.519 . . . . 3.15 109.598 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.591 -0.718 . . . . 3.35 110.784 -175.74 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.426 ' HB2' HG23 ' B' ' 25' ' ' THR . 19.5 ptp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.105 0.478 . . . . 3.6 110.934 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.31 -159.03 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.552 -0.749 . . . . 2.04 109.562 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.434 ' HA ' ' N ' ' A' ' 38' ' ' VAL . 13.9 m -51.44 131.06 28.69 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.475 0.655 . . . . 1.17 111.428 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.573 ' HB ' HD13 ' B' ' 6' ' ' ILE . 12.4 p -102.28 -30.71 10.92 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.139 -0.937 . . . . 0.28 110.146 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.55 40.37 96.06 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.49 -1.444 . . . . 0.29 109.49 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.0 OUTLIER -110.61 126.1 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.354 -0.923 . . . . 0.2 109.906 -168.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.5 m -94.88 143.09 12.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.106 -0.638 . . . . 0.2 111.163 -175.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.813 ' HE ' ' HG3' ' B' ' 19' ' ' PRO . 34.3 mmt180 -133.54 157.4 45.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.915 -0.584 . . . . 1.94 109.773 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.527 ' CE ' ' HB2' ' A' ' 33' ' ' ALA . 1.5 mmpp? -79.32 157.24 27.73 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.39 0.431 . . . . 1.37 110.168 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.748 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 21.3 t -89.8 12.2 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.158 0.98 . . . . 0.22 109.437 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.405 ' CG ' ' HG2' ' B' ' 12' ' ' GLU . 38.8 t70 74.77 -101.67 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 114.435 -1.257 . . . . 1.17 111.62 168.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.449 ' HG3' ' CD2' ' B' ' 13' ' ' LEU . 2.3 pt-20 -160.12 -45.87 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.279 0.561 . . . . 2.09 110.082 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.449 ' CD2' ' HG3' ' B' ' 12' ' ' GLU . 4.2 mm? -84.05 -3.25 57.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.085 -0.507 . . . . 0.49 110.909 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.01 14.24 17.56 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 120.77 -0.728 . . . . 0.17 111.612 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.778 ' HB3' HG22 ' A' ' 17' ' ' VAL . 8.3 ptt180 -103.13 121.19 42.11 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.721 0.296 . . . . 1.72 111.568 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.752 HG11 HD21 ' A' ' 45' ' ' LEU . 9.7 p -83.21 125.68 40.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.346 -0.983 . . . . 0.17 108.346 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 15' ' ' ARG . 16.3 t -76.12 85.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 119.948 -0.701 . . . . 0.14 109.402 -177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.439 HD12 HD13 ' A' ' 43' ' ' ILE . 1.9 tt -67.62 121.26 78.47 Favored Pre-proline 0 N--CA 1.436 -1.127 0 CA-C-N 115.101 -0.954 . . . . 0.16 109.242 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.813 ' HG3' ' HE ' ' B' ' 8' ' ' ARG . 51.2 Cg_exo -54.84 147.36 51.49 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.504 2.136 . . . . 0.19 113.293 -172.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.465 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 2.2 pp -59.34 -30.65 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 CA-C-O 121.212 0.53 . . . . 0.43 109.973 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.11 -42.97 93.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.688 -1.142 . . . . 1.27 109.99 -177.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.704 ' O ' HD22 ' B' ' 26' ' ' LEU . 7.1 mp -73.02 -42.62 63.01 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.262 -0.881 . . . . 0.52 110.756 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.668 ' HB2' HG13 ' B' ' 28' ' ' ILE . 7.0 ppt_? -68.68 -20.04 64.42 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.933 -0.766 . . . . 1.2 108.933 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.569 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.9 OUTLIER -73.78 -30.94 63.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.483 -1.235 . . . . 2.11 109.073 172.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 99.6 m -72.1 -39.03 69.21 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.67 -1.15 . . . . 0.51 110.846 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.704 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.1 OUTLIER -83.89 -19.28 35.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.996 0.427 . . . . 0.59 110.471 -178.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.18 25.47 55.04 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.983 -0.627 . . . . 0.52 112.079 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.85 HD13 HD21 ' B' ' 34' ' ' LEU . 39.6 pt -99.72 -159.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.799 0.333 . . . . 0.73 110.142 178.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.517 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -165.3 179.34 6.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.882 -0.599 . . . . 0.92 109.657 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.831 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 13.1 pt-20 -69.47 -32.77 71.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.481 0.658 . . . . 1.5 111.044 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.551 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 0.0 OUTLIER -85.48 1.64 48.01 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.521 -0.763 . . . . 0.46 109.368 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.517 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 0.7 OUTLIER -88.16 160.92 17.55 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.44 -0.8 . . . . 2.05 111.054 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 8' ' ' ARG . . . -108.75 155.84 20.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.475 -0.784 . . . . 0.25 109.233 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.85 HD21 HD13 ' B' ' 28' ' ' ILE . 98.8 mt -130.72 130.66 44.09 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.319 -0.993 . . . . 0.33 108.319 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.654 ' HG3' HG12 ' A' ' 7' ' ' VAL . 40.1 tt0 -89.25 100.3 13.11 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 107.994 -1.113 . . . . 1.29 107.994 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -89.24 135.89 24.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.021 -0.99 . . . . 0.14 112.477 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.501 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 41.0 m-85 -127.06 -178.89 4.59 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.154 -1.385 . . . . 1.59 108.134 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.558 ' H ' ' CB ' ' A' ' 3' ' ' SER . 24.0 t -145.29 134.68 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.274 0.559 . . . . 0.19 110.846 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.524 ' N ' HD11 ' B' ' 44' ' ' ILE . 6.2 t70 -100.1 97.05 7.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.246 -0.888 . . . . 1.71 108.788 176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.09 -65.56 0.15 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 124.232 0.958 . . . . 2.08 111.398 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.523 ' O ' HD12 ' A' ' 26' ' ' LEU . 6.7 pt-20 -150.35 19.39 0.84 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.494 -0.776 . . . . 2.39 111.205 -176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 52.8 pttt -130.18 156.96 43.71 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.256 -0.578 . . . . 0.83 111.865 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.964 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 9.7 mt -92.7 139.77 17.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 115.534 -0.757 . . . . 0.47 111.414 -169.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.524 HD11 ' N ' ' B' ' 39' ' ' ASP . 0.0 OUTLIER -128.08 104.64 12.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.684 -0.487 . . . . 0.18 109.684 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.929 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.2 mp -92.81 107.94 19.6 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.343 0.592 . . . . 0.13 110.689 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.552 ' HE2' ' HB3' ' B' ' 35' ' ' GLU . 30.4 ttpt -96.76 156.46 16.34 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.283 -1.377 . . . . 1.98 107.283 171.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.705 ' HA ' HD23 ' B' ' 34' ' ' LEU . 16.4 ptpt -74.93 139.5 43.09 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.734 -0.839 . . . . 2.2 108.734 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -64.64 136.87 57.43 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.296 -0.561 . . . . 3.32 109.794 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.446 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 15.6 tppt? -68.56 114.18 20.43 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.876 -0.602 . . . . 2.21 109.52 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.446 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 69.1 Cg_endo -82.52 21.4 0.99 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.784 2.323 . . . . 1.25 111.994 -174.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.31 99.15 5.42 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.286 -0.87 . . . . 2.26 110.081 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 23.4 ptt? -123.76 111.19 15.85 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.752 -0.658 . . . . 3.37 109.806 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.675 -0.693 . . . . 3.04 110.635 -179.231 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.202 -0.296 . . . . 2.99 110.202 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HE2' ' OG ' ' A' ' 3' ' ' SER . 17.1 ptmt -160.92 -123.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.238 -0.653 . . . . 1.86 109.238 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.556 ' CB ' ' H ' ' B' ' 38' ' ' VAL . 92.7 p -55.6 127.8 31.55 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.224 0.535 . . . . 1.15 110.85 173.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.819 ' HB ' HD13 ' A' ' 6' ' ' ILE . 17.7 p -100.06 -35.92 9.53 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.438 -0.801 . . . . 0.26 110.353 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.06 50.13 11.36 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.254 -1.539 . . . . 0.36 109.254 -172.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.819 HD13 ' HB ' ' A' ' 4' ' ' THR . 1.2 mp -122.42 125.32 72.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.447 -0.876 . . . . 0.19 109.83 -168.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.767 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 1.9 m -95.99 145.53 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.94 -0.704 . . . . 0.22 110.861 -178.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.634 ' HE ' ' HG3' ' A' ' 19' ' ' PRO . 38.7 mmt180 -135.97 157.95 45.58 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.109 -0.496 . . . . 1.6 110.442 177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.564 ' HE3' ' HB2' ' B' ' 33' ' ' ALA . 2.5 mmpp? -78.63 153.61 30.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.266 -0.424 . . . . 1.09 110.489 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.809 ' HB ' ' HA ' ' B' ' 30' ' ' GLU . 21.3 t -94.21 13.47 2.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.683 -0.69 . . . . 0.25 110.566 -177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 11.1 t70 66.2 -149.65 0.21 Allowed 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.692 -0.686 . . . . 1.32 110.037 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -115.75 -44.27 2.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.81 0.814 . . . . 2.06 109.061 176.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.57 -16.87 62.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.691 -1.141 . . . . 0.45 111.033 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.69 4.34 26.5 Favored Glycine 0 CA--C 1.495 -1.157 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.467 172.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.783 ' HD2' ' HG3' ' B' ' 15' ' ' ARG . 1.9 ptt85 -95.55 121.31 37.1 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 120.329 -0.548 . . . . 1.58 111.465 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 9.7 p -82.55 131.05 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 N-CA-C 108.261 -1.014 . . . . 0.17 108.261 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' B' ' 15' ' ' ARG . 14.6 t -75.58 85.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 119.666 -0.814 . . . . 0.19 109.304 -176.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.9 tt -71.28 116.96 52.41 Favored Pre-proline 0 N--CA 1.429 -1.481 0 N-CA-C 108.047 -1.094 . . . . 0.2 108.047 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.634 ' HG3' ' HE ' ' A' ' 8' ' ' ARG . 52.2 Cg_exo -54.17 138.82 72.05 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.046 1.831 . . . . 0.22 112.689 -171.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.437 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 2.6 pp -56.2 -29.64 28.02 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.692 -0.685 . . . . 0.51 109.945 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -66.34 -44.34 83.57 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.599 -1.182 . . . . 1.33 110.011 -177.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.796 ' O ' HD22 ' A' ' 26' ' ' LEU . 5.5 mp -69.89 -45.13 68.33 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.384 -0.826 . . . . 0.34 110.708 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -70.18 -13.8 62.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.694 0.759 . . . . 1.38 108.966 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 21' ' ' GLU . 2.0 tmt_? -82.83 -28.38 30.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.981 -1.009 . . . . 1.94 109.397 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 92.0 m -69.72 -43.91 71.39 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.199 -0.909 . . . . 0.48 109.919 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -80.38 -15.47 56.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.622 -0.717 . . . . 0.58 109.2 177.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.65 21.8 76.29 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.051 -0.977 . . . . 0.42 112.475 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.795 HD13 HD21 ' A' ' 34' ' ' LEU . 35.1 pt -83.91 -158.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 108.853 -0.795 . . . . 0.7 108.853 171.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . . . -154.8 179.34 9.18 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 110.136 -0.32 . . . . 0.31 110.136 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.979 ' HA ' ' HB ' ' B' ' 10' ' ' VAL . 1.5 pm0 -77.97 -32.74 51.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.951 0.881 . . . . 2.0 109.126 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.642 ' HA ' ' HE2' ' A' ' 31' ' ' LYS . 11.3 mmpt? -79.52 -0.01 31.55 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.026 -0.988 . . . . 0.67 109.712 177.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -87.53 172.96 9.38 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.601 -0.727 . . . . 1.65 109.16 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB2' ' HE3' ' B' ' 9' ' ' LYS . . . -120.95 150.92 40.36 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.613 -0.884 . . . . 0.26 108.613 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.838 HD13 HD23 ' A' ' 45' ' ' LEU . 53.5 mt -124.75 128.97 49.59 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.73 -0.841 . . . . 0.27 108.73 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.559 ' HA ' HG12 ' B' ' 7' ' ' VAL . 61.0 tt0 -88.57 97.65 11.22 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 108.952 -0.759 . . . . 1.11 108.952 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.7 mp -89.89 135.98 24.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.739 -1.119 . . . . 0.12 112.792 -173.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 1.053 ' HE2' ' HE2' ' A' ' 46' ' ' LYS . 78.5 m-85 -130.11 -177.62 4.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.126 -1.397 . . . . 1.54 107.57 174.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 43' ' ' ILE . 6.4 t -147.05 133.03 12.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.391 0.615 . . . . 0.26 110.798 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.551 ' HB3' ' HG2' ' A' ' 42' ' ' LYS . 22.4 t70 -99.09 95.18 6.94 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.079 -0.964 . . . . 1.74 108.671 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 65.52 -66.05 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.361 1.038 . . . . 2.01 112.181 -178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -137.08 -3.2 2.0 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.674 -0.694 . . . . 1.67 111.254 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 36.4 pttt -118.56 150.21 40.03 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.744 -0.783 . . . . 0.75 112.086 -173.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.959 ' HB ' ' HB2' ' B' ' 45' ' ' LEU . 19.4 mt -92.64 138.73 19.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.003 -0.999 . . . . 0.16 110.814 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -124.32 106.76 17.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.489 -0.56 . . . . 0.19 109.489 -177.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.888 HD13 HD13 ' B' ' 45' ' ' LEU . 10.9 mp -98.59 112.04 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.933 0.397 . . . . 0.13 110.657 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.053 ' HE2' ' HE2' ' A' ' 37' ' ' TYR . 38.0 mtmt -100.65 165.68 11.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 107.864 -1.162 . . . . 2.11 107.864 167.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HA ' HD23 ' A' ' 34' ' ' LEU . 19.0 ptpt -72.19 143.76 48.77 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.042 -1.466 . . . . 2.48 107.042 165.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 5.3 p90 -62.28 149.95 40.56 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.023 -0.671 . . . . 3.33 111.026 -173.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HD3' ' HD2' ' A' ' 50' ' ' PRO . 17.7 tppt? -66.85 111.93 8.29 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 115.819 -0.628 . . . . 1.88 110.352 -176.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 95.4 Cg_endo -83.61 35.99 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.784 2.323 . . . . 1.22 111.594 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -73.61 87.84 1.66 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.646 -0.706 . . . . 2.14 110.212 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.1 ptm -93.58 111.54 23.24 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.349 -0.841 . . . . 3.15 109.372 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.249 1.037 0 CA-C-N 116.107 -0.497 . . . . 3.35 110.405 -176.391 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mmm . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.583 -0.154 . . . . 3.6 110.583 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.512 ' HE2' ' OG ' ' B' ' 3' ' ' SER . 13.2 ptmt 42.59 -145.17 0.07 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.207 1.003 . . . . 2.04 113.334 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.602 ' CB ' ' H ' ' A' ' 38' ' ' VAL . 79.1 p -46.99 133.93 10.81 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 114.853 -1.067 . . . . 1.17 112.115 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.796 ' HB ' HD13 ' B' ' 6' ' ' ILE . 16.2 p -104.64 -37.02 7.27 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.842 -1.072 . . . . 0.28 110.253 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 77.1 46.25 10.59 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.394 -1.482 . . . . 0.29 109.394 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.796 HD13 ' HB ' ' B' ' 4' ' ' THR . 1.2 mp -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.221 -0.989 . . . . 0.2 109.945 -167.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.3 m -93.01 149.32 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.197 -0.601 . . . . 0.2 110.582 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 13.3 mmt85 -139.76 156.76 46.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.184 -0.462 . . . . 1.94 110.813 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.544 ' HE3' ' HB2' ' A' ' 33' ' ' ALA . 4.3 mmpp? -77.98 153.91 32.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.892 -0.595 . . . . 1.37 110.153 174.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.979 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 19.5 t -96.12 15.74 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.54 -0.754 . . . . 0.22 110.489 -177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' B' ' 12' ' ' GLU . 13.8 t70 68.19 -146.88 0.13 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.627 -0.715 . . . . 1.17 109.832 175.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.536 ' H ' ' CG ' ' B' ' 11' ' ' ASP . 0.0 OUTLIER -119.52 -44.93 2.54 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.984 0.897 . . . . 2.09 108.682 175.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.69 -28.86 69.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.021 -1.445 . . . . 0.49 110.715 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 123.9 0.14 9.08 Favored Glycine 0 CA--C 1.494 -1.27 0 C-N-CA 120.557 -0.83 . . . . 0.17 111.42 174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.783 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 5.6 ptt180 -92.48 121.41 33.91 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.913 0.387 . . . . 1.72 111.853 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 7.7 p -82.82 128.96 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.131 -1.063 . . . . 0.17 108.131 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.621 ' HA ' ' HA ' ' A' ' 15' ' ' ARG . 10.0 t -75.77 85.32 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 119.556 -0.858 . . . . 0.14 109.089 -176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.489 ' CD1' HD13 ' A' ' 43' ' ' ILE . 3.6 tt -70.19 115.66 36.67 Favored Pre-proline 0 N--CA 1.428 -1.539 0 N-CA-C 108.285 -1.006 . . . . 0.16 108.285 176.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.503 ' HB2' HD13 ' B' ' 22' ' ' LEU . 78.2 Cg_exo -50.09 138.99 35.37 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.304 2.003 . . . . 0.19 112.863 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 pp -54.86 -30.89 23.67 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 CA-C-N 115.684 -0.689 . . . . 0.43 109.977 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 0.7 OUTLIER -65.8 -42.94 90.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.621 -1.172 . . . . 1.27 110.555 -177.045 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.777 ' O ' HD22 ' B' ' 26' ' ' LEU . 6.4 mp -70.5 -46.81 62.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 116.017 -0.538 . . . . 0.52 110.856 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.597 ' HB2' HG13 ' B' ' 28' ' ' ILE . 4.5 ppt_? -69.78 -15.07 63.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.39 0.614 . . . . 1.2 109.635 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 0.8 OUTLIER -76.93 -32.55 57.42 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.057 -0.974 . . . . 2.11 109.041 170.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.1 m -72.0 -39.86 68.94 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.167 -0.924 . . . . 0.51 110.696 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.777 HD22 ' O ' ' B' ' 22' ' ' LEU . 0.2 OUTLIER -82.87 -14.58 54.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.863 -0.608 . . . . 0.59 110.778 -177.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.16 10.3 80.66 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.829 -0.7 . . . . 0.52 112.592 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.702 HD13 HD21 ' B' ' 34' ' ' LEU . 38.0 pt -83.39 -158.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.603 -0.517 . . . . 0.73 109.603 175.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 32' ' ' ASP . . . -158.51 175.17 14.02 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.878 0.371 . . . . 0.92 110.92 -176.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.809 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 7.6 pt-20 -72.41 -40.98 66.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.447 -0.797 . . . . 1.5 109.124 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.55 ' HG2' ' HG3' ' B' ' 30' ' ' GLU . 10.3 mmpt? -80.8 4.26 19.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.39 -0.823 . . . . 0.46 109.616 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.415 ' HB2' ' HB3' ' B' ' 29' ' ' ALA . 17.6 t70 -85.77 -176.11 5.89 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 109.109 -0.7 . . . . 2.05 109.109 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.564 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . . . -135.25 146.17 48.32 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.673 -0.862 . . . . 0.25 108.673 -176.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.857 HD13 HD23 ' B' ' 45' ' ' LEU . 53.0 mt -123.72 127.42 48.13 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.302 -0.629 . . . . 0.33 109.302 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' B' ' 48' ' ' TYR . 27.8 tt0 -87.63 95.89 10.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.263 -1.014 . . . . 1.29 108.263 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' B' ' 44' ' ' ILE . 2.7 mp -89.87 136.62 23.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.543 -1.208 . . . . 0.14 112.783 -173.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.434 ' CE1' ' HG2' ' B' ' 35' ' ' GLU . 77.6 m-85 -134.37 -177.99 4.85 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.083 -1.417 . . . . 1.59 107.4 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' B' ' 43' ' ' ILE . 6.5 t -147.56 135.62 14.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.311 0.577 . . . . 0.19 111.182 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -104.58 105.85 16.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.344 -0.844 . . . . 1.71 109.204 177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 61.15 -75.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 124.269 0.981 . . . . 2.08 111.035 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -141.62 14.99 2.15 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.632 -0.713 . . . . 2.39 111.485 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' B' ' 38' ' ' VAL . 9.7 pttm -124.11 151.53 43.81 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 119.62 -0.832 . . . . 0.83 112.077 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' A' ' 45' ' ' LEU . 4.9 mp -92.54 138.83 19.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.101 -0.954 . . . . 0.47 111.612 -169.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 36' ' ' ILE . 0.1 OUTLIER -121.74 110.62 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.546 -0.539 . . . . 0.18 109.546 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.959 ' HB2' ' HB ' ' A' ' 43' ' ' ILE . 11.0 mp -103.54 109.18 20.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.908 0.385 . . . . 0.13 110.992 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.52 ' HG2' ' HB2' ' A' ' 42' ' ' LYS . 53.4 mtmt -105.66 165.19 11.34 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.665 -1.235 . . . . 1.98 107.665 168.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.458 ' HE2' HG22 ' B' ' 28' ' ' ILE . 16.4 ptpt -68.89 150.97 47.16 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.153 -1.054 . . . . 2.2 108.153 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.631 ' HA ' ' HB2' ' B' ' 35' ' ' GLU . 35.9 p90 -59.3 153.46 18.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.324 -0.25 . . . . 3.32 110.324 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.18 112.28 10.38 Favored Pre-proline 0 N--CA 1.449 -0.505 0 N-CA-C 109.756 -0.461 . . . . 2.21 109.756 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -86.52 18.79 1.5 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.872 2.381 . . . . 1.25 111.637 -175.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -71.9 99.83 2.3 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.045 -0.979 . . . . 2.26 110.57 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 26.7 ptm -99.53 128.03 45.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.994 -1.003 . . . . 3.37 109.047 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.878 -0.582 . . . . 3.04 110.456 -178.058 . . . . . . . . 0 0 . 1 stop_ save_